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1  Abstract 
The formation of mature blood vessels requires recruitment of mural cells (MC) and 
generation of an extracellular matrix in order to stabilize and support the nascent vessel. 
The precise sequence of basement membrane protein expression and function during 
initiation, elongation and stabilization of the angiogenic sprout remains unclear. 
The first project describes a function of astrocytic Fibronectin (FN) in guided 
vessel migration. Integrin-binding is dispensable for fibrilliar FN assembly but mediates 
endothelial  cell  adhesion  in  vivo.  VEGF-A  dependent  migration  of  retinal  vessels 
requires PI3K activity and astrocytic FN possibly functions to retain VEGF protein on 
the astrocytic matrix. 
 
In a second project we discovered endothelial tip cells-specific expression of 
laminin alpha4 (Lama4) and provide first evidence for an influence of laminin α4 on 
endothelial Dll4/Notch signalling in sprouting angiogenesis. Loss of Lama4 leads to 
increased  filopodia  formation,  tip  cell  numbers  and  consequently  increased  vessel 
density, resembling the phenotype of disturbed Dll4/Notch signalling. Loss of Lama4 
leads  to  reduced  Dll4  and  Notch  target  gene  expression,  whereas  gain-of-function 
results in increased Dll4 expression in vitro. Preliminary results suggest that laminin α4 
induced Dll4 expression involves both VEGFR2 and integrin signalling.  
 
The third project addresses the cell-autonomous requirement of heparan sulfate 
(HS) production by MCs during mouse embryonic vascular development. Conditional 
deletion of HS synthesis in MC caused severe vascular defects and embryonic lethality. 
Unexpectedly, distinct regions of vascular growth showed selective requirement for MC 
HS production: whereas MC recruitment in peripheral skin vascularization is severely 
disrupted, MCs during brain angiogenesis appear unaffected. Similarly, PDGF-B and 
TGF-β signalling are impaired in the peripheral vessels, but not in the brain.  
These data suggest that cell-autonomous HS is essential for MC recruitment in 
the skin vasculature, where induction and differentiation of local progenitor cells from 
the mesenchymal cell lineage is mediated by TGF-β signalling. (299 words)    
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3  Abbreviation 
 
AKT/PKB    protein kinase B 
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4  Introduction  
4.1  Vascular development and circulatory system 
Living organisms must have the ability to transport nutrients, gases and waste to and 
from cells. Single-cell organisms exchange and interact with their outside environment 
via  their  cell  surface.  Multicellular  but  primitive-structured  organisms,  such  as  the 
hydra  lack  specialized  organs  like  blood  vessels  and  hearts,  therefore  exchanging 
biological materials through their skin. 
Higher developed organisms have developed a circulatory system to sufficiently 
supply  cells  with  nutrients  and  oxygen  and  to  remove  metabolic  waste  and  carbon 
dioxide. Insects and arthropods evolved an open circulatory system, pumping blood into 
cavities, so called hemocoels with blood, lymph and interstitiual fluids diffusing back to 
the circulatory system between cells. In contrast, vertebrates have a closed circulatory 
system, i.e. blood does not circulate through cavities but is closed at all times within 
vessels of different size and wall thickness.  
In 1628, William Harvey discovered that the heart pumps the blood around the 
body through arteries and that veins return blood to the heart {Carmeliet, 2005 #501}. 
The  vascular  system  of  higher  vertebrates  and  humans  consist  of  two  main  routes, 
including a heart. Firstly, the pulmonary circulation pumping blood to and from the 
heart to lungs to exchange gases in the lungs. And secondly, the systematic circulation 
pumping blood away from the heart out to the body. Both circulatory systems consist of 
a  network  of  arteries,  capillaries,  and  veins.  The  pulmonary  circulation  transports 
oxygen-depleted  blood  away  from  the  heart  (pulmonary  arteries)  to  the  lungs,  and 
returns  oxygenated  blood  back  to  the  heart  (pulmonary  veins).  Arteries  of  the 
systematic circulation pump oxygenated blood away from the heart to provide the rest 
of the body with oxygen and nutrients and deoxygenated blood is returned to the heart 
by veins. 
Artery walls are composed of multiple layers of smooth muscle cells (SMC) and 
elastic  fibres  controlling  vessel  expansion  and  contraction  to  regulate  the  blood 
pressure. Arteries connect to a complex bed of smaller vessels, so called capillaries that 
function in the actual exchange of oxygen/CO2, nutrients and hormones carried by the 
blood to surrounding cells and tissues. The circulatory loop of the vascular system is 
completed via veins, carrying deoxygenated blood from the capillaries to the heart.   
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A network of coronary vessels supplies the heart itself with oxygen and nutrients to 
maintain cardiac muscle function. 
In  addition,  a  secondary  circulatory  system  the  so-called  lymphatic  system 
collects interstitial fluid that transports materials between cells. Because of the blood 
hydrostatic and osmotic pressure, blood plasma continuously leaks from the capillaries 
and  lymph  vessels  return  this  fluid  back  to  the  blood  circulation  {Carmeliet,  2005 
#501}. Lymph flows from small lymphatic capillaries into lymph vessels, connecting to 
the  lymph  nodes,  lymph  organs  or  the  cardiovascular  system  via  the  thoracic  duct 
(Purves 2002).  
The complex networks of blood and lymphatic vessels not only effective nutrient 
supply and fluid homeostasis during physiology but are also required for organ growth 
during development and repair of wounded tissues. 
Given the importance of the vascular system in physiology, it is not surprising 
that vascular dysfunction contributes to many pathologic conditions. The most common 
disabling and fatal complications of the vascular systems are atherosclerotic injuries. 
Arthrosclerosis describes a condition of progressive, narrowing and hardening of the 
arteries that leads to ischemia, cardiovascular infarct or stroke. Ischemia, the lack of 
blood supply to an organ or tissue is caused by constriction or obstruction of blood 
vessels. In a wide variety of pathologies, vascular dysfunction causes tissue ischemia 
followed by new vessel formation. The newly formed vessels are often poorly patterned 
and  leaky  vessel,  leading  to  further  complications.  Cancerous  growth  requires  new 
vessel  formation,  and  dysfunctional  tumour  vessels  and  the  presence  of  lymphatic 
vessels  accelerate  metastatic  spreading  of  tumour  cells.  In  cancer,  metastasis  is  the 
migration and spreading of tumour cells from an original tumour site to other tissues in 
the body via body and lymph. 
 
4.2  Angiogenesis in pathological condition 
Understanding how blood vessels form could lead to great advances in treating vascular 
diseases  such  as  ischemia  by  inducing  vessels  growth  and  stimulating  myocardial 
angiogenesis  (Carmeliet  and  Jain  2000).  However,  the  majority  of  pathological 
conditions are a result of excessive and uncontrolled vessel growth such as cancer and 
diabetic retinopathy. Is there a possibility to interfere with the mechanism of vessel 
formation by targeting the molecular key players to suppress vessel growth?  
Pathological retinal neovascularization in patients with diabetes is a result of the  
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imbalance of pro-angiogenic and anti-angiogenic factors, such as the accumulation of 
vascular endothelial growth factor (VEGF, for detailed description see 4.7 ) leading to 
microvascular retinal changes (Campochiaro 2004). Hyperglycemia impaired insulin 
signalling and adipose-derived adipokines are characteristic features of diabetes playing 
a pivotal role in diabetes-associated microvascular complications (Bakker, Eringa et al. 
2009). Hyperglycemia, an excessive amount of glucose circulating in the blood plasma -
induces pericyte apoptosis and thickening of the basement membrane (BM) leading to 
incompetence of the vascular walls. These damages change the formation of the blood-
retinal  barrier  and  also  make  the  retinal  blood  vessels  become  hyper-permeable, 
eventually leading to retinal micro-hemorrhaging. 
Sima et al. report on the vascular endothelium in artherosclerosis, pointing out 
that the activation of endothelial cells may involve the modulation of permeability and 
of the biosynthesis activity with respect to the  synthesis of BM components (Sima, 
Stancu et al. 2009). 
The  existence  of  tumour-derived  factors  responsible  for  promoting 
neovascularization was postulated 70 years ago (Ide et al., 1939) and tumour growth 
was  proposed  to  be  crucially  dependent  on  the  development  of  neovascular  supply 
(reviewed in (Ferrara and Kerbel 2005)). Judah Folkman hypothesized the inhibition of 
angiogenesis  as  a  concept  for  anti-tumour  therapy  in  1971  (Folkman,  Merler  et  al. 
1971).  Most  investigations  over  the  last  decades  focused  on  finding  inducers  and 
inhibitors as an effective treatment for tumour onset and progression. However, recent 
data  highlight  the  reciprocal  relationship  between  tumour  endothelial  cells  and  its 
surrounding microenvironment. Endothelial cells (EC) play a critical role in defining 
the  local  immune  response  and  provide  support  for  tumour  growth  and  metastasis 
(reviewed in (Nikitenko 2009) and (Aird 2009)). EC origin has been widely discussed 
and  accepted  that  ECs  derive  from  either  pre-existing  vessels  or  from  endothelial 
progenitor  cells  (EPCs).  In  general,  EPCs  are  cells  that  have  the  potential  to 
differentiate into ECs receiving pro-angiogenic stimuli. EPCs are mobilized from the 
bone marrow and/or differentiate from mesenchymal stem cells. 
 Endothelial  cell  progenitors  and  hematopoietic  cells  share  a  common  bone 
marrow  derived  progenitor,  putatively  termed  haemangioblast  (Figure  4.1).  VEGF 
family members stimulate these cells to develop into ECs. The microenvironment of 
various tissues provide the signal for EPC mobilization from original sources (e.g. bone 
marrow  and/  or mesenchymal  stem  cell)  and  the  niche  for  their  differentiation  into 
mature endothelium during embryogenesis or neovascularization of the adult organism  
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under  physiological  and  pathological  conditions.  Likewise  to  vascular  development 
during embryogenesis, the induction of angiogenesis in the tumour is a consequence of 
an  imbalance  between  multiple  inhibitory  and  stimulatory  molecules,  referred  as 
“angiogenic switch”. Pro-and anti-angiogenic stimuli trigger tumour vascularization and 
may  be  provided  and  released  by  tumour  cells,  EC,  stromal  cells,  blood  and 
extracellular matrix (reviewed in (Nikitenko 2009)). 
 
 
 
Figure 4.1 Putative pathway of normal and tumour endothelial cell differentiation 
Normal endothelial cells are derived from progenitor cells (haemangioblast) that can 
give rise to both endothelial and blood cells. Angioblasts can give rise to pericytes and 
smooth-muscle cells, which form the outer walls of most blood vessels, or to 
endothelial precursor cells. These are committed to becoming either vascular ECs 
(“endothelioblasts”, which are then capable of undergoing arterio-venous specification) 
or “lymphangioblasts” (committed to becoming lymphatic endothelium). Lymphatic 
ECs can also trans-differentiate from venous endothelium. “Tumour endothelial cells” 
in “non-endothelial” tumours derive from either normal endothelium or from 
endothelial progenitors that acquire specific properties and express specific markers that 
are not expressed in normal endothelium or tumour endothelial markers (adapted from 
(Nikitenko 2009)).  
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The balance of these factors determines the intensity of the vascular response and varies 
between different types of tumours. A greater vascular density often correlates with 
metastasis and spreading of tumour cells by gaining access to the circulatory system 
(Langley and Fidler 2007). The presence of functional lymphatics around the tumour is 
sufficient  for  lymphatic  metastasis  and  these  tumours  do  not  require  intratumour 
lymphatic for cancer dissemination (Nikitenko 2009). 
 
4.3  Angiogenesis during development 
The vascular system is the first organ that arises during embryonic development. Apart 
from the nutritive function, vessels also provide instructive trophic signals to promote 
organ morphogenesis (Carmeliet 2005). 
Development of the vascular system begins with the aggregation of mesoderm 
derived angioblast precursors in the embryo and the formation of blood islands in the 
visceral yolk sac (Rossant and Howard 2002). A close association between the primitive 
hematopoietic cells and the developing endothelium exists in the yolk sac, suggestive of 
a common precursor, the so-called haemangioblast. Within the embryo itself, the first 
blood vessels form in the absence of haematopoiesis, indicating that these precursors 
are  exclusively  endothelial  precursors  or  angioblast.  The  early  blood  vessels  in  the 
embryo  or  yolk  sac  develop  by  aggregation  of  de  novo  forming  angioblasts  into  a 
primitive  network  of  simple  endothelial  tubes-  a  process  known  as  vasculogenesis 
(Figure 4.2).  
Hierarchical organization and development of a mature vascular system involves 
a complex process of remodelling and refining the initial pattern by endothelial cell 
proliferation  and  sprouting  of  new  vessels  from  existing  ones-  the  process  of 
angiogenesis (Rossant and Howard 2002). The establishment of a highly organized and 
functional vascular network is far more complex than suggested by this frequently used 
division  in  vasculogenesis  and  angiogenesis.  As  vessels  start  to  remodel  into  a 
circulatory vascular system, they undergo localized migration into different parts of the 
body,  regulated  branching  into  capillary  plexus,  proliferation  to  expand  the  vessel 
network as well as vessels regression and pruning (Figure 4.2).  
Depending on their function, ECs need to be specialized, vessel calibre will be 
determined  and  differentiation  of  vessels  into  arteries,  veins,  capillaries  and  lymph 
vessels  takes  place.  Maturation  and  stabilization  of  newly  formed  vessels  is  
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accompanied by the recruitment of mural cells (MC) and the formation of basement 
membrane (BM). 
 
Figure 4.2 Development of a vascular plexus by vasculogenesis and angiogenesis 
Development of the vascular system occurs by vasculogenesis and subsequent 
angiogenesis. Endothelial progenitors assemble and give rise to a primitive vascular 
labyrinth which further expands during angiogenesis; mural cells (MC) are recruited 
and the vascular network remodels in a hierarchical plexus consisting of arteries, veins 
and capillaries (adapted and modified from (Carmeliet 2000)). 
 
Although great efforts were undertaken to understand these processes in more detail 
within the last decades, we still know very little about the spatial and temporal cues that 
leads  to  an  a  functional  mature  vascular  plexus.  Are  these  processes  genetically 
programmed?  What  signalling  pathways  are  involved  in  vascular  patterning?  Are 
angiogenic  processes  coordinated  by  multiple  signalling  pathways  that  interact  and 
interfere with each other? Or is proliferation regulated by one signalling pathway while 
an other directs migration? What determines branching morphogenesis? How is the fine 
balance between stimulatory and inhibitory signals controlled? And how do other cell 
types and matrix components influence vessel formation and patterning?  
Angiogenesis in its simplest description is the expansion of the vascular plexus 
from existing vessels. Expansion and remodelling of the vascular plexus may occur by 
intussusceptive, collateral and guided angiogenesis and these events likely occur under 
different circumstances including the absence or presence of blood flow and external 
stimuli.  Remodelling  of  the  vascular  plexus  by  intussuseptive  growth  involves  the 
enlargement of venules, which sprout or become divided by pillars of periendothelial  
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cells or by transendothelial cell bridges, which  then split into individual capillaries. 
Collateral  growth  denotes  the  expansive  growth  of  pre-existing  vessels,  forming 
collateral bridges between arterial networks (reviewed by (Carmeliet 2000)).  
Guided  angiogenic  sprouting  involves  the  specialization  of  ECs  within  the 
growing  vessels  and  requires  external  stimuli  as  well  as  a  patterned  environment 
(reviewed in (Roca and Adams 2007);(Gerhardt, Golding et al. 2003); (Hellstrom, Phng 
et al. 2007)). 
4.4  The retinal vasculature -a model system to study sprouting 
angiogenesis 
The idea of precise guidance and directional migration during angiogenesis arose from 
observations of filopodia rich leading cells (Marin-Padilla 1995) and analogies to other 
pervasive organ systems such as the axonal guidance by attractive and repulsive forces. 
Axonal guidance requires the formation of growth factor gradients and axon outgrowth 
relies  on  guidance  of  cells  and  subcellular  processes  along  predefined  tracks, 
characteristics that have been implicated during guided angiogenesis.  
Further, the formation of the insect tracheal system shares many signalling pathways 
navigating  sprouting  cells  through  the  tissue  that  may  function  in  vascular 
morphogenesis. Additionally both the tracheal system as wells as axonal guidance share 
structurally  and  functionally  similarities  to  the  vertebrate  vasculature  (reviewed  in 
(Affolter  and  Caussinus  2008)).  Several  cellular  and  molecular  paradigms  in 
Drosophila tracheal system, such as cell migration, competition and rearrangement, as 
well as the elaboration of a complex apical luminal environment might serve related 
roles  in  the  formation  of  other  branched  organs  or  tissues,  such  as  the  retinal 
vasculature. 
VEGF-A controls angiogenic sprouting by guiding filopodial extensions from specialized 
endothelial cells situated at the tip of vascular sprouts that is rather similar to tracheal 
cell  navigating  through  the  developing  embryo.  Further  studies  have  shown  the 
distinction of leading tip cells and the following stalk cells in growing angiogenic sprouts 
that involves notch signalling via the Delta-like 4 (Dll4) ligand. The control of tip cell 
formation in branching tubules such as the tracheal branches, malpighian tubules and 
intersegmental vessels of zebrafish are also linked to Delta-Notch signalling (Affolter 
and Caussinus 2008); (Roca and Adams 2007).  
Each angiogenic sprout is composed of two different endothelial cell (EC) types, see  
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Figure 4.3. The sprouting tip consists of a single, highly polarized EC that extends long 
actin-rich filopodia. This cell is referred to as tip cell (T), whereas the following ECs 
trailing the angiogenic tip cell are referred to as stalk cells (S). Stalk cells line the 
vascular lumen, form firm EC junction and extend comparably less filopodia protrusion. 
Interestingly, the morphological differences of tip and stalk cells are also reflected in 
their function and behaviour. Figure 4.4 summarize the characteristics of endothelial tip 
and stalk cells. 
 
 
Figure 4.3 Angiogenic sprout 
The leading angiogenic sprout consists of two endothelial cell types that differ in their 
cell morphology, behaviour and gene expression. T- tip cell, S- stalk cell 
 
The tip cell is active, expressing a motile and invasive behaviour in order to migrate in 
an avascular tissue and to respond in a polarized manner and by directed migration to 
attractive cues such as growth factor gradients. In contrast, stalk cells are less dynamic 
but highly proliferative to expand vessel growth in diameter and length. In addition, 
endothelial stalk cells are polarized cells with an apical surface orientated towards the 
lumen and a basal surface that is enclosed by BM, indicating that endothelial stalk cell 
primarily contribute to BM formation (Figure 4.4). 
Endothelial tip and stalk cells also differ in their gene expression profile. Tip  
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cells strongly express the following genes but their expression is not exclusive and 
therefore,  can  not  considered  as  truly  unique  tip  cell  markers:  Pdgfb,  Dll4,  Unc5b, 
Vegfr2 and Vegfr3 (Gerhardt, Golding et al. 2003); (Claxton and Fruttiger 2004); (Lu, 
Le Noble et al. 2004); (Tammela, Zarkada et al. 2008). Whereas stalks cells express 
higher levels of Robo4 (Huang, Yu et al. 2009) and Vegfr1. Thus, the endothelial cell 
population is heterogeneous in their morphology, cell behaviour and gene expression 
(quantitatively)  but  should  not  be  mistaken  with  a  stable  cell  fate  or  terminal  cell 
differentiation. 
 
 
 
Figure 4.4 Phenotypic and molecular differences between endothelial tip and stalk 
cells 
Tip  cells  (green)  head  each  vascular  sprout  stimulated  by  an  extracellular  VEGF-A 
gradient (orange). Following endothelial cells (purple) form the lumenized stalk (Phng 
and Gerhardt 2009). 
 
 
Most  observations  described  above  addressing  angiogenesis  on  a  cellular  level  are 
derived  from  the  retinal  vasculature.  Well-defined  patterning  events  as  well  as 
simultaneous vascular sprouting at the periphery and remodelling at the centre, allows 
to  study  different  aspects  of  vessel  formation, maturation  and  gene  expression  in  a 
single preparation. This system, preferably used in our lab, is easily accessible and an 
ideal structure for visualization and high resolution imaging (Gerhardt, Golding et al. 
2003). 
The  cup-like  mouse  retinas  starts  out  as  an  avascular  tissue  in  the  embryo. 
Retinal vascularization begins in the most superficial (or inner) retinal layer at the optic  
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nerve head and radiates outwards from this central point. It reaches the retinal periphery 
during  the  first  week  of  birth  (Gariano  and  Gardner  2005).  Similar  to  the  central 
nervous system (CNS), angiogenic sprouting is the predominant mechanism of vessels 
growth in the retina however; vessel expansion by intussusception cannot be excluded. 
The  growth  pattern  facilitates  the  analysis  of  the  initially  planar,  two-dimensional 
vasculature in the retina at great detail (Roca and Adams 2007). Previous work has 
shown that this rapid and highly directional growth of blood vessels is controlled by a 
spatial concentration gradient of matrix-anchored vascular endothelial growth factor A 
(VEGF-A) released by astrocytes in response to local hypoxia (Stone, Itin et al. 1995); 
(Forsythe, Jiang et al. 1996); (Gerhardt, Golding et al. 2003). VEGF-A is a very potent 
chemo attractive signal for ECs and promotes the polarized sprouting of specialized 
endothelial tip cells, at the leading edge of the vascular plexus (Figure 4.5). Whereas the 
explorative, invasive nature of tip cells leads to an extension of the endothelial network 
along  the  VEGF-A  gradient,  a  second  process,  tubulogenesis,  is  required  for  the 
generation of patent, blood-carrying vessels.  
Although angiogenic growth in the retina, like in most other tissues, has so far 
not been observed dynamically, tip cells can be frequently seen in close contact with 
other tips, suggesting that the interaction of filopodial processes and, subsequently, cell 
bodies leads to bridge-like structures in which ECs lack long filopodia and no longer 
display tip cell features. It may be at this stage that sprouts are converted into new 
tubules, form anastomoses, and become part of a simple, plexus-like network at the 
vascular perimeter (Roca and Adams 2007). Each new sprout eventually connects via 
the  leading  tip  cell  with  neighbouring  sprouts  to  form  continuous  lumen  and  thus, 
establish  blood  flow  in  the  new  vascular  loop  (Blum,  Belting  et  al.  2008).  The 
emergence  of  new  endothelial  tip  cells  from  the  stalk  plexus  will  promote  further 
extension  of  the  vascular  network  so  that  growth  of  the  vasculature  is  presumably 
achieved through repeated cycles of EC sprouting and tubulogenesis. 
Recent data provide support for a model in which the formation and intracellular 
and  intercellular  fusion  of  endothelial  vacuoles  drives  vascular  lumen  formation 
(Kamei, Saunders et al. 2006). Using high-resolution time-lapse two-photon imaging of 
transgenic zebrafish, Kamei and colleagues examined how endothelial tubes assemble 
in  vivo,  comparing  results  with  time-lapse  imaging  of  human  endothelial-cell  tube 
formation in three-dimensional collagen matrices in vitro. Their observation proposed a 
model  of  pinocytic  vesicles  formation,  followed  by  fusion  and  enlargement  of 
intracellular vacuoles and eventually fusion of intercellular vacuolar compartments to  
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form a patent lumen. In vitro data support this model, Bayless and colleagues showed 
that  intracellular  vacuoles  arise  from  integrin-dependent  and  cdc42/Rac1-dependent 
pinocytic  events  downstream  of  integrin-extracellular-matrix  signalling  interactions 
(Bayless, Salazar et al. 2000). Although not shown for murine vascular development, it 
is  likely  that  vacuole  fusion  is  also  favourably  model  for  lumen  formation  during 
sprouting angiogenesis. 
 
 
 
Figure 4.5 Mouse retinal vascular development 
In the sprouting zone (1), directional extension of tip cells and filopodia promote 
vascular growth along a gradient of matrix bound VEGF-A, which is released by 
astrocytes in response to hypoxia. Upper panel demonstrates Vegfa expression (black) 
by astrocytes (red) ahead of the growing vasculature (green). Lower panel, left: Tip cell 
extends filopodia (green) that closely align to and follow the astrocytic network (red). 
Interaction of sprouting tips (blue arrow) and anastomosis generates a plexus of patent 
but non-hierarchically organized vessels (2). Pruning (3) and secondary sprouting in a 
perpendicular direction (4) leads to vascularization and remodelling of the retinal 
vascular plexus. Differentiation of vessels in arteries and veins (5) as well as the 
recruitment of pericytes (6) occurs; lower panel, right: Close association of pericyte 
(green) to the blood vessel (red). Adapted and modified from (Roca and Adams 2007); 
(Gerhardt, Golding et al. 2003)  
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Extensive  angiogenic  remodelling  in  the  retinal  plexus  converts  the  primary 
capillary plexus into arteries, veins, and capillary beds. While growth into the periphery 
continues, the region of the plexus that is closer to the centre of the retina is remodelled 
by pruning and secondary sprouting processes. Pruning is most pronounced in areas in 
close proximity to arteries so that the periarterial vasculature is relatively sparse and 
contains  only  few  branchpoints.  This  remodelling  correlates  with  reduced  VEGF-A 
messenger  RNA  (mRNA).  Presumably,  relative  hyperoxia  surrounding  arteries  and 
flow-dependent  tissue  oxygenation  negatively  regulates  VEGF-A  production.  In 
contrast,  the  perivenous  vasculature  remodels  at  a  much  slower  rate,  is  a  site  of 
extensive EC proliferation, retains a higher density of vessels and branchpoints, and 
contains numerous secondary sprouts emerging from capillaries. Although it is unclear 
whether these regional features are caused by hemodynamic factors (i.e., differences in 
the pressure and speed between arterial and venous blood flow), the concentration of 
oxygen  in  the  blood  stream,  differential  gene  expression  in  arteries  and  veins,  or  a 
combination of all three, angiogenic remodelling around the arterial branch appears to 
strongly favour tube formation over new sprouting whereas the perivenous vasculature 
is permissive for both processes (Roca and Adams 2007). 
Astrocyte precursors enter the retina through the optic nerve and radiate towards 
the  periphery.  Vascularization  subsequently  follows  the  pre-existing  astrocytic 
meshwork,  suggesting  a  function  in  guidance  and  scaffolding  for  growing  vessels. 
Consistent with this, filopodia extension of the growing endothelial tip often align with 
process of the underlying astrocytes that secret VEGF-A (Figure 4.5).  
In  addition  to  close  astrocyte-  endothelial  cell  interaction  during  angiogenic 
sprouting, mural cell (MC) intimately associate with the developing blood vessels. MC 
consist of pericytes (PC) that envelope capillaries and vascular smooth muscle cells 
(vSMC) which tightly wrap around bigger vessels such as arteries and veins (Figure 
4.5).  In  the  retina,  pericytes  recruitment  is  dependent  on  paracrine  platelet  derived 
growth factor B (PDGF-B) signalling. Endothelial cells at the sprouting vascular front 
express Pdgfb. CNS-derived pericytes express the receptor, Pdgfrb and by sensing the 
growth factor invest the growing vessels by longitudinal migration. The establishment 
of mature blood vessels by formation of firm adhesion junction, pericyte recruitment, 
and deposition of BM components restricts vessels growth. However, are there other 
limiting  factors?  What  initiates  endothelial  specification?  And  how  are  tip  cells 
selected? And what determines growth arrest?  
  31 
 
4.5  Notch signalling in sprouting angiogenesis 
Recent studies highlighted the importance on Notch signalling in the process of tip cell 
selection  and  the  induction  of  angiogenic  sprouts.  The  Notch  pathway  is  an 
evolutionary  conserved  signalling  system  that  has  multiple  roles  in  cell  fate 
specification, tissue patterning and morphogenesis through effects on differentiation, 
proliferation, survival and apoptosis (Phng and Gerhardt 2009). 
The Notch receptor is a single-pass transmembrane protein consisting of a single 
peptide,  an  extracellular  domain  that  is  responsible  for  ligand  interaction,  and  a 
transmembrane domain that is in involved in receptor activation and an intracellular 
signalling  domain  {Dufraine,  2008  #506}.  Notch  signalling  is  initiated  when  the 
extracellular domain of the receptor engages ligand found on neighbouring cells that are 
in close proximity to one another (Figure 4.6). Thus, Notch signalling depends on cell-
contact dependent interaction (Dufraine, Funahashi et al. 2008). In mammals, there are 
four Notch receptors, Notch1, Notch2, Notch3  and Notch4 and five canonical DSL 
(Delta, Serrate, LAG-2) ligands: Delta-like (Dll) 1, Dll3, Dll4 and Jagged-1 (Jag1) and -
2 (Jag2). These ligands are type I cell surface proteins with multiple tandem epidermal 
growth factor (EGF) repeats in their extracellular domains. Several Notch receptors and 
ligands as well as signalling components have been identified in ECs, including Notch1 
and -4, and ligands Dll1, Dll4 and Jag1 and -2. Global knockout studies and endothelial 
specific deletion of Notch and/ or their ligands highlighted the importance in proper 
construction  of  the  vascular  system  and  it  become  clear  that  Notch  signalling  is 
indispensable for vascular development during embryogenesis. 
Notch-ligand  binding  leads  to  a  cascade  of  proteolytic  cleavages,  first  by  a 
member  of  the  disintegrin  and  metalloproteases  (ADAM)  family  within  the 
juxtamembrane  region  releasing  the  extracellular  domain,  followed  by  γ-secretase 
within the transmembrane domain. The final cleavage releases the Notch intracellular 
domain (NICD) and translocates to the nucleus where it interacts with CSL (CBF1, 
Su(H)  and  Lag-2)  transcriptional  repressors  and  converts  them  to  transcriptional 
activators (Figure 4.6).   
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Figure 4.6 Dll4/ Notch signalling during angiogenic sprouting 
Notch receptors are expressed on the cell surface. Upon binding and interaction with 
Notch ligand, Delta and Jagged, notch intracellular domain (NICD) becomes released 
by γ-secretase cleavage. NICD translocates to the nucleus to trigger transcriptional 
activation of Notch target genes. Notch ligand, Dll4 is strongly upregulated and 
expressed by endothelial tip cells (yellow) stimulated by VEGF-A gradient. Interaction 
with adjacent stalk cell (blue) results in induction and activation of mature quiescent 
stalk cell phenotype. 
CSL (CBF1, Su(H) and Lag-2) transcriptional repressors are converted into 
transcriptional activators upon interaction with NICD. CSL dependent and independent 
activation occurs. The latter, requires cytoplasmic factors (CF) such as MAGP. 
 
 
In  the  absence  of  NICD,  CSL  represses  transcription  through  interaction  with  co-
repressor  complex.  Upon  binding  of  NICD, the  co-receptor  complex  is  replaced  by 
transcriptional  activator  complex  including  NICD,  mastermind-like  and  histone 
acetyltransferases that turns on expression of Notch targets such as the basic helix-loop 
helix proteins Hairy/Enhancer of Slit (Hes), Hes-related proteins and Notch-regulated 
ankyrin  repeat  proteins  (Nrarp).  Hes  and  Hey  genes  are,  in  turn,  transcriptional 
repressors of their own transcription and further downstream target genes (Phng and 
Gerhardt 2009); (Dufraine, Funahashi et al. 2008). Notch signalling controls multiple 
aspects of endothelial specification, e.g. the role of Dll4/ Notch signalling in arterial 
differentiation  has  been  well  established.  At  approximately  E9.5-E11.5  of  murine  
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embryogenesis the primary vascular plexus remodels leading to the establishment of a 
hierarchical vascular network consisting of arteries and veins. This process coincides 
with Notch1 and -4 expression, as well as notch ligand Dll4 expressing around the 
developing vasculature, however by E13.5, expression of these genes is restricted to the 
arterial  endothelium.  At  the  same  time,  members  of  the  Eph  signalling  pathway, 
ephrinB2  and  EphΒ4,  are  expressed  and  serve  as  markers  of  arterial  and  venous 
identity, respectively. Studies in mouse and zebrafish illustrated that Notch functions 
upstream  of  ephrinB2,  promoting  arterial  specification.  Targeted  deletion  of  several 
members of the Notch family and Notch ligands result in deregulation of arterial and 
venous specification of ECs and deformation of arteries and veins in vivo.  
As outlines in chapter 4.4  of this thesis, guided angiogenic sprouting requires 
the induction of a motile leading tip cell to migrate and expand the growing vasculature. 
Recent studies in mouse retina, in zebrafish intersegmental vessels (ISV) and tumour 
angiogenesis models highlighted that the specification of endothelial tip and stalk cells, 
both spatially and temporally is regulated by Dll4/Notch signalling. Tip cells express 
high levels of Dll4 (Claxton and Fruttiger 2004) while Notch activity is predominantly 
observed in stalk cells (Hellstrom, Phng et al. 2007). Disruption of Dll4 or endothelial 
specific loss of Notch1, as well as suppression of Notch activity by pharmacological 
inhibitor γ-secretase inhibitor results in increased vessels density of the vascular plexus 
and excessive vessel sprouting. Increased and widespread expression of tip cell gene 
Pdgfb  as  well  as  aberrant  filopodia  induction  in  stalk  ECs  indicated  dramatically 
augmented tip cell formation and sprouting (Hellstrom, Phng et al. 2007); (Suchting, 
Freitas et al. 2007).  
In summary, Dll4-expressing endothelial tip cell activates Notch signalling in 
the adjacent, proliferating stalk cell (Figure 4.6). Loss of Notch signalling is associated 
with  increased  vascular  endothelial  growth  factor  receptor  (VEGFR)  VEGFR2 
expression (Suchting, Freitas et al. 2007); (Lobov, Renard et al. 2007), suggesting the 
following model: Dll4 signals through Notch1 in the adjoining cell to initiate a VEGF-
feedback loop, limiting sprouting by downregulation of VEGFR2 (Figure 4.6), likely 
through  direct  binding  of  Hey1  to  the  VEGFR2  promoter  (Holderfield,  Henderson 
Anderson et al. 2006). The tip cell phenotype is the default acquired in the absence of 
Notch  signalling,  whereas  the  stalk  cell  phenotype  is  acquired  by  Notch  signalling 
(Hellstrom, Phng et al. 2007). Thus, Dll4 functions in restricting tip cell formation and 
excessive sprouting and therefore, has an anti-angiogenic capacity (Dufraine, Funahashi 
et al. 2008).  
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Dll4 expression is increased in ECs of murine and human tumours and its expression is 
regulated by VEGF-A (Thurston et al., 2007). Blockade of Dll4 in tumours resulted in 
overgrowth of tumour vasculature, similar to increased vessel density in mouse retinas 
after suppression of Notch signalling. Despite the increased tumour vasculature, Dll4 
inhibition led to decreased tumour growth (Noguera-Troise, Daly et al. 2006). Perfusion 
studies revealed that Dll4 blockade resulted in abnormal non-functional tumour vessels 
that  could  not  efficiently  deliver  blood  to  the  tumour  leading  to  hypoxic  tumours 
negatively affecting tumour growth (Thurston, Noguera-Troise et al. 2007). 
 
Notch receptor activation can also be mediated by non- DSL ligands, such as 
microfibril-associated  glycoprotein  family,  MAGP-1  and  -2,  small  glycoprotein  that 
specifically associate with fibrillin-containing microfibrils to promote cell adhesion by 
binding to integrin αvβ3 (Gibson, Leavesley et al. 1999). Integrins are heterodimeric 
transmembrane cell adhesion molecules that mediate cell-matrix interactions and are 
discussed in chapter 4.18 .  
MAGP-Notch  interactions  induce  γ-secretase-dependent  NICD  generation  and  CSL-
dependent  activation  of  reporter  constructs.  MAGP-2  only  activates  Notch  when 
expressed in the same cell as the receptor, suggestive of autocrine signalling. MAGP-2 
can have an inhibitory effect on Notch in several EC lines and promotes angiogenic cell 
sprouting by blocking Notch signalling in ECs in vitro (Albig, Becenti et al. 2008); 
reviewed in (D'Souza, Miyamoto et al. 2008). 
Increasing studies reveal Notch- ECM interaction and that Notch can influence matrix 
production during sprouting angiogenesis. Endothelial specific overexpression of Dll4 
(mDll4) resulted in increased expression of Notch effectors such as Hey1, Hey2 and 
Hes5  and  vascular  defects  leading  to  embryonic  lethality.  Further,  mDll4  showed 
increased expression and transcription of fibronectin, laminin and CollagenI and -IV but 
reduced  expression  of  matrix  degrading  enzymes,  matrix  metalloproteases  (MMP) 
MMP-1, -2 and -9 (Trindade, Kumar et al. 2008).  
Conversely,  Benedito  and  colleagues  showed  that  Dll4-/-  mutants  display  a 
defective BM around the forming aorta and increased EC migration from the dorsal 
aorta to peripheral regions, which constitute the main causes of arterial lumen reduction 
in these embryos (Benedito, Trindade et al. 2008). 
Notch activation in ECs increases the affinity of β1−integrin for fibronectin, 
collagens I and IV, and vitronectin, which in turn allows cells to adhere to β1 integrin 
substrates and prevents cell migration, endothelial sprouting and, angiogenesis (Leong,  
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Hu et al. 2002). Overexpression of intracellular domain of Notch 4 in ECs results in a 
β1 integrin mediated increase in matrix adhesion and a reduced sprouting response to 
VEGF-A in vivo and in vitro (Leong, Hu et al. 2002). 
Notch-mediated  integrin  activation  is  independent  of  the  abundance  of  β1 
integrin, but rather due to changes in the activation status of β1 integrin. The Ras family 
of small guanosine triphosphate (GTP) binding proteins and their downstream effectors 
are  key  players  in  the  regulation  of  integrin  activation.  R-Ras  enhances  integrin-
mediated cell adhesion by increasing integrin affinity and avidity, whereas H-Ras and 
its  downstream  effector  Raf-1,  a  mitogen-activated  protein  kinase  (MAPK),  inhibit 
integrin  activity.  Hodkinson  and  colleagues  show  that  the  intracellular  domain  of 
mammalian Notch-1 activates integrins without affecting integrin expression. Integrin 
activation  is  dependent  on  γ  –secretase  mediated  intra-membranous  cleavage  of 
membrane  bound  Notch  releasing  intracellular  Notch  which  activates  R-Ras, 
independent of CSL-transcription. Notch activation reversed H-Ras-and Raf-mediated 
suppression of integrin affinity. Membrane-bound Notch mutants that are inefficiently 
cleaved  or  intracellular  Notch  mutants  lacking  the  ankyrin  repeat  sequence  do  not 
activate  R-Ras  or  integrins.  Notch  ligand,  Dll4  stimulates  R-Ras  dependent  α5β1 
integrin -mediated adhesion, demonstrating the physiological relevance of this pathway 
(Hodkinson, Elliott et al. 2007). 
 
Dll4/Notch  induced  restriction  of  vascular  sprouting  via  downregulation  of 
VEGFR2 is based on endothelial specific interaction. Dll4 –expressing ECs signal to 
neighbouring EC activating Notch signalling. However, recent studies implicated Notch 
signalling  to  neighbouring  cells  including  vSMC  during  embryogenic  vascular 
development and to tumour cells during tumour angiogenesis. In particular, endothelial 
specific  deletion  of  Jag1  results  in  embryonic  lethality  and  cardiovascular  defects, 
recapitulating the Jag1 null phenotype. These embryos show striking deficits in vSMCs, 
whereas endothelial Notch activation and arterial-venous differentiation appear normal. 
Endothelial Jag1 mutant embryos are phenotypically distinct from embryos in which 
Notch  signalling  is  inhibited  in  endothelium  (High,  Lu  et  al.  2008).  Further,  Jag1-
selective Notch  signalling induces SMC differentiation via a RBP-Jkappa-dependent 
pathway.  Overexpression  of  NICD  promoted  SMC-  specific  gene  expression  in 
mesenchymal 10T1/2 cells but not non-mesenchymal cells (Doi, Iso et al. 2006). 
Further analyses suggest vSMC-autonomous function for Notch signalling in patterning  
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and collateral formation within the cerebral arterial circulation (Proweller, Wright et al. 
2007). 
Mutations  in  Notch3  are  associated  with  CADASIL,  a  stroke  and  dementia 
syndrome  with  vSMC  dysfunction.  Jin  and  colleagues  linked  Notch  signalling  to 
PDGF-B  signalling,  a  major  pathway  in  vSMC  recruitment,  differentiation  and 
proliferation  and  showed  that  PDGFR-β is  a  novel  immediate  Notch  target  gene. 
PDGFR-β  expression  is  upregulated  upon  Notch  activation,  depending  on  the  CSL 
pathway.  Conversely,  PDGFR-β  expression  is  strongly  reduced  in  Notch3  deficient 
mice and embryonic stem cells (Jin, Hansson et al. 2008). 
 
Branching  of  blood  vessels  to  form  a  tube-like  vascular  network  is  equally 
important as angiogenic sprouting and the restriction of new sprouts. 
Notch is among the pathways crucial for branching morphogenesis. During Drosophila 
tracheal  development,  cross  talk  between  Notch  and  Wnt/wingless,  TGF-β/Dpp  and 
receptor tyrosine kinase (RTK)/FGFR pathway generates branch patterning through the 
cooperative  specification  of  cell  fate.  In  vertebrates,  Notch  cross-talk  functions  in 
epithelial bud formation and branching of the developing prostate gland. Specifically, 
Notch/TGF-β antagonizism regulates branching (Grishina, Kim et al. 2005). Further, 
when  murine  embryonic  ECs  are  in  contact,  ligand-depending  Notch  signalling  is 
activated, and BMP/TGF-β- mediated migration is inhibited, suggesting a mechanism 
for  contact-depending  cross-talk  regulating  endothelial  migration  (Itoh,  Itoh  et  al. 
2004).  
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4.6  Sensing  oxygen  levels  -  Hypoxia  induced  angiogenic 
responses 
Angiogenesis  is  mostly  an  adaptive  response  to  tissue  hypoxia,  referring  to  oxygen 
levels that are reduced due to rapid oxygen consumption and/ or poor circulation. This 
process occurs in a wide variety of physiological and pathological conditions such as 
embryonic  development  and  tumour  growth,  situations  in  which  the  rate  of  tissue 
expansion  outpaces  the  accompanying  angiogenesis  leading  to  inadequate  supply  of 
blood and therefore, generating an highly hypoxic environment. 
Angiogenesis  is  dependent  on  the  accumulation  of  hypoxia-induced  factors 
(HIFs), which are heterodimeric transcription factors of α- and β-subunits (reviewed in 
(Fong 2008)). During normal oxygen concentrations, intracellular HIF levels are low, 
due to rapid degradation mediated by oxygen-dependent prolyl hydroxylases (PHD), 
polyubiquitination,  and  proteosomal  degradation  of  α-subunits.  However,  under 
hypoxia, PHD activity is suppressed, resulting in increase levels of HIFs, stabilization 
of α-subunits and the formation of heterodimers with HIF-1β, which is not subject to 
oxygen dependent regulation. 
The accumulation of HIFs under hypoxia allows them to activate the expression 
of  many  angiogenic  genes,  such  as  phosphoglycerate  kinase  (PGK)  and  Vegfa  and 
thereby, initiates an angiogenic response. As a result, glycolysis is increased, which 
partially  compensate  for  reduced  oxidative  phosphorylation.  Likewise,  increased 
VEGF-A facilitates the adaptation to hypoxia, due to improved oxygen delivery as a 
result of angiogenesis (reviewed in (Fong 2008)). 
HIF-1α and HIF-2α both activate the transcription of target genes by binding to 
hypoxia response elements (HRE) or similar sequence elements. The presence of HRE 
has been demonstrated for many angiogenic genes such as Vegfa and Vegfr2 (Marti, 
Bernaudin et al. 2000). In contrast to HIF target genes, many other angiogenic genes 
like Pdgfb, angiopoietin and Tgfb lacking HRE are also upregulated by hypoxia or HIF-
1α overexpression (Nilsson, Shibuya et al. 2004). Hypoxia also regulates endothelial 
cell-cell junctions and vascular permeability. In the brain, tissue hypoxia disrupts the 
blood  brain  barrier.  Elevated  VEGF-A  levels  under  hypoxia  are  responsible  for 
increased vascular leakage (Schoch, Fischer et al. 2002). 
In  EC  as  well  as  vSMC  cultures,  moderate  hypoxia  promotes  expression  of  
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angiogenic  genes  Vegfa  and  Pdgfb,  respectively  promoting  cell  proliferation  and 
survival (LeCouter, Kowalski et al. 2001). However, hypoxia near anaerobic conditions 
reduces  proliferation  and  triggers  apoptosis,  suggesting  that  the  functional  outcome 
depends  on  severity  of  hypoxia.  Hypoxia  may  also  regulate  vSMC  migration  and 
adhesion  properties  (Schultz,  Fanburg  et  al.  2006).  Overexpression  of  HIF-1α 
significantly  reduced  FAK  (focal  adhesion  kinase)  phosphorylation  and  diminished 
vSMC adhesion to ECM. Since sprouting angiogenesis requires loosening of vSMCs 
from BM and ECs, reduced vSMC adhesion to ECM may favour angiogenesis (Corley, 
Taylor et al. 2005). 
 
4.7  VEGF-VEGFR signalling in angiogenesis 
In the yolk sac, the initial ECs associated with the blood islands fuse together to form a 
primitive  capillary  plexus,  a  honeycomb  network  of  developing  vessels.  Within  the 
embryo, dispersed angioblasts start to join together to form a capillary network in the 
head  mesenchyme  and  posterior  lateral  plate  mesoderm.  In  the  developing  cardiac 
crescent, endothelial progenitors form the primitive endocardial lining of the developing 
cardiac tube. These initial phases of vascular development are known as vasculogenesis 
and  are  largely  dependent  on  vascular  endothelial  growth  factor  (VEGF)  signalling 
(reviewed in (Rossant and Howard 2002). The VEGF family members are secreted, 
dimeric glycoproteins of approximately 40kDa. In mammals, the VEGF family consist 
of five members, VEGFA, -B, -C, -D and placenta growth factor (PlGF).  
 
The  Vegf  gene  consists  of  nine  alternatively  spliced  exons,  resulting  in  five 
VEGF-A isoforms in humans; the mouse Vegf gene produces at least three isoforms of 
120,  164  and  188  amino  acids  (aa).  The  VEGF  isoforms  are  denoted  VEGF120, 
VEGF164  and  VEGF188  and  differ  in  their  ability  to  interact  with  VEGFR  co-
receptors, such as neuropilins (Nrp) and heparan sulfate proteoglycans (HSPG), see 
Figure 4.7.   
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Figure 4.7 VEGF receptor signalling is modulated by different co-receptors 
VEGFs as well as VEGFRs bind to co-receptors such as heparan sulfate proteoglycans 
(HSPGs) and Neuropilins. These interactions can influence VEGFR-mediated responses 
(Olsson, Dimberg et al. 2006). 
 
 
The  bioactivity  of  VEGF  family  members  is  regulated  by  proteolytic  processing, 
suggesting specific interaction with different receptors and co-receptors (Lee, Jilani et 
al. 2005). VEGF164 and -188 can bind heparin, and associate with the ECM and is 
therefore retained in close vicinity to the secreting cell. In contrast, the short isoform 
VEGF120 lacks the HSPG- and Nrp- binding domains generating a freely diffusible 
VEGF variant. Recently, a new model has been proposed for Nrp interactions with 
VEGF isoforms. Pan and colleagues suggest that VEGF121 binds directly to neuropilin 
1 (Nrp1); however, unlike VEGF165, VEGF121 is not sufficient to mediate the Nrp1-
VEGFR2  complex  (Pan,  Chathery  et  al.  2007).  Protease  cleavage  of  matrix-bound 
VEGF188 results in release of an active, freely diffusible fragment.  
Recent  studies  showed  that  heparin  enhances  VEGF165  induced 
phosphorylation  of  VEGFR2  but  not  VEGF120.  Depletion  of  cell  surface  heparan 
sulfate results in reduction of the phosphorylation. Therefore it is likely that a heparin-
like domain of heparan sulfate/heparin forms a complex with VEGF165 and VEGFR2 
via  the  exon  7-encoded  region,  thereby  enhancing  VEGF165-dependent  signalling 
(Ashikari-Hada,  Habuchi  et  al.  2005).  Further,  biochemical  studies  indicate  that 
heparin/ HS form a complex by simultaneously binding growth factor and receptor and 
thereby prolonging the half-life of the receptor complex (Ibrahimi, Zhang et al. 2004). 
Similar findings revealed a stabilization function for VEGF/VEGFR2 by co-receptors 
neuropilin when expressed by adjacent cells (Miao and Klagsbrun 2000).   
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Most cells however, produce multiple VEGF isoforms simultaneously with VEGF164 
and VEGF120 being predominantly expressed. 
The  functional  relevance  of  VEGF  isoform  has  been  studied  in  the  retinal 
vasculature,  expressing  solely  one  isoform.  While  VEGF164/164  mice  exhibit  no 
vascular defects, the VEGF120/120 mice lacking heparin-binding, and therefore ECM 
interaction domains, displayed decreased vessel density and branch formation. Instead 
of being recruited into additional branches, nascent ECs were preferentially integrated 
within existing vessels to increase lumen calibre. Embryos harbouring only a heparin-
binding  isoform  of  VEGF-A  (VEGF188/188)  developed  opposing  defects,  including 
excess  endothelial  filopodia  and  abnormally  thin  vessel  branches  in  ectopic  sites. 
Therefore, differential VEGF-A isoform localization in the extracellular space provides 
a control point for regulating vascular branching and guided migration towards a growth 
factor gradient (Ruhrberg, Gerhardt et al. 2002). 
   
The  VEGF  ligands  bind  in  an  overlapping  pattern  to  three  receptor tyrosine 
kinases,  denoted  as  VEGF  receptor  1  (VEGFR1,  Flt1),  VEGFR2  (Kdr,  Flk1)  and 
VEGFR3 (Flt4). The VEGFR1 and -2 are primarily expressed in the vascular system 
and their expression is mainly restricted to the endothelial and lymphatic cell lineage, 
implying  crucial  function  during  vascular  development.  However,  expression  and 
perhaps  function  in  other  tissues  have  been  described.  VEGF  and  VEGFR2  are 
expressed by neurons during development, and VEGF has a direct effect on neuronal 
growth and maturation mediated by VEGFR2 (Khaibullina, Rosenstein et al. 2004). 
VEGFR1 is expressed in macrophages and is involved in their migration (Sawano, Iwai 
et al. 2001). VEGFR3 is expressed in early blood vessels but expression becomes later 
restricted to the developing lymphatic vasculature. 
VEGFR2 binds VEGF-A, -C and –D, while VEGFR1 binds VEGF-A, -B and 
PlGF  and  VEGFR3  binds  VEGF-C  and  –D.  VEGF  receptor  binding  properties  are 
illustrated in Figure 4.8.  
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Figure 4.8 VEGF/ VEGFR family and its binding properties 
Mammalian vascular endothelial growth factors (VEGFs) bind to the three VEGF 
receptor (VEGFR) tyrosine kinases, leading to the formation of VEGFR homodimers 
and heterodimers. Proteolytic processing of VEGFC and D allows binding to VEGFR2 
(Olsson, Dimberg et al. 2006). 
 
 
VEGF binding induces receptor dimerization, followed by activation of tyrosine kinase 
leading  to  autophosphorylation  and  subsequently  activation  of  the  downstream 
signalling cascade. Guided by the binding properties of the ligands, the receptors can 
form homodimers and heterodimers. 
Interestingly, VEGFR1 has a 10-fold higher affinity to VEGF-A than VEGFR2 
but  VEGFR1  undergoes  little  detectable  phosphorylation  when  bound  to  VEGF-A, 
whereas  VEGF  binding  to  receptor  2  results  in  autophosphorylation  in  several 
phosphorylation sites. VEGFR1 acts as a positive and negative regulator of VEGFR2 
signalling capacity. Negative regulation of VEGFR2 is exerted, at least in part, by an 
alternatively  spliced  soluble  variant  of  VEGFR1  that  binds  to  VEGF  and  thereby 
prevents VEGF from binding to VEGFR2. 
The requirements and importance of VEGF signalling during cardiovascular and 
lymphatic development has been illustrated by knockout studies. Inactivation of a single 
Vegfa allele resulted in early embryonic lethality due to severe reduction and calibre of 
the  developing  vessels.  VEGF-A  is  haploinsufficient;  homozygous  embryos  were 
produced  by  aggregation  of  homozygous  mutant  ES  cells  with  tetraploid  wildtype 
embryos  revealing  an  even  more  severe  phenotype  and  impaired  vessel  formation  
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(Carmeliet,  Ferreira  et  al.  1996),  indicating  a  tight  dose-dependent  regulation  of 
embryonic  vessel  development  by  VEGF.  The  importance  of  regulated  VEGF 
signalling  is  illustrated  by  the  fact  that  a  2-3fold  overexpression  of  Vegfa  from  its 
endogenous  locus  results  in  aberrant  heart  development  and  embryonic  lethality 
(Miquerol, Langille et al. 2000). Induced deletion of VEGF-A in neonatal and adult 
mice as well as short-term withdrawal of VEGF-A by pharmalogical inhibitors leads to 
endothelial apoptosis and regression of blood vessels (Gerber, Hillan et al. 1999). 
Deletion of Vegfr2 leads to early embryonic lethality at E8.5 displaying a similar 
phenotype  to  Vegfa-/-  but  additionally,  embryos  developed  early  defect  in  the 
development of haematopoietic and ECs. Yolk-sac blood islands were absent at 7.5 
days, organized blood vessels could not be observed in the embryo or yolk sac at any 
stage, and haematopoietic progenitors were severely reduced (Shalaby, Rossant et al. 
1995). In contrast, Vegfr1 deficient embryos die at E9.0 due to excessive endothelial 
proliferation and impaired lumen formation. The development and expansion of ECs in 
Vegfr1-/- animals is possibly a consequence of increased accessibility of VEGF-A for 
binding  and  activation  of  VEGFR2,  implicating  VEGFR1  as  a  negative  regulator. 
Several  studies  have  highlighted  that  VEGFR1  negatively  influences  VEGFR2 
signalling.  VEGFR2  mediated  proliferation  of  ECs  can  be  suppressed  by  VEGFR1, 
dependent on phosphoinositide 3-kinases (PI3K) activity and signalling while migration 
is unaffected (Zeng, Dvorak et al. 2001). 
Activation  of  VEGFR2  signalling  regulates  multiple  EC  functions  including 
proliferation, migration and survival. Knockout studies and inhibition of VEGFR2 has 
elucidated that VEGFR2 is essential in all aspects of normal and pathological vascular 
development. Targeting VEGFR2 by small-molecular-weight tyrosine kinase inhibitors 
has  become  in  focus  of  current  anti-angiogenic  tumour  therapies.    However, 
understanding the specific signal transduction pathways of VEGFR2 and downstream 
signalling pathways may help targeting precise endothelial functions in tumours. The 
positions of several phosphorylation residues in VEGFR2 have been mapped and are 
summarized in Figure 4.9.  
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Figure 4.9 VEGFR phosphorylation sites and signal transduction 
Intracellular domain and activated VEGFRs are shown with tyrosine phosphorylation 
sites that are indicated by numbers. Circled R indicates that use of the phosphorylation 
site is regulated dependent on the angiogenic state of the endothelial cell (for VEGFR2). 
Dark blue squares in the receptor molecules indicate positions of tyrosine residues. 
Binding of signalling molecules (dark blue ovals) to certain phosphorylation sites 
(boxed numbers), initiates signalling cascades (light blue ovals), which leads to the 
establishment of specific biological responses (pale blue boxes). The mode of initiation 
of certain signalling chains is unclear (dashed arrows). Final biological outcomes that 
are coupled to the respective receptors are indicated in pink boxes. DAG, 
diacylglycerol; EC, endothelial cell; eNOS, endothelial nitric oxide synthase; FAK, 
focal adhesion kinase; HPC, haematopoietic progenitor cell; HSP27, heat-shock 
protein-27; MAPK, mitogen-activated protein kinase; MEK, MAPK and ERK kinase; 
PI3K, phosphatidylinositol 3′ kinase; PKC, protein kinase C; PLCγ, phospholipase C-γ; 
Shb, SH2 and β-cells; TSAd, T-cell-specific adaptor (Olsson, Dimberg et al. 2006). 
 
 
Phospholipase C gamma (PLCγ) binds to phosphorylated tyrosine residue 1175 
(Tyr1175) and mediates the activation of MAPK/ ERK1/2 inducing EC proliferation. 
Mice expressing mutated Tyr1173Phe VEGFR2 die at E8.5-9.5 because of vascular 
defects resembling Vegfr2-/- mice, indicating an essential function of this particular 
phosphorylation residue (Takahashi, Yamaguchi et al. 2001); (Sakurai, Ohgimoto et al. 
2005). The serine/threonine kinase AKT/PBK is activated downstream of PI3K and 
mediates survival of ECs (Fujio and Walsh 1999). Tyrosine residue 951 is a binding site  
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for the signalling adaptor TSAd (T-cell specific adaptor). Mutation of Y951 to F and 
introduction of phosphorylated Y951 peptide or TSAd siRNA into ECs blocked VEGF-
A-induced  actin  stress  fibers  and  migration,  but  not  mitogenesis.  Tumour 
vascularization  and  growth  was  also  reduced  in  TSAd-deficient  mice,  indicating  a 
critical  role  of  Y951-TSAd  signalling  in  pathological  angiogenesis  (Matsumoto, 
Bohman et al. 2005). The same study reported differential phosphorylation patterns of 
VEGFR2  within  developing  blood  vessels  in  mouse  embryoid  bodies  (Matsumoto, 
Bohman et al. 2005). More developed patent vessels associated with mural cells lacked 
Y951 VEGFR2 phosphorylation. 
 
In  addition  to  the  VEGFR  binding  properties  discussed  above  (Figure  4.9), 
VEGF  receptors  can  bind  and  interact  with  a  variety  of  molecules  that  do  not 
necessarily act as co-receptors. Vascular endothelial cadherin (VE-cadherin) localized 
at  adhesion  junction  forms  a  complex  with  VEGFR2  and  thereby  modulates  its 
signalling properties (Lampugnani and Dejana 2007), see Figure 4.10. 
 
 
 
Figure 4.10 Mechanosensory complex formation 
Blood flow might activate VEGFRs in a ligand-independent manner, by the formation 
of mechanosensory complexes that consist of platelet-endothelial-cell adhesion 
molecule-1 (PECAM1), vascular endothelial (VE)–cadherin, VEGFRs and integrins 
(Olsson, Dimberg et al. 2006).   
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Shear  stress  and  blood  flow  determine  at  least  to  some  extend  vascular 
remodelling and homeostasis. Previous work showed that the conversion of integrins to 
a high-affinity state mediates a subset of shear responses, including cell alignment and 
gene expression. However, platelet/endothelial cell adhesion molecule-1 (PECAM-1, 
which  directly  transmits  mechanical  force),  VE-cadherin  (which  functions  as  an 
adaptor) and VEGFR2 (which activates PI3K) comprise a mechanosensory complex 
that  functions  upstream  of  integrin  activation  (Figure  4.10).  Together,  this  receptor 
complex is sufficient to confer responsiveness to flow in heterologous cells (Tzima, 
Irani-Tehrani et al. 2005). 
Integrin signalling will be discussed in more detail but at this point it is worth 
mentioning  that  αvβ3  integrin  directly  interacts  with  VEGFR2  and  its  engagement 
promotes phosphorylation and activation of VEGFR2 (Soldi, Mitola et al. 1999). In 
addition, this interaction appears to be synergistic, as VEGFR2 activation induces β3 
integrin tyrosine phosphorylation that in turn, is crucial for VEGF-induced VEGFR2 
phosphorylation (Mahabeleshwar, Feng et al. 2007). These findings are in agreement 
with the in vivo data, deletion of the integrin beta 3 chain in mice results in elevated 
expression levels of VEGFR2 (Reynolds, Reynolds et al. 2004). 
 
4.8  PI3 kinase activity in angiogenesis 
The PI3K signalling pathway has been implicated in many diverse  cellular aspects, 
including cell growth, proliferation, differentiation, motility, survival and intracellular 
trafficking. Many of these functions relate to the ability of PI3-kinases to activate AKT, 
also known as protein kinase B (PKB), a regulator of small GTPases and scaffolding 
proteins. Upstream components of AKT signalling pathway such as PI3K, PTEN, and 
Ras are commonly mutated in many human cancers. 
Class IA PI3Ks are composed of a p110 catalytic subunit (p110α, -β and –γ) 
bound  to  one  of  five  regulatory  subunits,  known  as  p85s.  Under  unstimulated 
conditions, p85 stabilizes the labile p110 protein, while inhibiting its catalytic activity. 
Recruitment of the p85–p110 complex to receptors and adaptor proteins via the p85 
SH2 (Src homology 2) domains alleviates this inhibition, leading to PI3K activation and 
production  of  PIP3  (phosphatidylinositol  3,4,5-trisphosphate).  PIP3  formation  is 
required  to  translocate  AKT  to  the  cell  membrane  (Figure  4.11).  At  PIP3,  AKT 
becomes  phosphorylated  at  specific  serine  (473)  and  threonine  (308)  residues  and  
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thereby is activated (review by (Geering, Cutillas et al. 2007)) 
 
Figure 4.11 Schematic representation of PI3K/AKT signalling 
Activation of receptor tyrosine kinases (RTKs) initiates receptor dimerization, and 
activates the intracellular pathways to increase PI3K activity. PI3K produces 
phosphatidylinositol-3,4-diphosphate (PIP2) and phosphatidylinositol-3,4,5-
triphosphate (PIP3), which activates PDK1 and Akt (adapted and modified from (Jiang 
and Liu 2008)). 
 
 
As discussed previously, PI3K signals downstream of VEGFR2 and has been implicates 
in angiogenesis, e.g. EC survival and regulation of VEGF and HIF-2 expression in 
human tumours by AKT activation (Fujio and Walsh 1999); (Jiang, Jiang et al. 2001); 
(Jiang and Liu 2008).  
Graupera and colleagues showed that p110α isoform is selectively required for 
angiogenesis.  Ubiquitous  or  EC-specific  inactivation  of  p110α  led  to  embryonic 
lethality at mid-gestation because of severe defects in angiogenic sprouting and vascular 
remodelling. p110α exerts this critical EC-autonomous function by regulating VEGF-A 
induced EC migration through the small GTPase RhoA (Graupera, Guillermet-Guibert 
et al. 2008).  
  PTEN is an important tumour suppressor gene, upregulated in many tumours (Li, 
Yen  et  al.  1997).  PTEN  functions  as  a  multifunctional  phosphatase  whose  major 
substrate  is  phosphatidylinositol-3,4,5-trisphosphate  (PIP3).  By  using  its  lipid 
phosphatase activity to dephosphorylate PIP3, PTEN negatively regulates the PI3K–
AKT pathway. Endothelial specific deletion of PTEN results in embryonic lethality at 
E11.5 due to bleeding and cardiac failure caused by impaired recruitment of PC and 
vSMCs to blood vessels, and of cardiomyocytes to the endocardium. These phenotypes 
depend strongly on p110γ rather than on p85α and were associated with increased  
expression of angiogenic factors, such as VEGF-A and VEGFRs (Hamada, Sasaki et al. 
2005). Endothelial deficient PTEN mice displayed enhanced tumourigenesis due to an  
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increase in angiogenesis driven by vascular growth factors suggesting an indispensable 
role  in  normal  cardiovascular  morphogenesis  and  post-natal  angiogenesis,  including 
tumour angiogenesis (Hamada, Sasaki et al. 2005).  
 
4.9  Stabilization of vessels by endothelial junctions 
Vessel growth requires the formation of tight junctional complexes between ECs in 
order  to  form  functional  vessels.  Cell-to-cell  contacts  control  critical  endothelial 
functions both in quiescent  and activated  conditions during angiogenesis.  Junctional 
proteins restrain cell migration, contact inhibition of EC proliferation and apoptosis, and 
maintenance of apical-basal cell polarity (reviewed in (Dejana, Orsenigo et al. 2009)). 
Junctional signals counteract to angiogenesis and therefore, cell-to cell junctions need to 
be sufficiently dynamic to allow vessels to respond to an angiogenic switch and return 
the endothelium to a mature, quiescent state. In the endothelium, junctional complexes 
comprise  tight  junctions,  adherent  junction  and  gap  junctions.  These  structures  are 
formed  by  distinct  transmembrane  proteins  that  promote  homophilic  cell-to-cell 
interactions and the transfer of intracellular signals (Dejana, Orsenigo et al. 2009).  
Depending  on  functional  requirements  of  vessels,  EC  junctions  vary  considerably 
between tissues, e.g. tight junction in CNS are enriched controlling strict permeability 
whereas junctions in venules are dynamic and specialized in allowing plasma leakage 
and leukocyte migration. 
  Endothelial  junctions  generally  consist  of  transmembrane  and  cytoplasmic 
components.  At  junctions,  dimeric  adhesive  proteins  bind  to  other  identical  dimers 
present on the adjacent cell, resulting in lateral clustering of adhesive complexes at cell-
to-cell  contact;  the  complex  then  organizes  into  zipper-like  structures  by  lateral 
adhesion  along  cell  borders.  Several  transmembrane  adhesive  proteins  have  been 
identified including vascular endothelial (VE-) and neural (N-) cadherin at adherent 
junctions (Lampugnani and Dejana 1997), occluding and members of the claudin family 
(Nitta, Hata et al. 2003) and junctional adhesive molecules (JAM) at tight junctions 
(Ebnet, Aurrand-Lions et al. 2003). Adherent junction of the endothelium are formed by 
transmembrane  adhesive  protein  VE-cadherin,  which  is  directly  or  indirectly  bound 
intracellularly to β-catenin, p120, plakoglobin and others (Bazzoni and Dejana 2004). 
Targeted inactivation of VE-cadherin or truncation of the β-catenin-binding cytosolic 
domain of the VE-cadherin gene was found not to affect assembly of ECs in vascular 
plexi, but to impair their subsequent remodelling and maturation, causing lethality at 9.5  
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days  of  gestation.  Deficiency  or  truncation  of  VE-cadherin  induced  endothelial 
apoptosis and abolished transmission of the endothelial survival signal by VEGF-A to 
AKT kinase and Bcl2 via reduced complex formation with VEGF receptor-2, β-catenin, 
and PI3K (Carmeliet, Lampugnani et al. 1999). The p85 subunit of PI3K can associate 
with VE-cadherin/ β-catenin complex and PI3K and AKT phosphorylation are activated 
by VE-cadherin clustering, leading to inhibition of EC apoptosis. 
  Endothelial-specific  deletion  of  β  catenin  leads  to  embryonic  lethality  due  to 
abnormal development of the vascular system with enlarged and irregular lumen and 
multiple hemorrhages (Cattelino, Liebner et al. 2003). The molecular mechanism of 
VE-cadherin/  β-catenin  is  complex  and  may  involve  multiple  signalling  pathways. 
Lampugnani and colleagues showed that the association of VE- cadherin with VEGFR2 
contributes to density-dependent growth inhibition by de-phosphorylation of VEGFR2 
by DEP-1 and other phosphatase associated with this complex (Lampugnani, Orsenigo 
et  al.  2006).  VE-  cadherin  limits  cell  proliferation  by  retaining  VEGFR2  at  the 
membrane and preventing its internalization into signalling compartments, in turn the 
lack of internalization is accompanied by the inhibition of MAPK activation and cell 
proliferation (Lampugnani, Orsenigo et al. 2006). 
  Further, endothelial adherent junction might be required for the formation of tight 
junctions. Endothelial VE-cadherin at adherent junctions upregulates the gene encoding 
the tight junction adhesive protein claudin-5. This effect requires the release of the 
inhibitory  activity  of  forkhead  box  factor  FoxO1  and  the  Tcf-4-beta-catenin 
transcriptional repressor complex. VE-cadherin acts by inducing the phosphorylation of 
FoxO1 through AKT activation and by limiting the translocation of β-catenin to the 
nucleus (Taddei, Giampietro et al. 2008). 
  N-cadherin, although expressed by many ECs does not appear to be involved in 
endothelial cell-to-cell junctions in cultured ECs and mature vessels in vivo (Bazzoni 
and Dejana 2004). N-cadherin localizes to endothelial cell-cell junctions in addition to 
its well-known diffusive membrane expression. Loss of N-cadherin in ECs results in 
embryonic lethality at mid-gestation due to severe vascular defects. Intriguingly, loss of 
N-cadherin caused a significant decrease in VE-cadherin and its cytoplasmic binding 
partner,  p120ctn,  indicating  that  N-cadherin  regulates  angiogenesis,  in  part,  by 
controlling VE-cadherin expression at the cell membrane (Luo and Radice 2005). The 
same study revealed that N-cadherin controls the level of β1 integrin in ECs. 
In addition, N-cadherin might be important in pericyte-endothelial cell interaction.   
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Pluripotent  embryonic  stem  cells  (ES  cells)  genetically  null  for  N-cadherin  can 
differentiate  normally  into  ECs.  In  addition,  sprouting  angiogenesis  was  unaltered, 
suggesting that N-cadherin is not essential for the early events of angiogenesis including 
EC migration and proliferation. However, the lack of N-cadherin led to impairment in 
pericyte  covering  of  endothelial  outgrowths,  suggesting  a  function  in  subsequent 
maturation of endothelial sprouts by interacting  with PC (Tillet, Vittet et al. 2005). 
Likewise,  blocking  N-cadherin  function  during  chicken  embryogenesis  resulted  in 
defective  pericyte  adhesion,  increased  pericyte  recruitment  and  disturbed  vascular 
morphogenesis including hemorrhaging (Gerhardt, Wolburg et al. 2000). 
 
4.10  Vessel regression and endothelial cell apoptosis 
Regression of vessels occurs under a variety of settings and is tightly controlled with 
apoptosis. Withdrawal of pro-angiogenic factors such as VEGF and FGF resulted in 
regression  of  newly  formed  vessels.  It  is  possible  that  vessel  regression  is  a 
consequence of cell apoptosis, but it is also possible that apoptosis temporally follows 
regression.  With  loss  of  cell-cell  and  cell-matrix  contacts  as  the  vessels  begins  to 
regress precipitating apoptosis of cells. Degradation of the ECM surrounding tubes led 
to  the  collapse  of  capillary  tubes  and  subsequent  apoptosis  of  ECs,  Saunders  and 
colleagues  demonstrated  that  MMP-1  zymogen  activation  is  mediated  by  multiple 
serine  proteases  and  MMP-10,  and  that  these  events  are  central  to  EC-mediated 
collagen degradation and capillary tube regression in 3D collagen matrices (Saunders, 
Bayless et al. 2005). Depolymerization of microtubule component of the cytoskeleton 
and interference with cell spreading and attachment resulted in collapse of vessels and 
subsequent apoptosis (Bayless and Davis 2004); reviewed in (Im and Kazlauskas 2006). 
Using an in vitro angiogenesis model, Im and Kazlauskus discovered that PI3K was 
essential  for  tube  formation,  whereas  PLCγ  promoted  regression.  The  underlying 
mechanism by which PLCγ antagonized tube formation appeared to be by competing 
with  PI3K  for  their  common  substrate,  phosphatidylinositol-4,5-bisphosphate.  This 
study identified signalling enzymes involved with vessel regression, and reveal that the 
angiogenic  program  can  be  coordinated  by  the availability  of  a  membrane  (Im  and 
Kazlauskas 2006), suggesting that regression is not merely a default of EC apoptosis.  
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4.11  Lymphatic vessel development during embryogenesis 
Lymphatic  vessels  are  generally  found  closely  associated  with  and,  in  many  cases, 
ensheathing major blood vessels. Present in almost all tissues, with the exception of the 
CNS, cartilage and cornea and epidermis, the lymphatic vasculature forms a complex 
network of vessels to maintain fluid homeostasis. Unlike the cardiovascular system, the 
lymphatic  vasculature  is  not  a  closed  circulatory  system  and  has  no  central  pump. 
Interstitial proteins and water, extravasated from capillary blood vessels are absorbed by 
lymphatic  capillaries  and  transported  to  the  blood  circulation  by  the  peristalsis  of 
collecting lymphatic vessels and contractions of surrounding skeletal muscles. Despite 
the main function in maintaining tissue fluid balance and uptake of fat and fat-soluble 
vitamins via the lacteal vessels in the digestive tract, lymphatic vessel provide a route 
for immune cell trafficking and antigen delivery (reviewed in (Hosking and Makinen 
2007). In addition to their role in homeostasis, lymphatic vessels are involved in several 
human  diseases,  such  as  tumour  metastasis,  lymphedema  and  inflammation.  While 
tumour  cells  escape  to  regional  lymph  nodes  via  peritumoural  lymphatic  vessels 
promoting spreading of tumour cells, blockage and lack of proper lymphatic vessels 
causes  lymphedema,  suggesting  important  functions  of  lymphatic  vasculature  in 
pathological conditions and human diseases. 
  The  lymphatic  systems  develops  mid  gestation  during  mouse  embryonic 
development  after  the  establishment  of  blood  vasculature.  Lymphatic  ECs  arise  at 
specific locations of embryonic veins when a subset of venous ECs becomes committed 
to  lymphatic  endothelial  lineage  and  sprout  from  the  major  veins  in  jugular  and 
perimesonephric  area  to  form  primitive  lymphatic  sacs  (Figure  4.12).  The 
homeodomain transcription factor Prox-1 has been identified as a critical regulator of 
lymphatic endothelial cell (LEC) differentiation. Induction of polarized expression of 
Prox-1  in  cardinal  vein  leads  to  upregulation  of  lymphatic-specific  genes,  such  as 
vascular endothelial growth factor receptor 3 (VEGFR-3) and LYVE-1 (Wigle, Harvey 
et al. 2002). 
Lymphatic  vessels  further  sprout  and  migrate  from  jugular  lymph  sacs  to  form  a 
primary lymphatic plexus.  
VEGFR-3, one of the genes upregulated by Prox-1 in lymphatic endothelium, is a key 
regulator of lymphangiogenesis. Continuous signalling via VEGFR-3 is required not 
only for the growth but also for the survival of LECs and for the maintenance of the  
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vessels. Inhibition of VEGFR-3 signalling resulted in apoptosis of LECs and regression 
of  lymphatic  vessels  during  embryogenesis  (Makinen,  Jussila  et  al.  2001).  The two 
known ligands for VEGFR-3, VEGF-C and VEGF-D, can induce lymphagiogenesis in 
vivo and stimulate proliferation, migration, and survival of LECs in vitro (Makinen, 
Veikkola et al. 2001). Genetic ablation of VEGF-C leads to failure in the migration and 
proliferation of the LECs, and as a result the embryos do not develop lymphatic vessels 
(Karkkainen, Haiko et al. 2004).  
Remodelling  of  the  primary  lymphatic  plexus  produces  a  hierarchically  organized 
network consisting of lymphatic capillaries and collecting lymph vessels. Both vessel 
types  differ  in  morphology  and  function:  the  lymphatic  capillaries  are  valveless 
endothelial tubes which have discontinuous BM, overlapping EC junctions and lack PC 
and SMCs, making them highly permeable to large macromolecules. 
 
 
 
Figure 4.12 Development of lymphatic vasculature during embryogenesis 
After the remodelling of the blood vasculature, lymphatic endothelial cells differentiate 
and sprout from the major veins to form lymphatic capillary plexus. Further maturation 
involves establishment of collecting lymphatic vessel versus lymphatic capillary 
identities and acquisition of SMC coverage as well as formation of luminal valves in the 
collecting vessels. Proteins involved in different processes in lymphatic development 
are shown below each section (Karpanen and Makinen 2006). 
 
 
In contrast, collecting lymphatic vessels have sparse SMC coverage, which helps in 
propelling  lymph  forward,  and  numerous,  irregularly  located  valves,  which  prevent 
backflow. 
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Maturation of lymphatic vessels correlates with the formation of luminal valves, 
the attachment of SMCs and PC, as well as the deposition of BM components and the 
assembly in a continuous matrix (Figure 4.12). In turn, lymphatic vessels may receive 
additional survival signals from the ECM, which can promote LEC survival in vitro by 
modulating integrin signalling (reviewed in (Karpanen and Makinen 2006). 
Integrin  α5β1  can  associate  with  VEGFR-3  and  thereby  regulate  VEGFR-3 
phosphorylation and function upon stimulation with VEGFR-3 ligands or ECM (Zhang, 
Groopman et al. 2005); (Wang, Zhang et al. 2001). In addition, integrins may have 
more  direct  functions  in  lymphangiogenesis.  Integrin  α9β1,  which  is  required  for 
normal  lymphatic  development  in  vivo,  was  shown  to  directly  bind  VEGF-C  and 
VEGF-D and thereby promote EC adhesion and migration (Huang, Wu et al. 2000). 
  Deficient valve formation and impaired SMC recruitment have severe effects on 
the  functionality  of  lymphatic  vessels,  resulting  in  retrograde  backflow  and 
lymphedema.  Substantial  progress  in  understanding  the  development  and  molecular 
mechanism of the lymphatic vasculature has been made in the recent years and led to 
new insights into the role of lymphatic vessels in many diseased and might be beneficial 
in future therapeutics.  
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4.12   Stabilization of vessels by mural cells 
Maturation of newly formed vessels during embryonic development and angiogenesis in 
general,  is  accompanied  by  the  recruitment  of  mural  cells  (MC).  MC  consist  of 
pericytes (PC) and vascular smooth muscle cells (vSMC) that associate with the vessel. 
MC  may  contribute  to  physical  stability  upon  attachment,  however  recent  studies 
suggest  a  major  function  of  MC  in  EC  differentiation,  growth  cessation  and  vessel 
stabilization. 
While PC closely attach to the endothelium and are embedded in the BM of capillaries, 
vSMCs reside at arteries and veins. Their localization at the interface between ECs and 
the surrounding tissue makes them a key player in the interaction of the vessel and the 
extracellular space, therefore they may not only function in deposition and degradation 
of ECM components but also in sensing and shaping growth factor gradients.  
In contrast to PC, vascular SMCs are enveloped by a continuous BM rich in 
collagen  and  elastin  fibers.  Smooth  muscle  cells  can  form  up  to  several  layers 
surrounding  the  endothelium  of  larger  vessels,  such  as  the  dorsal  aorta.  Therefore, 
vSMCs are not in direct cell-cell contact with ECs and are separated by BM and in 
larger  arteries  by  a  tissue  layer  called  the  intima.  Smooth  muscle  cells  are  highly 
contractile, regulating hemodynamic processes as a consequence of their high content of 
myofilaments and their strong smooth muscle alpha-actin (αSMA) expression.  
PC instead express low levels of αSMA but can be detected using markers such 
as NG2 (chondroitin sulphate proteoglycan), desmin, regulator of G-protein signalling -
5 (RGS5) and PDGFR-β. Characteristically, PCs extend long processes and one single 
PC often contacts several ECs through specialized contacts, suggesting that PC facilitate 
and integrate cell communication. In areas where BM is absent between ECs and PCs, 
different  types  of  endothelial-pericyte  contacts  have  been  described.  In  adhesion 
plaques,  the  intercellular  space  between  two  cells  types  is  maintained  and  contains 
fibronectin  deposits.  Focal  contacts  called  peg-socket-contacts  represent  membrane 
invaginations extending from either cell type, which contain tight-, gap- and adherent 
junctions (reviewed in (Armulik, Abramsson et al. 2005). 
Pericyte coverage varies extensively between microvessels in different organs, 
with  highest  number  of  PC  in  the  CNS  and  the  lowest  in  skeletal  muscle.  These 
differences much likely reflect their function: while prevalent PC coverage contributes 
to the establishment of blood-brain-barrier in the CNS whereas PC coverage is low in  
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vessels surfaces engaged in exchange of gas and metabolites. Likewise PC morphology 
differs in distinct organs, adapting to their specific function in the organ.  
In contrast to ECs, PC have a more complex ontogeny, as they can develop from 
various cells, as a function on their location in the embryo. In the CNS, PCs are derived 
from neural crest whereas PC enveloping coronary vessels arise from epicardial cells of 
the cardiac tract. Most commonly, however, PC originate from the mesenchyme. De 
Ruiter  and  colleagues  demonstrated  that  embryonic  ECs  may  transdifferentiate  into 
vSMCs (reviewed in (Lamagna and Bergers 2006).  
Recent studies identified PDGFRβ+ perivascular progenitor cells in tumours that are 
partly recruited from the bone marrow. These PDGFRβ+ cells differentiated into mature 
PC  expressing  pericyte  markers  NG2  and  SMA  and  are  able  to  elicit  vascular 
stabilization,  maturation  and  survival  during  adult  angiogenesis  (Song,  Ewald  et  al. 
2005). 
PCs have the ability to modulate and differentiate in vSMCs and vice versa in 
conjunction with vessel growth and remodelling. In addition, PC may also give rise to 
other cell types of mesenchymal origin such as fibroblasts (Armulik, Abramsson et al. 
2005). In the following chapters, I will summarize major findings, as well as signalling 
pathways,  ECM  components  and  junctional  molecules  functioning  in  mural  cell 
recruitment.  Pericyte–endothelial  interactions  are  controlled  by  a  host  of  different 
molecules,  including  platelet-derived  growth  factor  (PDGF)-BB/PDGF  receptor 
(PDGFR)  β,  membrane  type  (MT)  1-matrix  metalloproteinase  (MMP),  Heparan 
sulphate proteoglycans (HSPG), N-cadherin, Ang1/Tie-2, transforming growth factor 
(TGF)  β,  hepatocyte  growth  factor  (HGF),  EphrinB2  and  vascular  cell  adhesion 
molecule (VCAM) 1/α4-integrin (Gerhardt and Semb 2008). Figure 4.13 illustrates the 
principles  of  pericyte/  endothelial  interaction  and  mural  cell  recruitment  during 
development. 
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Figure 4.13 Schematic model of pericyte recruitment, attachment and detachment  
Genes listed in the figure positively regulate pericyte recruitment and attachment; a) 
TGF-β dependent induction of mesenchymal progenitor cells to differentiate into 
pericytes; b) during sprouting angiogenesis, recruitment, proliferation and migration of 
pericytes requires endothelial PDGF-BB signalling to pericytes expressing PDGFR-
β; MT1-MMP enhances this effect by direct interaction with PDGFR-β; Ang1 activates 
the endothelial Tie2 receptor, leading to endothelial HGF secretion, which increases 
pericyte motility. c) Vascular maturation requires firm pericyte adhesion regulated by 
endothelial–pericytic N-cadherin junctions, EphrinB2 and integrin signalling. HSPG 
and PDGF-BB retention are essential for attachment. NCAM expression by surrounding 
tissue enhances pericyte recruitment and attachment in a PDGF-BB dependent manner. 
d) Detachment of pericytes destabilizes the vasculature and leads to loss of diameter 
control. Ang2 counteracting the effect of Ang1 can lead to pericyte detachment. ECM 
degradation through either MMPs or alteration of HSPG may also contribute to this 
process (Gerhardt and Semb 2008). 
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4.13   De novo induction of vSMCs depends on TGF-β 
Members  of  the  TGF-β  superfamily  exert  their  effect  by  binding  to  specific 
serine/threonine kinase type I and type II receptor complexes. In mammals, seven type 
I, also termed activin receptor-like kinase (ALK) 1 to 7, and five type II receptors have 
been identified. TGF-β has high affinity for the TGF-β type II receptor (TβRII), and 
upon binding a specific TGF-β type I receptor (TβRI) is recruited. In ECs, TGF-β has 
been shown to bind and signal via both, ALK1 and ALK5. On heteromeric complex 
formation between type I and type II receptors, the TβRI is transphosphorylated by 
TβRII (Figure 4.14). This results in a conformational change in and activation of the 
type  I  receptor,  which  can  subsequently  propagate  the  signal  inside  the  cell  by  the 
phosphorylation of specific effectors.  
Endoglin, a third type of transmembrane TGF-β receptor, acts as a  co-receptor and 
participates in TGF-β mediated ALK1 and ALK5- signalling in ECs. After receptor 
activation and phosphorylation, receptor-regulated Smads (R-Smads) are recruited and 
presented  to  the  TβRI,  which  become  phosphorylated  and  form  a  complex  with 
common mediator (Co-)Smad 4, accumulate in the nucleus and regulate the expression 
of  specific  target  genes.  In  ECs,  ALK1  activation  leads  to  phosphorylation  of 
Smads1/5/8,  while  catalytic  engagement  of  ALK5  results  in  phosphorylation  of 
Smads2/3 (reviewed in (Bertolino, Deckers et al. 2005);(Goumans, Liu et al. 2009). 
 
Genetic  inactivation  of  members  of  the  TGF-β  signalling  pathway  including 
TGFb1,  TbRII,  Alk1,  Alk5,  endoglin  and  Smad5  revealed  that  TGF-β  signalling  is 
essential for vascular development. Mice carrying loss of function mutations in any of 
these genes die at mid gestation between E9.5- E11.5 during embryonic development 
due to disrupted vasculogenesis in the yolk sac. Detailed analyses demonstrated TGF-β 
components  to  be  crucial  for  several  steps  of  the  angiogenic  process,  including  the 
maintenance of the integrity of the vessel wall, the recruitment of SMCs, the deposition 
of ECM, as well as the differentiation of ECs into a more specialized endothelium such 
as arteries and veins. 
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Figure  4.14  Schematic  representation  of  TGF-β/SMAD  signal  transduction 
pathway 
TGF-β induces a heteromeric complex of type I and type II serine/threonine kinase 
receptors. On ligand binding, a type II receptor interacts with a type I receptor and 
phosphorylates the GS domain of the type I receptor. Then, the activated type I receptor 
activates R-Smads by phosphorylating their C-terminus. On phosphorylation, R-Smads 
form heteromeric complexes with Smad4 that translocate into the nucleus. Within the 
nucleus, the heteromeric Smad complexes, in collaboration with transcription factors 
(TFs), cofactors (ie, coactivators and corepressors) participate in the regulation of target 
gene expression (Bertolino, Deckers et al. 2005). 
 
 
Mutations  in  endoglin  and  ALK1  result  in  the  human  autosomal-dominant  disorder 
called hereditary hemorrhagic telangiectasia (HHT) displaying vascular malformation 
including fragile and leaky vessels with defects in MC recruitment.  
The primary target cell for TGF-β is the EC since endothelial-specific deletion 
of ALK5 and TβRII phenocopied the complete loss of TβRII or ALK5, indicating that 
the defects in the recruitment or differentiation of SMCs in these knockout mice are 
likely to be an indirect consequence of the primary defect in the ECs (Carvalho, Itoh et 
al. 2007). 
Dependent on context and dosage, TGF-β has a stimulatory or inhibitory effect  
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on  blood  vessel  formation.  TGF-β  signalling  via  ALK1  promotes  endothelial 
proliferation, tube formation and migration while TGF-β/ALK5 signalling inhibits these 
responses. ALK1 and ALK5 physically interact, and their cross-talk provides ECs with 
a  TGF-β  dependent  switch  to  fine  tune  endothelial  function.  ALK5,  for  example 
induces the expression of fibronectin and plasminogen activator inhibitor type 1 (PAI-
1),  a  negative  regulator  of  EC  migration.  ALK5  signalling  has  been  proposed  to 
regulate  TGF-β-induced  vascular  permeability  and  actin  cytoskeleton  remodelling. 
Clustered VE-cadherin recruits TβRII and may promote TGF-β signalling by enhancing 
TβRII/ALK5  assembly  in  an  active  receptor  complex.  Elevated  TGF-β-induced 
Smad2/3 activation by VE-cadherin indicates a positive and endothelial specific role for 
VE-cadherin  in  TGF-β/ALK5-induced  vessel  stabilization.  Taken  together,  TGF-
β/ALK5  signalling  plays  an  important  role  in  keeping  the  endothelium  quiescent 
(Rudini, Felici et al. 2008). 
Although the EC appears to be the primary target for TGF-β signalling during 
early blood vessel assembly, there is ample evidence for signalling from the EC to the 
MC important for maturation and stabilization of vessels. TGF-β is a potent stimulator 
for  vSMC  differentiation  and  vSMC  express  endoglin  and  multiple  type  I  and  II 
receptors, activating the expression of SMC differentiation genes such as SM22α. TGF-
β-induced growth inhibition of vascular SMCs was found to be ALK5- mediated via 
both  Smad3-dependent  and  p38  MAPK-dependent  signalling  pathways.  Smad3-
deficient vascular SMCs demonstrated reduced growth inhibition by TGF-β, but did not 
show any attenuated TGF-β-mediated migratory response (Feinberg, Watanabe et al. 
2004). ECs produce latent TGF-β that upon EC-SMC interaction can be activated and 
induce  SMC  differentiation  and  function  (Ding,  Darland  et  al.  2004).  Hirschi  and 
colleagues  identified  that  gap  junction  communication  between  endothelial  and 
mesenchymal  cells  mediates  TGF-β  activation  and  subsequent  MC  differentiation 
(Hirschi, Burt et al. 2003). Cook et al. report that TGF−β induces rearrangement of the 
adherent junction complex by separating VEGFR2 from VE-cadherin and increasing β-
catenin association with both VEGFR2 and VE-cadherin. This rearrangement requires 
VEGF signalling through VEGFR2 in ECs, highlighting a new mechanism in VEGF-
TGF-β interaction (Cook, Ferrari et al. 2008). 
The functional relevance of TGF-β expression and MC development in vivo has 
been  demonstrated  by  gene  inactivation  in  mice.  Alk1  and  endoglin  deficient  mice 
display  defective  remodelling  of  the  primary  capillary  plexus  of  the  yolk  sac  and  
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aberrant development of SMCs. Mice lacking TbRII, Smad5, Smad1 and TGFb1 show 
defects in vasculature structure or blood vessel organization indicative of a defect in EC 
lining  and  impaired  SMC  development  (reviewed  by  (Goumans,  Liu  et  al.  2009)). 
Taken together, TGF-β signalling is important for vascular development and depending 
on  the  context  acts  pro-or  anti-angiogenic  on  EC  functions  and  controls  SMC 
differentiation. 
 
4.14  PDGF-B/PDGFRb signalling in pericyte recruitment 
Similar to the VEGF growth factor family, platelet derived growth factor (PDGF) are 
dimers of disulfide-linked polypeptide chains. In mammals, four different genes encode 
for PDGF chains, PDGF-A, PDGF-B, PDGF-C and PDGF-D. All four ligands, which 
are inactive in their monomeric form, assemble intracellularly to form disulfide-linked 
homodimers. One heterodimer PDGF-AB has been demonstrated in human platelets, 
however,  PDGF  homodimers  dominate,  at  least  during  development.  Also,  the 
endogenous expression of Pdgfa and Pdgfb are generally non-overlapping, suggesting 
that  heterodimers  are  infrequent.  All  members  of  the  PDGF/  VEGF  family  carry  a 
growth factor core domain containing a conserved set of cysteine residues. The core 
domain is necessary and sufficient for receptor binding and activation. Classification 
into PDGFs and VEGFs is based on receptor binding, assuming selectivity for their 
cognate  receptors  (reviewed  in(Andrae,  Gallini  et  al.  2008).  Recent  studies  showed 
however, that VEGF-A might bind to and activate PDGF receptors in bone-marrow-
derived mesenchymal stem cells (Ball, Shuttleworth et al. 2007). Further challenges to 
functional  distinctions  come  from  the  finding  of  VEGFR2/  PDGFRβ  complexes 
(Greenberg, Shields et al. 2008). 
PDGFs act via two membrane-bound receptor tyrosine kinases, PDGF receptor 
α  and  –β,  with  common  domain  structures.  Ligand  binding  initiates  receptor 
dimerization  and  subsequently  autophosphorylation  and  activation  of  downstream 
signalling  cascade.  Phosphotyrosine  residues  provide  docking  sites  for  SH2-domain 
containing signalling molecules such as PI3K, PLCγ, Ras GTPase-activating protein 
(Ras-GAP) and Src family kinases, which initiate signal transduction. 
Tallquist  and  colleagues  generated  mice  that  bear  a  PDGFR-β  that  can  no  longer 
activate PI3K or PLCγ and showed that that loss of PI3K and PLCγ activation does not 
fully incapacitate the β-receptor, but rather quantitatively represses the ability of the  
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receptor to carry out normal functions (Tallquist, Klinghoffer et al. 2000). 
  Depending  on  ligand  configuration  and  the  pattern  of  receptor  expression, 
different receptor dimers may form. However, in vivo there is functional evidence for 
only few interactions, i.e. PDGF-AA and PDGF-CC via PDGFR-α and PDGF-BB via 
PDGFR-β. PDGFs act primarly as paracrine growth factors. Both PDGF and PDGFR 
expression patterns are spatio-temporally regulated in vivo, and several factors induce 
PDGFR  expression,  including  TGF-β  and  basic  fibroblast  growth  factor  (bFGF) 
(reviewed in (Andrae, Gallini et al. 2008)). Pdgfb is mainly expressed in vascular ECs, 
whereas Pdgfrb is expressed in the mesenchyme, particularly in PC and vSMCs. As 
described for VEGF-A, binding to ECM components regulates diffusion of PDGFs in 
the  tissue  interstitium.  For  PDGF-B  such  binding  is  accomplished  in  part  by  the 
positively  charged  C-terminal  motifs,  referred  to  as  retention  motif,  containing  a 
conserved  sequence  of  basic  amino  acid  residues.  The  presence  or  absence  of  the 
retention motif is determined by alternative C-terminal proteolytic processing of the 
PDGF-B chain (reviewed in (Andrae, Gallini et al. 2008)). 
Combined expression and loss of function studies of Pdgfb and Pdgfrb suggest that 
PDGF-B is released from the endothelium and promotes recruitment and proliferation 
of adjacent MC.  
A detailed analysis of Pdgfb expression in the CNS revealed a heterogeneous 
endothelial Pdgfb expression pattern. At E11.5 and E14.5, Pdgfb expression occurred in 
most  vascular  EC  recognized  in  the  brain,  while  at  later  embryonic  stages  and 
postnatally Pdgfb expression is restricted to few, immature ECs (Hellstrom, Kalen et al. 
1999).  Pdgfb  expression  is  strongest  in  leading  endothelial  tip  cell  of  the  retinal 
vasculature (Gerhardt, Golding et al. 2003), and endothelial specific ablation of Pdgfb 
results in cardiovascular defects resembling the Pdgfb null mice, indicating that the 
endothelium is the main source of PDGF-BB expression (Bjarnegard, Enge et al. 2004). 
Deletion  of  pdgfb  in  two  other  major  cellular  sources  of  PDGF-B,  neurons,  and 
hematopoietic cells had no effect on the vasculature (Enge, Bjarnegård et al. 2002); 
(Kaminski, Lindahl et al. 2001). 
In  mid-to-late  gestational  embryos,  developing  PC  are  normally  seen  as  solitary 
PDGFR-β-positive  cells  in  close  proximity  to  capillaries  (Lindahl,  Johansson  et  al. 
1997).  Developing  vSMC  of  arteries/arterioles  are  likewise  PDGFR-β  positive,  and 
occur in single or multiple layers around the endothelial tube (Lindahl, Johansson et al. 
1997).  Hellstrom  and  colleagues  confirmed  the  presence  of  abundant  PDGFR-β- 
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positive vSMC/PC progenitors in a wide range of organs, including brain, skin and 
heart with the exception of the liver (Hellström, Kalén et al. 1999). 
Pdgfb and Pdgfrb -deficient mice both displayed substantial loss of MC investment of 
capillary  vessels  due  to  reduced  MC  proliferation,  suggesting  a  role  of  PDGF-B  in 
vSMC/PC cell proliferation during vascular growth. Their findings led to a model in 
which PDGFR-β-positive vSMC/PC progenitors initially form around certain vessels by 
PDGF-B-independent  induction.  Subsequent  angiogenic  sprouting  and  vessel 
enlargement  involves  PDGF-B-dependent  vSMC/PC  progenitor  co-migration  and 
proliferation, and/or PDGF-B-independent new induction of vSMC/PC, depending on 
tissue context (Hellström, Kalén et al. 1999). 
The degree of MC loss differs between different organs, reflecting a role of 
PDGF-B/PDGFR-β  as  a  selective  rather  than  inductive  signal  in  PC/vSMC 
development.  Induction  of  MC  differentiation  from  the  perivascular  mesenchyme 
around the early aorta occurs independent of PDGF-B/PDGFR-β signalling. In contrast, 
the recruitment of MCs from a pre-existing pool of such cells, by means of co-migration 
and  proliferation,  is  completely  dependent  on  PDGF-B/PDGFR-β  signalling,  which 
would explain the almost complete loss of CNS MCs in the absence of PDGF-B or 
PDGFR-β (Hellström, Kalén et al. 1999).; reviewed in (Andrae, Gallini et al. 2008) and 
(Armulik, Abramsson et al. 2005). 
Detailed analysis of the vasculature in CNS of Pdgfb and Pdgfrb deficient mice 
revealed  that  the  absence  of  PCs  correlates  with  endothelial  hyperplasia,  increased 
capillary diameter, abnormal EC shape and ultrastructure, changed cellular distribution 
of  certain  junctional  proteins,  and  morphological  signs  of  increased  transendothelial 
permeability  (Hellstrom,  Gerhardt  et  al.  2001).  These  findings  suggest  that  MC 
investment negatively controls EC proliferation and promotes vessel stabilization by 
maturation of ECs and the establishment of firm junctions. Despite severe MC defects 
and hypoplasia starting from embryonic day 10, Pdgfb and Pdgfrb null mice developed 
until E16-19.5. Although PC deficiency appears to have direct effects on EC number 
before E13.5, the subsequent increased VEGF-A levels may further aggravate defective 
microvessel  architecture,  promote  vascular  permeability,  and  contribute  to  the 
formation of the edematous and widespread hemorrhagic phenotype causing embryonic 
lethality in late gestation Pdgfb and Pdgfrb knock out embryos (Hellstrom, Gerhardt et 
al. 2001). 
  PDGF-B/PDGFR-β signalling also controls mesangial cell development in   
  62 
kidney  glomeruli.  In  Pdgfb  and  Pdgfrb  knockout  kidneys,  mesangial  cells  are  not 
properly recruited into the developing glomerular tufts, and as a consequence capillary 
branching fails. These data identified PDGFR-β positive mesangial cells as a primary 
target for endothelium-derived PDGF-BB (Lindahl, Hellstrom et al. 1998). Conversely, 
blocking  PDGFR-β  by  administration  of  neutralizing  antibodies  resulted  in  severe 
disruption of the glomerular structure, whereas no apparent deformation was observed 
in the collecting ducts. In the disrupted glomeruli, the number of the mesangial cells 
was reduced markedly and capillary ECs of the glomeruli in the outer cortex region 
underwent apoptosis (Sano, Ueda et al. 2002). 
Wagner  and  colleagues  further  established  that  mitogenic  signalling  is  mediated  by 
PDGFR-β in metanephric mesenchymal cells. PDGF signalling stimulates proliferation 
and  migration  of  metanephric  mesenchymal  cells,  from  which  mesangial  cells  are 
derived  and  PI3K  is  an  important  regulator  of  PDGF-induced  DNA  synthesis. 
Activation of ERK1/2 is partially dependent on PI3K, and both the PI3K and MEK-
ERK1/2 pathways contribute to PI3K–dependent mitogenesis (Wagner, Ricono et al. 
2007).  
  PDGF-B/PDGFR-β signalling also affects vessel formation and PC recruitment in 
the labyrinthine layer of the mouse placenta. Normally, the placenta develops a complex 
network of capillaries that generates a large surface for excretion and absorption. The 
reduced numbers of PC and trophoblasts in mutants of Pdgfb and Pdgfrb null embryos 
correlates with specific vascular defects including dilated vessels and an abnormal ratio 
of  the  surface  area  of  maternal  and  fetal  blood  vessels  in  the  placental  labyrinth. 
Therefore, PDGF-BB acts locally to contribute to MC recruitment in the placenta and 
PC  possibly  control  capillary  branching  through  intussusceptive  vessel  splitting 
(Andrae, Gallini et al. 2008); (Ohlsson, Falck et al. 1999).  
  Recent  results  indicate  a  role  for  PDGF-B/PDGFR-β  signalling  in  epicardial 
epithelial-to-mesenchymal  transition  (EMT)  and  recruitment  of  epicardium  derived 
mesenchymal cells into the myocardium (Van den Akker, Winkel et al. 2008). Pdgfb 
and  Pdgfrb  deficient  embryos  displayed  perimembranous  and  muscular  ventricular 
septal defects, maldevelopment of the atrioventricular cushions and valves, impaired 
coronary arteriogenesis, and hypoplasia of the  myocardium and cardiac nerves. The 
abnormalities correspond with models in which epicardial development is impaired and 
with neuronal neural crest-related innervation deficits. This implies a role for PDGF-
B/PDGFR-β-signalling specifically in the contribution of these cell lineages to cardiac  
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development (Van den Akker, Winkel et al. 2008). 
 
VEGF-A,  FGF-2  and  PDGF-B  are  pro-angiogenic  factors  that  play  essential  roles 
during  vascular  development  and  pathological  conditions.  However,  their  precise 
interplay or potential synergysm is not well established. Using the matrigel plug assay, 
an  in  vivo  angiogenesis  model,  Kano  and  colleagues  showed  enhanced  intercellular 
PDGF-B signalling in a cell-type specific manner: VEGF-A enhances endothelial Pdgfb 
expression,  whereas  FGF-2  enhances  mural  Pdgfrb  expression.  Co-stimulation  with 
VEGF-A  and  FGF-2  caused  significant  MC  recruitment  in  vitro  and  formation  of 
functional neovasculature in vivo, compared with single-agent stimulation, suggesting a 
synergistic effect by co-stimulation with growth factors (Kano, Morishita et al. 2005). 
VEGF and PDGF stimulate proliferation and migration of EC and MC, respectively and 
thereby promote vessel growth and stabilization of newly formed sprouts. One would 
expect  that  both  act  synergistically  during  angiogenesis,  however,  a  recent  study 
revealed that combination of both growth factors completely suppressed angiogenesis.  
Greenberg  and  colleagues  found  that  under  conditions  of  VEGF/PDGF  stimulation 
VEGFR2  negatively  regulates  neovascularization  (Greenberg,  Shields  et  al.  2008). 
Stimulation  of tissues  with  VEGF/PDGF  results  in  a  reduction  of  vascular  pericyte 
coverage, but VEGFR2 inhibition restored pericyte coverage and neovascularization, 
suggesting that MC VEGFR2 negatively regulates this response. 
Further  in  vitro  studies  demonstrated  that  VEGF-mediated  activation  of  VEGFR2 
suppresses  PDGFR-β  signalling  in  vSMC  through  the  formation  of  a  VEGFR2/ 
PDGFR-β complex. Therefore, Greenberg et al. identified VEGF-A as an angiogenic 
inhibitor by disrupting vSMC function. However, crucial expression studies are missing 
in this study. The authors have not demonstrated VEGFR2 expression in mural cells and 
the study lacks in vivo evidence for a function of VEGFR2 in SMC coverage. One could 
address this aspect by Cre-lox mediated deletion of VEGFR2 in mural cells.  
 
Several  isoforms  of  the  growth  factors  PDGF  and  VEGF  contain  long  C-
terminal stretches of positively charged amino acids that mediate the binding to the 
ECM. This domain is referred to as retention motif and promotes binding to heparan 
sulfate (HS) proteoglycans.  
In PDGF-A and PDGF-B, the HSPG-binding motifs do not affect receptor binding or 
biological  activity  of  the  recombinant  proteins.  However,  in  transfected  cells,  these 
motifs confer retention of the secreted growth factor to the surface of the producing  
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cells.  Conversely,  absence  of  the  retention  motif  leads  to  increased  secretion  of  a 
diffusible protein that readily accumulates in the cell culture medium. Deletion of the 
PDGF-B retention motif in vivo by gene targeting (Pdgfb
ret/ret) resulted in defective 
investment  of  PC  in  the  microvessel  wall.  Although  Pdgfb
ret/ret  mice  survived  into 
adulthood, the phenotype strongly resembled defects observed in Pdgfb/ Pdgfrb null 
mice  including  abnormal  formation  of  the  renal  glomerulus  mesangium.  Detailed 
analysis  suggested  that  retention  of  PDGF-B  in  microvessels  is  essential  for  proper 
recruitment and organization of PC and for renal and retinal function in adult mice 
(Lindblom, Gerhardt et al. 2003). 
 
4.15  Heparan sulfate interaction during angiogenesis 
The  heparan  sulfate  (HS)  complexity,  their  ubiquitous  and  evolutionary  conserved 
expression pattern as well as their enormous spectrum of interaction may reflect the 
importance of HS during embryonic development and pathological condition.  
Heparan  sulfate  glycosaminoglycans  are  members  of  the  glycosaminoglycan  (GAG) 
family,  which  are  complex  polysaccharides  that  are  characterized  by  a  repeat 
disaccharide unit of uronic acid linked to a glucosamine, also referred to as HS. These 
HS chains are unbranched and of variable length, with one end covalently bound to a 
core protein via serine residues. Their structural complexity arises from the differential 
modification of the saccharide backbone including N-and O-sulfations, as well as N-
acetylation or unmodified N-residues. HSPG are classified into several families based 
on  the  core  protein  structure.  Glypicans  and  Syndecans  are  two  major  cell  surface 
HSPGs,  and  are  linked  to  the  plasma  membrane  by  a  glycosylphosphatidylinositol 
(GPI) linkage or a transmembrane domain, respectively. Perlecans are secreted HSPGs 
that  are  mainly  distributed  in  the  ECM  (Figure  4.15).  In  contrast, to  glypicans  and 
perlecans, the syndecan family contains chondroitin sulftate in addition to the heparan 
sulfate chain (reviewed in (Lin 2004)). 
 
HS chain biosynthesis takes place in the Golgi and can be divided in three major 
sequential  processes:  chain  initiation,  polymerization  and  modification.  Figure  4.16 
summarizes a simplified three-step process of HS chain synthesis.  
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Figure 4.15 The three main classes of cell-surface heparan sulfate proteoglycans 
(HSPGs) 
(A) Syndecan core proteins are transmembrane proteins that contain a highly conserved 
C-terminal cytoplasmic domain. Heparan sulfate (HS) chains attach to serine residues 
distal from the plasma membrane. Some syndecans also contain a chondroitin sulfate 
(CS) chain(s) that attaches to a serine residue(s) near the membrane. (B) The glypican 
core proteins are disulphide-stabilized globular core proteins that are linked to the 
plasma membrane by a glycosylphosphatidylinositol (GPI) linkage. HS chains link to 
serine residues adjacent to the plasma membrane. (C) Perlecans are secreted HSPGs 
that carry HS chains (Lin 2004). 
 
 
HS chain synthesis begins with the assembly of a linkage tetrasaccharide (glucuronic 
acid-galactose-glactose xylose) at the GAG attachment site(s) of the core protein, which 
contains  two  to  four  Ser-Gly  sequences.  After  addition  of  an  N-acetylglucosamin 
residue, the HS polymer is generated by alternating addition of N-acetylglucosamin and 
glucuronic acid catalyzed by glycosyl transferase encoded by EXT.  
As the chain grows, modifying enzymes introduce sulfate groups at various positions, 
and  some  of  the  glucuronic  acid  residues  are  converted  into  iduronic  acid 
(epimerization).  Any  of  the  four  NDST  enzyme  (glucosaminyl  Ndeacetylase/  N-
sulfotransferase 1-4) can replace the acetyl group in N-acetylglucosamine with a sulfate 
group. 2O-, 3O- and 6O-sulfotransferases (OST) attach additional sulfate groups. The 
addition of negatively charged sulfation groups results in a highly negatively charged, 
hydrophilic  HS  product  that  contains  clusters  of  N-and  O-sulfated  sugar  residues 
separated by non-sulfated regions (Figure 4.16). The negative charge contributed by 
carboxyl and sulfate groups is essential for interactions between HS and basic amino 
acid residues in proteins such as VEGF-A and PDGF-B. 
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Figure 4.16 Heparan sulfate chain biosynthesis 
Heparan sulfate (HS) glycosaminoglycan (GAG) chains are synthesized on a core 
protein by the sequential action of individual glycosyltransferases and modification 
enzymes, in a three-step process involving chain initiation, polymerization and 
modification. HS chain synthesis begins with the assembly of a linkage tetrasaccharide 
on serine residues in the core polypeptide. This process is catalyzed by four enzymes 
(Xyl transferase, Gal transferase I-II and GlcA transferase I), which add individual 
sugar residues sequentially to the non-reducing end of the growing chain. After the 
assembly of the linkage region, one or more α-GlcNAc transferases add a single α1,4-
linked GlcNAc unit to the chain, which initiates the HS polymerization process. HS 
chain polymerization then takes place by the addition of alternating GlcA and GlcNAc 
residues, which is catalyzed by the EXT family proteins. As the chain polymerizes, it 
undergoes a series of modifications that include GlcNAc N-deacetylation and 
Nsulfation, C5 epimerization of GlcA to IdoA, and variable O-sulfation at C2 of IdoA 
and GlcA, at C6 of GlcNAc and GlcNS units, and, occasionally, at C3 of GlcN residues. 
The HS GAG chains are ~100 or more sugar units long and have numerous structural 
heterogeneities. Gal, galactose; GlcNAc, Nacetylglucosamine; GlcA, glucuronic acid; 
GlcNS, N-sulfoglucosamine; IdoA, iduronic acid (Lin 2004).  
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The  final  HS  structure  depends  in  the  activity of  modification  enzymes  and  differs 
greatly in various tissues, cells and physiological and pathological conditions. However, 
almost  every  cell  has  the  capacity  to  express  HS.  Heparan  sulfate  and  structurally 
related  protein  heparin  interact  with  a  wide  variety  of  growth  factors,  morphogens, 
proteases  and  protease  inhibitors,  cytokine  and  ECM  components.  HS  interactions 
mediate many biological functions from the formation of growth factor/ morphogen 
gradients, to the stabilization and activation of ligand-receptor-complexes, over acting 
as scaffolding proteins. The functional relevance of HS is reflected in the early lethality 
of  mice  at  E8.5  lacking  HS  biosynthesis  by  deletion  of  glycosyl  transferease  Ext1. 
Ablation of the polymerization enzyme results in total absence of HS but increased 
chondroitine  sulfate  synthesis.  Ext1  homozygous  mutants  fail  to  gastrulate  and 
generally  lack  organized  mesoderm  and  extraembryonic  tissues,  resulting  in  smaller 
embryos compared to normal littermates (Lin, Wei et al. 2000).  
The  Drosophila  Ext1  homologue,  tout-velu,  regulates  Hedgehog  diffusion  and 
signalling, which play an important role in tissue patterning.  
Mutation of the EXT1 and EXT2 gene in humans result in a pathological condition, 
termed hereditary multiple exostosis (HME). EXT patients carrying mutations in one of 
the EXT genes develop multiple benign bone tumours and often have a short stature. 
EXT1 heterozygous humans develop exostoses in their bones at an early age, correlating 
with reduced HS production. Further, HS on the tumour-cell surface have been shown 
to  be  important  in  many  aspects  of  tumour  phenotype  and  development,  including 
cellular transformation, tumour growth, invasion and metastasis. In vivo studies in mice 
indicate that changes in the fine structure of tumour-cell-surface HSs have profound 
effects  on  tumour-cell  growth  kinetics  and  metastasis  formation  (reviewed  in 
(Sasisekharan, Shriver et al. 2002)). Human heparanase, a matrix-degrading enzyme is 
rarely found in human tissues but its expression is often increased in tumours promoting 
invasion, angiogenesis and spontaneous metastasis. Heparanse-mediated cleavage of the 
HS  chain  releases  10-20  residue  sugar  long  fragments  that  influence  activity  and 
availability of HS-binding growth factors that regulate cell behaviour of tumour cells 
and  host  cells  in  the  tumour  environment  (reviewed  in  Sanderson  et  al.,  2005). 
Inhibition  of  heparanase  results  in  reduction  of  tumour  growth  and  impaired 
angiogenesis,  correlating  with  diminished  VEGF-A  interaction  to  VEGFR2  on  the 
tumour  endothelium  (Joyce,  Freeman  et  al.  2005).  Taken  together,  genetic  studies 
highlight the importance of HS biosynthesis and expression in human diseases such as  
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cancer and hereditary multiple exostosis.  
The location of HS at the cellular-matrix interface makes them important modulators of 
cell signalling events, and thereby regulating how cells perceive their environment. The 
formation  of  growth  factor  gradients  is  essential  during  embryonic  development  as 
shown by target inactivation of global and cell-type specific deletion in HS-biosynthesis 
and altered HS modification. 
As  described  previously,  loss  of  HS-binding  domain  in  VEGF  and  PDGF-B 
leads to abnormal vessel morphology and patterning defects as well  as reduced PC 
recruitment, respectively.  The  vascular  defects  are  caused  by  loss  of  spatial  growth 
factor  distribution  due  to  lack  of  growth  factor  retention  properties.  Following  the 
studies of Lindblom and colleagues, demonstrating that HS-binding of PDGF-BB is 
essential for proper pericyte recruitment and association to the vessel, Abramsson et al. 
investigated the functional relevance of N-sulfation in HS-mediated PDFG-BB binding 
and its effect on pericyte recruitment (Abramsson, Kurup et al. 2007). Studying PC 
recruitment  in  the  developing  hindbrain  of  mouse  mutants  for  Ndst1,  Hsepi,  and 
Pdgfb
ret/ret revealed an astonishing degree of correlation between in vitro binding of 
PDGF-BB  to  HS  and  in  vivo  PC  recruitment/attachment.  Moreover,  the  data 
demonstrate that N- and O-sulfation of HS are required for efficient PDGF-BB binding, 
whereas saccharide fine structure is of lesser importance. Cell culture assays provided 
corroborating direct evidence for reduced retention of PDGF-BB on cells deficient in 
HS and indicated that HS may contribute to PC recruitment by augmenting PDGFRb 
signalling  and  directed  cell  migration  toward  PDGF-BB.  Therefore,  interaction  of 
PDGF-BB  with  sulfated  HS  regions  is  essential  for  PC  recruitment  in  vascular 
development. 
In  agreement  with  these  findings,  endothelial  PDGF-BB  retention  is 
indispensable  for  proper  integration  of  PC  in  the  vessel  wall  of  tumour  vessels 
(Abramsson, Lindblom et al. 2003). In tumours transplanted into PDGF-B retention 
motif–deficient (Pdgf-b
ret/ret) mice, PC were fewer and were partially detached from the 
vessel  wall,  coinciding  with  increased  tumour  vessel  diameter  and  hemorrhaging. 
PDGF-B expression from the tumour cells enhances PC recruitment in both wildtype 
and Pdgf-b
ret/ret mice but failed to correct the pericyte detachment in Pdgf-b
ret/ret mice. 
Fuster  and  colleagues  addressed  the  function  of  endothelial  heparan  sulfate  during 
angiogenesis  by  deleting  Ndst1  from  endothelial  cells.  Physiological  angiogenesis 
during  cutaneous  wound  repair  was  unaffected,  as  was  growth  and  reproductive 
capacity of the mice.  
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However,  loss  of  endothelial  Ndst1  resulted  in  smaller  tumours  and  reduced 
microvascular density and branching in vivo due to reduced growth factor binding and 
apoptosis. Ndst1 deficient ECs exhibited reduced binding of FGF-2 and VEGF164 to 
cells  and  to  purified  heparan  sulfate,  suggesting  an  cell-autonomous  effect  of 
endothelial HS (Fuster, Wang et al. 2007). 
Likewise, embryonic stem (ES) cells lacking Ndst1 and -2 were unable to bind 
VEGF-A164 and failed to differentiate and form vessels that could not be rescued by 
addition of HS or heparin (Jakobsson, Kreuger et al. 2006). Vegfr2 deficient ES cells 
also fail to form vascular structures, however mixing Ndst1/2-/- and Vegfr2-/- ES cells 
resulted  in  normal  vessel  formation  and  differentiation,  suggesting  that  endothelial 
derived HS is dispensable for vascular development in embryonic bodies.  
Therefore, VEGF signalling in ECs is fully supported by HS expressed in trans by 
adjacent  perivascular  smooth  muscle  cells,  at  least  in  this  culture  system. 
Transactivation of VEGFR2 leads to prolonged and enhanced signal transduction due to 
HS-dependent trapping of the active VEGFR2 signalling complex (Jakobsson, Kreuger 
et al. 2006). 
 
This study highlights the crosstalk between endothelial and MC and a mechanism of 
transactivation by HS. The aspect of the spatial constellation of HS production between 
signal sending and signal receiving cell will become important in the third project of my 
thesis. I will follow up on this aspect later in thesis.  
In summary, HS is required for embryogenesis and plays important roles during normal 
and pathological angiogenesis by shaping growth factor gradients, activation of receptor 
complexes and mediating many signalling pathways involved in vascular development.  
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4.16  Extracellular matrix/ mircoenvironment surrounding blood 
vessels 
Maturation of vessel is accompanied by the recruitment of MC and the deposition of 
extracellular matrix (ECM) components. Both stromal cells and the ECM surrounding 
the endothelium provide crucial interaction to form stable quiescent vessels. The ECM, 
a scaffold of proteins secreted and organized by endothelial and MC, provides structural 
support, serves as a substrate for EC migration, and regulates pro-and anti-angiogenic 
factors  (reviewed  in(Red-Horse,  Crawford  et  al.  2007)).  ECM  molecules  directly 
influence EC morphogenesis by changing cytoskeletal arrangements and by mediating 
adhesion,  migration  and  proliferation  of  ECs  but  ECM  components  also  regulate 
endothelial  functions  indirectly  by  presenting  and  shaping  growth  factor  gradients. 
Hence, the ECM affects many fundamental aspects of EC biology through mechanical 
support and signalling pathways.  
The basement membrane (BM) underlying the basal side of ECs is a specialized form of 
the ECM, 50-100nm in thickness. Originally described as a distinct ultra structure in the 
electron micrographs, BMs are now defined as much by their molecular composition as 
by their intimate association with the cell surface (Sasaki, Fassler et al. 2004). In mature 
blood vessels BMs form a continuous sleeve around endothelial tubes, consisting of a 
tight meshwork mainly comprised of laminin, collagen, fibronectin and proteoglycans 
(Figure 4.17). Various isoforms of these matrix molecules have been identified and 
combine to form structurally and functionally distinct BMs.  
Recent  data  suggest  that  extracellular  scaffolding  molecules  control  the 
signalling pathways necessary for blood vessels to form and stabilize, and disruption of 
these  signals  catalyzes  vascular  regression  (reviewed  in  (Davis  and  Senger  2008)). 
Davis  and  Senger  propose  a  concept  in  which  collagen  matrices  stimulate  vessel 
formation  whereas  exposure  to  laminin  inhibits  this  process.  Collagen-integrin 
interaction  in  ECs  stimulates  intracellular  vacuole  formation  and  regulates  capillary 
lumen and tube formation. Lumen formation is mediated by Cdc42 and Rac1 GTPases 
and requires Pak2, Pak4 and Par3 and PKCγ activity (Bayless and Davis 2002);(Koh, 
Mahan et al. 2008). The role for laminin matrices in this process is less clear. Absence 
of any laminin matrices in embryoid bodies in vivo resulted in ES cell differentiation 
and vessel formation however vessels exhibited increased lumen diameter (Jakobsson, 
Domogatskaya et al. 2007).  
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Figure 4.17 Basement membrane components forming a tight meshwork 
Laminin polymerizes through its short arms creating a multivalent network. Type IV 
collagen (Col-IV network) forms a second network that is linked to the Laminin 
network (LN network) via nidogen (Nd). Perlecan (Perl) is incorporated in endothelial 
BM {Li, 2003 #681}. 
 
 
  Recent  studies  addressed  the  function  of  matrix  metalloproteases  (MMP)  in 
regulating vascular morphogenesis and vessel regression. MMP degrade a variety of 
ECM molecules, cleave cell surface receptors and release apoptotoic ligands but also 
process bioactive molecules and thereby (in)activate a range of chemokines and growth 
factors. The ability of ECs and their supporting cellular elements to directly modify (ie, 
remodel) their immediate ECM environment is critically important for forming tubular 
networks, stabilizing these networks, and inducing regression of these networks. MMP 
mediated proteolysis appears likely to be critical during EC morphogenesis include the 
initiation of angiogenesis whereby BM breakdown occurs, invasion into collagen type I 
or fibrin matrices, and lumen formation (reviewed in (Davis and Senger 2005)). 
MT1-MMP has been identified as a proteolytic modifier of PDGF-B/PDGFR-β 
signal transduction that cooperatively regulates vessel wall architecture in vivo. 
In  vSMCs,  catalytically  active  MT1-MMP  associates  with  PDGFR-β  in  membrane 
complexes  that  support  the  efficient  induction  of  mitogenic  signalling  by  PDGF-B. 
Conversely,  MT1-MMP-deficient  vSMCs  display  PDGF-B-selective  defects  in 
chemotaxis and proliferation and MT1-MMP-deficient brain tissues exhibit a marked 
reduction in MC density as well as abnormal vessel wall morphology similar to that 
reported in mice expressing Pdgfb or Pdgfrb hypomorphic alleles (Lehti, Allen et al. 
2005).  
  Davis  and  colleagues  found  that  PC  stabilize  tubes  by  inhibiting  the  natural  
  72 
tendency of EC-lined tubes to regress by blocking MMP-1 and -10 dependent pathways 
of  vascular  regression.  Periyctes  perform  this  function  by  delivering  the  proteinase 
inhibitor TIMP-3, and thereby suppressing MMP-1 and -10 dependent regression.  
  MMPs  also  function  in  the  release  of  ECM-bound  VEGF  by  converting 
VEGF165 isoforms in VEGF121-like fragments resulting in a decrease of local VEGF 
concentration  (i.e.  VEGF  withdraw)  and  thereby  stimulating  vessel  regression  (Lee, 
Jilani et al. 2005); reviewed in (Davis and Senger 2008). 
 
One of the most fundamental functions provided by ECM involves support of EC 
proliferation  and  survival.  Both  proliferation  and  survival  are  highly  dependent  on 
adhesion to ECM through cell-surface integrins. In particular, activation of the p44/p42 
(ERK1/ERK2) mitogen-activated protein kinase (MAPK) signal transduction pathway 
in ECs is critical for EC proliferation and angiogenesis (reviewed in (Davis and Senger 
2005)). 
 
4.17  Laminin 
Little is known about which cell type expresses which BM component and whether the 
expression  pattern  changes  during  vessel  development  in  embryogenesis  and  adult 
angiogenesis. However, a major finding in the last years is that laminins are the primary 
determinants of BM assembly and that other BM components such as collagen type IV 
variants, perlecan, nidogens, and collagen type XVIII are accessory components. The 
endothelial cell BMs have been demonstrated to be unique in regards of their laminin 
isoform composition. 
Laminins  are  a  family  of  large  glycoprotein  heterotrimers,  composed  of  an 
alpha, a beta and a gamma chain that assemble to form a cross-shaped molecule. To 
date,  5  distinct  alpha  (α),  4  beta  (β)  and  3  gamma  (γ)  laminin  chains  have  been 
identified that can combine to form up to 15 different isoforms. Laminin α, β and γ 
chains share homologous structures that include globular domains (domains IV and VI), 
rodlike domains containing EGF-like repeats known as laminin-like EGF or LE repeats 
(domain III and V), and domains forming the α-helical coiled-coil of the long arm of 
the molecule (domain I and II). In addition, all laminin alpha chains contain a large 
COOH-terminal  globular  (G)  domain  with  five  internal  repeat  motifs  (known  LG 
domains)  that  possess  binding  sites  for  several  cell  membrane-associated  molecules  
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such as integrin, a-dystroglycan and nidogen, see Figure 4.18 (Hallmann, Horn et al. 
2005).  
The laminin alpha chains are considered to be the functionally important portion 
of the heterotrimers, as they exhibit tissue-specific distribution patterns and contain the 
major  cell  interaction  sites.  The  diverse  function  of  laminin  chains  has  also  been 
verified by inactivation and genetic ablation leading to distinct phenotypes. 
 
 
 
Figure 4.18 Laminin structure and domain composition 
The prototype laminin 111 isoform is characterized by the presence of the laminin α1 
chain, which combines with laminin β1 and γ1 chains. All laminin chains share 
structural similarities defined as domains, shown in Roman numerals. Note the NH2-
terminal short arms composed of laminin α, β, and γ chain sequences, and the COOH-
terminal globular (G) domains composed solely of laminin α chain sequences. The 
central long arm of all the laminins is a coiled-coiled structure composed of all three 
chains. Globular domains contain binding sites for sulfated carbohydrates (S-CHO/s-
cho; high and low affinity sites), integrins (e.g. a6b1), dystroglycan (aDG/adg), agrin 
and nidogen. The N-terminal end mediates laminin polymerization (adapted from 
(Hallmann, Horn et al. 2005); (Yurchenco and Wadsworth 2004)).  
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It  is  believed  that  the  endothelium  only  expresses  two  laminin  molecules,  namely 
laminin 411 (α4, β1 and γ1) and laminin 511 (α5, β1 and γ1) and that their expression 
pattern  varies  depending  on  developmental  stage,  vessel  type  and  activation  state 
(reviewed by (Hallmann, Horn et al. 2005)). 
Mice  lacking  Laminin  a5 die  during  late  embryogenesis  at  E16.5,  exhibiting 
exencephaly,  syndactyly  and  placental  dysmorphogenesis  (Miner,  Cunningham  et  al. 
1998).  The  lethality  of  Laminin  a5 mice appears  to  relate  to  abnormalities  of  the 
placental  as  well  as  fetal  vasculature.  In  these  animals,  reduced  complexity  in  the 
branching patterns of these vascular beds was observed, and existing vessels had larger 
lumen diameters. 
 
In contrast to Laminin a5, mice deficient for Laminin a4  are viable. Thyboll and 
colleagues showed that Laminin a4  knockout mice display haemorrhages during late 
embryonic development, and that the phenotype is rescued by postnatal laminin α5 
expression,  which  occurs  earlier  than  in  wildtype  mice  (Thyboll,  Kortesmaa  et  al. 
2002). Previous studies showed that Laminin a4  deficient mice exhibit enhanced blood 
vessel formation in pathological condition, such as tumour angiogenesis (Zhou, Doi et 
al. 2004). Using the cornea angiogenesis assay Thyboll and colleagues demonstrated 
aberrant branching of vessels with dilation and fluctuation in diameter, suggesting an 
inhibitory role of laminin α4 (at least in pathological angiogenesis). 
Reduced  expression  of  BM  components  including  collagenIV,  laminin  β1  and  γ1 
chains, and nidogen 1 was found in BM surrounding Laminin a4  null mice. Electron 
microscopic  analysis  revealed  defects  in  BM  assembly  and  density,  suggesting  that 
laminin α4 is required for the integrity of vessels and their proper maturation but not 
essential for blood vessel development per se. 
Laminin α4 LG4–5 but not LG1–3 was shown to inhibit EC migration in an in 
vitro wound healing assay and to perturb tube formation in an in vitro model (Talts, 
Sasaki et al. 2000). Although the mode of action of laminin α4 LG4–5 is unclear, it has 
been  proposed  to  involve  interference  with  integrin  α6β1-  and  α3β1-mediated 
interactions. DeHahn and colleagues suggested that laminin α4 mediates EC survival in 
vitro, by activating β1 integrins (DeHahn, Gonzales et al. 2004). 
Interestingly,  distinct  functions  for  laminin  α4  and  α5  have  also  been  reported  in 
zebrafish (Pollard, Parsons et al. 2006). In contrast to laminin α5 that does not effect  
  75 
notochord differentiation and intersegmental vessels (ISV) formation, laminin α4 in 
combination with laminin α1 fail to form the notochord and ISV in zebrafish. 
 
Despite these and various other attempts very little is known about the precise 
function  of  the  laminin  α4  and  –  α5  although  distinctive  expression  patterns  and 
structural characteristics of laminin α4 and -α5 chains may provide  some clues for 
possible functions. The laminin α4 chains is truncated and in comparison to laminin α5 
much shorter, missing the N-terminal domain that has been associated with laminin 
self-assembly and cross-linking the laminin network to collagen.  
In the absence of laminin, collagenIV is essentially excluded from the BM (Jakobsson, 
Domogatskaya et al. 2007). Laminins bridge between the cell surface and the collagen 
network via nidogens and perlecan forming a tight network. 
 
Genetic  inactivation  of  collagen  IV  and  perlecan  revealed  that  both  BM 
components  are  essential  for  stability  and  integrity  of  BM  in  blood  vessels  but 
dispensable  for  the  initiation  of  its  assembly  during  early  development  (Poschl, 
Schlotzer-Schrehardt et al. 2004); (Costell, Gustafsson et al. 1999). These data indicate 
that laminin is sufficient for BM-like matrices during early embryonic development, but 
at later stages and under mechanical stress such as blood flow the specific composition 
of  components  including  CollagenIV  and  perlecan  defines  integrity,  stability  and 
functionality. 
The BM not only functions in vessel integrity but much likely controls cell polarity. 
Laminin and the small GTPase Rac1 are required for orientation of apical polarity in 
epithelial  kidney  cysts.  Intracellular  Rac1  activity  regulates  extracellular  laminin 
assembly. Assembled laminin reciprocally acts back on the cell, initiating a transcellular 
signal that relays positional information to the site of apical pole formation. Disruption 
of  the  autocrine  loop  inverts  apical  polarity.  Dominant-negative  Rac1  alters  the 
supramolecular  assembly  of  endogenous  laminin  and  causes  a  striking  inversion  of 
apical polarity (O'Brien, Jou et al. 2001).  
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4.18   Integrin 
Vascular  development  is  a  multi-step  process  that  involves  cell-cell  and  cell-matrix 
adhesion. Each of the many ECM molecules mentioned above (e.g. laminin, collagen) 
has cell surface receptors, predominantly of the integrin family.  
Integrins  are  a  family  of  non-covalently  associated  heterodimeric  transmembrane 
glycoprotein adhesion molecules. They comprise an α- and β-subunit, with numbers 
varying between species.  In mammals, 18 α-and 8 β-subunits combine to form more 
than  24  different  integrin  heterodimers.  Heterodimer  composition  confers  ligand 
specificity, with most integrins recognizing several ECM proteins and, in turn, most 
matrix proteins binding to more than one integrin (reviewed in (Silva, D'Amico et al. 
2008)). Genetic inactivation, receptor inhibition and expression studies have revealed 
that at least 10 integrins are expressed by EC and mediate angiogenic processes to one 
degree or another. The fibronectin receptors, α4β1, α5β1; the collagen receptors, α1β1, 
α2β1;  the  laminin  receptors,  α3β1,  α6β1,  and  α6β4;  and  the  osteopontin  receptor, 
α9β1.  In  addition  PC  also  express  α7β1  (laminin  receptor)  and  α8β1  (osteopontin 
receptor) integrins. The vitronectin receptors, αvβ3 and αvβ5, are expressed by ECs, 
and αvβ3 is also expressed on glial cells (reviewed in (Silva, D'Amico et al. 2008)). 
Their expression is not unique among ECs and it has become clear that their expression 
and activity is strongly regulated during sprouting angiogenesis. VEGF can modulate 
angiogenesis via increased expression and activation of α6β1 integrins, the  specific 
blocking or siRNA knockdown of which inhibited capillary morphogenesis, adhesion 
and migration (Lee, Seng et al. 2006). 
 
In the following, I will summarize the vascular phenotypes of integrin deficient 
mice that have been implicated in angiogenesis and proven to be relevant for my work. 
Laminin  receptors  integrin  α3  and  α6  die  during  birth  (Kreidberg,  Donovan  et  al. 
1996);  (Georges-Labouesse,  Messaddeq  et  al.  1996).  Although,  no  vascular 
abnormalities have been reported, this does not exclude a possible function in adult and 
pathological  angiogenesis.  Integrin  β4-/-  mutants  display  reduced  angiogenesis  in 
response  to  bFGF  in  the  Matrigel  plug  assay  and  to  hypoxia  in  the  retinal 
neovascularization model (Nikolopoulos, Blaikie et al. 2004). Signalling and tumour 
implantation  studies  revealed  that  integrin α6β4  promotes  the  onset  of  the  invasive  
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phase of pathological angiogenesis (Nikolopoulos, Blaikie et al. 2004).  
β1 intergins are essential during angiogenesis and expressed in both ECs and 
PC. Mice deficient in β1 integrin die at E5.5 before the onset of vascular development. 
Endothelial specific deletion of integrin β1 results in embryonic lethality at around E10, 
allowing  the  formation  of  a  simple  vasculature.  Consistently  with  mice  lacking 
endothelial integrin β1, embryoid bodies null in integrin β1 differentiate but display 
defects  in  angiogenic  sprouting  and  vascular  branching  morphogenesis  (Fassler  and 
Meyer 1995); (Bloch, Forsberg et al. 1997).  
β1 integrin expression on PC is thought to help stabilize the blood vessels. In 
vivo,  mice  deficient  in  pericytic  integrin  β1  die  postnatally  and  display  vascular 
abnormalities. Pericyte and vSMC proliferation is enhanced, whereas differentiation and 
their ability to support blood vessels are compromised. Integrin β1 deficient pericytes are 
poorly  spread,  adhesion  to  ECM  molecules  is  delayed  despite  the  presence  of  focal 
adhesions (Abraham, Kogata et al. 2008). 
α7β1 integrin is mainly expressed by MC and loss of integrin α7 results in 
reduced  vSMC  number,  assembly  and  differentiation  leading  to incomplete  cerebral 
vascularization, and cerebral hemorrhage (Flintoff-Dye, Welser et al. 2005). A recent in 
vitro study suggested a cross talk between PDGF receptors and integrin α7β1, showing 
elevated α7β1 integrin expression levels and adhesion to laminin in the presence of 
PDGF (Chao, Martinez-Lemus et al. 2006). 
The relevance of integrin α5 in angiogenesis is highlighted by genetic studies. 
Mice  deficient  in  α5  fail  to  form  a  proper  vascular  network  in  yolk  sac  and  the 
developing embryos (Yang, Rayburn et al. 1993). These defects result in embryonic 
lethality  at  E10  to  11  of  gestation.  Similar  defects  in  vessel  development  are 
recapitulated in α5-null embryoid bodies, α5-null teratomas, and, to a greater extent, in 
the Fibronectin (FN) null embryos, indicating the importance of α5–FN interactions 
during vessel development (Taverna and Hynes 2001). 
Integrin α5 expression is upregulated in tumours and blocking experiments resulted in 
reduced tumour growth. The anti-angiogenic properties of blocking reagents against α5 
are currently tested in PhaseI clinical trials (reviewed in (Silva, D'Amico et al. 2008). 
Integrin α5 predominantly interacts with FN, however recent data highlight the capacity 
of integrin α5 to bind and signal via angiopoietin-1 and its receptor Tie-2, as well as 
VEGFR1  to  mediate  EC  migration  (reviewed  by  (Serini,  Napione  et  al.  2008); 
(Orecchia, Lacal et al. 2003).  
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Similar properties have been described for integrin β3. Mice deficient in  β3 
integrin  are  viable  and  fertile  and  develop  no  apparent  vascular  defects  during 
development,  but  exhibit  increased  tumour  angiogenesis.  The  enhanced 
neovascularization  in  tumours  correlates  with  elevated  VEGFR2  levels.  Serini  and 
colleagues summarize recent finding in the tyrosine kinase receptor-integrin cross talk, 
highlighting the formation of VEGFR2-β3 integrin complex.  
  Complex formation requires the extracellular domain of VEGFR2, and receptor-
2 activation by its ligand VEGF and the ensuing binding of PI3K and c-src.  
Upon  VEGF-A  stimulation,  VEGFR2  recruits  and  activates  c-src,  which,  in  turn, 
phosphorylates the cytosolic tail of β3 integrin. This c-src-dependent post-translational 
modification  is  required  for  the  formation  of  the  VEGFR2/αvβ3  complex  and  the 
conformational activation of the integrin. Recently, the transglutaminase factor XIII was 
shown to stabilize VEGFR2/αvβ3 integrin complex, leading to VEGF-A-independent 
receptor activation (reviewed by (Serini, Napione et al. 2008)). 
The increased VEGFR2 expression observed in β3-/- mice could represent a 
molecular  compensation  that  further  emphasizes  the  importance  of  VEGFR2/αvβ3 
integrin co-regulation in ECs. This hypothesis is supported by the recent finding that 
tumour angiogenesis is impaired in knock-in mice expressing a αvβ3 mutant unable to 
form a complex with VEGFR2 (reviewed by (Serini, Napione et al. 2008)). 
As discussed in previous sections of my thesis, many other integrins including α5, α9β1 
but also collagen receptors α1β1 and α2β1 interact with VEGF receptors and are, at 
least in part, able to bind VEGF ligands. Collagen I, the ligand of α1β1 and α2β1 
integrins, exerts an inhibitory action on VEGFR2 by promoting the recruitment of the 
tyrosine  phosphatase  SHP2  to  the  receptor  cytosolic  tail.  The  higher  VEGFR2  de-
phosphorylation  correlates  with  a  higher  degree  of  its  internalization  (reviewed  by 
(Serini, Napione et al. 2008)). 
Taken together, the recent findings convincingly demonstrate that integrins not only 
mediate cell-matrix adhesion and endothelial migration but also function actively in 
signalling events during sprouting angiogenesis.  
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4.19  Fibronectin 
Fibronectin, is a major component of the vascular BM that mediates several functions, 
including the binding and assembly of ECM components, providing structural support 
for  cell  adhesion  and  controlling  the  availability  of  growth  factors  (summarized  in 
(Leiss, Beckmann et al. 2008)). The functional relevance of FN is underscored by the 
dramatic consequence in mice that lack a constitutive FN gene. FN null embryos die at 
E8.5 due to severe mesodermal, vascular and neural tube defects (George, Georges-
Labouesse et al. 1993). Detailed analysis of the cardiovascular system revealed that FN 
is essential for organization of heart and blood vessels, but is dispensable for cellular 
specification  in  the  appropriate  regions  within  the  embryo  (George,  Baldwin  et  al. 
1997). 
FN is a large 220-250kDa modular protein, containing type I, II and III domains 
that mediate FN-binding and interactions (Figure 4.19). FN is secreted as a disulfide-
bonded dimer; dimerization takes place at the C-terminus and seems to be required to 
assemble  FN  into  a  fibrilliar  matrix). 
 
Figure 4.19 Molecular structure of Fibronectin 
FN consists of three different modules (type I, blue; type II, brown; type III, green). The 
alternatively spliced extradomains B, A, and variable region (V) are shown in ochre. 
The dimer forms via two disulfide bonds at the C-terminus. Integrin binding sites are 
indicated. The N-terminal type I domains marked with a red asterisk harbour an IGD 
motif. Binding domains for FN, collagen, fibrin, heparin and bacteria are indicated. 
Note that the α5β1 as well as the αIIbβ3 integrins require the synergy region to bind to 
the RGD motif (Leiss, Beckmann et al. 2008).  
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Further,  FN  fibril  assembly  is  a  cell-driven  process  that  crucially  involves  integrin 
interaction. The double knock out of the integrin α5 and av gene results in a complete 
ablation of FN fibril formation (Yang, Bader et al. 1999). Cell adhesion to FN depends 
on the RGD motif (arginine –glycine- asparagine) that is located in the 10
th type III 
domain  and  mediates  binding  to  many  integrins  including  α5β1  and  αvβ3 (Figure 
4.19Substitution of the RGD motif to an integrin-binding inactive RGE motif results in 
early embryonic lethality due to severe defects in the posterior mesoderm (Takahashi, 
Leiss  et  al.  2007).  Surprisingly,  FN  assembly  is  not  dependent  on  RGD-mediated 
integrin binding in vivo. 
Fibronectin exists in two forms: cellular FN, which is present in tissues where it 
is assembled into a fibrillar matrix, and plasma FN, which is produced by hepatocytes 
and is secreted into the blood where it remains in a non-fibrillar, soluble form. 
FN is alternatively spliced at three regions, which can be either completely (EIIIA and 
EIIIB, both type III repeats) or partially (the V region), included or excluded, generating 
up to 12 different variants in mammals and 20 in humans (reviewed in (Hynes 2007). 
These FN isoforms are spatially and temporally differentially expressed, however their 
expression is re-activated and increased in development and disease. Surprisingly, mice 
lacking either the FN EIIIA or EIIIB fragments did not display vascular defects (Astrof, 
Crowley et al. 2004) but mice deficient in both segments exhibited multiple embryonic 
cardiovascular  defects,  including  vascular  hemorrhage,  failure  of  remodelling 
embryonic and yolk sac vasculature, defective placental angiogenesis and heart defects 
(Astrof, Crowley et al. 2007). Deletion of both EIIIA and EIIIB exons did not affect 
synthesis or cell surface deposition of FN, indicating that embryonic lethality at E10.5 
was due specifically to the absence of EIIIA and EIIIB exons from FN (Astrof, Crowley 
et  al.  2007).  The  importance  of  FN  isoforms  has  been  demonstrated,  however  the 
precise  function  of  extra  domains  EIIIA  and  EIIIB  during  developmental  and 
pathological angiogenesis still remain to be elucidated. 
 
FN controls the availability of growth factors, for example by regulating their 
activation  from  latent  complexes  as  shown  for TGF-β  (Fontana,  Chen  et  al.  2005). 
Wijelath and colleagues mapped two binding domains on FN that modulate the activity 
of the angiogenic factor, VEGF. Further analysis demonstrated that VEGF binds to the 
heparin-II domain of FN and that the cell-binding and VEGF-binding domains of FN, 
when  physically  linked,  are  necessary  and  sufficient  to  promote  VEGF-induced  EC 
proliferation, migration, and ERK activation (Wijelath, Murray et al. 2002; Wijelath,  
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Rahman et al. 2006). Mutation in heparin-II binding domain abolished VEGF-binding 
and  reduced  EC  responses.  However,  presence  of  both  integrin  α5β1-  and  VEGF-
binding domains significantly enhanced EC proliferation, migration and induced strong 
phosphorylation of the VEGF receptor and ERK, suggesting a synergistic function FN 
and VEGF. 
 
4.20  Aim of my PhD 
Extracellular matrix components modulate EC functions directly via integrin adhesion 
and indirectly by interacting with multiple signalling pathways, e.g. stabilizing receptor 
complexes, controlling growth factor (GF) availability or presentation to the EC. 
The aim of my PhD was to elucidate the spatial expression and precise function 
of  BM  molecules  during  developmental  angiogenesis.  The  projects  undertaken 
investigate the role of fibronectin in vessel migration and laminin in vascular sprouting 
and patterning by studying the retinal vasculature.  
In a third project I addressed the relevance of heparan sulfate proteoglycan in 
mural  cell  recruitment  and  explored  the  underlying  mechanism. 
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5  Material and Methods 
5.1  Animals 
All mice analysed in thesis were housed in the Porta Cabin 2, Clare Hall and services 
were  provided  by  Biological  Resources,  Cancer  Research  UK.  Maintenance  and 
breeding of mice are in accordance with legal and UK ethical standards.  
Table 1 summarizes a list of mice used in my projects described. If not stated explicitly, 
mice were bred on C57Bl/6 background. 
 
Briefly, to generate conditional transgenic mice lacking astrocytic Fibronectin (FN), FN 
floxed mice were crossed to GFAP Cre and Nestin Cre mice. To specifically analyse the 
functional role of RGD-binding motif in astrocytic FN, FN floxed GFAP Cre mice were 
bred to RGE/wildtype (RGE/wt) mice, containing a mutation in RGD sequence. 
The laminin a4 deficient mice were generated by targeted disruption of the first 2 exons 
of Lama4 gene and replacement with PGK Neo cassette (Thyboll, Kortesmaa et al. 
2002). Mice were kindly provided by Lydia Sorokin. 
To investigate loss of pericytic heparan sulfate (HS) Ext1 floxed mice were bred to 
Pdgfrb  Cre  mice,  referred  as  Ext1
MCko.  To  obtain  Ext1
MCko  embryos  at  specific 
embryonic stages, breedings were set up for timed mating and detection of a vaginal 
plug was considered as embryonic day 0.5 (E0.5). 
To  verify  Pdgfrb  Cre  specificity,  Pdgfrb  Cre  mice  were  crossed  to  reporter  mice 
ROSA26eYFP and tissue was analysed at several embryonic stages.  
Finally,  to  study  the  function  of  endothelial  HS  during  embryogenic  vascular 
development we breed Ext1 floxed mice with PDGFB-iCreER transgenic mice. Cre 
mediated  recombination  and  deletion  of  Ext1  in  endothelial  cells  (EC)  expressing 
PDGF-B is dependent on tamoxifen induced translocation of iCreER
T2 to the nucleus of 
ECs.  To  activate  Cre  recombination,  4OH-tamoxifen  (Sigma)  was  injected 
intraperitoneally in pregnant females in 2-3 constitutive days at embryonic stages E8.5- 
E12.5.  
Eyes of FN splice variants (FNEIIIA, FNEIIIB, FNEIIIAB, FNEIIIBA), integrin alpha5 
Tie2 (Itga5ECko), dy
2J/ dy
2J, integrin alpha 7 (Itga7), and integrin beta 3 (Itgb3) mice as 
well as embryos of Pdgfrb null and control mice were provided either PFA-fixed or  
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snap frozen for protein analysis. For further information regarding generation of mice 
and a detailed list on collaboration initiated during my PhD see Table 1. 
 
All breedings, including experimental and stock breedings were set up by myself and I 
was  in  charge  for  maintenance  of  multiple  colonies  including  Ext1,  Pdgfrb  Cre, 
PDGFB-iCreER
T2.  Animal  procedures  were  carried  out  in  accordance  with  the  UK 
Coordination  Committee  on  Cancer  Research  UK  guidelines  and  Home  Office 
regulation. Experimental  procedures  on  mice  were  performed  by  myself  and/  or  by 
animal  technicians  Sue  Watling,  Craig  Thrussell  and  Claire  Darnborough (Biological 
Resource Services).  
 
 
mouse line published by in collaboration with
FN floxed R. Faessler R. Faessler
GFAP Cre Bajenaru et al., 2002 D. Gutmann
Nestin Cre Petersen et al., 2004 W. Zhong
RGE/ wt Takahashi et al., 2007 R. Faessler
FNEIIIA Tan et al., 2004 M. Vogelzang, R. Hynes
FNEIIIB Fukuda et al., 2002 M. Vogelzang, R. Hynes
FNEIIIAB Astrof et al., 2007 M. Vogelzang, R. Hynes
FNEIIIBA Astrof et al., 2008 M. Vogelzang, R. Hynes
itga5 Tie2 A. v.d Flier, unpublished A.v.d Flier, R.Hynes
itga7 Flintoff-Dye et al., 2005 D. Burkin
dy2J/dy2J Besse et al., 2003 M. Hager & M. Durbeej
Lama4 Thybol et al., 2002 L. Sorokin
itgb3 Hodivala-Dilke et al., 1999 S.Robinson & K.Hodivala-Dilke
Pdgfrb Cre Foo et al., 2005 R.Adams
PDGFB Cre ERT Claxton et al., 2008 M. Fruttiger
Pdgfrb null  Soriano P., 1994 M.Nisancioglu 
Ext1 floxed Inatani et al., 2003 Y.Yamaguchi
ROSA26eYFP Srinivas et al., 2001 R. Adams  
Table 1 List of mouse lines used in this thesis 
 
 
Administration of Tamoxifen to induce Cre mediated gene inactivation 
4-hydroxy tamoxifen (4OH-tamoxifen, Sigma) was dissolved in 1ml of ethanol. A stock 
solution of 20mg/ ml was stored at 4°C. Corn  oil was added to prepare  a working 
solution of 4 mg/ml fresh for each experiment. 
Cre induction was activated upon intraperiteonally injection of 75µl of working solution 
in pregnant PDGFB-iCreER
T2 females at several embryonic stages.  
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5.2  Genotyping of mice 
Ear and tails biopsis of mice as well as embryonic yolk sac samples of experimental 
mice were lysed over night (o/n) at 55°C using 200µl of direct lysis buffer (tail or yolk 
sac, respectively) (Viagen Biotech Inc.) containing 0.2mg/ ml proteinase K (Roche). 
After heat inactivation for 45 minutes (min) at 85°C samples were kept at -20°C.  
Embryonic tail samples of Ext1
MCko, Pdgfrb null and control embryos were kept and 
lysed using 500µl tail lysis buffer (50mM Tris-HCl, pH8.0, 100mM EDTA, 100mM 
NaCl2, 1%SDS) containing 15µl Proteinase K (20mg/ml stock solution, Roche) at 55°C 
o/n. Briefly, after NaCl precipitation (200µl of 5M NaCl), same volume of isopropanol 
was added to extract DNA. Centrifugation at 13,000rpm for 10min, 4°C resulted in a 
visible pellet that was resuspended in 100µl of distilled H2O. 
Polymerase chain reaction (PCR) was performed using HotStarTaq® Plus Mastermix 
(Qiagen), containing loading buffer, dNTPs and polymerase in the kit provided. To a 
final volume of 20µl, 1-2 µl of DNA samples and 1µl of 10µM primer were added to 
the  PCR  reaction.  To  detect  sharper  bands  by  gel  electrophoresis  1µl  of  dimethyl 
sulfoxide (DMSO, Sigma) was added to PDGFB-iCreER
T2 PCR reaction.  
Details of primers used, their specific annealing temperature to amplify DNA and PCR 
product size are listed in Table 2. Conditions for PCR reaction are as follows. 
Initial denaturation at 95°C for 5 min, 95°C for 1 min, annealing temperature (see Table 
2) 30 sec, extension at 72°C for 1 min and a final elongation step at 72°C for 10 min 
were run on Mastercycler (Eppendorf).  
The PCR reactions were separated on 1-2% agarose gel (Invitrogen) diluted in TBE 
buffer containing 0.2mg/ml ethidium bromide (Sigma).  
10x  TBE  buffer  was  provided  by  Biological  Resources,  Cancer  Research  UK  and 
contained 104g Tris base, 55g orthoboric acid, 10ml 0.2M EDTA and distilled H2O in 
final volume of 1 litre. Bands of PCR products were visualized using UV light and 
compared to 1kb protein ladder (Invitrogen).  
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gene primer sequence annealing temperature product size
FN  FW 5' GTACTGTCCCATATAAGCCTCTG 3' 63°C 10 cycle wt 230bp
RV 5' CTGAGCATCTTGAGTGGATGGGA 3' 53°C 35 cycle floxed 280bp
GFAP/ Nestin Cre FW 5' GACACCAGACCAACTGGTAATGGTAGCGAC 3' 62°C 10 cycle 850bp
RV 5' GCATCGAGCTGGGTAATAAGCGTTGGCAAT 3' 52°C 35 cycle
RGE FW 5' CAAAGAAGACCCCAAGAGCA 3' 67°C 10 cycle wt 340bp
RV 5' ACAAGCCCTGGCCTTTAGTT 3' 57°C 35 cycle mut 480bp
Lama4 WT FW 5' CAGCAGGCATCACTGCATCTC 3' 55°C 35 cycle wt 280bp
WT RV 5' CTGAGTCGCTAGTCTCCGATG 3' ko 520bp
NEO FW 5' TGTCATCTCACCTTGCTCCTG 3'
NEO RV 5' TCAAGAAGGCGATAGAAGGCG 3'
Ext1  FW 5' AAGGATTCTCGCTGTGACAG 3' 55°C 35 cycle wt 389bp
RV 5' CCAAAACTTGGATACGAGCC 3' floxed 460bp
Pdgfrb Cre FW 5' GGACATGTTCAGGGATCGCCAGGCG 3' 65°C 32 cycle ~200bp
RV 5' GCATAACCAGTGAAACAGCATTGCTG 3'
PDGFB-iCreERT2 FW 5' GCCGCCGGGATCATCCTCG 3' 57°C 35 c ycle 450bp
RV 5' CCAGCCGCCGTCGAACTC 3' 
Rosa26 eYFP FW 5' AAAGTCGCTCTGAGTTGTTAT 3'  65°C 30cycle YFP+ 350bp
YFP RV 5' GCGAAGAGTTTGTCCTCAACC 3'  wt 650bp
wt RV 5' GGAGCGGGAGAAATGGATATG 3'
Pdgfrb  FW 5' AAA AGT ACC AGT GAA ACC TCG CTG 3'  58°C 40 cycle wt 114bp
wt RV 5' ACA ATT CCG TGC CGA GTG ACA G 3'  mut 320bp
mut RV 5' ATC AGC CTC GAC TGT GCC TTC TAG 3' 
 
Table 2 PCR primer and conditions used for genotyping 
 
5.3  Immunofluorescence staining of whole-mount retinas 
Pups were culled by decapitation and eyes were gently removed using curved forceps. If 
not  stated  otherwise,  eyes  were  fixed  with  4% paraformaldehyde   (PFA,  Sigma)  in 
phosphate- buffered saline (PBS), pH 7.4 for 2 hours (h) at room temperature (RT) prior 
to dissection. Briefly, the cornea was incised with a needle and a microscissor was 
introduced through the incision. The cornea was removed by cutting circumferentially 
along the line of surgical limbus (defined as a gray zone that demarcates the transition 
between the cornea and sclera). The vitrous body was pulled out gently and the hyaloid 
vessels were separated. Finally, the pigment epithelium was detached and 4-5 small 
incisions were made to flatten the retina. In this state, retinas could be kept in PBS at 
4°C. 
For immunofluorescent (IF) staining with antibodies directed against VE-cadherin and 
claudin-5,  pups  were  anaesthetized  by  injection  of  a  combination  of  Hypnovel 
(Midazolam) and Ketaset intraperitoneally before transcardiac perfusion with PBS until  
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blood has drained from body. Eyes were removed, fixed in 4% PFA for 5-10 min at RT, 
and dissected in PBS to remove hyaloid vessels. Retinas were then flattened, excess PBS 
was removed and retinas were fixed in ice-cold methanol while flattened. Retinas were 
snap frozen on dry ice and kept at -20°C. Prior to staining retinas were rehydrated in a 
methanol/ PBT (PBS containing 0.1% Tween-20) gradient and finally washed in PBT 
for 10 min. 
Generally, IF staining of retinas were performed by blocking retinas in PBS containing 
1% bovine serum albumin (BSA, Sigma) and 0.5% Tween-20 for 1h at RT with gentle 
shaking. Retinas were then incubated with primary antibodies in appropriate dilution 
(Table) for 2h at RT or over night at 4°C. All primary antibodies listed in table were 
incubated in 0.5% BSA/ 0.25% Tween-20 in PBS except for isolectin B4, NG2 and 
endomucin which were incubated with PBlec (PBS, pH6.8 containing 1% Tween-20, 
1mM CaCl2, 1mM MgCl2 and 0.1mM MnCl2). 
Primary  antibody  solution  was  removed  and  retinas  washed  3  times  in  PBT  for 
approximately 10 min followed by incubation with secondary antibodies in 0.5% BSA/ 
0.25% Tween-20 for 2h at RT or over night at 4°C. A list of secondary antibodies used 
is presented in Table 3. 
After final wash steps with PBT, retinas were post fixed using 4% PFA for 10 min and 
flat  mounted  on  glass  slides  (Menzel)  applying  a  drop  of  Mowiol  (Calbiochem) 
containing anti-fading reagent DABCO (Sigma).  
 
secondary antibody conjugate company
goat anti-rabbit Alexa®488 Molecular Probes
goat anti-rabbit Alexa®568 Molecular Probes
goat pAB anti-mouse IgM FITC Abcam
goat anti-mouse IgM Alexa®568 Molecular Probes
goat anti-mouse IgG Alexa®488 Molecular Probes
goat anti-mouse IgG Alexa®568 Molecular Probes
ECL
TM anti mouse IgG HRP GE Healthcare
ECL
TM  anti rabbit IgG HRP GE Healthcare
ECL
TM anti-rat IgG HRP GE Healthcare
goat anti-rat Alexa®488 Molecular Probes
goat anti-rat Alexa®568 Molecular Probes
strepdavidin Alexa® Fluor 488 Molecular Probes
strepdavidin Alexa® Fluor 568 Molecular Probes
strepdavidin Alexa® Fluor 633 Molecular Probes
 
Table 3 List of secondary antibodies used 
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antibody conjugated raised in/ host reactivity company dilution Cat.No
biotin conjugate Isolectin B4 Sigma 1:10 L2140
isolectin IB4 Alexa®488 Molecular Probes 1:1000 I21411
isolectin IB5 Alexa®568 Molecular Probes 1:1000 I21412
PECAM-1 (CD31) r ms BD Pharmingen 1:100 553370
endomucin r ms D. Vettweber 1:20
GFAP CloneG-A-5 Cy3 Sigma 1:75 C9205
biotinylated Pdgfra ms R&D Systems 1:40 BAF1062
NG2 rb Chemicon 1:100 AB5320
SMA FITC ms Sigma 1:100 F3777
SMA Cy3 ms Sigma 1:100 C6198
phalloidin  Alexa®568 Molecular Probes 1:40 A12380
BrdU  Alexa®488 ms Molecular Probes 1:50 A21303
VE-cadherin (CD144) r ms BD Pharmingen 1:50 555289
claudin-5 ms ZYMED® Labortaories 1:100 35-2500
phosphoHistoneH3 rb Upstate 1:100 06-570
Hoechst Sigma 1:750 33258
paxillin m BD Pharmingen 1:100 610051
integrin alpha5 CD49e) r ms BD Pharmingen 1:100 550540
integrin beta1 (CD29) r ms BD Pharmingen 1:100 550531
integrin beta3 FITC hamster ms BD Pharmingen 1:100 553346
laminin a4 (377) rb ms L. Sorokin 1:200
laminin a5 (405) rb ms L. Sorokin 1:500
fibronectin rb ms Chemicon 1:100 AB2033
Heparan Sulfate 10E4 ms Biodesign® 1:200 M56573M
pSMAD2 rb h, ms, r Chemicon 1:1000 AB3849
pSMAD3 rb h, ms, r Epitomics 1:1000 1880-1
SMAD2/3 rb h, ms, r Cell Signaling 1:1000 3102
SMAD4 1:1000
connexin43 ms Sigma 1:1000 C8093
b-tubulin ms mammalian Covance 1:3000 MMS-435P
VEGFR2 rb ms, h Cell Signaling 1:1000 2479   
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antibody conjugated raised in/ host reactivity company dilution Cat.No
pVEGFR2 rb ms, h Cell Signaling 1:1000 2478
VEGFR2 pY951 rb h, ms Biosource 1:1000 44-1040
phospho tyrosine  ms Cell Signaling 1:1000 9411
 collagenIV rb ms AbD Serotec 1:100 2150-1470
LYVE-1 rb RELIA Tech 1:1000 102-PA50AG
phospho-Akt (Ser473) rb h, ms, r Cell Signaling 1:1000 4060
Akt  rb Cell Signaling 1:1000 9272
caspase 3 active rb h, ms R&D systems 1:750 AF835
Pdgfrb r ms Bioscience 1:75 14-1402-81
TUNEL assay Promega G7130  
Table 4: List of primary antibody 
h- human; ms- mouse; r-rat; rb-rabbit 
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5.4  BrdU administration and detection by IF staining 
Bromodeoxyuridine (BrdU, Sigma) was dissolved in a final concentration of 10mg/ ml in 
PBS and stored at -20°C. Laminin a4 null and control pups were weight and injected 5µl/ g 
weight intraperiteonally at day 5 postnatally (P5). After 2 hours, pups were culled, eyes 
harvested  and  fixed  in  4%  PFA  over  night.  Fixation  was  removed  and  eyes  were 
dehydrated  in  an  increasing  methanol/  PBT  gradient  and  were  stored  at  -20°C.  Prior 
dissection of retinas, eyes were rehydrated in methanol/ PBT and finally washed in PBT. 
Retinas were incubated in with 10µg/ml Proteinase K (Invitrogen) in PBT for 30 min, RT. 
Digestion was stopped by treatment of retinas with 2mg/ml glycine dissolved in PBT for 10 
min, washed twice in PBT and post-fixed in 4% PFA, containing 0.1% glutaraldehyde in 
PBT for 20 min. Prior DNase treatment, retinas were washed in DNase I buffer (50mM 
Tris-HCl, 10mM MgCl2, pH 7.5) 3 times for 20 min, RT. Retinas were then treated with 
0.1unit/µl DNase I diluted in DNase I buffer for 2 hours at 37°C and heat-inactivated by 
incubating samples for 10 minutes at 70°C with preheated 50 mM Tris-HCl, pH 7.5 and 
then cooled on ice for 3 min. After washing with PBT, retinas were blocked in 1% BSA/ 
0.5% Tween-20 for 1h at RT. BrdU Alexa® Fluor 488 was incubated in 0.5%BSA/ 0.25% 
Tween-20 for 2h at RT and washed before incubation with isolectin B4 Alexa® Fluor 568 
(1:500 in PBlec) for 2h at RT. Staining was completed by final washing with PBT, post-
fixation in 4% PFA for 10 min and flattening of retinas in Mowiol.  
 
5.5  Intraocular injection of peptides in C57Bl/6 pups 
Fibronectin  peptides  inhibiting  VEGF-A  binding  (FnIII13-14)  and  control  peptides  were 
generated by the Peptide Synthesis Laboratory, Cancer Research UK. Peptide sequences 
are as follows 
FnIII13-14   AKKQRFRHRNRKGYR   IC50 0.08µM 
Fn control   KDRKRSELRRIASQVK  IC50 250µM 
Peptides  were  dissolve  in  distilled  H2O  and  prepared  freshly  for  each  experiment. 
Inhibitory concentration were calculated according IC50 and a total volume of maximal 
500µl of FnIII13-14 and control peptides were injected once intraocularly in C57Bl/6 pups at 
postnatal day 4. Eyes were collected 15-24 hours later. To carry out this procedure, mice 
were deeply anaesthetized by isoflurane inhalation. Injections were performed in the right  
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eye using 10µl gastight Hamilton syringes equipped with 33 gauge needles attached to a 
micromanipulator. 
Eyes were either fixed in 4% PFA for IF staining or snap frozen on dry ice for protein 
analysis. 
 
5.6  In situ hybridization of whole-mount retinas 
5.6.1  Generation of in situ riboprobes 
Vegfa  and  Pdgfb  plasmid  DNA  was  generated  previously  by  (Gerhardt,  Golding  et  al. 
2003) and Lama4 and Lama5 plasmid DNA was kindly provided by Lydia Sorokin.  
Competent XL-Blue subcloning–grade competent cells (Stratagene) were transformed with 
the plasmid according to manufacturer’s instruction and cultured on LB agar containing the 
appropriate  antibiotic,  ampicillin  o/n  at  37°C.  Clones  were  picked  and  cultured  in  LB 
medium containing ampicillin o/n at 37°C. Plasmid DNA was isolated using Qiagen Maxi 
Prep kit. 
10-15 µg of plasmids containing template for riboprobe generation were linearized using 
the appropriate restriction enzyme and buffer according to NEB at 37°C for several hours 
(Table  5).  Complete  linearization  was  confirmed  by  gel  electrophoresis.  Plasmids  were 
purified using Qiagen PCR clean up Kit to remove buffer and enzyme.  
 
 
Gene restriction enzyme Vector RNA polymerase
Pdgfb XbaI pBluscript SK+ T7
Vegfa SalI pGEM-T Easy T7
Lama4 HindIII pGEM3Z T7
Lama5 BamHI pGEM3Z T7
 
Table 5 Enzymes used to generate antisense riboprobes for ISH 
 
 
In vitro transcription was performed by adding 1µg linearized DNA, transcription buffer, 
DIG-labelled RNA Labelling Mix (Roche), 25U/µl RNase inhibitor (Promega) and 2U/µl 
of RNA polymerase (Stratagene) in nucleasefree water to a total volume of 20µl. Incubated  
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reaction in 37°C for 2 hours. To test probe quality, 0.5µl of reaction mix was run on a 1% 
agarose gel. At the end of the transcription, 2µl RNAse-free DNase I (Ambion) was added 
to the reaction and incubated for 30 min at 37°C. To precipitate the riboprobe, 2.5µl 4M 
lithium  chloride  and  75µl  cold  ethanol  were  added  to  the  reaction,  mixed  well  and 
incubated at -80°C for 30 min. Precipitated RNA was pelleted by centrifugation at 13,200 
rpm at 4°C and stored at -20°C. RNA concentration was measured using a NanoDrop ND-
1000 spectrophotometer. 
 
5.6.2  In situ hybridization 
Hybridization mix 
50%  deionized  formamide  (Sigma),  1.3X  SSC,  5mM  EDTA  (2-[2(Bis(carboxymethyl) 
amino)ethyl-(carboxymethyl)amino]acetic  acid),  50Mg/ml  yeast  RNA  (Sigma),  0.2% 
Tween-20, 0.5% CHAPS (3-[(3-Cholamidopropyl)dimethylammonio]-1-propane sulfonate; 
Sigma) and 50mg/ml heparin (Sigma) prepared in nuclease-free water. 
 
TBST 
137mM NaCl, 2.7mM KCl, 25mM Tris-HCl, pH7.5, 0.1% Tween-20 and 2mM levamisole 
hydrochloride (Sigma) in Milli-Q water (ultrapure laboratory grade water that has been 
filtered and purified through reverse osmosis). 
 
MABT 
0.1M Maleic acid, pH 7.5, 0.15M NaCl and 1% Tween-20 in Millipore water. 
MABT was made fresh on the day of use. 
 
NTMT 
100mM  NaCl,  100mM  Tris-Cl,  pH9.5,  50mM  MgCl2,  0.1%  Tween  20  and  2mM 
levamisole in Milli-Q water. 
 
Retinas and buffer used during the initial procedure until hybridisation were treated and 
kept in RNase free environment. Eyes were harvested from P5 laminin a4 deficient and 
control pups and fixed in 4% PFA for 20 min at RT. Vitrous body and hylaoid vessels were 
removed  before  fixation  in  4%  PFA  o/n  at  4°C.  Pigment  epithelium  of  retinas  were  
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dissected, 4-5 incision were made and retinas were fixed with cold methanol while flatten. 
Retinas were stored in methanol at -20°C until used. 
Retinas were transferred from methanol in a decreasing gradient of methanol/PBT until 
finally washed in PBT. Pigmented retinas were bleached in 6% hydrogen peroxide in PBT 
for  1h,  RT  and  washed  again  in  PBT  (3x  5  min).  Retinas  were  treated  with  10µg/ml 
proteinase K (Invitrogen) for 30-40 min, RT and digestion was terminated by addition of 
2mg/ml glycine in PBT for 10 min. Samples are very fragile at this state and were carefully 
washed with PBT, 2x 5min before fixation in 4% PFA containing 0.1% glutaraldehyde for 
20 min (25% stock solution of glutaraldehyde in PBT were kept at -20°C). Retinas were 
washed in PBT, rinsed in 1:1 PBT/hybridization mix and then in hybridization mix for 1 
hour at 65°C. Retinas were then incubated with approximately 0.2µg/ml DIG-labelled RNA 
probe diluted in hybridization mix overnight at 65°C with gentle and intermittent shaking. 
Next day, hybridization mix was removed and stored at -20°C for future use. Retinas were 
rinsed and subsequently washed twice with pre-warmed hybridization mix at 65°C for 30 
min. This was followed by a wash step with pre-warmed 1:1 hybridization mix/TBST at 
65°C for 20 min and another 4 washes in TBST, 30 min RT. Samples were then rinsed 
twice  in  MABT  and  blocked  in  10%  heat-treated  sheep  serum  in  MABT  for  1h,  RT. 
Finally, retinas were incubated over night at 4°C in MABT containing 10% sheep serum 
and anti-digoxigenin-alkaline phosphatase (AP), Fab fragments (Roche) diluted 1:1000. 
Before detection and colour development, samples were washed in MABT throughout the 
day at RT and MABT solution was changed regularly until finally washed in MABT o/n at 
4°C. 
Retinas  were  washed  in  NTMT  (2x  10  min)  before  incubation  in  NBT  (Nitro-Blue 
Tetrazolium  Chloride;  Roche)/BCIP  (5-Bromo-4-Chloro-3'-Indolyphosphate  p-Toluidine 
Salt; Roche) diluted 2.5µl/ ml NTMT at RT. Colour development was stopped by washing 
with PBT and post fixation in 4% PFA. Finally, retinas were counterstained with isolectin 
B4 and/ or GFAP as described in section 5.3 . 
5.7  PI3 kinase activity assay 
Assays on PI3K isolated from retinas was performed by Mariona Graupera. Briefly, total 
protein  lysate  of  P5  retinas  was  immunoprecipitated  using  phosphotyrosine  peptide  (p-
peptide)  matrix  YPVPMLG  (where  YP  is  phosphotyrosine—the  YPVPMLG  peptide 
contains  the  consensus  binding  sequence  for  the  SH2  domain  of  the  class  IA  PI3K  
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regulatory  subunits).  Kinase  assays  were  performed  using  phosphatidylinositol-4,5-
bisphosphate  (PtdIns(4,5)P2;  Lipid  Products,  Redhill,  Surrey,  United  Kingdom)  as  a 
substrate.  Radioactivity  in  the  phosphatidylinositol-3,4,5-trisphosphate  (PtdIns(3,4,5)P3) 
spot  was  measured  by  a  Molecular  PhosphorImager  FX  (Bio-Rad,  Hercules,  CA)  and 
expressed as arbitrary units. The activity present in the control IgG immunoprecipitates was 
subtracted from that found in IRS immunoprecipitates. 
 
5.8  Immunofluorescent  staining  of  embryos  and  embryonic 
tissues 
Pregnant females were euthanised by CO2 asphyxialation and/ or cervical dislocation at 
various  gestational  stages.  Embryos  were  harvested  and  the  yolk  sac  was  removed. 
Embryos were fixed in 4% PFA for several hours at RT or o/n at 4°C before transferred to 
PBS.  To  visualize  the  embryonic  vasculature,  whole  embryos  were  stained  with 
endomucin, 1:20 in PBlec. Prior to antibody incubation, embryos were dehydrated in an 
increasing proportion of methanol/ PBT (25% methanol/ PBT- 50%- 75%- 100% methanol) 
and rehydrated in decreasing methanol/ PBT gradients until finally washed for 10 min in 
PBT. Permeabilization of embryos was achieved by incubation of embryos with PBlec for 
1h at RT followed by endomucin/ NG2 incubation in PBlec o/n at 4°C. Embryos were 
washed extensively with PBT, 20 min at RT for at least 3-times and primary antibodies 
were  detected  using  Alexa  Fluor  488  or  568  (Molecular  Probes)  conjugated  secondary 
antibody.  
For detailed analysis of vessel morphology and vascular patterning of embryonic skin, back 
(vasculature along the spinal cord) and hindbrain the tissue of interest was dissected and 
cleaned from surrounding tissue prior staining. Stainings were performed as described in 
section 5.3  of this thesis and (Gerhardt, Golding et al. 2003). 
 
Various organs have been analysed macroscopically and microscopically, including heart, 
placenta, brain and kidneys of Ext1
MCko embryos. Therefore, the organ was removed from 
the remaining body and cleared of surrounding tissue prior to documenting the morphology 
with  a  stereomicroscope  (Zeiss).  For  high  magnification  imaging  and  visualization  of 
coronary blood vessels of E13.5 heart, the entire organ was stained using PECAM-1, 1:200  
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in 0.5% BSA/ 0.25% Tween-20 o/n at 4°C. After washing with PBT, primary antibody was 
detected using goat anti-rat Alexa® Fluor 488, 1:100 in 0.5% BSA/ 0.25% Tween-20 for 
2h, RT.  
Blood vessels of the placental labyrinth of E17.5 placenta were detected in the same way as 
described for coronary vessels of embryonic heart. 
 
High resolution analysis of embryonic skin, brain and kidney were performed on paraffin 
sections as well as vibrotome sections. 
In order to obtain vibrotome section of Ext1
MCko and control embryos, and sagittal as well 
as transverse section of embryonic brain (E19.5) the tissue was embedded in 3% agarose 
gel and cut in 100µm section using Vibrotome, Leica VT1000S. Staining of section was 
performed as described in 5.3 .  
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5.9  Immunohistochemic  (IHC)  analysis  of  embryonic  tissue 
sections 
After dissection and fixation of embryos and/ or embryonic tissues e.g. kidneys in 4% PFA 
o/n, embryos were embedded in paraffin and cut in section of 5µm size. Briefly, paraffin 
section were de-waxed using xylene and dehydrated in 100% ethanol, 70% ethanol and 
finally in H2O before washing in PBS. Antigen retrieval was carried out by microwaving 
slides  in  sodium  citrate  buffer,  pH  6.0  followed  by  incubation  with  1.6%  hydrogen 
peroxide. To block unspecific binding slides were incubated in PBS containing 10% normal 
goat serum (Sigma), 1% BSA for 30 min at RT. Primary antibodies were incubated for 1h 
in 1% BSA/PBS, except for NG2 and endomucin slides were incubated in PBlec. After 
washing in PBS, 3 times at RT slides were incubated with secondary antibodies. Generally, 
primary  antibodies  were  detected  by  incubation of  biotinylated  secondary  antibodies  in 
1%BSA/  PBS  for  1h,  RT  before  applying  Avidin  Biotin  Complex  Vectastain  Elite 
Peroxidase-based  kit  (Vector  Laboratories)  with  3,3’diaminobenzidine  tetrahydochloride 
(DAB, Vector laboratories) according to manufacturer’s instructions. 
For immunofluorescent staining and double labelling of slides, eg LYVE-1 and endomucin 
secondary antibodies conjugated with Alexa Fluor ® 488 and 568 (Molecular Probes) were 
applied for 1h at RT.  
Sections were counterstained with haematoxylin and mounted in Permount (Sigma). 
These  procedures  were  done  by  Emma  Nye,  staff  of  the  Experimental  Pathology 
Laboratory in Cancer Research UK.  
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5.10  Real Time PCR 
5.10.1  RNA isolation of tissues 
Eyes were harvested from pups, immediately transferred to RNAlater (Qiagen) and kept at 
4°C until dissection. Likewise, embryos were harvested and stored in RNAlater, 10 times 
the volume of RNAlater per tissue. Dissection  was performed in RNAlater, liquid was 
removed, tissues snap frozen on dry ice and stored at -80°C until use.  
To isolate RNA, 2 retinas/ pup or embryonic tissue samples (not exceeding 20mg) were 
lysed in Buffer RLT (RNeasy Mini Kit, Qiagen) containing 10µl/ml b-mercaptoethanol 
(Sigma).  By  pipetting  and  vortexting  of  samples,  tissue  was  disrupted  and  finally 
homogenized by using QiaShredder (Qiagen). Total RNA was isolated using the RNeasy 
Mini  Kit,  according  to  the  manufacturer’s  protocol.  An  on-column  DNAse  I  (Qiagen) 
digestion was carried out to remove genomic DNA. RNA was eluted from RNeasy column 
by addition of 40µl RNase free water. Concentration was determined using a NanoDrop 
ND-1000 spectrophotometer and stored at -80°C. 
5.10.2  Generation of complementary DNA (cDNA) 
Next, cDNA was generated from isolated RNA by reverse transcription using Super Script 
III (Invitrogen). According to manufacturer’s protocol, 1µg RNA was applied to oligodT(20) 
primer, dNTP mix and polymerase. Final RNase H (1U/µl) treatment was performed at 
37°C  for  20  min  to  remove  excessive  RNA  templates  that  could  interfere  with  PCR 
reaction. Long-term storage of cDNA was avoided and kept at -20°C until use. 
5.10.3  Quantitative real-time PCR 
Quantitative real-time PCR (qPCR) was performed to address differential gene expression 
between two experimental groups. TaqMan Gene expression assays (Applied Biosystems) 
were applied to assess differences in gene expression of laminin a4 deficient mice and 
control retinas as well as to determine gene induction in treated and untreated control cells. 
Each assay consists of two unlabeled PCR primers, amplifying the sequence of interest 
(final  concentration  900nM  each)  and  a  FAM™  dye  labeled  TaqMan®  MGB  (minor 
groove binder) probe for detecting the sequence of interest (final concentration 250nM), see  
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Table  6.  TaqMan  Endogenous  Controls,  b-  actin  are  VIC®  dye-labeled  TaqMan  MGB 
probes and added to each PCR reaction. 
In the PCR step, PCR products are synthesized from 3µl cDNA samples (generated from 
1µg RNA) using the TaqMan PCR master mix (Applied Biosystems) and performed on the 
Applied Biosystems 7900HT sequence detection system. 
PCR  reactions  were  carried  out  in  duplicates  or  triplicates;  The  gene  of  interest  was 
normalized to endogenous control, delta CT values were calculated and data compared by 
relative quantification. 
 
 
gene species product number
Dll4  ms Mm00444619_m1
Dll4  hu Hs00184092_m1
Flt-1 (Vegfr1) ms Mm00438980_m1
Hey1 ms Mm00468865_m1
Hey2 ms Mm00469280_m1
itgb1 hu Hs00236976_m1
itgb3 hu Hs00173978_m1
itga3 hu Hs00233722_m1
Kdr (Vegfr2) ms Mm00440099_m1
Nrarp ms Mm00482529_s1
Pdgfb ms Mm00440678_m1
Slc2a ms Mm00441473_m1
Vegfa ms Mm00437304_m1
b-atin  ms 4352341E
b-actin hu 4326315E  
Table 6 TaqMan® probes used in qPCR  
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5.11  Reverse – transcriptase PCR (RT-PCR) 
RNA was isolated from Laminin a4 null and control retinas and subsequently, cDNA was 
generated as illustrated in 5.10.2. 
To determine differences in gene expression between Lama4 genotypes we applied semi-
quantitative PCR using ReactionReady
TM developed by Superarray. Internal Normalizer 
mouse glyceraldehyde-3-phosphate dehydrogenase (GAPD) was added to standard PCR 
(Hot Start “Sweet” PCR master mix, 2X) containing first strand cDNA template (1µl) and 
primers specific for gene of interest (Table 7) to a final volume of 25µl.  
PCR reaction was performed at 95°C, 15 min; 30cycles of (95°C, 30 sec; 55°C, 30 sec; and 
72°C, 30 sec); 72°C, 5 min; PCR product was run on 1% agarose gel containing ethidiume 
bromide  (Sigma)  and  bands  were  visualized  by  UV  ligt.  When  analyzing  data,  the 
expression level of the gene of interest is calculated as the target-to-GAPD signal intensity 
ratio. 
 
gene species product number band size (bp)
Lama4 ms PPM35489A 83
Lama5 ms PPM25090A 157
GAPD ms PA-021-24 436
 
Table 7 List of RT-PCR primers 
 
5.12  SDS gel electrophoresis and Western Blotting 
Eyes were harvested from pups and immediately dissected in PBS. Any excessive liquid 
was removed, retinas snap-frozen on dry ice and stored at -80°C. When eyes were sent 
from collaborators, the entire eye was snap-frozen and shipped on dry ice. Upon arrival, 
retinas were dissected and lysed in RIPA buffer. 
 
RIPA buffer 
50mM  Tris-HCl,  pH  7.5,  150mM  NaCl,  1mM  EDTA,  1%  Nonidet  P-40,  0.25%  Na-
deoxycholate  and  Complete®  protease  inhibitor  cocktail  (1  tablet/  10ml,  Roche)  and  
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phosphotase inhibitor cocktail (1:100, Sigma) 
 
Retinas were homogenized in RIPA buffer by pipetting up and down and finally lysed by 
sonication for 2-3 seconds on ice. Followed by centrifugation at 13,000 rpm for 10 min at 
4°C  the  clear  supernatant  was  transferred  in  a  new  tube  and  protein  quantity  was 
determined  by  bicinchoninic  acid  assay  (BCA  assay,  Pierce).  Basically,  protein 
concentration  was  measured  at  562nm  in  a  spectrophotometer  (SpectraMax  Plus)  and 
compared to a standard curve of known concentrations of bovine albumine serum (BSA, 
Pierce).  
Equal amounts of protein containing 4x loading buffer (NuPAGE® LDS, Invitrogen) and 
reducing agent β-mercaptoethanol (final concentration 2.5%) were heated at 70°C for 10 
min  and  then  loaded  on  4-12%  NuPAGE®  Novex  Bis-Tris  gel.  The  NuPAGE® 
electrophoresis system (Invitrogen) applied consist of SDS-PAGE, pre-cast polyacrylamide 
mini gels, running buffer and transfer buffer. Separation of protein was observed by pre-
stained  protein  ladder  (Amersham)  loaded  in  the  gel.  After  electrophoresis,  gel  was 
transferred onto polyvinylidene difluoride membranes (Amersham) that were pre-wetted in 
methanol. Successful transfer was achieved at 30V for 1h. 
Next, membrane was rinsed in TBS and unspecific binding blocked by incubation in 5% 
milk powder in TBS-T (TBS containing 0.1% Tween-20) for 1h at RT.  
 
10x TBS 
24.2g Tris base, 80g NaCl in 1 litre H20, pH 7.6 
 
Primary antibodies were incubated in 2% BSA/ TBS-T containing 0.02% sodium azide at 
4°C over night. Primary antibody solution were removed and kept at 4°C for future use. 
After washing the membrane with TBS-T (3x 5 min), secondary antibodies were incubated 
in  2%  milk  powder/  TBS-T  for  2h  at  RT.  Secondary  antibodies  (Table  3)  were  HRP 
conjugated  and  detected  by  chemiluminescence ECL Western  Blotting  detection  reagent 
(Amersham). Immunoreactive bands were visualized by incubating the membrane with ECL 
reagents  and  exposition  to  autoradiography  film  (Amersham).  Exposed  films  were 
developed using automatic X-ray processor, JPI. 
Several times the membrane was re-blotted with primary antibodies raised in the same  
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species. Therefore, stripping of membrane was achieved by incubation of the membrane in 
100 mM 2-mercaptoethanol, 2% SD, 62.5 mM Tris-Cl pH 6.7 heated at 50°C for 30 min. 
Followed by washing in TBS-T (3x 10min), the membrane was blocked and incubated with 
primary antibodies as described above. 
Embryos were harvested at E13.5 and yolk sac was removed. Embryonic skin sections of 
back and brain were dissected and snap frozen on dry ice. If not used immediately, samples 
were stored at -80°C.  
Pdgfrb null and control embryos were harvested and snap frozen by collaborator Maya 
Nisancioglu. After shipping on dry ice, tissues were dissected as described (see 5.8 ).  
Homogenization of tissue samples was  achieved by lysation in RIPA buffer containing 
protease  and  phosphotase  inhibitor  followed  by disruption  using  Disperser  T18  (IKA® 
Fisher). Centrifugation at 13,000rpm for 10 min at 4°C pelleted insoluble material and 
supernatant was transferred for protein analysis. Protein quantity was measured by BCA 
assay as described in 5.12 . Equal amounts of protein were loaded on SDS PAGE gel and 
transferred to membrane. For details see 5.12 . 
5.13  Immunoprecipitation of embryonic protein lysate 
Embryos  were  harvested  and  yolk  sac  was  removed  and  kept  for  genotyping.  Entire 
embryos  were  lysed  in  RIPA  buffer  containing a  mixture  of  phosphotase  and  protease 
inhibitor.  After  homogenizing  embryos,  protein  lysates  were  incubated  with  1.5µg/  ml 
primary antibody VEGFR2 (Cell Signalling) for 2 hours at 4°C. Protein G- sepharose beads 
(SAFC) were washed in RIPA buffer before 40µl 1:1 slurry was added to the protein lysate 
and incubated for 45min at 4°C while rotating. This was followed by short centrifugation at 
3000rpm for 30 sec to separate supernatant form beads and 4 washes in lysis buffer. Pellet 
was resuspended in 40µl 4x loading buffer containing SDS and heated to 95°C for 5 min. 
Beads were spun down by short puls centrifugation and supernatant loaded onto a gel. 
Followed by SDS gel electrophoresis and blotting, membrane was incubated with phospho 
tyrosine and/ or pVEGFR2 antibodies. A detailed description on SDS electrophoresis and 
Western Blotting can be found in section 5.12 .  
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5.13.1  Densitometric quantification 
Developed chemiluminescent films were scanned, tiff images were then analysed by Image 
J, applying uncalibrated OD (gray value). Bands sizes were measured and normalized to the 
appropriate control gene. 
 
5.14  Confocal microscopy 
Confocal laser scanning microscopy was performed using a Zeiss LSM 510 Meta 
microscope. Objectives used were: 63x water immersion NA1.2 CAPOCHROMAT, 40x 
water  immersion  NA1.2,  C-APOCHROMAT,  25x  water  immersion  NA0.8  Plan-
NEOFLUAR and 2.5x NA0.075 Plan-NEOFLUAR. 
Images were processed using Volocity 4.3.1, Improvision and Adobe Photoshop CS2. 
 
5.15  Quantification of retinal parameters 
5.15.1  Vessel density 
A visual field (20x20 µm) was determined at the sprouting vascular front and branchpoints 
were counted. 
 
 
Figure 5.1 Quantification of vessel density  
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5.15.2  Migratory length/ speed of retinal vessels 
Migration of vessels was analysed by measuring the total length of the retinal vasculature 
from the optic nerve towards the retinal periphery.  
Migratory  length  of  vessels  upon  treatment  with  blocking  peptides  was  accessed  by 
measuring  the  total  length  of  retinal  vessels  (injected  and  uninjected  eyes).  The  daily 
distance of migration was calculated by dividing the length of uninjected control eyes by 5 
(5 days). This distance was multiplied by 4 (4 days without treatment) resulting in the 
distance of vessels have migrated in each group (control injected, peptide injected and 
uninjected  eyes).  By  subtracting  the  distance  vessels  have  migrated  within  first  4  days 
without treatment from the total migratory length of each group we determined the distance 
vessels have migrated from day 4 to day 5 when injected. 
 
Figure 5.2 Determining migrational length of retinal vessels 
 
5.15.3  Number of filopodia extension 
To ascertain number of filopodia, vessel length at the leading tip cells were measured and 
filopodia were counted. For each quantification at least 4 confocal images /retina were 
taken and at least 4 mice/ genotype were analysed. Statistical significance was verified 
using t-test, Graph Pad Prism® Version 5.0a.  
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Figure 5.3 Quantification of filopodia number 
 
5.15.4  Quantification of proliferation 
Confocal microscopy images were taken with 40x objective and BrdU positive cells that 
are counterstained with isolectin were counted. n=3, mice per genotype; 
BrdU positive endothelial nuclei were calculated per visual field. Statistical significance 
was determined by unpaired t-test, Graph Pad Prism® Version 5.0a. 
 
 
Figure 5.4 Quantification of endothelial cell proliferation 
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5.15.5  Quantification  of  vessel  density,  vessel  diameter  and 
regression of vessels in embryonic vasculature  
Regression was determined by measuring the length of CollagenIV positive but endomucin 
negative profiles using the line measurement tool of Volocity 4.3.1, Improvision software. 
Quantification and graphic illustration represents a comparison of the sum of regression 
profile length per image analysed.  
Total vessel length per image was quantified measuring the skeletal length of endomucin 
positive vessels. 
Vessel  diameter  was  quantified  measuring  the  width  of  vessel  profiles  using  the  line 
measurement  tool  of  Volocity,  Improvision  (n>20,  images  per  genotype).  Statistical 
significance was verified using t-test, Graph Pad Prism® Version 5.0a. 
 
Figure 5.5 Quantification of vessel regression 
 
5.16  Electron Microscopy of retinal tip cells and embryonic skin 
samples 
Isolated eyes were fixed in 4% PFA for 5-10 min at RT before dissecting retinas. The 
sprouting vascular front was identified by light microscopic reflection of vessels and cut 
out from the remaining retina. Samples were then fixed in 2% PFA + 1.5% glutaraldehyde 
prepared in 0.1M phosphate buffer (PB) for 2–3 hours. Finally retinas were washed and 
stored in PBS at 4°C 
Likewise,  embryos  were  harvested  at  E13.5  and  fixed  in  4%  PFA  for  30  min  before 
dissecting of embryonic skin samples. This was followed by fixation in 2% PFA + 1.5% 
glutaraldehyde prepared in 0.1M phosphate buffer overnight at 4°C before storing in PBS.  
The following procedures were done by Ken Blight, staff from the Electron Microscopy  
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Unit, Cancer Research UK. 
Tissue was post-fixed in reduced Osmium Tetroxide in 0.1M Sorensens buffer at RT for 1 
hour, washed and fixed in 1% Tannic acid for 45mins at RT. Samples were then rinsed in 
1% sodium sulphate before washing in double distilled water (ddH2O), twice for 5minutes. 
After dehydration of samples through a graded  series of ethanol (70%, 80%, 90% and 
100%) 20mins each, tissue samples were washed in intermediate solvent [propylene oxide] 
for  20mins,  RT.  Overnight  infiltration  with  50:50  Epon/propylene  oxide  at  RT  was 
followed by three infiltration steps with Epon for 2 hours. Subsequently, the tissue was 
embedded  in  fresh  resin  and  polymerized  overnight  at  60°C  before  cutting  ultra-thin 
sections of approximately 75nm thickness on a Leica Ultracut S Ultratome and were collect 
on 200 mesh copper grids. 
Finally, samples were stained with a saturated solution of uranyl acetate in methanol for 
approximately 6 minutes at RT, washed in methanol and stained with Reynold's lead citrate 
for  4mins  at  RT.  Sections  were  analysed  using  an  JEOL  1010  transmission  electron 
microscope (TEM). 
If not stated otherwise, solutions were made up in Sorensens buffer. 
 
Sorensens Buffer System 
Solution X: 
0.2M Disodium Hydrogen Orthophosphate, Na2HPO4 29.82g in 1050ml ddH2O 
Solution Y: 
0.2M Sodium Dihydrogen Phosphate, Na2HPO4.2H2O 15.6g in 500ml ddH2O 
Double Buffer: 
0.2M Phosphate Buffer, 202.5ml Solution X, 47.5ml Solution Y 
 
Reduced Osmium 
5ml 0.2M Phosphate (Double Buffer), 2.5ml 4% Osmium Tetroxide in ddH2O, 1ml of 15% 
Potassium Ferricyanide, 1.5ml ddH2O 
 
Araldite Resin 
20ml Araldite CY212, 20ml Dodecenyl Succinic Anhidride (DDSA), 1ml Benzyl Dimethyl 
Amine, 0.25ml Dibutyl phthalate  
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5.17  Cultivation of endothelial cell lines 
If not indicated otherwise, all reagents and media were provided by cell line and media 
production  service,  Cancer  Research  UK.  Cells  lines  and  isolated  primary  cells  were 
cultured at 37°C in 5%CO2. 
 
5.17.1  Culturing of bEND5 cells  
The endothelial cell line utilized during this thesis was established from brain endothelial 
cells of BALB/c mice and is referred to as bEND5 (ECACC). Immortalisation has been 
carried  out  by  infection  of  primary  cells  with  retrovirus  coding  for  the  Polyoma  virus 
middle  T-antigen.  Cells  were  cultured  in  Dulbecco’s  modification  of  Eagles  medium 
(DMEM) containing 10% fetal calf serum (FCS), 1% Penicillin/ Streptomycin (Pen/ Strep) 
and 1% glutamine.  
Cells were passaged by incubation of trypsine/ versene (try/ver) for several minutes until 
cells floated of the cell culture flask. Cells were then pelleted by centrifugation at 1200rpm 
for 5 min and transferred to new flask; cells were split 1:3. 
For  long  term  storage  in  liquid  nitrogen  containers,  bEND5  cells  were  collected  by 
centrifugation and resuspended in DMEM containing 20% FCS and 10% DMSO. 
 
Coating of dishes with laminin matrices 
The laminin proteins used throughout my experiments were provided by Karl Trygvasson 
and are referred as LN411 (laminin α4β1γ1) and LN511 (laminin α5β1γ1). Both laminins 
are dissolved in PBS and were sterilized by filtration (0.2µm filter). Cell culture dishes and 
plates were incubated with a final concentration of 10µg/ml at 4°C over night. Laminin 
solution was removed before cells were cultured.  
 
Immunofluorescence staining of bEND5 cells 
Cells were cultured confluent or non-confluent on either coverslips or MatTek dishes and 
were passaged 24-48 hours before IF staining. Medium was aspirated and cells were rinsed 
in PBS before fixation with 4% PFA for 20 min at RT. Unspecific binding was blocked by 
incubation in 1%BSA/ 0.5% Tween-20 for 1h, RT before incubation of primary antibody in  
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0.5%BSA/ 0.25% Tween-20 for 1h, RT. After washing with PBT (3x 5min) cells were 
incubated with secondary antibody diluted 1:100 in 0.5%BSA/ 0.25% Tween-20 for 1h, 
RT. Finally cells were washed again and post fixed with 4% PFA for 10 min at RT. 
 
Neutralizing of VEGFR2 in endothelial cells  
bEND5  cells  were  cultured  on  LN411,  LN511  and  uncoated  12-well  plates  containing 
30ng/ ml VEGF 165 (R&D systems) in DMEM medium supplemented with 10% FCS, 
Pen/Strep  and  glutamine.  To  block  VEGFR2  signalling,  mouse  specific  neutralizing 
antibody DC101 (ImClone) was added at a final concentration of 30µg/ml. After 24 hours, 
cells were harvested and prepared for protein or gene expression analysis; n>3 
To  determine  VEGFR2  signalling,  cells  were  lysed  in  RIPA  buffer  containing 
protease and phopshotase inhibitor cocktails. Equal amounts of protein samples were run 
on  SDS  PAGE  gel  followed  by  Western  Blot  to  detect  phospho  VEGFR2  and  total 
VEGFR2 levels upon DC101 neutralization. For details on this procedure see 5.12 . 
To analyse differences in gene expression upon blocking of VEGFR2, cells were 
lysed in RLT buffer and RNA was extracted. After cDNA was generated samples were 
exploit to quantitative PCR (qPCR). A detailed description can be found in 5.10 . 
 
Inhibition of Notch signalling by pharmacological inhibitor (DAPT)  
Gamma secretase activity was inhibited pharmacologically using DAPT (N-[N-(3,5- 
Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-Butyl Ester (Merck, Cat. No. 
565770). DAPT was dissolved in DMSO and aliquotes were stored at -20°C. 
DAPT was added to confluent bEND5 cells cultured on LN411 or uncoated dishes at a final 
concentration  of  50µM.  DMSO  was  used  as  a  control  substance.  After  24  hours  of 
incubation, cells were collected and RNA was isolated to determine differences in gene 
expression; n>3 
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siRNA transfection of human endothelial cells  
Human  umbilical  vein  endothelial  cells  (HUVECs)  were  cultured  using  EGM  medium 
supplemented  with  Bullet  Kit  (Lonza)  and  passages  P2-P5  were  used  for  experimental 
procedures.  Culture  flasks  were  incubated  with  0.5mg/  ml  human  plasma  fibronectin 
(Chemicon) in PBS for at least 30 min at 37°C. 
Short interfering RNA (siRNA) tranfection was applied to knock down integrin activity and 
assess its function in LN411 induced gene expression. 
To silence integrin gene expression ON-TAGETplus SMARTpool developed by Dharmacon 
was applied to HUVEC cells. The ON-TAGETplus SMARTpool consists of a mixture of 4 
siRNAs targeting one gene and guarantees most efficient knockdown. Table 8 summarizes 
the siRNAs used and the negative control targeting at least 4 mismatches to any mouse 
gene (ON-TAGETplus non-targeting control).  
siRNA was dissolved in RNase free water to a stock concentration of 20µM and stored at -
20°C. Transfection was performed according to Manufacturer’s guidelines using Cell Line 
Nucleofector® Kit-V (Amaxa). In summary, 2.5x10
5 HUVEC cells were mixed with 2µg 
of siRNA (100nM final concentration), 100µl of Nucleofector Solution V and transferred to 
amaxa cuvette applying AMAXA devise, program V-001. Cells were cultured on LN411, 
LN511 or uncoated plates for 72h before RNA extraction. To assess transfection efficiency 
GFP conjugated control plasmid was transfected to HUVEC cells and GFP expression was 
observed by fluorescent microscopy. 
Likewise,  Nucleofector®  mediated  transfection  was  performed  with  2µg  ILK  plasmids 
(Table 8) that have been provided by Vassiliki Kostourou. 
Gene expression upon siRNA and ILK transfection was determined by qPCR as described 
in 5.10 . 
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gene product number
itgb1 004506
itgb3 004124
itga3 004571
non-targeting control D-001810-01-05
ILK GFP Vassiliki Kostourou 
ILK PBS Vassiliki Kostourou 
ILK E395K Vassiliki Kostourou 
  
Table 8 List of OnTarget siRNA and Ilk plasmids used 
 
Culturing of integrin b3 deficient endothelial cells 
Integrin b3 -/- and wildtype control immortalized endothelial cell lines were established by 
Stephen Robinson (unpublished data). Briefly, endothelial cells were isolated from lungs of 
integrin β3 -/- and control mice crossed to C57Bl/6 /129 genetic background. Immortalized 
endothelial  cell  lines  were  generated  by  Polyoma  virus  middle  T  antigen  expression 
introduced  by  ecotropic  retrovirus  transduction  according  to  May  (May,  Mueller  et  al. 
2005) et al., 2005. Cells were cultured in E4 low glucose, Ham’s F12 containing 20% FCS, 
0.1 mg/ml heparin (Sigma) and endothelial growth supplements (Sigma).  
 
5.18  Retroviral Cre infection of primary smooth muscle cells 
5.18.1  Mural  cell  isolation  of  mouse  aorta  according  to  (Ray, 
Leach et al. 2001)  
Ext1 floxed mice were euthanized by CO2 asphyxialation and aorta was dissected from its 
origin at left ventricle to the iliac bifurcation. Aorta was flushed with PBS and cleaned from 
tissue as well as adventitia until aorta appeared as a smooth tube. Aorta was cut into pieces 
of 1-2mm size and digested in 100µl filter sterilized enzyme solution containing 7.5mg 
collagenase A (Roche) in 5.5ml DMEM, 10% FCS, 1% Pen/ Strep and 1% glutamine. After 
6  hours  of  incubation  at  37°C  in  5%CO2,  3ml  of  culture  medium  were  added  and 
centrifugated at 300x g for 5 minutes. Medium was aspirated and replaced by 5ml of fresh 
medium followed by an additional centrifugation step before cells were resuspended in  
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700µl medium and transfered in 48-well plate. Cells were cultured and undisturbed for 5 
days. 
Mural cells were identified by IF staining for MC marker smooth muscle actin (SMA) and 
PDGFR-β. 
 
5.18.2  Retroviral Phoenix cell line transfection  
Phoenix cells were plated 24 hours before transfection at a density of 2x10
6 cells per 6cm 
dish to reach subconfluency. Cells were cultured in DMEM supplemented with 10% FCS, 
1% Pen/ Strep and 1% glutamine.  
For the transfection plasmid DNA (pBabe CRE hygro, pBabe CRE puro, pBabe neo CRE 
IRES-EGFP) was prepared in HBS (2x HBS: 8g NaCl, 6.5g HEPES, 10ml Na2HPO4). 
About  5  minutes  before  transfection  25µM  chloroquine  was  added  to  Phoenix  cells  to 
inhibit lysosomal DNases. Transfection mix containing 5-10µg DNA, 61µl 2M CaCl2 and 
sterile water to a final volume of 500µl was added to 6cm dishes of Phoenix cells and 
distributed  evenly.  Medium  was  detoxified  next  day  by  addition  of  fresh  medium. 
Supernatant was collected 48 hours post-transfection of Phoenix cell and centrifugated at 
1500rpm  for  5  min  to  pellet  cell  debris.  Finally,  1ml  of  viral  supernatant  and  3µl  of 
polybrene (5mg/ml) were added to primary mural cells isolated from Ext1 floxed aortas. 
Medium was changed 24 h later and MC were analysed 24-48 hours post infection of viral 
supernatant. 
Infection  of  Ext1  floxed  mural  cells  was  analysed  by  fluorescence  microscopy  and 
detection  of  GFP-,  RFP-  Cre. 
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6  Astrocytic  Fibronectin  regulates  retinal  endothelial 
tip  cell  migration  through  integrin  activation  and 
VEGF-A retention  
6.1  Results 
6.1.1  Fibronectin localization in retinal vasculature 
Fibronectin (FN) is a major component of the extracellular matrix (ECM) and functions 
in  cell  adhesion,  spreading  and  cell  migration.  Its  expression  is  widespread  during 
embryonic development and is upregulated in various pathological conditions such as 
cancer and wound healing (Hynes 2007). In addition, FN promotes cell migration and is 
prominently  deposited  in  areas  of  active  cell  migration  in  embryos. To  address  the 
function of FN during developmental angiogenesis and in particular during blood vessel 
sprouting and migration we analysed FN expression in the retinal vasculature. 
Visualization  of  FN  by  immunofluorescence  (IF,  red)  staining  revealed  strong  FN 
localization on astrocytes ahead of the growing vessels at postnatal day 5 (P5) in the 
mouse retina (white arrows, Figure 6.1 a, b). Co-labelling with PDGFRα, a marker used 
to detect astrocytes (d) and staining with isolectin B4 (green) to visualize endothelial 
cells (EC) support the specificity of astrocytic FN (Figure 6.1 b-d).  
These findings are in line with Uemura et al., 2006 showing FN expression by in situ 
hybridization on astrocytes ahead of the growing vasculature (Uemura, Kusuhara et al. 
2006). Astrocytes enter the retina and spread just ahead of the newly formed vessels, 
initiating  vessel  growth.  Jiang  and  colleagues  demonstrated  that  fibronectin  but  not 
laminin is expressed in the astrocytic zone. Increased mRNA expression revealed that 
astrocytes synthesis FN. In vitro experiments using conditioned medium approaches 
showed that astrocytes  stimulate endothelial cell FN expression, suggesting that FN 
expression is an essential component in the initiation of retinal vasculogenesis (Jiang, 
Liou et al. 1994). 
In  addition,  RT-PCR  of  FACS  sorted  retinal  endothelial  and  astrocytic  cell 
fraction revealed FN expression in both  cell types (Uemura, Kusuhara et al. 2006). 
Fibronectin assembly appears fibrilliar and is distributed over the entire network of 
central nervous system (CNS) derived astrocytes (b). Interestingly, FN expression is 
significantly  reduced  on  astrocytes  when  vascular  sprouts  grow  over  the  astrocytic 
network  (arrowheads,  a,  b).  Possibly,  FN  is  transiently  deposited  by  astrocytes  
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providing  a  provisional  matrix  and  functioning  in  guiding  sprouting  endothelial  tip 
cells. That would suggest that astrocytic FN is only transiently required and FN protein 
might be degraded once vessels have grown over the astrocytic matrix. Furthermore, the 
strong  localization  of  FN  around  endothelial  BM  of  retinal  vessels  suggest  that 
astrocytic FN is re-distributed and taken up by ECs while growing over the astrocytic 
FN  matrix.  Alternatively,  most  of  the  BM  FN  deposition  may  represent  de  novo 
production by ECs and pericytes.  
High magnification imaging revealed that extended filopodia protrusion lack FN but 
closely  align  to  the  FN-rich  astrocytic  network  (e).  In  marked  contrast  to  the  FN 
distribution, we find collagenIV (green, f-g), a major basement membrane component 
localized along retinal vessels forming a continuous layer surrounding endothelial cells 
of growing vessels (f). Tip cells of the growing angiogenic sprout lack a continuous 
collagenIV matrix and collagenIV is completely absent from filopodia protrusions and 
the astrocytic BM (g).  
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Figure 6.1 Localization of extracellular matrix component Fibronectin and 
CollagenIV in the retinal vasculature 
Fibronectin (FN, red) staining revealed strong deposition ahead of the growing 
vasculature (white arrows, a, b) whereas astrocytic FN expression is reduced in the 
mature vascular plexus (arrowheads, a, b). Blood vessels were visualized with isolectin 
(green) and co-labeling with Pdgfrα (blue) confirmed astrocytic deposition of FN (c, d). 
High magnification imaging showed alignment of filopodia to astrocytic matrix, 
however arrowheads indicate absence of FN on extended filopodia (arrows, e). In 
contrast to FN, collagenIV (green, f) is distributed in the abluminal basement membrane 
of retinal vessels (red, f) and absent from endothelial tip cells and filopodia (g).  
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To study the function of astrocytic FN we took advantage of the Cre-lox system and 
specifically deleted fibronectin from astrocytes expressing glial fibrillary acidic protein 
(GFAP),  an  intermediate  filament  expressed  by  mature  astrocytes  in  the  retina.  For 
details on the Cre-lox mediated gene targeting please see section 5.1 . After crossing FN 
floxed mice (provided by R. Faessler) with mice expressing Cre recombinase under the 
GFAP promoter (Bajenaru, Zhu et al. 2002), referred to as FN
ACko we observed a strong 
reduction  of  FN  expression  in  astrocytes  (Figure  6.2).  Immunofluorescence  staining 
with  fibronectin  (red)  revealed  astrocytic  FN  deposition  ahead  of  the  growing 
vasculature in control retinas (a) whereas astrocytic FN is completely absent (b) or 
significantly  reduced  (c)  in  FN
ACko  retinas.  Retinas  in  which  GFAP  Cre  mediated 
recombination has effectively deleted FN from most astrocytes display absent/reduced 
FN ahead of the vessels (e) and also show severe reduction of FN localization around 
blood vessels (b, e) suggesting that astrocytic FN contributes to the endothelial BM. 
However, deletion of astrocytic FN is often incomplete resulting in variable degrees of 
mosaic loss of astrocytic FN staining in-between FN
ACko littermates. Recombination of 
only one allele in heterozygous FN flox/+ GFAP Cre mice leads to reduced astrocytic 
FN staining, illustrating a quantitative correlation between allelic contribution and FN 
protein deposition (Figure 6.2 c, f). 
High magnification images revealed robust fibrilliar FN assembly in control mice (j). 
However, arrowheads highlight patches of efficient deletion of FN, while white arrows 
indicate astrocytes still expressing FN in FN
ACko (k, l). This mosaic pattern allows us to 
analyse astrocytic FN function in a dose dependent manner, comparing regions of Cre 
recombination and therefore FN inactivation and regions of reduced FN expression. We 
particularly applied that mosaicism when analysing the vascular defects at the sprouting 
front however, the following quantifications do not take the mosaic FN expression into 
account.  
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Figure 6.2 Loss of astrocytic fibronectin results in increased vascular density at the 
sprouting front 
Cre mediated deletion of astrocyte-derived fibronectin (FN
ACko) leads to reduced FN 
expression in mutant mice (b, c, h, i) compared to control retinas (a, g) as shown by FN 
staining (red, d-f). Co-labeling of astrocytes with Pdgfrα (red) and FN (green) reveals 
normal network development but reduced FN deposition in FN
ACko (g- i). Images k, l 
illustrate residual FN expression (red, arrow) in FN
ACko resulting in mosaicism while 
arrowheads point to regions with complete loss  of FN. Deficiency of astrocytic FN 
matrix leads to aberrant filopodia extension (asterisk, k).  
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Figure 6.3 Loss of astrocytic fibronectin results in reduced migration of vessels and 
increased vascular density at the sprouting front  
Overview images of the retinal vasculature visualized by isolectin staining (green, a-b) 
revealed reduced migration towards the retinal periphery in mice deficient of astrocytic 
FN. Vessel migration was quantified by measuring total length as illustrated by the 
white arrow (a, b). Graph (c) displays reduced radial expansion of superficial vessels at 
P5 in control (n > 5), heterozygous (FN
ACko/wt, n > 3) and FN
ACko mice (n > 5). **, p < 
0.01 1-Way ANOVA.Values represent mean ± S.E.M. 
Deficiency of astrocytic FN matrix leads to aberrant filopodia extension and graph (d) 
summarizes the number of filopodia protrusion per vessel length at the migrating 
vascular front of P5 mice, n ≥ 20. ***, p < 0.0001. Values represent mean ± S.E.M. 
Graph (e) illustrates the number of branchpoints per image field of P5 FN
ACko and 
control mice, n ≥ 10. ***, p < 0.0001. Values represent mean ± S.E.M. 
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When  comparing  the  migratory  length  of  vessels  towards  the  retinal  periphery  we 
observed that blood vessels of mice lacking astrocytic FN (Figure 6.3 b) have migrated 
significantly less than control littermates (a). The distance of vessel migration (c) in 
retinas of FN
ACko as well as FN
ACko/wt as compared to wildtype (wt) littermates was 
delayed by 9% in FN
ACko, 1354 ± 31.58 vs. 1474 ± 18.50 µm, p<0.01, and reduced by 
5.5% in FN
ACko/wt 1393 ± 24.68 vs. 1474 ± 18.50 µm, p<0.01). We speculate that the 
delay  in  migration  would  be  more  drastic  if  the  conditional  deletion  of  FN  were 
complete  and  uniform  throughout  the  astrocyte  population.  Indeed,  the  most 
pronounced reduction in vessel outgrowth was regularly found in areas with strongest 
reduction in FN expression. 
To investigate the possibility that the delay in migration is caused by defective network 
formation of astrocytes in the absence of FN, astrocytes were analysed using the marker 
PDGFRα. However, network formation and morphology of the astrocytes ahead of the 
vessels as well as astrocytes in the mature plexus were unaffected upon loss of FN 
(Figure 6.2 g-i), suggesting that loss of astrocytic FN selectively affects the forming 
vasculature. 
GFAP  has  been  described  as  a  marker  of  mature  astrocytes.  GFAP  expression  is 
strongest after remodelling of the immature astrocytic network once retinal vessels have 
grown over the provisional network. It is possible therefore that late onset of the GFAP 
promoter driving Cre expression resulted in residual astrocytic FN, masking a more 
fundamental  role  in  vascular  patterning.  To  address  whether  the  delay  of  vessel 
migration is enhanced when FN is deleted in early stages of retinal development we 
used a Cre line expressing Cre recombinase under the nestin promoter. Nestin is an 
intermediate filament transiently expressed by dividing and migrating cells of the CNS 
during  early  stages  of  development  and  is  later  replaced  by  cell-type  specific 
intermediate filaments such as GFAP (Beech, Cleary et al. 2004). In order to delete FN 
from early stage and immature astrocytes we crossed FN floxed mice and Nestin Cre 
mice (Lin, Sandusky et al. 2003) and analyzed the distance vessels have migrated at P5. 
We could confirm that vessel migration was further reduced by 12% (Figure 6.4 a-c). 
Immunostaining with FN revealed a substantial loss of FN in the astrocytic network and 
in the vascular compartment (c-f), indicating that recombination of FN in astrocytes 
expressing Nestin takes place. To study that the increased delay in vessel migration of 
FN Nestin Cre mice indeed caused by an increased loss of astrocytic FN compared to 
FN
ACko, I propose to quantitatively analyse FN mRNA expression.  
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When comparing the sprouting vascular front of FN
ACko (Figure 6.2 k, l) and wildtype 
littermates  (j)  we  observed  increased  number  of  filopodia  and  comparably  short 
filopodia burst on endothelial tip cells (asterisk, k). The loss of astrocytic FN appears to 
affect  the  filopodia  alignment  and  orientation  towards  the  astrocytes.  Further 
quantification of the growing vascular front in retinas lacking astrocytic FN revealed 
increased numbers or activity of endothelial tip cells, as determined by counting the 
number of filopodia (Figure 6.3 d) at the vascular front (filopodia number increased by 
131%, 36.7 ± 1.7 vs. 27.9 ± 1.1, p<0.0001). To examine whether the loss of astrocytic 
FN affects vascular density we compared number of branch points in of FN
ACko and 
wildtype control littermates (Figure 6.3 e) and found a significant increase by 35% 
(62.1 ± 2.2 vs. 45.8 ± 1.4, p<0.0001). In addition to the denser vascular plexus at the 
sprouting  front,  we  detected  slightly  dilated  vessels  (Figure  6.2  k,  l)  particularly  in 
regions where astrocytic FN is absent. Initial analysis of FN
ACko and quantification of 
filopodia number and vessel density has been carried out by Andrea Lundkvist.  
Similar defects seen in FN
ACko were observed when analysing the vascular front 
of mice lacking astrocytic FN in Nestin Cre mice. Although FN expression (green) is 
not completely absent in FN/ Nestin Cre positive retinas (d, f) we observed a reduction 
of FN assembly and deposition in astrocytes ahead of retinal vessels (c-f). The reduction 
of astrocytic FN resulted in morphological defects. Blood vessels of the sprouting front 
are  dilated  and  the  plexus  appears  denser  than seen  in  control  littermates  (c,  e).  In 
addition,  high  magnification  revealed  increased  numbers  of  filopodia  (g,  h)  in  FN/ 
Nestin Cre mice compared to control littermates.  
In summary, loss of astrocytic FN leads to delayed migration of retinal vessels 
and an increased number of filopodia and subsequently a denser plexus in the sprouting 
vascular front that could be a result of increased proliferation due to instable vessels. 
The  loss  of  astrocytic  FN  possibly  affects  basement  membrane  composition  and 
assembly  around  mature  blood  vessels  leading  to  aberrant  sprouting  and  EC 
proliferation. Another possible explanation of vessel hyperplasia could be a failure of 
filopodia to align and stretch along the astrocytic network lacking FN resulting in non-
adherent  ECs  causing  delayed  migration  and  therefore  dilated  vessels.  Possibly,  the 
increased number of filopodia extension could be a compensatory effect upon the loss 
of filopodia- astrocytic matrix adhesion. Or the increase in filopodia could reflect an 
increased number of endothelial tip cells as a result of enhanced proliferation.  
  119 
 
Figure 6.4 Nestin Cre mediated loss of fibronectin results in reduced vessel 
migration 
Overview images of the retinal vasculature visualized by isolectin staining (a, b) 
revealed reduced radial expansion towards the retinal periphery in mice deficient of 
astrocytic FN (FN Nestin Cre). Graph c illustrates reduced migration in P5 FN Nestin 
Cre mice (n = 3) compared to control retinas (n =7). ***, p < 0.0001. Values represent 
mean ± S.E.M. 
Fibronectin staining (green, c-f) shows reduced assembly and expression of FN in 
astrocytes (blue, e, f) and reduced deposition of FN in basement membrane of retinal 
blood (red, c-f) upon Nestin Cre recombination (d, f). Loss of astrocytic FN results in 
increased vessel density and excessive filopodia extension of vessels at the sprouting 
vascular front (g, h).  
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6.1.2  Migratory delay of retinal vessels in several FN splice variants  
We hypothesized that the delayed migration of vessels lacking an astrocytic FN matrix 
could be caused by misguidance and/or a defective adhesion of vessels to the astrocytic 
plexus. Confocal microscopy revealed a close interaction of leading endothelial tip cells 
with the underlying matrix deposited by the astrocytic network providing a guiding 
network  for  growing  vessels.  As  shown,  FN  is  almost  exclusively  provided  by  the 
astrocytes ahead of the vessels and its deposition is strongly down regulated in the 
mature  astrocytic  plexus,  while  FN  is  mainly  localized  around  blood  vessels  in  the 
mature plexus (Figure 6.1Error! Reference source not found. a). 
Fibronectin  is  high-molecular  weight  glycoprotein  and  its  function  in  adhesion, 
migration,  and  cell  survival  has  been  extensively  described.  Its  complexity  is  also 
reflected  in  its  structural  diversity,  cell-type  specific  alternative  splicing  results  in 
several  FN  isoforms.  In  collaboration  with  Richard  Hynes,  we  analysed  the  retinal 
vasculature of FN  spliced variants missing  extra domain EIIIA or EIIIB as well as 
double splice mutants EIIIAB and EIIIBA. Although the presence of FN splice variants 
EIIIA  and  EIIIB  correlates  with  embryonic  vascular  development  and  vascular 
remodelling,  and  their  expression  is  strongly  upregulated  during  pathological 
angiogenesis such as tumour development, mice lacking either domain are viable and 
vascular development and retinal angiogenesis appear normal (Astrof, Crowley et al. 
2004).  In  contrast,  EIIIA/EIIIB  double  null  mice  are  embryonic  lethal  and  exhibit 
severe  cardiovascular  defects,  including  hemorrhages  and  extraembryonic  defects 
(Astrof, Crowley et al. 2007). Therefore, we analysed the retinal vasculature of mice 
null for EIIIB or EIIIA, and of compound mutants null for EIIIB and heterozygous for 
EIIIA,  or  null  for  EIIIA  and  heterozygous  EIIIB,  referred  as  EIIIBA  or  EIIIAB 
respectively. In all cases, we observed that a vascular plexus has formed, vessel density 
appeared normal and vessels have migrated towards the retinal periphery (Figure 6.5). 
However,  when  we  determined  the  distances  vessels  have  migrated  we  noticed  a 
significant delay in FN splice variants FN EIIIB, FN EIIIAB and FN EIIIBA, but not FN 
EIIIA  (c).  Figure  6.5  is  a  summary  of  the  analysis  of  multiple  litters  of  FN  splice 
mutants. The migratory length was compared to control littermates, set to 100%. 
We observed the most prominent delay of vessel migration in FN splice mutant FN 
EIIIB, whereas mice deficient of splice variant FN EIIIA have no migrational defects. 
Fibronectin splice mutants FN EIIIAB and FN EIIIBA displayed a mild delay. To our  
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surprise,  retinal  vessels  of  mice  null  for  FN  EIIIB  and  heterozygous  for  FN  EIIIA 
migrated  further  than  vessels  of  single  splice  variant  lacking  FN  EIIIB.  A  possible 
explanation for this observation could be that loss of both splice domains results in 
conformational  changes  of  FN.  As  a  consequence,  FN-binding  properties  might  be 
altered, enabling and/or enhancing the binding of additional integrins that positively 
influence migration. Alternatively, the additional loss of one allele FN EIIIA in FN 
EIIIB null mice may result in compensatory effects and allowing vessels to migrate on a 
discrete ECM substrate. 
Next we analysed the vasculature of each FN splice variant in more detail.  
Studying the sprouting vascular front of FN EIIIA single mutants we found no 
differences  in  vascular  density,  number  or  alignment  of  filopodia  to  the  astrocytic 
network (Figure 6.6 a-b). 
Similarly, no striking defects were observed when analysing FN EIIIB single 
mutants. We found that FN is expressed in FN EIIIB-/- to the same extend as control 
littermates and has assembled in fibrilliar structures (c-d). Immunofluorescence staining 
with PDGFRα, a marker for astrocytes and combined staining with FN illustrates 
deposition and assembly of FN on the entire astrocytic network. Co-labelling with 
isolectin to visualize the ECs revealed that leading tip cells follow the underlying 
astrocytic plexus and extended filopodia align closely to astrocytes. Interestingly, FN 
EIIIBA and FN EIIIAB double mutant mice developed an abnormal vascular pattern 
(Figure 6.6 h-j). In particular, we found that EC tip cells appeared blunt ended and seem 
to have lost the interaction and guidance of the astrocytic network (red arrows). When 
comparing the retinal vasculature to control littermates we observed that vessels are not 
restricted to a two-dimensional network as seen in control mice. Instead blood vessels 
have grown off their track and migrated over each other resulting in an abnormal 
patterning of the vascular sprouting front, indicated by red arrowheads (i, j). This could 
be a result of the slight reduction in FN deposition in the astrocytic network ahead of 
the growing vasculature as seen in FN EIIIAB -/- compared to control retinas (k-o).   
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Figure 6.5 Fibronectin splice variant FNEIIIB and double splice variants 
FNEIIIAB and FNEIIIBA function in vessel migration during retinal angiogenesis 
Isolectin staining to detect the retinal vasculature revealed reduced radial migration to 
the retinal periphery in FN splice variants FNEIIIB (d, e), FNEIIIAB (f, g) and 
FNIIIBA (h, i) but not FN isoform FNIIIA (a, b). Graph c represents a summary of 
distance vessels have migrated in comparison to control retinas. ***, p < 0.0001, *, p < 
0.05. Values represent mean ± S.E.M.  
FNEIIIA +/- and FNEIIIA -/- n=7; FNEIIIB +/- n=6, FNEIIIB -/- n=12; FNEIIIAB +/- 
n=3, FNEIIIAB -/- n=4; FNEIIIBA +/- n=16, FNEIIIBA -/- n=13  
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Therefore, we suggest that individually, the FN splice variant EIIIA has no significant 
function  during  vascular  development  in  retina  as  reported  previously  by  (Astrof, 
Crowley et al. 2004), while FN EIIIB may play a role in migration of retinal vessels. 
Interestingly, a possible effect of EIIIB on FN matrix assembly and proliferation was 
observed in EIIIB-null MEFs in vitro and recombinant EIIIB-positive FN incorporated 
somewhat more efficiently into ECM (Fukuda, Yoshida et al. 2002);(Guan, Trevithick 
et al. 1990), suggesting a possible role for EIIIB in FN matrix assembly. This could be a 
possible explanation for the migratory delay observed in FN EIIIB but not FN EIIIA 
null retinas. 
Combined  loss  of  both  splice  variances  FN  EIIIA  and  EIIIB  results  in  embryonic 
lethality with vascular defects resembling the loss of full-length FN (Astrof, Crowley et 
al. 2007). In line with these findings, mice either null for EIIIA and heterozygous for 
EIIIB or null for domain EIIIB and heterozygous for EIIIA exhibited a reduction of 
migratory speed as well as abnormal vascular patterning, indicating that the presence of 
at least one domain is required for normal vascular development. 
6.1.3  FN binding domain RGD is not required for vessel migration 
Fibronectin has been reported to interact with various extracellular matrix components 
such as collagen and heparan sulfate proteoglycans, but also with growth factors such as 
vascular endothelial growth factor (VEGF). However, most extensively studied are the 
interactions  of  fibronectin  with  cell-surface  receptors,  namely  integrins  (ITG). 
Fibronectin binds to integrin receptor α5β1 via  the RGD (Arg- Gly- Asp) -binding 
domain and thereby mediates cell attachment.  
Using antibodies directed against integrin alpha 5 (ITGα5) or integrin beta 1 (ITGβ1) 
we observed that both integrins (Figure 6.7, green) are expressed by endothelial cells 
and localized at the abluminal endothelial cell surface facing the basement membrane 
(BM) of retinal vessels (red). High magnification imaging revealed a spotty localization 
of ITGα5 (g-i) and ITGβ1 (a-c) on filopodia of leading tip cells (arrows). In addition, 
ITGβ1 was strongly expressed by pericytes and vascular smooth muscle cells, indicated 
by arrowheads (d-f).  
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Figure 6.6 Fibronectin assembly and morphological analysis of retinal vasculature 
in fibronectin splice variants 
FN splice variants FNEIIIA -/- display no defects in vessel sprouting and the vascular 
plexus forms normal (a, b). FN assembles in a fibrilliar network (green, c-g) in FNEIIIB 
-/- splice variants and co-localizes with the astrocytic network (blue). High resolution 
imaging reveals close alignment of filopodia to FN-rich matrix in FNEIIIB-/- (f, g) as 
seen in control FNEIIIB +/- (e). In contrast to the single spliced mutants, double splice 
variants FNEIIIBA-/- mice develop blunt ended endothelial tip cells (red arrows, i and 
h) that result abnormal vessel patterning (arrowheads). Tip cells penetrate into the 
vitrous body and don’t align with the astrocytc matrix leading to vessels that grow over 
each whereas control vessels are restricted to a 2-dimensional plexus (h). Fibronectin 
staining (green) in FNEIIIAB splice mutants appears reduced in comparison to control 
FNEIIIAB-/- mice (k-o). This reduction might explain the mis-alignment of filopodia 
frequently observed in FNEIIIAB-/- (n, o) illustrated by red filopodia burst at leading tip 
cells (arrowheads, m-o)  
  125 
 
To gain insight whether the reduced migration in retinas lacking astrocytic FN is 
due to a failure of fibronectin – integrin binding we took advantage of a mouse line 
bearing  a  mutation  in  the  RGD  binding  domain  of  fibronectin.  The  RGD-motif  is 
replaced by an inactive RGE motif and thereby inhibits the binding of FN to integrin 
α5β1 and αvβ3. FN-RGE homozygous mice are embryonic lethal and embryos display 
severe vascular defects resembling the phenotype of alpha 5 integrin (Itga5)-deficient 
mice (Takahashi, Leiss et al. 2007). We crossed FN
ACko mice with heterozygous RGE 
mice to obtain FN
ACko /FN RGE mice. These mice are viable as they produce wildtype 
FN from one floxed allele in all Cre negative cells in addition to FN RGE from the 
second allele. Retinal astrocytes however loose the wildtype allele upon Cre mediated 
recombination, thus producing only FN RGE lacking the ITGα5 -binding domain.  
We then analysed the retinal vasculature and the migratory length of vessels as well as 
FN assembly. Co-labelling of astrocytes with PDGFRα and EC with isolectin as well as 
staining for FN revealed that the FN is reduced ahead of growing blood vessels but the 
remaining FN has assembled in fibrils (Figure 6.8 a-f). Therefore, we concluded that the 
astrocytic RGD- binding motif is not required for FN assembly. Takahashi and 
colleagues have demonstrated similar findings that the absence of a functional RGD 
motif in FN did not compromise assembly of an FN matrix in mutant embryos or on 
mutant cells (Takahashi, Leiss et al. 2007).  
 
To study the migration of retinal vessels we measured the distance vessels have 
reached towards the retinal periphery (g, h). As summarized in graph (i), we could not 
observe a significant delay in vessel migration of RGE/ wt mice compared to control 
littermates. Still, we found a similar degree of migratory delay in RGE/FN
ACko mice as 
seen previously for FN
ACko/ wt. The reduction of 5% in both genotypes obtaining one 
allele of FN reflected that the delay is independent of the RGE-motif.  
Therefore, we propose that RGD-mediated integrin binding of astrocytic FN is 
not required for retinal vessel migration. However, close examination of endothelial tip 
cells and alignment of filopodia along the astrocytic network revealed an increased 
number of mis-aligned filopodia in RGE/FN
ACko (a-c) compared to control littermates 
(arrowheads, d-f). Preliminary quantification identified a significant mis-alignment of 
filopodia to astrocytic FN containing the inactive RGE in comparison to FN expressing 
RGD-binding motif, suggesting a role of integrin-FN interaction in filopodia alignment.  
  126 
 
 
 
 
 
 
Figure 6.7 Localization of integrin α5 and β1 in retinal vasculature 
Staining with integrin β1 (a-f) and integrin α5 (g-l, green) and isolectin (red) revealed 
co-localization of β1 and α5 integrin at the abluminal basement membrane of blood 
vessels and spotty localization at filopodia protrusion of endothelial tip cells (arrows, b-
c, h-i). In addition, integrin β1 is deposited strongly at pericytes and vascular smooth 
muscle cells (arrows, e-f) but α5 chain is absent (j-l).   
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Figure  6.8  RGD-binding  of  astrocytic  FN  is  dispensable  for  FN  assembly  and 
vessel migration 
Mutation of integrin binding domain RGD in an inactive RGE motif in astrocytic FN 
does not affect FN assembly as shown by FN staining (green) and co-labeling of 
astrocytes with PDGFRa (blue, a-f). However, close examination of filopodia at leading 
tip cells displayed occasional mis-alignment of filopodia in mice lacking astrocytic FN 
RGD (arrowheads, a-c) when compared to control mice (d-f). 
Overview images illustrate no defects in vessel morphology and radial expansion of 
vessels towards the periphery (g, h). Graph i displays vessel migration of RGE/wildtype 
mice and mice inhabiting inactive RGE motif in astrocytic FN.  
Wt and RGE/wt n > 8; Control and FNACko/RGE n=5; *, p < 0.05. Values represent 
mean ± S.E.M.  
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6.1.4  Reduced  migration  of  retinal  vessels  in  mice  deficient  for 
endothelial integrin alpha 5 
To  investigate  the  hypothesis  that  vessel  migration  is  independent  of  integrin-FN 
interaction we analysed the retinal vasculature of mice deficient in endothelial integrin 
alpha5, referred as Itga5
ECko. The mice have been generated in the laboratory of R. 
Hynes and retinal material was provided. Conditional excision of floxed Itga5 exon 1 
containing the ATG sequence was achieved in endothelial cells using the Tie2-Cre line. 
As  shown  in  Fig.1.6  we  detected  endothelial  ITGα5  staining  juxtaposed  to  the 
abluminal BM of blood vessels.  
Analysis of several stages of retinal vessel development, including postnatal day 
3, 5 and 7 revealed a significant reduction of migration of Itga5
ECko compared to control 
littermates (Figure 6.8, a-c). Overview images of Itga5
ECko and control littermates (a, b) 
illustrate the distance vessels have migrated towards the retinal periphery.  
When analysing the sprouting vascular front we observed similar defects as seen in FN 
EIIIBA double splice mutants. Blood vessels are not restricted to a two-dimensional 
network and grow partially over each other and filopodia penetrate into the vitreous 
body (arrowheads, f-g). However, staining with FN confirms the presence of an intact 
and  complete  network  of  FN  fibrils  (d-g,  green).  Therefore,  we  hypothesize  that 
extended filopodia of Itga5
ECko do not closely align to the underlying astrocytic plexus 
and are not in close contact to the astrocytic FN matrix.  
This  observation  would  be  in  line  with  the  finding  that  retinal  vessels  exhibit  an 
increased number of mis-aligned filopodia when astrocytic FN lacks the RGD binding 
motif. And therefore, RGD-FN interaction functions in endothelial adhesion. However, 
Itga5
ECko  display  reduced  vessel  migration  and  these  data  are  contradictory  to  our 
findings  that  FN-RGD-binding  is  not  important  for  vessel  migration.  A  possible 
explanation could be the finding that FN contains a novel motif for integrin binding and 
fibril formation whose activity is controlled by amino acid modification (Takahashi, 
Leiss  et  al.  2007)  that  compensates  the  loss  of  astrocytic  FN  RGD  binding  and 
therefore, does not affect vessel migration. 
Alternatively, the diminished migration Itga5
ECko could be a result of alpha 5 integrin 
interaction with additional matrix component provided by astrocytes other than FN.  
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Figure 6.9 Loss of endothelial integrin a5 expression results in delayed migration 
and mis-alignment of filopodia to astrocytic FN matrix 
Overview images of retinal vasculature illustrate reduced migration of vessels in mice 
deficient of integrin a5 (Itga5
ECko a, b). Graph c summarizes the radial expansion of 
superficial vessels of mice (P3-P6). Control mice n=10, Itga5
ECko n=9; ***, p < 0.0001. 
Values represent mean ± S.E.M. 
FN staining (green, d-g) revealed that expression and FN assembly is not affected upon 
loss of endothelial integrin α5, however filopodia of Itga5
ECko mice fail to align to the 
astrocytic network and are not restricted to 2D plexus (arrowhead, f, g).  
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6.1.5  Decreased VEGFR2 signalling and PI3 kinase/ AKT activity in 
mice deficient for astrocytic Fibronectin 
Recent studies reported the extracellular interaction of FN with VEGF and showed that 
binding of VEGF to the heparin-II domain of FN is necessary and sufficient to promote 
VEGF-induced endothelial cell proliferation, migration, and ERK activation (Wijelath, 
Rahman et al. 2006). In addition, mice expressing only the soluble isoform of VEGF 
(VEGF121)  missing  the  heparin-binding  domain  exhibit  vascular  defects,  including 
misguidance of filopodia, ectopic filopodia extension (Ruhrberg, Gerhardt et al. 2002) 
and reduced migration (Gerhardt, Golding et al. 2003). Therefore, it has been suggested 
that filopodia sense a heparin- and extracellular matrix bound VEGF gradient expressed 
by astrocytes ahead of the growing vessels. Disruption of a VEGF gradient results in 
abnormal vessel morphology and patterning defects in the mouse retina.  
To address whether the reduced migration in FN
ACko is a consequence of decreased 
VEGF signalling due to incomplete binding of VEGF to FN we analysed VEGFR2 
activation by Western Blot. Total protein extracts of P5 retinas were analysed and total 
amount of VEGFR2 determined. Despite same levels of VEGFR2 protein expression 
the amount of phosphorylated VEGFR2 was strongly decreased in FN
ACko compared to 
control retinas (Figure 6.10 a), suggesting that FN is essential for a complete VEGF 
signalling. 
Among the downstream effector of VEGF, is the class IA Phosphoinositide 3-kinases 
(PI3K), which has been recently shown to regulate endothelial cell migration (Graupera, 
Guillermet-Guibert  et  al.  2008).  Class  IA  PI3K  are  heterodimeric  lipid  kinases 
consisting of a p110 catalytic subunit complexed to one of several regulatory subunits, 
collectively called p85. In response to stimulation by growth factors (i.e. VEGF), p110 
subunits catalyze the production of phosphatidylinositol-3,4,5-trisphosphate (PIP3) at 
the membrane. This second messenger in turn activates the serine/threonine kinase AKT 
and downstream effectors (Vanhaesebroeck and Waterfield 1999). Interestingly, it has 
been shown that integrins and receptor tyrosine kinases (RTKs) such as VEGFR2 share 
a number of important signalling molecules, including Src, FAK, and PI3K (Eliceiri 
2001). 
We therefore assessed whether FN
ACko retinas exhibited defects in the PI3K pathway. 
Total  class  IA  PI3K  lipid  kinase  activity  present  in  p85  immunoprecipitation  was 
reduced by about 50% in FN
ACko retinas (Figure 6.10 c), indicating that FN contributes  
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to a full activation of the class IA PI3K in mouse retinas. In agreement with this, PI3K 
activity associated with a phospho tyrosine peptide matrix (which binds all p85 species; 
referred to as pY peptide) was also reduced by approximately 50% in FN
ACko retinas 
(Figure 6.10 c). Immunoprecipitation with p85 and pY to investigate PI3K activity in 
FN
ACko retinas has been carried out by Mariona Graupera. 
We next assessed the impact of lack of astrocytic FN production on PI3K signalling. 
AKT is regulated via its
 phosphorylation on two highly conserved sites: the activation
 
loop of threonine (Thr-308) in the kinase core and a hydrophobic
 phosphorylation site 
on the carboxyl terminus at serine (Ser-473) (Andjelkovic, Alessi et al. 1997). 
Using antibodies detecting either AKT- pSer or AKT- pThr we found a reduction in 
AKT phosphorylation at Ser473 but not at phosphorylation site Thr308 (Figure 6.10 b). 
This  could  indicate  differential  involvement  of  activating  kinases  introducing  the 
phosphorylation; while pSer is phosphorylated by mTORC2, pThr becomes activated 
by  PDK-1.  The  level  of  total  AKT  is  unaffected  in  FN
ACko  compared  to  control 
littermates suggesting that the reduction in pSer473 signifies a specific reduction in 
AKT activity upon loss of astrocytic FN. Taken together, these results suggest that 
astrocytic  FN  plays  an  important  role  in  stimulating  endothelial  migration  by 
influencing endothelial VEGF-A signalling via the PI3K pathway.  
  A  recent  study  by  Graupera  and  colleagues  highlighted  p110α  isoform 
selectivity in angiogenic sprouting and vascular remodelling. Genetic inactivation of 
p110α revealed a cell-autonomous function in endothelial tip cell migration; VEGF-A 
induced AKT phosphorylation was almost completely abrogated in ECs lacking p110α 
and migration speed as well as distance was drastically reduced in mice and primary 
ECs lacking p110α (Graupera, Guillermet-Guibert et al. 2008). Combined these data 
suggest that VEGF-A dependent migration requires PI3K activity and astrocytic FN 
functions in this process.  
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Figure 6.10 Loss of astrocytic FN impairs VEGFR2 mediated migration via PI3K 
pathway 
Phosphorylation of VEGFR2 and VEGFR2 protein levels were examined in retinas of 
P5 mice lacking astrocytic FN (FN
ACko) and control mice by Western Blotting (a). 
Likewise, phosphorylation of Serine residue 473 (pSer) and Threonine residue 308 
(pThr) of AKT were analysed in comparison to total levels of Akt (b). VEGFR2 
phosphorylation was reduced by almost 50% and phosphorylation of Serine residue 
AKT is decreased while total levels of VEGFR2 and AKT are unaffected. 
Phosphorylation of Threonine is unchanged indicating differences in activating kinases 
of pSer and pThr.  
PI3kinase activity was determined by pull down assays of p-peptides or targeting p85, 
regulatory subunit of PI3K. Graph c illustrates reduction PI3K activity in mice lacking 
astrocytic FN. Both approaches are not significantly different when analysed by student 
t-test, however when data were pooled of both assays by calculating percentage 
differences, PI3K activity was significantly decreased.  
Control retinas for p-peptide n=3, FN
ACko n=3; control retinas for p85 pull down assay 
n=2, FN
ACko n=4; *, p < 0.05. Values represent mean ± S.E.M.  
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6.1.6  Inhibition of VEGF binding to FN 
Based on the finding that loss of astrocytic FN leads to reduced migration and decreased 
VEGFR signalling we hypothesized that loss of astrocytic cell surface VEGF-retention 
to FN could represent the primary defects leading to impaired retinal angiogenesis. 
To  further  investigate  into  the  role  of  FN-VEGF  binding  and  retention  in  retinal 
migration,  we  injected  peptides  inhibiting  the  binding  of  VEGF  to  FN  (FnIII13-14) 
intraocularly in postnatal C56Bl/6 pups. After 24h treatment eyes were harvested and 
stained  to  visualize  retinal  vessels  (red)  and  FN  matrix  (green,  Figure  6.11).  We 
measured the total migratory length of retinal vessels injected with FnIII13-14 peptides, 
control  peptides  and  uninjected  retinas.  Graph  (a)  illustrates  the  total  length  of 
migration  in  relation  to  uninjected  control  eyes  (100%)  and  we  observed  a  10% 
reduction in migration when comparing to uninjected and control peptide injected eyes. 
Firstly, this shows that the injection per se does not affect migration because retinal 
vessels in eyes injected with control peptides migrate the same distance as uninjected 
control  retinas.  Secondly,  the  10%  reduction  in  migration  is  very  significant  when 
taking in consideration that the peptides where only injected at postnatal day 4. On 
average, vessels migrate 200-250µm per day towards the retinal periphery. To estimate 
the acute effect of 24 hours peptide treatment, we reasoned that retinal vessels will have 
migrated normally before treatment on day 4 and therefore used the average day 4 level 
as the baseline to calculated the distance vessels have migrated after injection. This is 
represented in graph (b) showing that inhibition of FN-VEGF binding by injection of 
peptide FnIII13-14 for 24 h drastically reduced vessel migration by almost 40% while 
control peptides had no affect. 
In addition, overview images of the vascular front illustrate that a plexus has formed in 
retinas injected with FnIII13-14 peptide (c, d). Again, assuming that the morphology and 
density of vascular plexus has developed the same in all groups before treatment on day 
4, we analysed the sprouting front (~200µm) after injection (white dashed line). When 
study the sprouting vascular front, we observed subtle differences in vessels of retinas 
injected with FnIII13-14 peptides. As shown in Figure 6.11 the vascular density of mice 
injected with inhibiting peptides (d, f) is rather sparse than seen in uninjected control 
littermates (c, e) and mice injected with control peptides.   
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Confocal microscopy revealed that the sprouting vessels are thin and poorly branched, 
stretching over long distances before making contact to neighbouring vessels in FnIII13-
14 injected retinas (white arrows, e).  
 
Loss of VEGF binding to FN could affect migration in several ways. First, if FN 
should provide the major binding and thus retention mechanism of astrocytic VEGF-A, 
the  overall  protein  distribution,  and  thus  gradient  formation  of  VEGF-A  could  be 
disturbed.  Interestingly,  vascular  pattern  defects,  in  particular  the  combination  of 
reduced migration and branching frequency resemble the phenotype caused by reduced 
VEGF  gradient  formation  in  VEGF120  mice  (Ruhrberg,  Gerhardt  et  al.  2002); 
(Gerhardt, Golding et al. 2003). Secondly, FN binding could play a more local role in 
promoting a co-receptor function of integrin and VEGFR2 (Wijelath, Rahman et al. 
2006). Heparan sulfate could still provide overall VEGF retention and thus gradient 
formation, but loss of co-receptor function and signalling complex formation between 
integrin and the VEGFR could severely affect signalling properties, leading to reduced 
migration. It is unfortunately very difficult to distinguish between the two possibilities 
as there are currently no good antibodies available to visualize the VEGF gradient in the 
developing retina.  
To  verify  that  VEGF-FN  binding  influences  vessel  migration,  we  analysed 
VEGFR2 signalling and AKT/PI3K activity in mice treated with FnIII13-14 peptides. 15 
hours post-injection of blocking peptide FnIII13-14 and control peptide in P4 C56Bl/6 
mice, eyes were harvested and protein extracted. We determined the total amount of 
VEGFR2 and found that protein expression levels are unaffected upon treatment with 
FnIII13-14, however phosphorylation of VEGFR2 tends towards a decrease in retinas 
injected with FnIII13-14 inhibiting the binding of VEGF to FN. Densitometric analysis 
indicated  a  40%  reduction  (Figure  6.12  a,  b)  which  numerically  reflects  the  40% 
reduced migration after peptide injection.  
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Figure 6.11 Inhibition of VEGF binding to FN leads to reduced vessel migration 
and affects sprouting of leading tip cells 
Graph a illustrates distances vessels have migrated towards retinal periphery at P5 when 
treated with inhibiting peptide of FN-VEGF binding (FnIII13-14 ) and control peptide for 
24 hours compared to uninjected control eyes. By measuring the total length of radial 
expansion of vessels we determined a significant reduction upon injection of FnIII13-14 
while control peptides have no effects. When calculating the distance vessels have 
migrated during the 24h of peptide treatment (b, day P4-P5), we found an almost 40% 
decrease in vessel migration upon FnIII13-14 injection. 
Mice injected with FnIII13-14 n=3, control peptide injected mice n=2; **, p < 0.01. 
Values represent mean ± S.E.M. 
Injection of peptides does not affect FN assembly as shown by IF staining with FN 
(green, c-f). Isolectin staining (red) revealed that the vascular plexus developed 
normally until P4 (dashed line, d) but upon injection of FnIII13-14 peptides vascular 
plexus appears sparse (d) when compared to sprouting front of uninjected retinas (c). In 
addition, vessels are thin and un-branched (arrows, f) while control vessels connect to 
form a vascular plexus (e).  
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However,  likely  due  to  limited  number  of  peptide  injected  retinas  the  decrease  in 
VEGFR2 phosphorylation is not significant and needs further analyses.  
To gain further insight into the underlying mechanism we studied the expression and 
phosphorylation of downstream signalling molecules AKT. Using an antibody directed 
against pSer-AKT and total AKT we detected a slight reduction in phosphorylated AKT 
in  mice  treated  with  FnIII13-14  compared  to  control  injected  mice  (c,  d).  These 
preliminary  analysis  and  densitometric  analysis  revealed  a  12%  reduction  in  AKT 
activity  (Figure  6.12  b,  d).  This  numerical  difference  between  VEGFR2  and  AKT 
effects  could  be  explained  by  a  faster  turnover  and  de-phosphorylation  of  AKT 
compared  to  VEGFR2  signalling.  Combined  these  data  suggest  that  inhibition  of 
VEGF-FN  binding  and  therefore,  the  likely  disruption  of  a  matrix  bound  VEGF 
gradient accounts for diminished vessel migration in the developing retina. 
 
6.1.7  Delayed  migration  in  FN  splice  variants  and  Itga5
ECko  is 
independent of PI3K/AKT signalling 
Finally, we asked whether the delayed migration of retinal vessels in FN splice mutants 
and Itga5
ECko is a result of diminished AKT/PI3K signalling. To address this question 
we examined AKT activity in relation to the total level of AKT. However, we could not 
detect any differences in phosphorylation levels of AKT (Figure 6.13). Although it has 
been described that Fn fragments containing both the α5β1 integrin-binding domain and 
the  VEGF-binding  domain  significantly  enhanced  VEGF-induced  EC  migration  and 
proliferation and induced strong phosphorylation of the VEGFR and ERK (Wijelath, 
Rahman et al. 2006) we cannot detect differences in PI3K signalling in mice lacking 
endothelial ITGα5. 
Structurally,  mutations  in  the  extra  domain  EIIIA  and  EIIIB  do  not  affect  VEGF 
binding and therefore, we speculate that delayed migration of FN splice variants EIIIA/ 
EIIIB and double splice mutants is not caused by decreased VEGF binding and VEGFR 
activity. Since deposition of FN and assembly in a fibrilliar network appeared normal in 
the mutant retinas analyzed it is likely that the integrin binding site in the extra domain 
EIIIA is not essential for assembling a FN matrix and binding to integrin α5β1.  
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Figure 6.12 VEGFR2 signalling and PI3K activity is disturbed upon inhibition FN-
VEGF interaction 
Phosphorylation of VEGFR2 and VEGFR2 levels were accessed by total protein 
extraction and Western Blotting. VEGFR2 signalling upon intraocular injection of 
peptides inhibiting VEGF binding to FN and control peptides was analyzed 15 hours 
post injection (a). Densiometric analysis revealed a tendency towards reduced VEGFR2 
phosphorylation compared to total VEGFR2 expression levels in FnIII13-14 injected 
retinas (b).  
PI3K activity was addressed by determining expression levels of Akt and its 
phosphorylation (pSer) by Western Blotting (c). Graph d summarizes the percentage of 
phosphorylated AKT in relation total amounts of AKT. *, p < 0.05. Values represent 
mean ± S.E.M. Mice injected with FnIII13-14 n=3, control peptide injected mice n=2;   
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Figure 6.13 Migratory delay of FN splice variants is not caused by diminished 
PI3K activity 
PI3K activity was addressed by analyzing expression levels of Akt and its 
phosphorylation (pSer) by Western Blotting. Protein was isolated of P5 retinas from FN 
splice mutants FNEIIIBA and mice deficient in endothelial integrin a5. Blots a and b 
illustrate the levels of total Akt and phosphorylation detected by pSer-AKT antibody 
were not significantly different. 
Graph summarizes the percentage of phosphorylated AKT in relation total amounts of 
AKT. Values represent mean ± S.E.M. Litter 95H 1-7 FNEIIIBA wt n=1, FNEIIIBA+/- 
n=1, FNEIIIBA-/- n=1, Itga5 control mice n=4, Itga5
ECko n=5 
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6.2  Discussion 
The present study underlines a function of fibronectin in blood vessel migration by 
modulating  VEGF  availability.  Directed  EC  migration  and  expansion  of  the  retinal 
vascular plexus requires PI3K activity. Further, the study indicates that  adhesion of 
leading ECs and filopodia protrusion rely on FN-integrin interaction. 
 
6.2.1  Integrin-binding is dispensable for FN assembly and migration 
In the retinal vasculature, astrocyte precursors enter the retina through the optic nerve 
and radiate towards the periphery. Blood vessels subsequently follow along the pre-
existing astrocytic meshwork, therefore the astrocyte provide attractive cues and initiate 
vascularization. Hypoxia-induced expression and secretion of VEGF-A is mediated by 
astrocytes (Stone, Itin et al. 1995). The preceding newly formed vessels express high 
levels of VEGFR2, indicating that the secreted VEGF acts on the vessels in a paracrine 
fashion. Astrocytes further provide a provisional matrix that function as a preset track 
instructing retinal blood vessel growth. Extended filopodia at the leading endothelial tip 
cell closely align to the astrocytic network, suggesting controlled astrocytic-endothelial 
cell interaction. Already in 1994, Jiang and colleagues demonstrated FN expression by 
retinal astrocytes in the rat retina. Here we show that FN is deposited and assembled in 
a fibriliar network ahead of the growing vasculature. Counterstaining with an astrocytic 
marker revealed strong expression of immature astrocytes ahead of the growing vessels 
and reduced astrocytic FN deposition in BM of mature astrocytes in contact with the 
capillary vasculature. Loss of astrocytic FN results in delayed migration towards the 
retinal periphery.  
The Cre-mediated recombination of astrocytic FN is not 100% efficient, and we observe 
most prominent vascular defects in areas deficient of FN, indicating that migrational 
delay and increased vascular density are indeed caused by loss of FN. During normal 
retinal  development,  we  often  observe  extravasation  of  erythrocytes  just  behind  the 
sprouting front of the growing vessels. This leakage possibly could result in the release 
of plasma fibronectin (pFN) at the growing vasculature. A recent study demonstrated 
that a major fraction of the cellular FN-matrix is plasma-derived and therefore, pFN is 
incorporated in the cellular FN fibrils (Moretti, Chauhan et al. 2007). Combined the 
variation in Cre-recombination between FN floxed littermates and the plasma leakage 
due to extravasation in the tissue might contribute to the FN matrix and may prevent  
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more severe vascular defects. Still, we observe a significant reduction in retinal vessel 
spreading  radially  towards  the  periphery  when  astrocytes  are  deficient  in  FN 
production.  The  migratory  speed  is  independent  of  integrin-binding  domain,  RGD. 
Mice bearing an inactive RGE motif are embryonic lethal and display vascular defects 
reminiscent of mice lacking integrin alpha 5. However, FN-RGE mice are capable of 
assembling FN in fibrils (Takahashi, Leiss et al. 2007). We show that mice lacking 
astrocytic RGD-binding motif assemble FN and retinal vessels migrate a comparable 
distance  to  control  mice.  Therefore,  integrin  binding  to  FN-RGD  is  dispensable  for 
vessel  migration.  In  contrast,  mice  lacking  endothelial  ITGα5  display  reduced 
expansion of retinal vessels to the periphery. Integrin a5β1 and all integrins of the αv 
family  bind  and  interact  with  RGD  domain  of  FN.  One  would  hypothesize  that 
endothelial ITGα5 adheres and binds to the astrocytic FN matrix via RGD and thereby 
mediate cell migration. However, our results indicate that ITGα5 is required for normal 
vessel migration but might interact with different binding motifs of FN. A recent study 
by Takahashi and colleagues discovered a new integrin-binding site in the N-terminus 
of FN. This finding could explain the migrational delays in endothelial specific Itga5 
mice. Further loss of endothelial ITGα5 does not affect FN assembly, likely because the 
remaining FN binding integrins, predominantly integrin αv compensates for the loss 
and assemble FN in fibrils (Yang, Rayburn et al. 1993). 
Our  findings  also  revealed  that  extra  domain  EIIIA  or  EIIIB  individually  are  not 
required for FN assembly. Analyses of the retinal vasculature of alternatively spliced 
isoform  lacking  EIIIA  did  not  exhibit  vascular  defects.  Similar  results  have  been 
described  by  Astrof  et  al.,  indicating  that  fibronectin  domains  EIIIA  or  EIIIB  are 
dispensable  for  vascular  development.  However,  mice  lacking  alternatively  spliced 
domain EIIIB showed a reduction by 20% in retinal vessel migration suggestive that 
this particular domain plays a role in vessel migration. Detailed expression studies of 
the FN splice isoforms in the retina might help shedding light in the distinct function. 
Mutants for both alternatively spliced domain are embryonic lethal and therefore, do not 
allow us to study their function in retinal angiogenesis. However, double mutants null 
for either domain EIIIA and heterozygous for EIIIB (FNIIIAB) or null for EIIIB and 
heterozygous for EIIIA (FNIIIBA) display a delay in expansion of vessels toward the 
retinal  periphery.  Further,  theses  splice  mutants  exhibit  an  abnormal  vascular 
morphology at the sprouting front. Leading endothelial tip cells appear blunted and fail 
to  align  to  the  astrocytic  networking  resulting  in  patterning  defects.  Multiple  cell- 
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binding sites are present in alternatively spliced regions, e.g. domain EIIIA contains 
sequences that are recognized by integrin α4β1, α4β7 and α9β1 (reviewed in (White, 
Baralle et al. 2008). These cell-binding properties might play a role in EC adhesion and 
migration  of  retinal  vessels  resulting  in  migrational  delay  and  patterning  defects 
observed. 
Astrocyte-endothelial  cell  interactions  are  crucial  for  normal  retinal  vascular 
development.  Disruption  of  these  interactions  by  blocking  R-cadherin,  an  adhesion 
molecule known to be involved in neuronal cell guidance, resulted in stunted retinal 
vasculature,  which  fails  to  recapitulate  the  astrocytic  pattern  and  migrates  into  the 
normally avascular outer retina (Dorrell, Aguilar et al. 2002). When analyzing mice 
mutants  for  endothelial  Itga5  and  FN  double  mutants  EIIIAB  and  EIIIBA  we 
occasionally  observed  filopodia  that  fail  to  align  with  the  astrocytic  network  and 
penetrated into the vitreous body, indicating a loss of adhesion and possibly filopodia 
polarity. Defects in endothelial adhesion to the retinal astrocytes by integrin-Fibronectin 
interaction may account for the delayed migration as seen in Itga5
ECko and several FN 
splice mutants. 
6.2.2  Endothelial  –Astrocyte  interaction  are  crucial  for  vascular 
patterning 
Normal growth and differentiation of retinal astrocytes provides essential cues for the 
retinal vascularization. Loss of PDGF-A results in a sparser astrocytic network, while 
expression of astrocytic PDGF-A leads to super-numerous astrocytes intertwining into a 
dense network of radially orientated bundles (Gerhardt, Golding et al. 2003). 
Alteration of the astrocytic network is directly reflected in hypo- and hyperplasia of the 
retinal  vascular  patterning,  emphasizing  the  close  relationship  of  astrocytes  and 
endothelial cells. 
These fundamental cellular interactions of endothelial cells and astrocytes have 
been  studied  extensively  in  the  brain,  highlighting  a  functional  complex  between 
astrocytes and ECs. The blood-brain-barrier (BBB) constitutes of capillary endothelial 
cells, surrounded by pericytes and a basal lamina, as well as astrocytic perivascular 
endfeet. The specialized foot-processes of perivascular astrocytes are closely apposed to 
the outer surface of brain microvessels, and have specialized functions in inducing and 
regulating the BBB (Abbott, Ronnback et al. 2006). This close cell-cell association, the 
localization of ECM in the astrocytic endfeet and the induction/ regulation of growth 
factors  by  astrocytes  highlight  the  importance  of  astrocytes  in  the  development  of  
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microvessels  in  the  CNS,  very  similar  to  the  cellular  composition  in  the  retinal 
vasculature.  The  deletion  of  integrin  αv  highlighted  the  complex  interaction  and 
essential function of astrocytes during vessel development. Loss of integrin αv results 
in  intracerebral  hemorrhages  due  to  the  absence  of  αvβ8  integrin  from  astrocytic 
endfeet. This absence interfered with apposition of the glia with the invading vessels 
and led to vessel dilation and eventual rapture (McCarty, Monahan-Earley et al. 2002). 
6.2.3  Fibronectin  modulates  VEGF-A  availability  and  thereby 
receptor activity and signalling 
Our  study  further  indicates  that  astrocytic  fibronectin  may  not  only  mediate  EC 
adhesion  but  also  functions  in  growth  factor  retention  and  presentation  and  thereby 
influences  endothelial  migration.  Blocking  the  binding  of  VEGF  to  the  heparin  II 
binding domain in FN by intraocular injection resulted in reduced migration of retinal 
vessels.  Disruption  of  VEGF-FN  binding  is  accompanied  by  reduced  VEGFR2 
signalling and PI3K activity. We hypothesize that VEGF, synthesized and secreted by 
astrocytes,  binds  to  astrocytic  FN  and  that  this  interaction  is  required  for  VEGF 
presentation  to  the  leading  tip  cells  that  migrate  towards  the  VEGF  gradient. 
VEGF/VEGFR2  signalling  mediates  endothelial  cell  function  via  intracellular 
autophosphorylation of VEGFR2 and subsequent activation of signalling pathways such 
as PI3kinase and MAPK. PI3K activity is required for VEGF-A dependent migration of 
ECs  (Gille,  Kowalski  et  al.  2001).  Graupera  and  colleagues  further  identified  the 
catalytic subunit p110α to function selectively in EC migration. Endothelial specific 
and ubiquitous ablation of p110α resulted in embryonic lethality due to severe defects 
in angiogenic sprouting and vascular remodelling (Graupera, Guillermet-Guibert et al. 
2008).  Replacement  of  one  allele  of  p110α  with  a  kinase  dead-allele  resulted  in  a 
significant delay in the outgrowth of the primary vascular plexus towards the retinal 
periphery, indicating reduced migration of endothelial tip cells similar to seen in mice 
lacking astrocytic FN. In addition, p110α knockout ECs in vitro showed 30% reduction 
in  migratory  speed  and  total  distance  migrated  as  a  consequence  of  reduced  AKT 
phosphorylation  (Graupera,  Guillermet-Guibert  et  al.  2008).  The  reduction  in  PI3K 
activity analysed by pY peptide is 50 % in the heterozygous p110α, similar to mice 
lacking astrocytic FN.  
Our  data  demonstrate  that  loss  of  astrocytic  FN  results  in  reduced  VEGFR2 
phosphorylation and PI3K activity, indicated by reduced phosphorylation levels of AKT  
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and  pull  down  assays  using  pY-peptides  and  p85.  Diminished  VEGF/VEGFR2 
signalling in the absence of astrocytic FN may  be explained by reduced VEGF-FN 
interaction  and  therefore  delayed  migration.  These  findings  may  suggest  that  PI3K 
quantitatively  regulates  migration  and  the  observed  reduction  in  PI3K  activity  is 
sufficient to explain the reduced migration in mice deficient of astrocytic FN. 
This hypothesis is further supported by studies of Wijelath and colleagues showing that 
VEGF  binds  to  the  heparin-II  domain  of  FN  and  that  the  cell-binding  and  VEGF-
binding domains of FN, when physically linked, are necessary and sufficient to promote 
VEGF-induced  endothelial  cell  function  (Wijelath,  Rahman  et  al.  2006).  Mitsi  and 
colleagues  identified  two  classes  of  VEGF  binding  sites  on  fibronectin.  One  was 
constitutively  available  whereas  the  availability  of  the  other  was  modulated  by  the 
conformational state of fibronectin (Mitsi, Hong et al. 2006). Combined phenotypical 
analyses  and  biochemical  studies  revealed  delayed  migration  of  retinal  vessels  and 
reduced VEGFR2 and PI3K activity upon blocking VEGF-binding to FN and ablation 
of astrocytic FN. We further hypothesize that retention of VEGF to FN is important for 
normal retinal patterning. We observed increased filopodia extension, dilated vessels 
and an increase in vascular density predominantly at the sprouting vascular front, in the 
absence of astrocytic FN. These vascular defects are reminiscent of the morphology of 
vessels in mice expressing solely the diffusible VEGF isoform, VEGF120. VEGF
120/120 
mice lack cell surface and ECM-bound VEGF isoform resulting in alter extracellular 
distribution of VEGF-A. Loss of a VEGF gradient led to impaired directed extension of 
tip  cell  filopodia  and  reduced  branch  formation.  Instead  of  being  recruited  into 
additional  branches,  nascent  endothelial  cells  were  preferentially  integrated  within 
existing  vessels  to  increase  lumen  caliber,  resulting  in  dilated  vessels  (Ruhrberg, 
Gerhardt et al. 2002). Therefore, increased vessel diameter is not necessarily a result of 
increased EC proliferation, but can also result from ECs failing to form new branches.  
Mouse mutants only expressing VEGF120 lacked a distinctive astrocytic association of 
extracellular  VEGF;  instead  VEGF120  is  distributed  more  diffusely  in  the  retina 
resulting in loss of filopodia polarity and reduced cell migration (Gerhardt, Golding et 
al. 2003). 
It is not clear whether VEGF
120/120 mice also express altered VEGFR2 and PI3K levels 
that  could  account  for  the  reduced  migratory  phenotype.  Ruhrberg  and  colleagues 
showed that the increased vessel diameter in VEGF
120/120 mice is independent of EC 
proliferation but due to reduced migration and additional integration of ECs in existing 
vessels. It still needs to be addressed whether this is the case for the dilation observed in  
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retinal vessels of mice lacking astrocytic FN. Reduced migration could be a result of 
misalignment, reduced adhesion and the failure of filopodia to extend and stretch along 
the astrocytic network when lacking FN. Alternatively, the increased caliber could be 
caused  by  increased  or  more  widespread  EC  proliferation. Loss  of  VEGF  retention 
could cause both reduced migration and more widespread proliferation due to VEGF 
diffusion. 
Dayanir et al. demonstrated that activation of VEGFR2 results in activation of PI3K and 
that  activation  of  PI3K/S6kinase  pathway,  but  not  Ras/MAPK,  is  responsible  for 
VEGFR2-mediated cell growth (Dayanir, Meyer et al. 2001). 
Wijelath and colleagues highlighted a mechanism in which FN induced enhancement of 
VEGF activity arises from both the formation of an extracellular complex interacting 
with the cell surface receptors (integrin) and the resulting promotion of co-stimulatory 
signalling from integrin and VEGF receptor. FN fragments containing both the α5β1 
integrin-binding domain and the VEGF-binding domain significantly enhanced VEGF-
induced  EC  migration  and  proliferation  and  induced  strong  VEGFR2  and  ERK 
phosphorylation (Wijelath, Rahman et al. 2006). 
The findings indicate that loss of astrocytic FN and loss of VEGF-FN interaction may 
negatively effect EC proliferation. Analyzing EC proliferation by incorporation of BrdU 
as well as studying MAPK and ERK activity will allow to address EC proliferation and 
to elucidate the cause of increased vessel caliber in mice lacking astrocytic FN. 
6.2.4  Future perspectives 
The  data  presented  in  this  chapter  indicate  that  the  loss  of  astrocytic  FN  results  in 
decreased VEGFR2 signalling. Although VEGF receptors are expressed ubiquitously in 
endothelial cells, recent data highlighted that expression levels and signalling properties 
vary quantitatively between endothelial cell populations. Their expression levels and 
activity  is  influenced  by  a)  co-receptors  such  as  HSPG  and  neuropilins  (Ruhrberg, 
Gerhardt et al. 2002), b) Dll4/ Notch signalling (Siekmann and Lawson 2007) and c) 
other VEGF receptors, such as soluble VEGFR1 splice variant negatively modulates 
VEGFR2 activity by binding VEGF-A (Roberts, Kearney et al. 2004). 
Further,  activation  of  VEGFR2  is  negatively  regulated  by  the  phosphotyrosine 
phosphotase  Src-homology  phosphatase-1  (SHP1)  and  SHP2,  as  well  as  the  rapid 
internalization  and  degradation  of  VEGFR2  by  lysosomes  or  alternatively  by  the 
proteosomal pathway (reviewed in (Olsson, Dimberg et al. 2006).  
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We propose that VEGF availability and possibly presentation to migrating endothelial 
tip cells is impaired in mice lacking astrocytic FN. Therefore, it would be interesting to 
visualize the spatial expression pattern of VEGF-A protein in the presence and absence 
of FN. 
As a consequence of disturbed VEGF/ VEGFR2 interaction, VEGFR2 activity 
and  downstream  effector  PI3K  are  reduced  and  thereby  affecting  vessel  migration. 
Likewise to visualizing VEGF-A, it would be interesting to visualize VEGF/VEGFR2 
complex formation at leading endothelial tip cells. Since both FN and VEGF-A bind 
and interact with HSPGs, and HSPGs modulate VEGFR2 activity one could would like 
to investigate the role of HS in this FN/ VEGF interaction.  
Unpublished data in our lab indicate that the loss of astrocytic HS production leads to 
delayed migration of retinal vessels similarly to the loss of astrocytic FN. 
Activation  of  VEGFR2  triggers  multiple  cell  behaviours,  such  as  migration, 
proliferation and EC survival. We observed an increase in vessel calibre that could be a 
result  of  enhanced  endothelial  cell  proliferation.  EC  proliferation  and  EC  survival 
requires  VEGFR2  activation  via  MAPK/  ERK  pathway  (Cho,  Lee  et  al.  2004); 
(Takahashi, Yamaguchi et al. 2001). Therefore, it would be of interest to study EC 
proliferation  by  incooperation  of  BrdU  and  by  analysing  phosphorylation  of  ERK 
protein as mentioned in 1.2.3. 
Interestingly, loss of endothelial ITGα5 also results in reduced vessel migration. 
Integrin α5β1 is the major binding and interaction partner for Fibronectin; binding is 
mediated  by  the  FN  RGD  motif.  However,  RGD-binding  is  dispensable  for  retinal 
vessel migration, suggesting an additional binding domain for ITGα5. Alternatively, 
ITGβ1  has  been  shown  to  interact  with  notch,  promoting  Notch  sequestering  and 
trafficking  to  the  nucleus.  Loss  of  endothelial  ITGα5  might  affect  integrin/  Notch 
interaction  and  thereby  modulating  the  cellular  outcome.  It  would  of  interest  to 
investigate Dll4/ Notch mRNA expression in mice deficient of endothelial itga5 and to 
determine protein localization of Dll4, Notch and integrin α5β1 at the cell membrane.  
6.2.5  Summary 
In summary, our findings indicate that Fibronectin expressed by astrocytes positively 
stimulate  endothelial  cell  migration  in  vivo.  This  function  is  mediated  through  a 
coordinated  and  synergist  mechanism  of  VEGF-binding  and  presenting  to  leading 
endothelial tip cells and adhesion of ECs to the FN-rich astrocytic matrix by integrins 
(Figure  6.14).  
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Figure 6.14 Proposed model of astrocytic VEGF-FN interaction regulating vessel 
migration 
(a) FN is expressed by astrocytes ahead of the growing vasculature and assembled in a 
fibrilliar network providing instructive cues for vessel migration. Astrocytes produce 
and secrete VEGF-A in the extracellular milieu and are retained by the FN matrix. 
Endothelial tip cell filopodia express integrin receptors that guide filopodia alignment 
along the astrocytes and mediate adhesion to the FN matrix. VEGF-A binds to VEGFR2 
expressed on leading EC, thereby triggering VEGF receptor signalling in tip cells and 
downstream effectors PI3K. 
(b) Loss of astrocytic FN results in diffused VEGF-A gradient, reduced VEGF/ 
VEGFR2 signalling and decreased PI3K activity. As a consequence, migration of the 
vascular plexus is delayed. Endothelial tip cells extend increased number of filopodia 
and vessels appear dilated due to a still unknown mechanism, but possibly a result of 
ECs failing to spread and/ or increased proliferation. 
  147 
7  Laminin  α4  regulates  angiogenic  sprouting  by 
modulating Dll4/Notch signalling 
7.1  Results 
7.1.1  Basement membrane formation in retinal angiogenic sprouts 
In  order  to  form  a  complex  vascular  network  cells  need  attachment,  migration  and 
proliferation. Attachment of cells is mediated either directly by cell-cell contacts or 
indirectly  via  a  network  of  extracellular  matrix  (ECM)  components.  Epithelia  and 
endothelia organize ECM components at their basal or ablumenal side into  a dense 
structure visible in electronmicrographs. This morphological appearance has led to the 
term basement membrane (BM). The endothelial BM consists of a tight meshwork of 
collagens,  laminins,  heparan  sulfate  proteoglycans  (HSPG)  and  fibronectin. Little  is 
known  of  the  spatial  and  temporal  expression  pattern  of  the  individual  matrix 
components  during  vascular  development,  in  particular  during  the  initial  sprouting 
process. We also still lack information on the maturation of the BM around the growing 
vascular  sprout.  Therefore,  one  important  aim  of  my  studies  was  to  characterize 
composition,  deposition  and  function  of  matrix  molecules  in  retinal  blood  vessel 
sprouts.  
We utilized transmission electron microscopy (TEM) to investigate whether the 
tip-cell and its leading filopodia, as well as the first stalk cells, show signs of beginning 
BM  formation.  After  dissection  of  the  retinal  vascular  front  and  identification  of 
endothelial tip cells using reflective light microscopy semi-thin sectioning of retinal 
samples was performed. Figure 7.1a shows a cross-section of the mouse retina and 
illustrates the close interaction of retinal blood vessels with the underlying astrocytes, 
nerve fibers and ganglion cells. Retinal blood vessels are located at the inner most layer 
of the retina and to reach the vascular plexus en face sections through the underlying 
layers  were  made  until  we  reached  the  area  shown  in  (b).  Characteristically,  the 
endothelial tip cell extends fine filopodia that align tightly to the astrocytic network. 
Astrocytes (A) are numerous ahead of the vascular sprout, recognized by dark purple 
triangular  nuclei.  Once  the  correct  region  was  identified,  ultra-thin  sectioning  was 
performed.  Confocal  microscopy  of  angiogenic  tip  cells  visualized  by  isolectin  (c) 
showed the same morphology as seen in TEM. To illustrate the leading EC we highlight 
the cell in brown (Figure 7.1 d), asterisk point out filopodia protrusion and a lumen (L)  
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begins  to  form.  Mitochondria  (m)  accumulate  and  locate  close  to  the  lumen  in 
endothelial tip cells (d). Further magnification showed the close interaction of filopodia 
with  surrounding  astrocytes  (e)  and  patchy  matrix  deposition  as  well  as  early  BM 
formation could be detected (arrowheads, f-g). Figure g illustrates that endothelial tip 
cells of a vascular sprout deposit extracellular matrix in the extracellular space and form 
a BM (arrowheads). 
Therefore, we conclude that first continuous BM formation can be seen along the cell 
body of the tip cell, while only patchy and discontinuous BM is found along filopodia 
extension.  These  findings  are  consistent  with  the  current  literature;  It  is  generally 
believed  that  during  vascular  remodelling  and  sprouting,  the  quiescent  EC  layer 
becomes activated, EC breach the BM and migrate in the surrounding tissue (reviewed 
in (Hynes 2007)). In contrast, mature and non-proliverative vessels are surrounded by a 
complex meshwork, seen as continuous BM.  
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Figure 7.1 Basement membrane formation at sprouting endothelial tip cell 
Semi-thin sagitall sections were prepared to identify region of interest (a) showing that 
superficial vessels of retina are localized at the outer most layer. By cutting en face 
through  the  various  retinal  layers,  including  ganglion  layer  astrocytic  network  and 
lumenized  vessels  were  identified  (b).  Continuous  ultra-thin  sectioning  of  that  area 
isolated endothelial tip cell (brown, d) with filopodia aligning to astrocytes ahead of the 
growing  vasculature.  The  morphology  of  tip  cells  detected  by  electron  microscopy 
resembled  the  sprouting  tip  cells  seen  by  isolectin  staining  (green)  by 
immunofluorescence  microscopy  (c).  High  magnification  imaging revealed  filopodia 
extension  close  to  astrocytes  (e)  and  patchy,  discontinuous  basement  membrane 
formation along endothelial cell filopodia protrusion (arrowheads, f-g). 
A=  astrocytes,  EC=  endothelilal  cell,  L=  lumen,  F=  filopodia,  T=  tip  cell,  m= 
mitochondria, *= filopodia protrusion  
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7.1.2  Laminin α4 and α5 expression and localization in vivo and in 
vitro 
The expression of ECM components differs to some degree among vessels but certainly 
differ depending on the state of the vessel, e.g. migrating vessel vs. quiescent vessel. 
We therefore aimed to address the specific expression and deposition of ECM molecule 
laminin during guided angiogenic sprouting in the retina. 
Laminin  (LN)  is  a  heterotrimeric  cross-shaped  glycoprotein  and  a  major 
component of BMs. Composed of an alpha-, a beta- and a gamma chain, laminins can 
combine to form up to 15 different isoforms. The vascular BM is dominated by laminin 
chains alpha 4 and alpha 5, which assemble with the beta 1 and gamma 1 chains into 
Laminin 411 and Laminin 511, respectively. 
Laminin 411 (LN411) expression is thought to be ubiquitous by all endothelial cells 
regardless of their stage of development, from early embryonic development, E8.5 till 
adulthood  (Iivanainen,  Kortesmaa  et  al.  1997).  In  contrast,  Laminin  511  (LN511) 
expression  is  more  restricted,  commencing  later  in  development  during  vessel 
maturation.  LN511  is  detectable  primarily  in  BMs  of  capillaries  and  some  venules 
commencing 3–4 weeks after birth (Hallmann, Horn et al. 2005). 
Studying the expression of laminin alpha 4 (Lama4) by in situ hybridization in 
the  postnatal  retinal  vasculature  we  unexpectedly  found  that  Lama4  expression  is 
restricted  to  the  vascular  front  (Figure  7.2  a,  overview).  More  over,  Lama4  is 
specifically expressed by leading tip-cells. Co-labeling with markers detecting either 
endothelial cells (green) or astrocytes (red) revealed that Lama4 expression is restricted 
to retinal ECs (Figure 7.2 b-d). 
In  marked  contrast,  laminin  alpha  5  (Lama5)  expression  is  not  restricted  to 
endothelial cells in the retina. Overview images (e) show a network-like expression of 
Lama5. The pattern strongly resembles the retinal vascular plexus, however combined 
staining  with  isolectin  and  GFAP  revealed  an  astrocyic  expression  of  Lama5.  High 
magnification images of the sprouting tip region (f-g) as well as the mature plexus (h-i) 
illustrate expression that does not co-localize with endothelial marker isolectin (arrow) 
but instead overlap with the astrocyte marker GFAP. We also observed laminin α5 
deposition ahead of the vascular plexus confirming non-endothelial, astrocyte-specific 
expression.  
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This study revealed a distinctive expression pattern for Lama4 and a5 in the retinal 
vasculature.  While  Lama4  expression  is  restricted  to  leading  endothelial  tip  cells, 
Lama5 is mainly deposited by the astrocytes.  
 
To analyse the localization of laminin protein along the vascular sprout we used 
antibodies detecting either the laminin α4 or laminin α5 chain. 
Despite  the  tip-cell  specific  expression  of  Lama4  mRNA,  laminin  α4  protein  is 
distributed along the abluminal basement membrane of all retinal vessels (red, Figure 
7.3 b, e). This discrepancy between the restricted mRNA expression and widespread 
protein distribution suggests that the laminin α4 chain when assembled into mature 
laminin 411 heterotrimeric protein is stably integrated in the ablumenal endothelial BM. 
High magnification imaging revealed that laminin α4 is not located at extending tip cell 
filopodia and only weakly assembled along nascent sprouts despite the strong tip cell 
mRNA expression (white arrowheads, Figure 7.3 c-e). Intriguingly, laminin α4 protein 
is distributed not only at the ablumenal (basal) endothelial membrane consistent with 
BM formation, but additionally co-localizes with endothelial junctions. Staining with 
VE-cadherin,  the  primary  endothelial  cadherin  expressed  at  endothelial  adherent 
junctions and co-labeling with laminin α4 confirmed co-localization of laminin α4 at 
junctions  in  retinal  vessel  (yellow  arrow,  f-k).  However,  not  all  interendothelial 
junctions  show  laminin  α4  localization  (white  arrow).  A  functional  role  of  a  BM 
component at junctions has to our knowledge not been described.  
Interestingly,  IF  staining  with  laminin  α5  revealed  a  strong  expression  of 
laminin α5 on the immature astrocytic network ahead of the growing vasculature (l). 
The astrocytic expression occurs transiently, once vessels have grown over the laminin 
α5 rich matrix laminin α5 is visibly reduced in the mature astrocytic plexus (arrow, l). 
In  the  more  mature  vascular  plexus  closer  to  the  optic  nerve  head,  Laminin  α5  is 
predominantly localized in the abluminal BM of vessels and almost completely absent 
from the astrocytic network (n).  
Our  analysis  as  well  as  previous  expression  studies  showed  that  the  expression  of 
laminin chains α 4 and α5 is distinct in different blood vessels.  
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Figure 7.2 Differential Lama4 and Lama5 expression in the retinal vasculature 
Lama4 and Lama5 ISH (black) of early mouse postnatal retinas (P5). Retinas were 
counterstained with Isolectin-B4 to visualize blood vessels (green) and GFAP to label 
the astrocytic network (red). Lama4 is expressed is restricted to the migrating vascular 
front (a). High magnification microscopy revealed Lama4 expression by ECs, but not 
astrocytes at the sprouting vascular front (b-d). 
Lama5 expression could be detected throughout the developing vascular plexus (e), 
however counterstaining revealed astrocytic Lama5 expression at the vascular front (f, 
g) and the capillary plexus (h, i).  
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Figure 7.3 Laminin a4 is localized at endothelial cell junction while laminin a5 is 
deposited by astrocytic network and endothelial BM 
Immunofluorescence staining with an antibody recognizing laminin α4 (green) and co-
labeling with Isolectin-B4 (red) revealed abluminal localization of laminin α4 at 
endothelial BM in P5 mouse retina (a, b). Laminin α4 deposition is found in the 
developing vascular plexus (a) whereas laminin α4 is absent from newly formed sprouts 
at endothelial tip cells (arrowheads, c-e) and extended filopodia protrusion (c-e). 
Counterstaining with endothelial cell-cell junction molecule VE-Cadherin (red, f-k) 
revealed co-localization of laminin α4 (green) and endothelial junction (yellow arrows) 
in the capillary plexus while white arrows indicate junction with absent laminin α4 
expression. 
In marking contrast, laminin α5 (green) is deposited ahead of the growing vasculature 
(red) decorating the astrocytic network (l) and assembled in fibrilliar structures. In the 
mature vascular plexus, laminin α5 deposition is reduced (arrowhead, l) and can be 
found surrounding BM of retinal vessels (m, n).  
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Analysis with different cell lines derived from different tissues revealed that some ECs 
express predominantly laminin a4 and others laminin a5 and that the expression pattern 
can  be  altered  by  the  growth  state  or  activation  state  of  the  cells  (reviewed  by 
(Hallmann, Horn et al. 2005). This is also reflected in the distinct expression pattern of 
laminin α4 and α5 within the same cell (Figure 7.4 a, b). Using brain endothelial cells 
(bEND5) we observed a wide distribution of laminin α5 (a), while laminin α4 is located 
at endothelial junction as seen in vivo (b) and in small patches at cell protrusions in vitro 
(b). One could imaging that endothelial cells cultured on uncoated dishes for 24 hours 
would express and secrete matrix components themselves however, IF staining with 
laminin  antibodies  a4  and  a5  did  not  detect  extracellular  laminin  localization, 
suggesting that no laminin matrix is formed by bend5 cells.. 
Although the deposition of laminin α5 is strongly reminiscent to the pattern 
formed by focal adhesion (FA) co-labelling with paxillin (Figure 7.4 c, green), a major 
focal adhesion molecule does not co-localize. In fact, laminin α5 and paxillin staining 
exclude each other suggesting that laminin α5 is deposited in other cell compartments 
than  paxillin-positive  FAs.  Alternatively,  one  could  speculate  that  paxillin  staining 
shows the current FA in which laminin α5 is assembled and engaged whereas the spotty 
laminin α5 distribution marks historic FA.  
One could also hypothesis that the antibody detects intracellular vesicular laminin a5 
internalization.  Further,  co-labeling  studies  are  required  to  determine  laminin  a5 
intracellular localization in vitro. 
In summary, we found a striking difference in laminin α4 and α5 expression in 
the retinal vasculature as well as in the localization of these chains in ECs in vitro. 
 
7.1.3  Different laminin isoforms influence EC morphology 
Laminins  are  crucial  modulators  for  cell  behaviour,  e.g.  laminin  α4  regulates  EC 
proliferation and protects the cell from apoptosis (DeHahn, Gonzales et al. 2004). 
Fujita and colleagues reported the regression of glioblastoma tumours in mice following 
administration of LN411 inhibitors, while LN411 facilitates tumour progression and 
metastasis  (Lu,  Zhou  et  al.  2000).  We  therefore  asked  whether  laminin  α4  or  α5 
matrices can influence cell behaviour and are able to induce changes in EC morphology. 
When observing endothelial cell morphology of cells cultured on either LN411 (Figure 
7.5 b, d) or LN511 (a, c) for 24 h we found that ECs on LN411 appear to loose their  
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contact  inhibition  to  other  cells  when  confluent  and  form  less  continuous  adherent 
junction as seen when cultured on LN511. In contrast, endothelial cells cultured on 
LN511 display a confluent monolayer with firm junctions, indicated by VE-cadherin 
staining (red arrows, c) and exhibit an over all quiescent/mature state. 
Therefore, we suggest that ECs cultured on LN411 take on a tip cell behaviour while 
cultured on LN511 they take on a stalk cell behaviour.  
 
 
 
 
Figure  7.4  Laminin  a4  and  laminin  a5  localize  at  different  compartments  in 
endothelial cells in vitro 
Immunostaining of bEND5 endothelial cells in vitro with antibodies directed against 
laminin α4 and laminin α5 revealed a widespread distribution of laminin α5 (a) but 
restricted laminin α4 localization at endothelial cell junction (b). Counterstaining with 
paxillin (green, c) to identify focal adhesion contacts of laminin α5 elucidated exclusive 
expression of paxillin and no co-localization with laminin α5 (red, c).  
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Figure 7.5 Laminin matrix influence endothelial cell morphology in vitro 
bEND5  endothelial  cells  were  cultured  for  24h  on  Laminin  α5β1γ1  (LN511)  and 
LN411  matrices.  Cells  on  LN511  (a,  c)  formed  a  confluent  monolayer  with  firm 
continuous cell junction identified by VE-cadherin staining (red arrows, c). In contrast, 
cells coated on LN411 matrix develop a migratory phenotype and grow over each other, 
appearing to loose their contact inhibition (b, d).  
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7.1.4  Loss of laminin a4 results in increased vascular density 
Although previous studies described a role of laminin α4 in pathological angiogenesis, 
its function during vascular development received little attention. 
To  gain  further  insight  we  analysed  the  retinal  vasculature  of  postnatal  laminin  α4 
knock out mice (Lama4-/-) in more detail.  
We found a significant increase in vessel density and excessive branching in Lama4 
deficient mice. In particular the density of the sprouting vascular front was enhanced 
(Figure 7.6 a-b). By counting branchpoints per microscopic field we calculated a 60% 
increase in vascular density in Lama4-/- compared to heterozygous littermates (c). 
7.1.4.1 Increased vascularization is independent of hypoxia  
It has been reported that Lama4-/- mice develop oedema and are anaemic (Thyboll, 
Kortesmaa et al. 2002). Reduced oxygen delivery could potentially trigger increased 
(hypoxia-induced) vessel formation. To determine whether the increased density and 
aberrant sprouting of vessels in Lama4 -/- mice is caused by an upregulation of VEGF-
A expression induced by hypoxia we analysed VEGF-A expression and localization in 
the retinal vasculature. However, the relative mRNA expression of Vegfa and Slc2a, 
another  hypoxia  induced  gene  in  Lama4  deficient  mice  did  not  show  a  significant 
increase (Figure 7.7 c). In addition, in situ hybridization revealed that the retinal pattern 
of astrocyte-derived Vegfa expression was unchanged in Lama4 -/- mice (a, b), together 
indicating  that  the  observed  increase  in  retinal  vessel  density  is  not  a  primary 
consequence of tissue hypoxia. 
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Figure 7.6 Loss of Lama4 leads to increased vascular density  
Immunostaining with Isolectin B4 to visualize the retinal vasculature at P5 revealed an 
increased vascular density in mice deficient of Lama4 (a, b). Graph c summarizes the 
number of branchpoints per image field of P5 Lama4-/- and heterozygous control mice, 
n ≥ 5. ***, p < 0.0001. Values represent mean ± S.E.M. 
 
 
 
 
Figure  7.7  Increased  vascularization  in  Lama4  deficient  mice  is  not  caused  by 
hypoxia or an upregulation of Vegfa expression 
Vegfa ISH (green) and counterstaining with Isolectin-B4 (red) of Lama4 and control 
retinas revealed normal Vegfa expression and distribution at P5 (a, b). qPCR of Vegfa 
and Slc2a, a hypoxia-regulated gene in retinas of P5 mice (c), Lama4 -/- and control 
mice n ≥ 3; Values are mean ± S.E.M.  
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7.1.4.2 Delayed retinal vessel migration in Lama4 knock out mice  
Measuring  the  total  distance  vessels  have  spread  from  the  optic  nerve  towards  the 
periphery  (Figure  7.8  a,  b;  white  arrow)  we  observed  a  mild  decrease  of  vessel 
migration at day 5 postnatally (P5, c). Vessel migration is still delayed at P7 and vessel 
density of Lama4 deficient mice is strongly increased when compared to control retinas 
(d, e). The delay in vessel migration in the retina possibly reflects the overall smaller 
body size by 10% and delayed development of Lama4 -/- mice as reported by (Thyboll, 
Kortesmaa et al. 2002).  
Although no differences in Vegfa expression were detected, we asked whether 
the increased vessel density and the delay in migration is a result of disturbed VEGFR2 
signalling and subsequently, PI3K activity. To address that question we analysed retinal 
expression  of  VEGFR2  protein  and  phosphorylation  levels  of  VEGFR2  as  well  as 
downstream target AKT. As shown in blot (f), no striking differences were observed in 
pVEGFR2/VEGFR2 levels and likewise, levels of total AKT and phosphorylated AKT 
(pSer) were equal in Lama4-/- and control littermates (f). 
7.1.4.3 Detailed analyses of vessel composition and BM formation  
Previous  studies  suggested  that  Lama4  deficiency  results  in  torturous  vessels  with 
defects  in  vessel  maturation  and  integrity.  Vessel  maturation  is  accompanied  by 
recruitment  of  pericytes  (PC)  and  the  formation  of  a  shared  BM  between  the 
endothelium and PCs. We observed normal PC recruitment in retinal vasculature of 
Lama-/- mice (Figure 7.9 a-d). Staining with NG2, a marker used to detect PC (red, b 
and d) revealed investment of PC and close association with retinal vessels in Lama4-/- 
to  the  same  extent  as  seen  in  control  retinas.  Yet,  we  found  an  abnormal  BM 
composition  and  reduction  in  CollagenIV  expression,  a  major  BM  component. 
CollagenIV  assembly  appeared  disturbed  and  immunofluorescence  staining  with 
CollagenIV  (green)  revealed  a  loose  and  fibrilliar  collagen  structure  in  Lama4-/-  
(Figure 7.10 d-f) while control littermates display a dense collagen network covering  
the entire vessel (Figure 7.10 a-c). We hypothesized that the linkage to collagenIV and 
the formation of a complex BM network fails in Lama4-/- mice. 
It has been reported previously that the absence of laminin polymer assembly 
fails to sequester collagen in the same BM (Li, Harrison et al. 2002). Therefore, we  
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concluded  that  the  reduction  and  abnormal  deposition  of  ECM  components  reflects 
laminin α4 function in matrix assembly and BM integrity.  
Thyboll and colleagues speculated that the vascular defects in Lama4-/- seen during 
postnatal  development  are  rescued  by  compensatory  upregulation  of  laminin  α5 
expression. We studied laminin α5 expression and deposition in Lama4-/- retinas and 
found laminin α5 deposition on the astrocytic network ahead of the growing vasculature 
as described earlier (Figure 7.11 a-c, e-g). Although laminin α5 expression appears 
reduced  in  Lama4-/-  (g)  compared  to  control  littermates  (c),  it  is  present  on  the 
astrocytic network as well as in endothelial BM (e-g). Endpoint Reverse Transcriptase-
PCR  (RT-PCR)  revealed  loss  of  laminin  a4  in  Lama4-/-  mice,  however  Lama4 
heterozygous mice did not display reduced laminin a4 expression as one would predict 
due to genetic ablation of one Lama4 allele (d). This finding indicates that this method 
is not sensitive enough to distinguish gene expression levels and therefore, does not 
allow me to study laminin a5 compensation (d). In order to determine whether laminin 
a5 is upregulated and compensates for the loss of laminin a4 in Lama4 deficient mice, 
one would need to perform relative quantitative PCR. 
  
  161 
 
 
 
 
 
 
 
Figure 7.8 Reduced migration of retinal vessels in Lama4 deficient mice 
Vessel migration towards retinal periphery in Lama4 deficient and control retinas at P5 
(a, b) and P7 (d, e). Graph c summarizes radial expansion of superficial vessels in P5 
retinas. *, p < 0.05, Lama4 -/- and control mice n ≥ 3; Values are mean ± S.E.M. 
VEGFR2 signalling and PI3K activity was determined by Western Blotting of Lama4 -
/- and control retinas at P5 (f). No differences in phosphorylation of VEGFR2 could be 
observed, however total  protein levels of VEGFR2 are increased in Lama4 -/- mice. 
PI3K activity was accessed by immunoblotting of total AKT and phosphorylation of 
serine residue 473 of AKT (f).  
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Figure 7.9 Pericyte recruitment is unaffected in Lama4 deficient mice 
Pericyte investment and association with retinal blood vessels (green) was analysed by 
immunostaining  with  NG2  (red,  a-d).  No  defects  could  be  observed  and  pericytes 
migrate to a similar extent in Lama4 -/- mice (c, d) when compared to control retinas at 
P5 (a, b).  
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Figure  7.10  Reduced  CollagenIV  deposition  and  defective  basement  membrane 
assembly in Lama4-/- 
Immunostaining  with  CollagenIV  (green,  a-f)  revealed  decreased  CollagenIV 
deposition in Lama4-/- retinas (d-f). High magnification imaging identified abnormal 
assembly  of  CollagenIV  in  fibrilliar  structures  (e)  while  collagenIV  appears  as 
continuous BM sleeves in control vessels (b, c). 
 
 
 
Figure 7.11 Laminin α5 does not compensate for the loss of Lama4 
Immunostaining with laminin a5 (green, a-c, e-g) was performed to investigate laminin 
α5 localization and compensation upon loss of Lama4. Counterstaining with Isolectin 
B4 (red) showed laminin α5 deposition in the astrocytic network (a, d) and laminin α5 
decorating abluminal BM of retinal vessels (b-c, f-g). RT-PCR (d) of total retinal RNA 
(P5) confirmed absence of Laminin a4 in Lama4 deficient retinas but no upregulation of 
Laminin a5.  
  164 
 
7.1.4.4 Loss of Laminin a4 results in increased proliferation  
To address whether the increased vascular density observed in Lama4-/- mice is a result 
of  enhanced  proliferation,  we  injected  BrdU  for  2  hours  into  postnatal  mice  and 
quantified BrdU positive endothelial cells after co-labeling with isolectin. We observed 
a significantly increase number of BrdU positive ECs in Lama4-/- retinas (b) compared 
to  control  littermates  (a),  (Figure  7.13  a-c).  Similar  results  were  obtained  when 
analysing proliferation by IF staining with phospho-Histone H3 (red, Figure 7.13 d, e). 
Positive  staining  was  observed  in  the  growing  vascular  front  of  Lama4-/-  mice  for 
proliferating endothelial nuclei in mitosis.  
Therefore we concluded that the hypervascularization in Lama4 deficient retinas is, at 
least in part, a consequence of enhanced EC proliferation, independent of hypoxia and 
VEGF-A mRNA expression. 
7.1.4.5 Excessive tip cell formation and aberrant sprouting in Lama4-/- 
mice 
 When analysing the vasculature in greater detail, we found that the loss of Lama4 
results in elevated number of vascular sprouts and aberrant tip cell formation (Figure 
7.12  a-b).  By  counting  filopodia  extension  we  identified  a  significant  increase  in 
filopodia  protrusions  (c).  Also,  filopodia  extension  was  profoundly  increased  in  the 
more mature, central vascular plexus of the retinal vasculature, as can be seen in many 
pathological conditions when maturation and quiescening of vessels is disturbed (Figure 
7.12 d-f). By scanning through the entire plexus of the retinal vasculature we observed 
ectopic filopodia bursts reaching in deeper retinal layers. These additional filopodia 
extensions indicate excessive sprouting and enhanced tip cell formation in Lama4-/- 
mice. 
 
Immunostaining with an antibody against phosphoHistone H3 (red, d, e) and 
counterstaining with Isolectin-B4 (green) identified proliferative ECs. 
Furthermore, we show by in situ hybridization and relative quantitative PCR that Pdgfb 
expression, a selective tip cell marker (Hellstrom, Phng et al. 2007) is up to 2-fold 
increased and its expression is extended over the entire vascular front (Figure 7.12 g-i) 
compared to the restricted expression of leading tip cells in heterozygous littermates. 
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Figure 7.12 Increased tip cell formation and excessive sprouting in Lama4-/- 
Confocal images of tip cells of P5 control and Lama4-/- retinas stained with Isolectin-B4 
(red,  a-b)  revealed  aberrant  filopodia  formation.  By  counting  number  of  filopodia 
(white  dots)  extended  per  100µm  vessel  length  we  found  a  significant  increase  in 
filopodia (c). ***, p > 0.0001. control and Lama4-/- mice n ≥ 3; Values represent mean 
± S.E.M. 
Excessive filopodia formation was also detected in the mature capillary plexus of P5 
Lama4-/- retinas (white arrows, d-f). 
Pdgfb ISH (blue) of P5 retinas were counterstained with Isolectin-B4 (green) showing an 
increased area of Pdgfb expression in Lama4-/- retinas (g, h). Graph i illustrates the 
relative expression of Pdgfb in retinas of P5 animals. **, p < 0.01; control and Lama4-/- 
mice n ≥ 7. Values represent mean ± S.E.M.  
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Figure 7.13 Loss of Lama4 results in increased endothelial cell proliferation 
P5 Lama4-/- and control mice were injected with BrdU intraperitoneally and retinas 
were analyzed for BrdU incorporation 2 h later. Retinas were stained with anti-BrdU 
antibody  (green)  and  Isolectin-B4  (red,  a-b).  BrdU-positive  ECs  co-locabeled  with 
isolectin were counted. Bars in graph c show number of proliferated endothelial cells 
per visual image. **, p < 0.01. control mice n=4, Lama4-/- n=3; Values represent mean 
± S.E.M. 
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7.1.5  Loss of Lama4 alters Dll4/Notch gene expression 
The  phenotype  of  mice  lacking  Lama4  strongly  resembles  the  loss  of  Notch/  Dll4 
signalling. When disturbing Notch signalling using pharmacological inhibitors (DAPT) 
or deleting the Notch1 receptor or one allele of the ligand Dll4 blood vessels undergo 
excessive sprouting as a consequence of increased tip cell formation (Hellstrom, Phng 
et al. 2007); (Suchting, Freitas et al. 2007); (Lobov, Renard et al. 2007). 
To  examine  Dll4/  Notch  signalling  in  Lama4-/-  mice,  we  analysed  the  relative 
expression of mRNA levels of targets downstream of Dll4/ Notch signalling and found 
that expression of transcription factors such as Hey1, Hey2 as well as the ligand Dll4 are 
significantly downregulated (Figure 7.14 a). The regulation of genes downstream of the 
Notch/Dll4 signalling pathway has been studied extensively and previous studies have 
shown  that  expression  of  the  Notch  regulated  ankyring  repeat  protein  (Nrarp),  is 
decreased  by  up  to  70%  when  treated  with  DAPT  (Hellstrom,  Phng  et  al.  2007); 
(Lobov, Renard et al. 2007); (Phng, Potente et al. 2009). Treatment of postnatal mice 
with the gamma-secretase inhibitor, DAPT results in increased retinal vasculature and 
downregulation of several Notch targets, such as Hey1, Hey2 and Nrarp (Phng and 
Gerhardt 2009). 
Interestingly,  Lama4-/-  mice  also  show  a  significant  reduction  of  Nrarp  mRNA 
expression (Figure 7.14 a). 
7.1.6  Dll4 mRNA expression is induced by laminin 411  
Next we asked whether laminin α4 directly affects Dll4/Notch signalling in cultured 
endothelial cells. We cultured either human umbilical endothelial cells (HUVECs) or 
mouse brain endothelial cells (bEND5), on different matrices, including Laminin 411 
(LN411), Laminin 511 (LN511), and uncoated control cell culture dishes. Already after 
4h of incubation Dll4 was induced in bEND5 ECs when cultured on LN411. Expression 
of Dll4 was further increased over a period of 24h when bEND5 ECs were cultured on 
LN411 compared to uncoated dishes (Figure 7.14 b). In contrast to the effect of LN411, 
Dll4  was  not  induced  by  LN511,  but  rather  tend  to  result  in  reduction  of  Dll4  
expression,  illustrating  that  these  two  endothelial  BM  components  differentially 
influence expression of the endothelial Notch ligand Dll4. Similar results were obtained 
when human ECs (HUVECs) were cultured on distinctive laminin matrices or uncoated 
dishes.  
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Figure  7.14  Laminin  α4  modulates  expression  of  Dll4  and  Notch  downstream 
targets 
Quantitative-PCR was performed to investigate differential gene expression in retinas of 
Lama4 heterozygous control and Lama4 -/- mice (a). mRNA expression was analysed at 
P5. *, p < 0.05, **, p < 0.01, ***, p < 0.0001. Lama4+/- and Lama4-/- n ≥ 3. Values 
represent mean ± S.E.M. 
Endothelial cell line bEND5 was cultured on LN411, LN511 and uncoated matrices for 
4 and 24 hours prior analysing Dll4 mRNA expression by qPCR (b). n ≥ 5. ***, p < 
0.0001 ANOVA, 1way analysis. Values represent mean ± S.E.M. 
Values represent mean ± S.E.M.  
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7.1.6.1 Laminin  411  induced  Dll4  expression  is  dependent  on  Notch 
signalling 
To  test  whether  Laminin  411  mediated  Dll4  induction  requires  Notch  activity,  we 
treated ECs cultured on LN411 with DAPT for up to 24h. Disturbing Notch signalling 
with DAPT abolished LN411- induced Dll4 expression. Dll4 expression was similarly 
reduced in ECs cultured on LN511 (not shown) and control uncoated dishes (Figure 
7.15 a), suggesting that the induction of Dll4 expression requires Notch signalling on all 
matrices. 
7.1.6.2 Disturbing  VEGFR2  signalling  does  not  affect  Laminin  411 
induced Dll4 expression 
Previous studies illustrated an important role of VEGF/VEGFR2 signalling in inducing 
Dll4 expression (Lobov, Renard et al. 2007). To address whether LN411 induced Dll4 
expression  correlates  with  increased  Vegfr2  mRNA  expression  and  signalling,  we 
studied  VEGFR2  levels  in  vitro.  When  cells  are  cultured  on  LN411,  Vegfr2  is 
upregulated by 2 fold in comparison to ECs on uncoated dishes (Figure 7.15 b). To 
investigate  whether  Laminin  411  induces  Dll4  expression  is  dependent  on  VEGF-
A/VEGFR2 signalling, we blocked VEGFR2 using neutralizing antibody DC101 and 
analysed  Dll4  expression  of  ECs  cultured  on  LN411  or  uncoated  control  dishes. 
Analysis of phosphorylated VEGFR2 levels confirmed effective inhibition of VEGFR2 
activity by DC101 treatment (c). 
We found a significant reduction of Dll4 expression upon blocking VEGFR2 signalling 
in  uncoated  control  ECs.  Also  in  ECs  cultured  on  LN411  blocking  of  VEGFR2 
decreased  LN411-induced  Dll4  expression.  However,  Dll4  mRNA  expression  levels 
remained significantly greater compared to ECs on uncoated dishes (d), suggesting that 
Laminin α4 promotes Dll4 expression at least in part independently of VEGF/VEGFR2 
signalling.  
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Figure 7.15 Laminin 411 modulates Dll4/ Notch signaling 
Dll4  mRNA  expression  in  bEND5  ECs  was  analysed  after  24h  inhibition  of  Notch 
signalling with pharmalogical inhibitor, γ-secretase. Dll4 was decreased independently 
of matrix ECs were cultured on (a). n ≥ 3,  ***, p < 0.0001. Values represent mean ± 
S.E.M. 
Dll4 and VEGFR2 expression levels of bEND5 ECs were significantly increased when 
cultured  on  LN411  compared  to  uncoated  dishes  (b).  Graph  d  illustrates  mRNA 
expression levels by relative quantity. n ≥ 3,  **, p < 0.01. Values represent mean ± 
S.E.M. 
Dll4  expression  levels  of  bEND5  ECs  were  studied  after  treatment  with  VEGFR2 
neutralizing antibody, DC101 for 24h (c). Blocking VEGFR2 signalling had a reducing 
effect on Dll4 expression in uncoated and LN411 coated ECs. *, p < 0.05,  ***, p < 
0.0001. n ≥ 5. Values represent mean ± S.E.M. 
Inhibition  of  VEGFR2  signalling  after  DC101  treatment  was  examined  by  Western 
Blotting.  ECs  cultured  with  or  without  DC101  on  LN411  or  uncoated  dishes  were 
analysed  after  24  hours.  Wile  VEGFR2  protein  levels  were  similar  in  all  samples, 
treatment with DC101 resulted in reduced phosphorylation of VEGFR2 (f).  
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7.1.7  Laminin-integrin interaction modulate Dll4 expression 
Previous work in neural stem cells suggested that integrin receptors for ECM molecules 
and growth factors present on the cell surface act together with the Notch pathway to 
control the neural stem cell responses to changes in the microenvironment (Campos, 
Decker et al. 2006). The authors propose physical interaction of Notch and integrin by 
sequestering Notch intracellular domain (NICD) and by modulating NICD trafficking in 
the cytoplasm to the nucleus by regulating internalization. Further studies outline that 
Notch activates integrins (Hodkinson, Elliott et al. 2007) and that constitutively active 
Notch-4 alters integrin conformation and thereby activation (Leong, Hu et al. 2002). 
Laminin  α4  predominantly  binds  and  interacts  via  integrin  receptors  comprising 
integrin  α6β1,  α3β1  and  αvβ3  (Lian,  Dai  et  al.  2006);  (Belkin  and  Stepp  2000). 
Interestingly,  transfection  of  HUVECs  with  Dll4-retroviral  constructs  leads  to 
downregulation of integrin beta 3 (Itgb3) in microarray analysis (Harrington, Sainson et 
al.  2007).  In  addition,  deletion  of  Itgb3  results  in  vessel  overgrowth  mediated  by 
elevated  VEGFR2  levels  (Reynolds,  Reynolds  et  al.  2004)  and  causes  enhanced 
pathological angiogenesis (Reynolds, Wyder et al. 2002).The phenotypical similarities 
of Lama4 -/- and Itgb3-/- described as well as the capacity of laminins to bind and 
interact with integrin β3 (Gonzalez, Gonzales et al. 2002) led us to the hypothesis that 
LN411 mediated induction of Dll4 expression may require integrin signalling. 
7.1.7.1 Integrin β3 localizes at endothelial cell junction  
To  characterize  Itgβ3  expression  and  localization  in  greater  detail  we  combined 
isolectin staining (red) of retinal blood vessels with an antibody detecting Itgβ3 (green, 
Figure 7.16 a-d). We found that Itgβ3 is represent in endothelial BMs and particularly 
co-localizes  with  endothelial  cell  junction  (arrows,  a-b).  Interestingly,  a  similar 
expression  pattern  was  seen  for  laminin  α4  (Figure  7.3).  But  when  comparing  the 
expression pattern of Itgβ1 (Figure 6.7) and Itgβ3, we observed that Itgβ3 is absent in 
pericytes and vascular smooth muscle cells of arteries (arrowhead, c-d). Our findings 
are  supported  by  a  recent  study  from  Naik  and  colleagues  showing  that  Itgβ3  and 
junction molecule, JAM-A co-localize in EC junction of HUVEC cells (Naik, Mousa et 
al. 2003); (Naik and Naik 2006).  
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7.1.7.2 Reduced vascular sprouting in itgb3 knock out retinas 
Integrin β3 has been reported to function during angiogenesis but no vascular defect has 
been  observed  during  retinal  vessel  development  (Hodivala-Dilke,  McHugh  et  al. 
1999). We analysed the retinal vasculature of P5 pups using confocal microscopy. The 
following  results  are  preliminary  and  require  confirmation  by  additional  numbers. 
Retinas  of  Itgb3-/-  mice  were  provided  by  S.  Robinson  and  K.  Hodivala-Dilke, 
unfortunately the breeding did not provide us with control littermates. Therefore, the 
phenotype of Itgb3-/- was compared to P5 control retinas from a separate litter, which 
potential may result in subtle developmental differences. 
Overview images of control (Figure 7.16 e) and Itgb3-/- retinas (f) revealed that 
a vascular plexus has formed and that no apparent defects are present. However, when 
observing the sprouting vascular front in more detail (g, h) we found that the plexus is 
sparse  and  the  extension  of  leading  tip  cells  is  reduced  in  Itgb3-/-  (red  arrows,  h) 
compared  to  control  retinas.  In  addition,  high  magnification  imaging  revealed  that 
Itgb3-/- tip cells are thin, long, and fail to fuse to neighbouring cells (k, l). It appears 
that filopodia of Itgb3-/- vessels are straight and elongated (red arrowheads, l) whereas 
control tip cells branch and connect to neighbouring vessels, indicated by spread and 
wide distributed filopodia burst (i, j). These phenotypical observations could be a result 
of  diminished  integrin-VEGFR2  signalling.  It  has  been  shown  that  αvβ3  integrin 
directly  interacts  with  VEGFR2  and  its  engagement  promotes  phosphorylation  and 
activation of VEGFR2 (Soldi, Mitola et al. 1999). In addition, this interaction appears to 
be synergistic, as VEGFR2 activation induces β3 integrin tyrosine phosphorylation that 
in turn, is crucial for VEGF-induced VEGFR2 phosphorylation (Mahabeleshwar, Feng 
et al. 2007). Given that Itgb3 is expressed by leading tip cell in the retina, the reduced 
sprouting and filopodia extension observed in Itgb3-/- retinas could reflect a loss of 
effective VEGFR2 signalling and would indicate that hypervascularization of Lama4-/- 
is mediated independent of integrin β3 binding and interaction.  
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Figure 7.16 Integrin beta 3 localizes at endothelial junction and loss of Itgb3 leads 
to reduced sprouting 
Immunostaining with integrin beta 3 (green) and counterstaining of retinal vessels with 
Isolectin B4 (red, a-d) revealed junctional localization of itgb3 (arrows, b, d). Itgb3 
staining was absent from pericytes (arrowhead, c). 
Overview images of retinal vasculature of ITGb3 deficient and control mice, P5 (e-h) 
show that a vascular plexus has formed and vessels expanded radial over the entire 
retina. High resolution imaging of the migrating vascular front by Isolectin B4 staining 
revealed a reduced number of tip cells (red arrows, h). The extended tip cells of Itgb3 -/- 
mice appear thin and fail to connect to neighbouring cells (k, l) when compared to 
control  retinas  (i,  j).  Red  arrowheads  indicated  straight  and  unbranched  filopodia 
protrusion (j).  
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7.1.7.3 Integrin β3 knockdown diminishes Laminin 411 induced Dll4 
expression 
To test whether LN411 induced Dll4 expression is mediated by integrin β3 signalling, 
we  transfected  HUVEC  cells  with  Itgb3  siRNA  and  analysed  the  Dll4  mRNA 
expression in relation to Itgb3 knock down. 
Preliminary data, revealed that LN411-induced Dll4 expression (Figure 7.17 a) is 
decreased when integrin β3 signalling is reduced (Figure 7.17 b). In contrast, ECs 
cultured on LN511(blue bar, a)  that initially display a reduction of Dll4 expression 
compared to ECs cultured on uncoated and LN411 coated dishes, result in an 
upregulation of Dll4 upon Itgb3 siRNA knock down (b). Itgb3 knockdown in ECs 
plated on uncoated dishes does not have an effect on Dll4 expression (a, b). All 
quantifications have been set in relation to EC treated with control siRNA in uncoated 
culture condition.  
Despite a consistent induction of Dll4 expression in HUVECs coated on LN411 (Figure 
7.17 a, c), we found a highly variable degree of Dll4 expression in cells coated on 
LN511. One possibility resulting in the variation of LN511 mediated Dll4 expression is 
LN511 matrix formation in vitro. Laminin a5 is a particularly large glycoprotein, that is 
more adhesive due to its capability of self-polymerization and network formation when 
compared to the shorter, truncated laminin a4 isoform. Thus, inconsistency in matrix 
coating might result in gene expression discrepancies. Therefore, further experiments 
are required to establish a role of laminin a5 in the induction of Dll4 expression. 
An aggravating factor, as shown in Figure 7.17 b is the knock down efficiency of Itgb3 
siRNA is only around 20% reduction of Itgb3 mRNA expression. This could explain the 
variations seen and the rather small effect of Itgb3 siRNA treatment on LN411 induced 
Dll4 expression. In summary, these data require additional experiments to be able to 
draw solid conclusion. 
 
To investigate whether LN411-induced Dll4 upregulation can be also mediated by other 
integrin subunits, we transfected HUVEC cells coated on either matrix with integrin 
beta 1 (Itgb1) and integrin alpha 3 (Itga3) siRNA. The following quantification and 
results were obtained from a single experiment and will need further confirmation.  
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Although we could detect a sufficient knockdown we did not observe any significant 
reduction of Dll4 expression. (Figure 7.17 c-d) Thus, we hypothesise that integrin beta 3 
specifically interacts with LN411 and LN511 but transmits diverse functions.  
To gain further insights in ITGβ3- LN411 interaction we studied Dll4 expression of 
Itgb3-/- EC and control wildtype EC. The cells were obtained from S. Robinson and K. 
Hodivala-Dilke. 
Surprisingly, unlike bEND5 and HUVEC cells, control ECs derived by the Hodivala-
Dilke lab did not significantly upregulate Dll4 expression when cultured on LN411 
(Figure 7.17 f). The reason for this difference is at present unclear. However, Itgb3-/- 
ECs Dll4 mRNA expression was reduced by 80% independent of the coated matrix (f). 
Thus, knockdown or complete absence of Itgb3 results in a reduced ability of ECs in 
vitro to promote Dll4 expression. 
 
 
7.1.8  Lama4-/- vessels display disorganized cellular junctions 
Recent studies on Dll4/ Notch signalling during vascular development in mouse retina, 
in zebrafish intersegmental vessels and tumour angiogenesis led to a model that Dll4 
expressed by the tip cell activates Notch on the neighbouring stalk cell to suppress tip 
cell formation in the stalk. The tip cell phenotype is the default response due VEGF-A 
stimulation,  whereas  Notch-signalling  is  cell  autonomously  required  for  stalk  cell 
selection  and  quiescening  of  the  growing  sprout.  Interfering  with  Dll4/  Notch  has 
drastic  effects  on  vascular  development  and  genetic  ablation  of  components  of  this 
pathway  results  in  early  embryonic  lethality.  Our  study  revealed  that  laminin  α4 
restricts  tip  cell  formation  and  angiogenic  sprouting  by  modulating  Dll4/  Notch 
signalling.  Although  we  clearly  showed  a  role  of  ECM  molecule  laminin  α4  in 
promoting Dll4 expression, Lama4-/- mice are viable and develop a functional vascular 
system.  
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Figure 7.17 Function of integrins in LN411 induced Dll4 expression  
Dll4 mRNA expression was analysed of human ECs (HUVEC) cultured on LN411, 
LN511 or uncoated dishes after siRNA transfection with Itgb3 (a), Itga3 and Itgb1 (c) 
for 72h. Efficiency of siRNA treatment and gene silencing was detected by qPCR of the 
appropriate gene, Itgb3 (b), Itgb1 (d) and Itga3 (e) for cells treated with non-targeting 
control and OnTarget
TM siRNA. Transfection was performed in triplicates, qPCR in 
duplicates and Itgb3 knockdown experiment was repeated twice. 
Dll4 gene expression was analysed by qPCR of Itgb3 deficient and control ECs coated 
on LN411 or uncoated dishes for 24h (f).  
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  Therefore, we propose that laminin α4 is not absolutely essential for Dll4/ Notch 
signalling and vascular development rather ‘helps’ to restrict excessive sprouting and 
vessel formation by promoting Dll4 expression and therefore more effectively pattern 
the growing sprout. We speculate that its junctional deposition may have a role in EC 
polarization  and  basolateral  (basal-apical)  EC  orientation.  Bayraktar  and  colleagues 
established a role for Par-1 in cell polarity and showed that Par-1 functions upstream of 
Notch  and  is  critical  for  proper  localization  of  the  Notch  ligand  Delta  (Bayraktar, 
Zygmunt et al. 2006). Unfortunately good antibodies and EC polarization marker, like 
Par-1  and  Rab-5  are  missing  in  mouse.  Yet,  visualization  of  EC  adherent  junction 
molecule VE-cadherin and tight junction molecule claudin-5 elucidated the morphology 
of EC-EC junction in Lama4-/- (Figure 7.18). Although VE-cadherin (a-f) and claudin-
5  (g-l)  can  be  localized  in  both,  Lama4-/-  (a-c,  g-h)  and  control  littermates,  mice 
deficient  for  Lama4  display  a  very  chaotic  pattern  of  EC  junction  at  the  growing 
vascular  front.  Control  mice  exhibit  long,  continuous  junction  along  the  leading 
vascular sprouts (d, h). In the capillary plexus of control retinas junction appear even 
more mature and firm (e, i). In contrast, EC junctions of Lama4-/- are jagged, disrupted 
and much shorter (arrows). Consistent with the observed increase in EC proliferation, 
we  detected  an  enhanced  number  of  EC-EC  junction  per  circumference  of  Lama4 
deficient vessels (a). This holds true when analysing transverse section of retinal vessels 
by electron microscopy (data not shown). Preliminary analysis revealed excessive EC 
junction in the vascular plexus of Lama4 -/- mice. Combined the increase in endothelial 
cells  and  EC-EC  junction  may  account for  the increase  in  vessel  calibre.  Thus,  we 
hypothesize that lack of firm continuous junction is a consequence of the enhanced 
sprouting and tip cell formation in Lama4 deficient mice. However, it is also possible 
that junctional abnormalities are a primary defect, which in turn impacts on Dll4/Notch 
signalling, together resulting in the hypersprouting phenotype.  
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Figure 7.18 Immature EC-EC junction in Lama4 deficient mice 
Immunostaining  of  junction  molecules  VE-cadherin  (a-e)  and  claudin-5  (f-i)  at  the 
migrating front and the mature vascular plexus in Lama4 -/- and control P5 retinas. 
Staining revealed enhanced endothelial cell junctions in Lama4 -/- (a-c) that appear 
immature, jagged shaped (arrows, b). In contrast, cell junctions are long and continuous 
in control vessels (d-e, h-i).  
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7.1.9  Laminin  α2  and  integrins  β4  and  -α7  are  dispensable  for 
retinal vascular development 
Finally to study whether the similar defects could be observed in other laminin/integrin 
mutant mice, we analysed the retinal vasculature of laminin α2 (dy
2J/ dy
2J), integrin α7 
and integrin β4 mice (data not shown). Deficiency in laminin α1, -γ1 and α5 chains as 
well as most integrin chains result in early embryonic lethality and does not allow us to 
study developmental angiogenesis.  
IF staining with an antibody directed against laminin α2 showed deposition of laminin 
α2  in  BM  of  retinal  endothelial  cells  and  therefore  could  have  a  function  in  the 
developing vasculature. Deficiency in laminin α2 chain leads to congenital muscular 
dystrophy and it has been shown that laminin α4 and integrin α6 are upregulated upon 
loss of Lama2 (Sorokin, Maley et al. 2000). Investigation of the retinal vasculature 
showed no defects in the mature vascular plexus and no abnormal tip cell formation or 
defects in vessel sprouting (Figure 7.19), indicating that laminin α2 is dispensable for 
vessel formation in the retina. 
 
Flintoff-Dye and colleagues demonstrated that the α7β1 integrin is important for 
the  recruitment  or  survival  of  cerebral  vascular  smooth  muscle  cells  and  that  this 
integrin plays an important role in vascular development and integrity (Flintoff-Dye, 
Welser et al. 2005). We studied vascular development in the retina of Itga7 deficient 
mice. Staining with isolectin and NG2 however revealed no significant differences in 
vessel formation and pericyte recruitment (Figure 7.20). Given that PC recruitment in 
the CNS is impaired in Itga7 deficient mice (Flintoff-Dye, Welser et al. 2005), it is 
surprising  that  we  could  not  detect  defects  in  PC  investment  in  the  retina.  Retinal 
pericytes  are  recruited  by  longitudinal  migration  of  PCs  from  the  CNS.  However, 
pericytes cover the capillary plexus (c, d) and have migrated to a similar extent towards 
the leading tip cells in Itga7 -/- mice as seen in control retinas (a, b). These observations 
indicate that integrin α7β1 does not play a role in retinal PC investment and might be 
compensated by other integrins. 
In summary, loss of laminin α2 or integrin α7β1 does not result in an increased 
vascular density as seen in Lama4 deficient mice, suggesting that laminin α4 chain 
uniquely  regulates  vessel  sprouting  by  modulating  Dll4/Notch  signalling. 
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Figure 7.19 Loss of Lama2 does not affect development of retinal vasculature 
Isolectin B4 immunostaining of migrating front and capillary plexus of Lama2 -/- (c, d) 
and  control  P5  retinas  (a,  b)  revealed  no  defects  in  vessel  formation  and  sprouting 
angiogenesis.  
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Figure 7.20 Integrin a7 (Itga7) is dispensable for pericyte investment and vessel 
formation in the retina 
Co-labeling of ITGa7-/- and control retinal blood vessel (red) with pericytes marker 
NG2  (green,  a-d)  showed  close  association  of  vessels  with  pericyes  and  almost 
complete coverage of vessels by pericytes in the capillary plexus (c, d). 
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7.2  Discussion 
Our study identified a surprising and new function for the ECM molecule laminin α4 in 
restricting endothelial tip cell formation in vivo by modulating the expression of Dll4 
and thus activity of Notch signalling. 
7.2.1  Expression  pattern  and  loss  of  laminin  a4  is  phenotypically 
reminiscent to the vasculature when Dll4/ Notch signalling is 
disturbed  
My expression studies revealed that Lama4 mRNA is most prominently expressed by 
leading ECs at the sprouting vascular front and the mature protein is stably integrated in 
the  BM  of  the  growing  retinal  vasculature.  Confocal  microscopy  showed  a  distinct 
expression pattern of laminin α4 at endothelial cell junction in vitro and in vivo whereas 
ECM components such as laminin α5, collagenIV and fibronectin are assembled in the 
BM and deposited at the abluminal basal site of the endothelium.  
Detailed high-resolution microscopy showed that the loss of laminin α4 resulted 
in excessive tip cell formation indicated by ectopic and aberrant filopodia protrusion as 
well as increased and more widespread expression of the ‘tip cell gene’ Pdgfb. The 
increased vascular density is accompanied by enhanced EC proliferation as shown by 
incorporation of BrdU. These findings disagree with the current literature. DeHahn and 
colleagues demonstrated that the globular G domain of laminin α4 subunit plays a role 
in maintaining endothelial cell growth and proliferation and that an antibody directed 
against  an  integrin-binding  region  within  the  G  domain  of  the  α4  laminin  subunit 
triggers  the  mitochondrial-dependent  programmed  cell  death  pathway  in  endothelial 
cells  (DeHahn,  Gonzales  et  al.  2004).  The  authors  further  speculate  that  antibodies 
against laminin α4 subunit inhibit angiogenesis in vivo and assembly of tubular arrays 
in vitro on Matrigel by promoting EC apoptosis.  
Further, Lian et al. isolated an active site on the laminin α4 chain globular domain that 
binds to αvβ3 integrin and generated a corresponding peptide that is able to promote 
angiogenesis in vivo (Lian, Dai et al. 2006). However, neither of these studies identified 
the underlying mechanism of laminin α4 induced angiogenic responses. 
In contrast to the studies mentioned, Davis and Senger propose a model in which 
collagen  and  laminin  have  opposing  effects  on vascular  morphogenesis.  Endothelial 
cells exposed to collagen matrices stimulate vessel formation, initiate sprouting and  
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migration  by  interacting  with  integrin  and  promoting  Cdc42  and  Rac1  activity. 
Conversely,  laminin  suppresses  this  morphogenic  pathway  by  induction  of  Rac  and 
PKA but suppression of Rho activity (Davis and Senger 2005; Davis and Senger 2008). 
These studies are in line with our finding that laminin α4 rather restricts excessive 
vessel  formation  and  stabilizes  the  newly  formed  vessel  in  vivo  than  promoting 
angiogenesis. Still we need to take in consideration that the studies by Davis and Senger 
are carried out in collagen type-I and Laminin 111 (LN111) matrices. As we learnt from 
our  own  studies,  different  laminin  isoforms  can  have  opposing  effects  on  ECs. 
Endothelial cells cultured on LN511 form a monolayer with firm endothelial junction 
while  ECs  coated  in  LN411  appear  to  lose  their  contact  inhibition  and  exhibit  a 
migratory phenotype.  
When analyzing vessel migration in the retina of Laminin α4 deficient mice, we 
noticed a mild delay in the expansion of vessel towards the periphery. Unlike in mice 
deficient of astrocytic FN production, we could not detect reduced VEGFR2 signalling 
and activity as shown by immunoblotting. We also did not observe reduced levels of 
PI3K  activity  analyzed  by  phosphorylation  of  downstream  target  AKT.  In  fact,  we 
would argue that we see a slight increase in VEGFR2 protein expression levels that 
possibly correlate with the increased density and vessel area. However, it still remains 
unclear  whether  there  is  a  direct  correlation  between  VEGFR2  levels  and  vessel 
quantity.  Therefore,  we  argue  that  the  mild  delay  in  vessel  migration  reflects  the 
developmental delay reported for Lama4 null mice (Thyboll, Kortesmaa et al. 2002) 
rather than a function of laminin α4 in EC migration. 
Defective pericyte (PC) recruitment results in hyperplasia and increased ECs 
proliferation (Hellström, Kalén et al. 1999). However when analysing PC coverage in 
Lama4-/- mice we observed a normal PC investment and close association of PC with 
the endothelium. Therefore, we concluded that increased EC proliferation and excessive 
sprouting is not due to disturbed EC-PC interaction. 
Thyboll  and  colleagues  showed  that  capillaries  of  the  lower  back  muscle  in 
laminin  α4  deficient  mice  displayed  a  structurally  abnormal  BM  and  reduced 
expression  of  BM  components,  suggesting  that  laminin  α4  is  essential  for  vessel 
integrity. We also observed an abnormal deposition and assembly of BM components in 
the  retinal  vasculature.  These  findings  are  in  line  with  a  study  by  Jakobsson  and 
colleagues,  2007,  showing  that  embryoid  bodies  deficient  in  laminin  chain  γ1 
differentiate  and  form  vessels  that  recruit  PC  but  almost  fully  lack  collagenIV  
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deposition  (Jakobsson,  Domogatskaya  et  al.  2007).  Nidogen-1  and  -2  mediate  the 
formation of a ternary complex with laminin and collagenIV, while heparan sulfate 
proteoglycans are integrated into the laminin-collagenIV network. These data indicate 
that in the absence of laminin α4, collagenIV is reduced and fails to integrate in the 
BM. 
The phenotypical reminiscence of the retinal vasculature in Lama4-/- mice and 
mice defective in Dll4/Notch signalling led us to the hypothesis that laminin α4 may 
modulate this pathway. 
At the present time, the precise molecular mechanism still remains unclear however, we 
propose that laminin a4 may (1) directly activate Dll4/Notch signalling, (2) regulate 
Dll4 expression by promoting integrin/ VEGFR2 signalling or (3) promote Dll4 protein 
localization at EC junction. 
 
7.2.2  Alternative 1: Laminin a4 directly activates Notch 
The transmembrane protein, Dll4 activates Notch in the neighbouring cell by direct cell-
cell  contact.  During  retinal  vascular  development,  Dll4  expression  is  dynamically 
regulated and most prominent in the ECs of actively growing capillaries at the leading 
front of the superficial vascular plexus. Coinciding with the cessation of angiogenic 
sprouting Dll4 expression is lost in the maturing veins and capillary plexus (Hellstrom, 
Phng et al. 2007); (Lobov, Renard et al. 2007). This pattern of Dll4 expression strongly 
resembles Lama4 mRNA expression, which is also most strongly present at endothelial 
tip cells. Laminin α4 deposition at endothelial junction led us to speculate that laminin 
may directly interact with Dll4 at EC-EC junction. 
Our analysis revealed that mice deficient in laminin a4 express reduced mRNA 
levels of Notch ligand Dll4 as well as Notch downstream targets such as Hey1, Hey2 
and Nrarp. The altered gene expression profile in Lama4-/- retinas is comparable to 
mice deficient in one allele of Dll4 or mice challenged with pharmacological inhibitor 
γ-secretase (Hellstrom, Phng et al. 2007); (Suchting, Freitas et al. 2007).  
Conversely, ECs cultured on Laminin-411 induce Dll4 expression in a Notch dependent 
manner. 
Dll4 overexpression (mDll4) resulted in abundant deposition of ECM molecules 
and an upregulation of mRNA expression levels of laminin, collagenIV and fibronectin 
but a decrease in the expression of matrix degrading enzymes, MMPs (Trindade, Kumar 
et al. 2008), indicating that Notch signalling regulates ECM molecules.  
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Recent  data  implicated  the  co-expression  of  Notch  and  integrins  and  the 
activation of integrins by Notch signalling (Campos, Decker et al. 2006); (Hodkinson, 
Elliott et al. 2007); (Leong, Hu et al. 2002). According to Campos et al., β1-integrins 
may affect Notch signalling through physical interaction (sequestration) of the Notch 
intracellular domain fragment by the cytoplasmic tail of the β1-integrin and secondly, 
by affecting trafficking (internalization) of the Notch intracellular domain (NICD) via 
caveolin-mediated mechanisms (Campos, Decker et al. 2006). This event likely requires 
the β1-integrin binding to ECM component. The laminin α4 subunit binds and interacts 
with integrin α6β1, α3β1, αvβ3 (Gonzalez, Gonzales et al. 2002); (Lian, Dai et al. 
2006),  and  therefore,  laminin  α4  could  possibly  regulate  Dll4/Notch  signalling  via 
integrin interaction. 
Alternatively, Laminin α4 directly activates Dll4 expression by binding Dll4 
and/  or  Notch.  Although  we  have  no  evidence  for  or  against  this  hypothesis,  both 
laminin  a4  and  Dll4  contain  EGF-like  repeats  which  may  mediate  binding  and 
interaction. 
Dixelius and colleagues suggested that laminin may play a fundamental role in 
angiogenesis by directly affecting gene and protein expression profiles in ECs. Studying 
multiple  in  vivo  and  in  vitro  angiogenesis  assays  the  authors  reported  that  LN111 
induced angiogenesis and promoted EC differentiation in the absence of the growth 
factor FGF-2. Further, vascular development was stimulated in a synergistic manner by 
FGF-2  and  LN111  and  the  formation  of  tubular  structures  induced  by  LN111  was 
accompanied  by  increased  expression  of  the  Notch  ligand  Jagged-1  (Dixelius, 
Jakobsson  et  al.  2004).  LN111  mediated  angiogenesis  does  not  alter  endogenous 
laminin production and also does not affect ERK and AKT phosphorylation, indicating 
that LN111 does not converge with normal growth factor –induced signalling. Taken 
together with our findings, the data suggest that laminin induces expression of Notch 
ligands independently of additional growth factors such as VEGF and FGF.  
7.2.3  Alternative  2:  Laminin  α4  regulates  Dll4  expression  by 
promoting integrin/ VEGFR2 signalling 
Multiple  studies  find  co-dependence  or  regulation  of  Dll4/  Notch  signalling  and 
VEGFR2 (Suchting, Freitas et al. 2007); (Lobov, Renard et al. 2007).  
LN411 induced Dll4 expression in vitro correlates with increased Vegfr2 mRNA 
expression levels. Consistent with our observation, Lobov demonstrated that blocking  
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Dll4 expression by neutralizing antibodies decreased Vegfr2 mRNA expression (Lobov, 
Renard et al. 2007). 
The  current  model  of  tip  cell  formation  and  vascular  sprouting  suggests  that 
VEGF/VEGFR2  signalling  induces  Dll4  expression  in  leading  tip  cells,  activating 
Notch signalling in adjacent cells, which in turn results in down regulation of VEGFR2 
and induction of stalk cell phenotype.  
Our analyses revealed that LN411 promotes Dll4 expression by a mechanism 
that  is  not  entirely  dependent  on  VEGF/VEGFR2  signalling.  While  baseline  Dll4 
mRNA expression in EC is completely VEGF/VEGFR2 dependent, LN411 induced 
Dll4 expression cannot be fully inhibited by neutralizing VEGFR2. 
In  addition,  Dll4  mRNA  expression  is  not  upregulated  by  VEGF-A. 
Concomitantly with initiating angiogenesis, VEGF-A upregulates Dll4 expression in the 
endothelium of an angiogenic sprout (Lobov, Renard et al. 2007). However, VEGF-A 
and  hypoxia  expression  are  unaffected  in  Lama4-/-  mice  and  consistently,  LN411 
induced Dll4 mRNA expression in ECs in vitro occurs independently of low oxygen 
levels and without addition of VEGF-A.  
Further, β3 integrin forms a complex with VEGFR2 and promotes VEGFR2 
phosphorylation  (Soldi,  Mitola  et  al.  1999);  (Mahabeleshwar,  Feng  et  al.  2007). 
Harrington and colleagues reported that Dll4 regulates the expression of endothelial 
integrin β3 in vitro (Harrington, Sainson et al. 2007). 
The co-localization of Dll4, laminin and β3 at the cell membrane, and possibly at EC-
EC contacts led to the hypothesis that laminin interacts with integrin β3 and thereby, 
modulates Dll4/Notch signalling. Preliminary data using integrin β3 siRNA knockdown 
indicate that LN411 induced Dll4 expression is reduced upon blocking β3 integrin.  
The expression of integrin β3 and Dll4 is directly regulated by Forkhead transcription 
factor, Foxc2 (reviewed in (Kume 2008). Recent data imply that Foxc2 interacts with 
VEGF  signalling  to  induce  Dll4  expression  (Hayashi  and  Kume  2008)  and  directly 
induces  transcription  of  integrin  β3  by  activating  their  promoters  via  Foxc-binding 
elements (Hayashi, Sano et al. 2008). Therefore, one could speculate that Foxc2 is the 
transcriptional regulator of both, integrin β3 and Dll4, and mediates the angiogenic 
response.  
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7.2.4  Alternative 3: Laminin α4 promotes Dll4 protein localization by 
interacting at endothelial junction 
Alternatively, we propose that laminin α4 may function in cell polarity and membrane-
domain targeting, bringing Dll4 to the lateral cell membrane and thereby, regulating 
Dll4 availability and Notch activation in neighboring ECs. 
 Endothelial junctions contribute to the maintenance of apical-basal cell polarity 
(reviewed in (Dejana, Orsenigo et al. 2009); (Desai, Gao et al. 2009). Cell polarity is 
further established by the formation of a vascular lumen and the deposition/ assembly of 
ECM at the abluminal site of the endothelium. During zebrafish somitogenesis Notch 
and integrin α5-dependent cell polarization and FN assembly occurs concomitantly and 
interdependently during border morphogenesis (Julich, Geisler et al. 2005).  
Many of epithelial cell processes, including cell motility and intracellular signalling rely 
on the polarized distribution of plasma membrane proteins. Recent studies revealed that 
apical  localization  of  Notch  depends  on  polarized  exocytosis  and  transcytosis  in 
Drosophila epithelial cells (Sasaki, Sasamura et al. 2007). Disruption of apical polarity 
failed to localize Notch and delta to the correct apical plasma membrane and adherent 
junctions. Bayraker and colleagues supported the finding showing that Par-1, a serine/ 
threonine protein kinase is required for the establishment of cell polarity in embryonic 
Drosophila epithelia. Par-1 also functions upstream of Notch and is critical for proper 
localization of the Notch ligand Delta and in addition promotes Notch-mediated lateral 
inhibition during embryonic neurogenesis (Bayraktar, Zygmunt et al. 2006). 
We therefore hypothesized that ECM molecule laminin α4 might play a role in 
EC polarization and the correct localization of Dll4 to the membrane. Investigation of 
EC junctions by immunostaining with claudin-5 and VE-cadherin indicated that Lama4 
deficient  vessels  exhibit  an  increased  number  of  EC  junction  that  appear  chaotic, 
immature and disorganized. Preliminary results from our ongoing analysis of Lama4-/- 
retinal vessels using electron microscopy support this notion (data not shown).  
7.2.5  Future perspective 
Preliminary  data  indicate  that  laminin  α4  may  bind  to  integrin  β3  and  thereby 
promoting  integrin/  VEGFR2  crosstalk  resulting  in  increased  Dll4  expression. 
However, this hypothesis is based on the assumption that laminin α4 and integrin β3 are 
expressed  in  the  same  cell,  i.e.  leading  endothelial  tip  cells.  Therefore,  precise 
expression  studies  of  integrin  β3  will  be  of  interest  to  investigate  co-expression  of  
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laminin α4 and integrin β3. Further, analyses of potential complex formation and/ or 
co-localization of Dll4, integrin β3 and laminin α4 at endothelial junction would be 
helpful to gain insight in a potential interplay between these molecules. 
Detailed  investigations  of  the  role  of  integrin  β3  in  mediating  Dll4  expression  are 
necessary. Itgb3 deficient endothelial cells will be helpful in this analysis. Can Itgb3 
deficient cells bind, interact and communicate on a laminin α4 matrix. Is Dll4 mRNA 
expression still induced in these cells when plated on LN411? Is VEGFR2 required in 
this process? Although preliminary data do not support the hypothesis that loss of Itgb3 
results in excessive sprouting as seen in Lama4 -/-, it will be interesting to analyse 
mRNA expression levels of Dll4, Notch downstream targets and Vegfr2 in Itgb3 null 
mice.  
 
VEGFR2 functions up-and downstream of Dll4/ Notch signalling pathway. Activation 
of  Notch  modulates  VEGF  receptor  expression  levels;  VEGFR2  mRNA  levels  are 
quantitatively  downregulated  while  VEGFR1  expression  is  increased  in  endothelial 
cells with active Notch signalling (Suchting, Freitas et al. 2007); (Hellstrom, Phng et al. 
2007).  Therefore,  it  might  be  of  interest  to  analyse  the  spatial  expression  and 
distribution of these receptors in Lama4 -/- mice. Laminin α4 could have a role in 
locating VEGFRs to the cell surface and bring the receptor to the junction to form a 
VEGFR/ VE-cadherin complex and thereby, promote Dll4/ Notch signalling. 
 
Laminin α4/ integrin interaction may also play a role in endothelial polarization. Loss 
of laminin assembly by Rac1 results inversion and replacement of apical pole position 
during cyst development in Drosophila (O'Brien, Jou et al. 2001). The mis-assembly 
correlates with reduced integrin expression, and lack of lumen formation due to lack of 
apical-basal polarization (O'Brien, Jou et al. 2001). Therefore, it would be interesting to 
study vessel and lumen formation of Itgb3 and Lama4 deficient endothelial cells in a 3D 
setting. One would also like to investigate the cell-autonomous function of laminin a4 in 
a 3D sprouting model described by Jakobsson and colleagues (Jakobsson, Kreuger et al. 
2007). It would be of interest to analyse Lama4 -/- embryoid bodies differentiating in 
vascular sprouts and to monitor cell migration, remodelling and sprouting events in high 
magnification. The lack of firm endothelial junction in Lama4 -/- retinas could also 
reflect increased active migration which could be addressed in a 3D in vitro model.   
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Studying  the  dynamics  of  Lama4  embryonic  stem  (ES)  cells  in  chimeric  embryoid 
bodies containing colour-coded wildtype and laminin α4 ECs will allow us to study the 
cellular behaviour and competition of Lama4-/- cell during sprouting. 
 
Lastly,  transduction  of  extracellular  matrix  signals  through  integrins  requires 
intracellular  interaction  of  the  cytoplasmic  tail  of  integrins  with  cellular  proteins. 
Integrin-linked kinase (ILK) binds to β-subunit of integrins and mediates cell- adhesion, 
migration and signal transduction (Kaneko, Kitazato et al. 2004). 
Therefore, it would be interesting to explore whether ILK has a function in mediating 
Laminin/ Integrin induced Dll4 expression.  
7.2.6  Summary 
Taken together, my study revealed for the first time that the ECM molecule laminin α4 
functions  in  restricting  excessive  tip  cell  formation  and  enhanced  sprouting  by 
modulating Dll4/Notch signalling (summarized in Figure 7.21). Laminin α4 and Dll4 
are upregulated in many tumours correlating with enhanced pathological angiogenesis 
and  increased  tumour  growth  and  metastasis  (Zhou,  Doi  et  al.  2004);  (Thurston, 
Noguera-Troise  et  al.  2007),  suggesting  that  a  deeper  understanding  of  the  co-
dependence of LN411 and Dll4 may have substantial pathological relevance. Further 
analyses to fully understand the molecular mechanism are necessary. Nevertheless, our 
present results combined with recent findings in integrin-Notch interaction indicate that 
laminin potentially modulates Dll4/Notch signalling via integrins.  
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Figure 7.21 Proposed model of laminin α4 modulating Dll4/Notch signalling 
(a) VEGF expressed ahead of the growing vasculature binds to endothelial tip cells and 
thereby,  triggers  VEGFR2  signalling.  Dll4  expression  in  tip  cells  is  upregulated  by 
VEGF and activates Notch signalling by binding to Notch receptors in neighbouring 
ECs. Notch intracellular domain (NICD) is translocated to the nucleus and initiates the 
expression of Notch target genes (such as Hey1, Hey2 and Nrarp). The induction of 
Notch is acquired to restrict sprouting.  
Laminin a4 and itgb3 are located at EC junction and laminin a4 is deposited at the 
abluminal side of the endothelium. 
(b) Loss of laminin a4 results in excessive filopodia formation and increased sprouting. 
We propose that laminin a4 is required for EC polarization and its absence fails to 
locate  Notch  ligand  Dll4  to  the  cell  membrane.  Hypersprouting  correlates  with  a 
decrease of Dll4 mRNA expression and reduced expression of Notch targets due to 
reduced  Dll4/  Notch  signalling  at  EC-EC  contacts.  
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8  Peripheral  mural  cell  recruitment  requires  cell-
autonomous heparan-sulfate 
8.1  Introduction 
The recruitment of pericytes (PC) is required to stabilize the newly formed angiogenic 
sprout and is essential to establish a functional vasculature. Loss of PC attachment and 
engagement  to  the  blood  vessel  is  associated  with  many  vascular  diseases  and 
pathological condition such as diabetic retinopathy and cancer. In fact, the degree of PC 
dissociation in the tumour vasculature correlates with tumour metastasis.  
Various pathways have been described to play a role in PC investment, proliferation and 
attachment  of  PCs  to  the  endothelium,  including  TGF-β  and  PDGF-Β signalling 
pathway.  Based  on  phenotypical  observations,  Hellstrom  et  al.  demonstrated  the 
fundamental role of paracrine signalling of PDGF-B expressed by EC via its receptor 
PDGFR-β (expressed by mural cells) in mural cell (MC) recruitment. Deletion of Pdgfb 
or  Pdgfrb  leads  to  embryonic  lethality  due  to  vascular  defects,  with  a  significant 
reduction of MC and loose attachment of present MCs resulting in abnormal vessel 
morphology and leaky blood vessels (Hellstrom, Gerhardt et al. 2001). 
The growth factor PDGF-B contains a highly conserved C-terminal sequence, so called 
retention motif, mediating the binding to heparan sulfate proteoglycan (HSPG) within 
the cell, anchored to the cell  surface, or secreted in the extra cellular matrix. Mice 
deficient in the PDGF-B retention motif (Pdgfb ret/ret) display similar, but less severe 
vascular defects observed in the Pdgfb/ Pdgfrb null mice. However, the lack of HS 
bound PDGF-B leads to detachment of MCs Lindblom (Lindblom, Gerhardt et al. 2003) 
consistent  with  the  idea  that  matrix  components  retain  a  PDGF-B  gradient  that  is 
required for proper MC recruitment and adhesion to the vessel. 
Multiple studies highlighted the importance of HSPG interacting with various growth 
factors, morphogens and matrix molecules. In order to specifically bind and interact 
with the large variety of molecules, the HS chain consists of a highly complex structure, 
involving N-and O-sulfation (Esko and Lindahl 2001). 
Interestingly, we have been able to show that an altered HS biosynthesis by global 
reduction of N-sulfation on the HS chain leads to mural cell detachment, and delayed 
MC  migration,  but  not  proliferation.  Appropriate  N-sulfation  is  required  to  retain  
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PDGF-B  and  activate  PDGFR-β  in  MCs  in  vivo  (Abramsson,  Kurup  et  al.  2007). 
Therefore, HSPG are important co-receptors and activators of signalling events.  
Jakobsson and colleagues demonstrated in vitro that pericytic HS is sufficient to support 
vessel  formation  in  embryoid  bodies  deficient  in  endothelial  N-sulfated  HS.  These 
studies  illustrated  that  HS  presented  in  trans  can  fully  support  VEGF-A  signalling 
(Jakobsson, Kreuger et al. 2006). 
However,  we  lack  information  on  the  cell  specific  contribution  of  HS  in  normal 
vascular development and it has remained unclear whether pericytic HS is required for 
vessel formation and stabilization in vivo. This study address the relevance of pericytic 
HS  in  MC  recruitment  and  attachment  in  order  to  stabilize  newly  formed  vessels. 
 
8.2  Results 
8.2.1  Genetic approach for the deletion of HS in MCs 
The Ext1 gene encodes for the key glycosyltransferase that is essential for elongation of 
the  dissacharide  backbone  chain  of  HS.  The  EXT1  protein  forms  homodimers  or 
heterodimers with EXT2 and resides as single pass transmembrane protein in the Golgi 
apparatus. Deletion of Ext1 leads to complete loss of HS. The original observation that 
loss-of function mutations cause multiple exostosis in humans led to the name Exostosis 
proteins  (EXT1).  In  order  to  study  the  functional  role  of  MC  derived  HS  in 
angiogenesis, we deleted the floxed Ext1 allele (Inatani, Irie et al. 2003) selectively in 
MC using transgenic Pdgfrb Cre mice (Foo, Turner et al. 2006). This genetic approach 
results  in  the  excision  of  Ext1  in  MCs  (for  simplicity  we  will  refer  to  Pdgfrb 
Cre+/Ext1
flox/flox mice as Ext1
MCko). 
We initially confirmed the selectivity of Cre mediated deletion in MC at embryonic 
stages by crossing the Pdgfrb Cre to the ROSA26R eYFP reporter line (Soriano et al., 
1999).  The  ROSA26  eYFP  mice  carry  a  targeted  insertion  of  an  enhanced  yellow 
fluorescent protein (EYFP), preceded by a loxP-flanked (floxed) strong transcriptional 
termination sequence (tpA), into the ubiquitously expressed ROSA26 gene locus. The 
ROSA26 allele terminates transcription prematurely, but when mice are crossed with 
Cre-expressing  transgenic  mice  e.g.  Pdgfrb  Cre,  the  Cre-mediated  excision  of  the 
floxed termination sequence leads to YFP expression. Thus, these doubly transgenic 
animals express eYFP only in the cells that have expressed Pdgfrb Cre, as well as in all 
of their daughter cells (Srinivas, Watanabe et al. 2001).  
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Analysis of the embryonic back and skin of an E13.5 embryo (Figure 8.1 a-b) as well as 
skin samples of the vasculature of an E17.5 embryo (c) reveals nuclear YFP staining in 
mural cells closely attached to blood vessels (dashed line). The YFP expression pattern 
(a-c)  closely  resembles  MC  staining,  indicating  specific  and  efficient  Cre-mediated 
recombination. These data are in line with findings of Abraham and colleagues showing 
a highly specific deletion of itgβ1 in mural cells at embryonic stage E17.5 but not 
endothelial cells using the Pdgrfb Cre line (Abraham, Kogata et al. 2008). 
In addition we studied Pdgfrb Cre specificity in E10.5 hindbrain samples (d-e). YFP 
expression is strongly observed in ROSA26 eYFP/ Pdgfrb Cre hindbrain samples (e). 
Co-labelling  with  isolectin  (red,  d)  to  visualize  ECs  revealed  YFP  expression 
exclusively in pericytes and not in the endothelium of the hindbrain vasculature.  
 
 
 
Figure  8.1  Pdgfrb  Cre  line  specificity  detected  by  ROSA26  eYFP  expression  in 
embryonic skin and hindbrain 
Crossing of reporter line ROSA26 eYFP with Pdgfr Cre mice revealed pericyte specific 
eYFP (red) staining in embryonic skin samples at E13.5 (a, b) and E17.5 (c).  
Co-labeling  of  embryonic  hindbrains  of  Pdgfrb  Cre  ROSA26  eYFP  at  E10.5  with 
Isolectin B4 (red, d) revealed pericyte specific expression of eYFP (green, d, e). 
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To further evaluate the specific loss of HS in pericytes, we analysed HS expression in 
paraffin section of Ext1
MCko and control embryos. 
HS staining (green) confirms substantial loss of HS in the MC compartment of major 
arteries and veins of Ext1
MCko embryos (Figure 8.2 a-b). The 10E4 antibody is widely 
used to detect HS and recognizes an epitope that is destroyed by N-desulfation (David, 
Bai  et  al.  1992).  Co-labelling  of  HS  (10E4)  and  MC  using  NG2-antibodies  that 
selectively label MC in many tissues (Ozerdem, Grako et al. 2001) indicates that a small 
fraction of MCs does not recombine the floxed Ext1 allele (d, arrow). Alternatively, 
slow HS turnover and more recent recruitment could explain residual HS as more cells 
of the outermost smooth muscle layer around arteries retain HS staining (b, d). High 
resolution analysis of vessels in the embryonic skin revealed NG2 positive cells lacking 
HS expression (e, f) whereas pericytes in control samples deposit both, HS and NG2 (g, 
h). Effective depletion of HS from most MCs allows us to address for the first time the 
functional importance of MC HS expression for vascular development.  
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Figure 8.2 Reduced heparan sulfate (HS) expression in Ext1
MCko embryos 
Sections of E13.5 embryos were stained with an antibody directed against the HS chain 
(green), NG2 (red) and DAPI. Vascular smooth muscle cells (vSMCs) of the dorsal 
aorta (a, b) have strongly reduced HS deposition with residual HS on the most outer 
layer of vSMCs in Ext1
MCko embryos (arrow, b).  
Immunostaining revealed loss of HS in vSMC and pericytes of Ext1
MCKO (b, d) while 
HS is strongly expressed in control littermates (a, c) and localized at the abluminal 
surface of mural cells (MCs). 
High  magnification  imaging  of  capillaries  in  the  embryonic  skin  (e-h)  showed  co-
localization of HS and NG2 in control sections (arrows, g-h) while NG2 positive cells 
in Ext1
MCko sections lack HS (arrows, e-f).  
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8.2.2  MC HS is not required for MC recruitment in the CNS 
Ext1
MCko  embryos  harvested  at  E11.5  are  macroscopically  indistinguishable  from 
control littermates. We labelled hindbrain samples with isolectin-B4 to visualize ECs 
(Figure 8.3 a-h) and NG2 antibody to detect MCs (Figure 8.3 b, f). Overview images of 
the developing vessel network in the hindbrain show no significant differences in vessel 
formation, patterning and vessel density (Figure 8.3 a, e).  
Confocal microscopy analysis of Ext1
MCko hindbrains reveals that MCs are recruited to 
the  blood  vessels  and  closely  associated  with  the  endothelium,  as  seen  in  control 
littermates (Figure 8.3 b, f). Detailed analysis of MCs investment at the midline (k-l) 
and migration of MCs towards the periphery of hindbrains (i-l) shows no substantial 
differences.  This  lack  of  phenotype  stands  in  marked  contrast  to  findings  in  mice 
deficient in PDGFR-β signalling, such as Pdgfrb
-/- (n), the PDGF-B retention motif 
knockout  (Lindblom,  Gerhardt  et  al.  2003),    and  the  Ndst1
-/-  mice  with  a  global 
reduction in N-Sulfated HS (Kurup, Abramsson et al. 2006; Abramsson, Kurup et al. 
2007). Both the PDGF-B retention motif knockout and the Ndst1
-/- mice show defective 
pericyte recruitment due to absent or reduced ability of PDGF-B to bind to HS (Kurup, 
Abramsson et al. 2006; Abramsson, Kurup et al. 2007). 
To address whether the attached MCs in the Ext1
MCko indeed lack HS expression, we 
labelled  the  hindbrains  with  the  10E4  antibody  (Figure  8.3,  Figure  8.4).  In  control 
hindbrain samples, we detect HS in the endothelium as well as in MCs, particularly at 
the interface of ECs and MCs (Figure 8.3 f, h arrows and Figure 8.4). Interestingly, 
hardly any HS could be seen in the abluminal BM of pericytes in Ext1
MCko and control 
vessels. In contrast to control PCs, less HS decorates the membrane of MCs in the 
mutant and significantly less HS is found at the abluminal side of the endothelium of 
mutant vessels (arrows, Figure 8.4 a-d) suggesting that pericytic HS is indeed absent 
and  normally  contributes  to  the  BM  surrounding  the  vessel.  These  results  indicate, 
however, that pericytic HS production is not required for MC recruitment, at least in the 
context of sprouting angiogenesis in the developing CNS. 
Therefore we propose that endothelial HS production is essential for PC investment in 
the CNS. Loss of HS binding motif in PDGF-B retention knockout as well as reduced 
N-sulfation of HS show defective PC recruitment, highlighting the importance of HS in 
this process. To further test this hypothesis we are currently generating mice deficient in 
EC HS production. By crossing Ext1 floxed mice with endothelial specific PDGFB Cre  
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ERT mouse line (Claxton et al., 2008) we generate mice that lack HS biosynthesis in 
cells expressing Pdgfb. To evaluate EC HS function during vascular development we 
induced Cre mediated deletion of Ext1 by administration of 4OH tamoxifen at various 
embryonic  stages.  However,  despite  several  attempts  we  did  not  achieve  sufficient 
deletion  of  endothelial  HS  to  study  the  effect  on  PC  recruitment  in  the  embryonic 
hindbrain (Figure 8.5). Heparan sulfate (green, d, h) can still be detected to a similar 
extent in mice treated with 4OH tamoxifen (h) as in control hindbrains. In addition, 
vessel morphology appears normal (a-h) and pericytes closely align to vessels (c, g).  
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Figure 8.3 Blood vessel formation and MC recruitment in the CNS 
Overview images of the vasculature from control (a) and Ext1
MCko (e) hindbrains. 
Wholemount hindbrains of E11.5 embryos were labelled with isolectin-B4 (blue) and 
NG2 (red) to detect ECs and MCs, respectively. High-resolution imaging revealed 
recruitment and attachment of MCs in Ext1
MCko (f) as well as control (b) embryos. 
Immunofluorescence staining with HS (green) confirmed the lack of pericytic HS 
(arrow, g, h), while HS expression is still detectable in MCs of control blood vessels (c, 
d). 
Comparison of MC coverage in Ext1
MCko and control hindbrains at the periphery (i, j) 
and midline (k, l) showed no differences in MC recruitment and migration by co-
labeling vessels (red) with pericyte marker NG2 (green). In contrast, Pdgfrb -/- 
hindbrains (n) lack MC coverage when compared to control littermates (m).  
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Figure 8.4 HS expression in hindbrain of Ext1
MCko embryos 
Immunostaining of E10.5 Ext1
MCko and control hindbrains with HS (green), NG2 (red) 
and isolectin B4 (blue) showed reduced HS deposition in Ext1
MCko (a-d). Strong HS 
localization was detected at interface between ECs and MCs in control hindbrains 
(arrow, e-h) but reduced in Ext1
MCko hindbrains (arrow, c-d). 
 
 
Figure  8.5  Tamoxifen  induced  deletion  of  endothelial  HS  in  the  embryonic 
hindbrain 
Analysis of pericyte investment and blood vessel formation in E11.5 embryonic 
hindbrains of Ext1
ECiERT2. Pregnant female was injected intraperiteonally with 10mg/ml 
tamoxifen at E9.5 and E.10.5 before harvesting embryos. 
Overview images display blood vessel network formation (a, e) by immunostaining 
with isolectin-B4 (green) and mural cell recruitment by co-labeling with NG2 (red, a, 
d). High magnification revealed HS deposition (green) in BM of blood vessels (blue) 
associated with pericytes (red, b-d and f-h). Expression of HS (green) correlates with 
close alignment of pericytes and normal vessel morphology in control (a-d) and 
Ext1
ECiERT2 embryos (e-h).  
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8.2.3  Lack  of  MC  HS  results  in  abnormal  vessel  morphology  and 
reduced vessel stability 
8.2.3.1 Analysis of vessel morphology in embryonic skin  
Despite apparently normal vascular patterning at E11.5, no viable mutants were born, 
indicating that the deletion of pericytic HS causes embryonic lethality at later stages. 
Further  analysis  revealed  that  lethality  occurs  between  E13.5  and  E19.  At  E13.5, 
Ext1
MCko  embryos  exhibit  hemorrhages  (  Vascular  defects  in  embryos  lacking  HS 
production  b, white arrowhead) and edema (black arrow, b) in the skin. Histological 
transverse  sections  illustrate  edema  formation  visible  as  increased  interstitial  space 
between the skin, spinal cord and muscle blocks ( Vascular defects in embryos lacking 
HS  production    c-d;  arrow).  Loose  connective  tissue  in  the  hypodermis  of  mutant 
embryos  further  confirms  the  presence  of  fluid  accumulation  (  Vascular  defects  in 
embryos  lacking  HS  production    e,  f).  However,  erythrocyte  extravasation  is  only 
occasionally  observed,  implicating  increased  plasma  leakage  and/or  poor  lymphatic 
uptake as primary cause of edema formation. 
 
 
Figure 8.6 Vascular defects in embryos lacking HS production  
Macroscopical analysis of E13.5 control (a) and Ext1
MCko embryos revealed edema 
(black arrow, b) and haemorrhages (white arrowhead, b) in the skin. Transverse sections 
demonstrate increased interstitial space (d, black arrow) and loose connective tissue in 
the epidermis of Ext1
MCko (f) compared to the control littermate (c, e). 
 
Detailed wholemount analysis of these skin areas using endomucin labelling to detect 
endothelial  cells  (Brachtendorf,  Kuhn  et  al.  2001)  reveals  striking  abnormalities  in 
superficial vessels around the spinal cord in mutant embryos (Figure 8.7 a-h). While 
control embryos display an organized and hierarchical vascular pattern (a), vessels in  
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mutant embryos appear random and chaotically branched with variable diameter (b). 
Higher magnification analysis emphasizes diameter variability (Figure 8.7 d) and shows 
frequent  formation  of  glomeruloid  structures  resembling  microaneurysms  (arrow, 
Figure 8.7 d).  
Confocal microscopy confirms the presence of a patent network of vessels in control 
embryos  (Figure  8.7  e),  whereas  mutant  tissue  shows  slender  processes  without 
filopodia resembling regressing vessels (arrowheads in Figure 8.7 f), and also numerous 
new sprouts alongside tortuous vessels of variable calibre (h). Quantification reveals a 
significant  increase  in  the  diameter  variation  between  smallest  and  largest  diameter 
vessels  in  mutant  tissues  (i).  Diameter  variations  and  co-existence  of  potential 
regression profiles and new sprouts suggest that vessels lacking pericytic HS are less 
stable. 
 
8.2.3.2 Pericytic HS does not affect cardiovascular development and 
vessel perfusion 
Given that perfusion is a stabilizing factor important for vessel maturation, we studied 
heart function, and major vessel perfusion. Invariably, all mutant and control embryos 
displayed  effective  heartbeat  and  evans  blue  or  FITC  dextran  distributed  quickly 
through the major central vessels following injection into the heart (not shown). Proper 
cardiac function beyond E14 requires coronary vessel formation, which is regulated by 
a series of HS dependent signalling pathways including hedgehog, TGF-β, FGF and 
VEGF reviewed in (Olivey, Compton et al. 2004). However, coronary vessel formation 
is unperturbed in Ext1
MCko embryos at E13.5. Overview images of the heart stained with 
PECAM  to  visualize  coronary  vessels  showed  no  difference  in  vessel  formation, 
morphology and patterning of Ext1
MCko and control embryos (Figure 8.8 a-d). Thus, 
central  cardiovascular  development  and  function  appear  not  to  require  MC  HS 
production. The observed vascular defects in the skin are therefore likely due to local 
defects associated with MC HS deficiency. 
 
Confocal  3D-analysis  illustrates  that  the  vascular  network  in  mutant  skin 
samples spanned a greater depth (Figure 8.9 g, h), possibly due to increased sprouting 
or due to the tissue swelling and edema. Paraffin cross sections confirm the presence of 
multiple layers of vascular profiles in the hypodermis (Figure 8.9 a, b). Quantification 
of vessel density by measuring the skeletal length of all vessel profiles in confocal z- 
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stacks, reveal no significant difference between mutants and controls (Figure 8.9 g), 
suggesting that the same number of vessels expand over larger depth in the mutant 
tissue. 
 
 
 
Figure 8.7 Abnormal vessel morphology and patterning defects in Ext1
MCko 
Endomucin staining (a-h, red) of E13.5 mutant embryos revealed abnormal patterning 
of the superficial vessels at the back along the spinal cord (a, b); (c) and (d) present 
higher magnification images of the boxed area in (a) and (b). The skin vasculature of 
the control littermates is uniform in its size and diameter (e). In contrast, Ext1
MCko 
display irregular shaped, tortuous vessels with fluctuation in their diameter (arrowheads, 
f). Ext1
MCko exhibit excessive filopodia extension (h) indicating aberrant sprouting 
processes On the contrary, the skin vasculature in control embryos is restricted to a 
2dimensional network (g). Graph i illustrates the measurement of 650 vessel profiles (n 
> 15 images/ embryo) reflecting the variability in vessel diameter in Ext1
MCko embryos. 
n =2, ***, F < 0.0001, F-test, variance of standard deviation.  
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Figure 8.8 Loss of pericytic HS does not affect cardiovascular development 
Visualization of coronary vessels in the developing embryonic heart at E13.5 with 
PECAM-1 (green, a-d) revealed uniform vessel formation. No morphological changes 
could be detected when comparing coronary vessels of Ext1
MCko (b, d) with control 
littermates (a, c).  
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8.2.3.3 Lymphatic vessel development occurs normally in mice lacking 
pericytic HS 
Edema formation during embryonic development can result from either primary defects 
in blood vessels, or alternatively, from defects in lymphatic development. Mutations in 
major signalling pathways relevant for lymphangiogenesis and the separation of blood 
and  lymphatic  vessels  lead  to  edema  formation between  E12.5  and  13.5,  similar  to 
pericyte HS mutants. LYVE-1 labelling (a marker for lymphatic endothelium (Banerji, 
Ni  et  al.  1999)  sections  illustrates  an  increase  in  lymphatic  vessel  profiles  in  the 
embryonic skin of Ext1
MCko E13.5 embryos compared to control littermates (Figure 8.9 
c, d). Double-labelling with endomucin show a clear separation of blood and lymphatic 
vessels.  Formation  of  mayor  lymphatic  vessels  and  jugular  lymph  sacs  also  appear 
unaffected in Ext1
MCko (Figure 8.9 e, f). These results indicate that lymphangiogenesis 
and segregation do not require HS production by MCs, and that the observed edema 
formation is likely caused by increased permeability in the blood vascular compartment.  
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8.2.3.4 Loss  of  MC  HS  results  in  increased  vessel  regression  and 
defective vessel integrity 
Detailed  studies  of  the  blood  vessel  morphology  using  endomucin  wholemount 
labelling  reveals  a  remarkable  increase  in  filopodia  extension,  indicating  increased 
sprouting activity (Figure 8.10 g, h). This increased sprouting, however, does not result 
in  greater  vascular  density  (Figure  8.10  g),  suggesting  that  nascent  vessels  are  less 
stable and prone to regress in the absence of MC HS production. To test this hypothesis, 
we studied the distribution of the basement membrane component collagen IV (CIV). 
CIV is a major component of the basement membrane (BM) surrounding the mature 
blood vessel but is absent from the tips of new sprouts. When blood vessels regress they 
leave behind empty BM sleeves containing CIV (Baluk, Lee et al. 2004). Comparing 
endomucin and CIV staining thus enables assessment of the relative amount of newly 
forming and regressing vessels. 
Using this technique, we consistently observe increased CIV staining and numerous 
CIV  positive  structures  devoid  of  endomucin  staining,  signifying  vessel  regression. 
Control embryos also display occasional regression profiles as part of normal vascular 
remodelling (Figure 8.10  a-c). Quantification of regression profiles in relation to the 
total skeletal length of vessels, however, reveals a significant increase in the length and 
number  of  CIV  sleeves  in  mutant  tissue  (Figure  8.10  j).  Higher  magnification 
occasionally  shows  vascular  sprouts  with  isolated  endothelial  cells  not  properly 
interconnected and apparently failing to form a patent stalk (Figure 8.10 g, boxed area 
in d). Together these results illustrate that the loss of MC HS leads to reduced stability 
of nascent vessels, promoting both increased regression and sprouting. 
The precise mechanism of blood vessel regression in vivo is not fully understood. It is 
conceivable that increased sprouting and concomitant regression would correlate with 
an increase in endothelial cell turnover. We therefore performed TUNEL assay and 
caspase  3  staining  to  detect  cell  death,  as  well  as  phospho  Histone  H3  staining  to 
analyse proliferation. Intriguingly, neither cell death nor proliferation are significantly 
changed in HS mutants during various stages of embryonic development (Figure 8.11 
and Figure 8.12) suggesting that migration/rearrangement of existing cells contributes 
substantially to the remodelling process.  
Increased regression of vessels can potentially be caused by the failure to form firm 
adherent cell-cell junction between endothelial cells. VE-cadherin, EC specific adherent  
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molecule  functions  in  cell  adhesion  and  controls  permeability  but  also  has  been 
described to transfer intracellular signals that contribute to vascular stabilization. Ridini 
et al. reported a regulatory function of VE-cadherin in promoting HS dependent TGF-β 
signalling in ECs. The observation that Ext1
MCko vessels fail to form patent connections 
and  partially  lack  EC  connection  (Figure  8.10  g-i)  led  to  the  hypothesis  that  VE-
cadherin  clustering  and  formation  of  EC-EC  junction  is  disturbed  in  mice  lacking 
pericytic  HS.  Unfortunately,  immunofluorescent  staining  of  wholemount  embryonic 
skin samples did not  succeed in detection of junctional VE-cadherin in control and 
mutant samples. In addition, analysing VE-cadherin protein expression in embryonic 
back skin samples of Ext1
MCko and control embryos revealed no significant differences 
in VE-cadherin (Figure 8.13) suggesting that production of pericytic HS is dispensable 
for VE-cadherin expression but still could play a role in clustering and formation of 
firm EC-EC junction.  
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Figure 8.9 Lymphatic vascular defects in mice deficient of pericytic HS 
Excessive sprouting and patterning defects of Ext1
MCko embryos are reflected in 
embryonic skin sections showing a widespread network of blood vessels (red, 
endomucin) through the entire depth of the skin (a, b). 
Visualization of lymphatic vessels (LYVE-1, green) revealed an increase in lymphatic 
vessels in Ext1
MCko embryonic skin (d) compared to control littermates (c) however, co-
labeling with endomucin (red) showed separation of lymphatic and blood vessels and no 
defects in lymphangiogenesis. (E=epidermis, D=dermis, S=subcutis). 
Staining of embryonic sections with LYVE-1 (green) and endomucin (red) showed no 
differences in lymphatic vessel development and expression of early lymphatic marker 
LYVE-1 in major vessels at the paired jugular lymph sacs in Ext1
MCKO mice (f) 
compared to control (e). Despite vessels spreading through the entire depth, graph g 
summarizes the density of the vascular network by measuring the skeletal length of skin 
vessels. n > 15 images/ embryo and n = 2/ genotype  
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Figure  8.10  Loss  of  pericytic  HS  leads  to  increased  regression  of  vessels  in 
embryonic skin 
Endomucin (red) and collagenIV (green) staining of embryonic skin revealed regressing 
blood vessel in Ext1
MCko embryos compared to control littermates (a-i). White 
arrowheads indicate regressing vessels lacking endothelial cell marker endomucin but 
positively stain for BM component CollagenIV. Higher magnification images (g-i) of 
the boxed area in (d) show disconnected endothelial cells that lack proper formation of 
lumen (arrowheads). Quantification for CollagenIV positive and endomucin negative 
vessels confirmed significant increase in regressing blood vessels of Ext1
MCko (j) while 
the density of the vascular network in the skin is unaffected (j, red bars). Quantifying 
the fluctuation in vessel diameter verified the significance in variance in Ext1
MCko 
compared to the control vessels (k).  
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Figure 8.11 Vessel regression does not correlate with increased apoptosis 
Immunohistochemistry staining of embryonic sections with TUNEL (a, b) and active 
caspase3 (c-f) illustrated no significant differences in apoptotic mural and endothelial 
cells (arrows) in Ext1
MCko as well as control embryos at E13.5.   
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Figure  8.12  Regression  of  vessels  is  not  a  result  of  increased  proliferation  and 
apoptosis 
Analysing proliferation of MCs by staining with phosphoHistone H3 (a-e) revealed no 
changes in Ext1
MCko and control vessels (a-b). No significant increase of apoptotic MC 
could be detected by caspase3 (e-f) and TUNEL staining (g-h) in E16.5 skin sections of 
mutant blood vessels (f, h) compared to control (e, g).  
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Figure  8.13  Vessel  regression  in  Ext1MCko 
embryos  is  not  caused  by  diminisehed 
expression of endothelial junction 
Immunoblotting of embryonic brain (B) and skin 
(S) samples of E13.5 control and Ext1
MCko 
embryos revealed no significant changes in 
protein levels of EC-EC junctional molecule VE-
cadherin. 
 
 
 
8.2.3.5 Pericytic  HS  is  dispensable  for  BM  formation  and  placental 
vessel development 
To  evaluate  vascular  defects  in  Ext1
MCko  further  we  harvested  embryos  at  later 
developmental  stages.  The  number  of  Ext1
MCko  embryos  obtained  decreased  with 
embryogenic development and mutant embryos display sever macroscopically defects. 
Mutant  embryos  appear  grossly  swollen  with  excessive  deposition  of  fat  on  lymph 
nodes  at  the  neck,  indicating  lymphatic  defects  proceed  during  late  embryonic 
development. Furthermore, we observed bleedings along the spinal cord of the back of 
Ext1
MCko embryos concentrated at regions we found abnormal vascular patterning and 
vessel morphology at E13.5 embryos. In addition, brains isolated from Ext1
MCko and 
control embryos revealed bleedings in both cerebral hemispheres (Figure 8.14 a, b). 
However, high resolution analysis of transverse  section and IF staining revealed no 
drastic defects in the morphology of CNS blood vessels (c, d). Co-labeling of vessels 
with HS showed a reduced expression of HS in the CNS. Nevertheless, HS deposition 
can still be found at BM enveloping PCs due to the endothelial expression and HS 
contribution to the BM. Despite the apparent loss of pericytic HS and the hemorraghing 
observed, PC closely associate to the vessel (e-h). In addition, auto fluorescence of 
erythrocytes  within  the  vessel  reveal  functional  vessels  and  normal  blood  flow, 
suggesting the bleeding occurred from a localized aneurism. 
Also matrix deposition appeared normal in Ext1
MCko embryos (Figure 8.14 i-p). 
We co-labeled vessels with laminin α4 (i-l) and laminin α5 (m-o) to visualize ECM 
components and found no significant differences in matrix assembly and deposition 
suggesting that pericytic HS productions is not required for ECM deposition in CNS 
vessels.  
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Figure 8.14 Pericytic HS is dispensable for pericyte recruitment in CNS and BM 
formation 
Brains of E18.5 Ext1
MCko embryos exhibit sever bleedings and haemorrhaging (a, b). 
Sectioning and IF staining of the brain with endothelial marker isolectin B4 (red, c-d) 
revealed normal vessel morphology and vessel density in Ext1
MCko (d). Co-labeling of 
vessels (green, e-h) with NG2 to visualize pericytes (red) showed attachment of 
pericytes despite loss of MC HS (arrows, h). Likewise, staining with extracellular 
matrix components laminin a4 (red, i-l) and laminin a5 (red, m-p) displayed no defects 
in matrix assembly and deposition in vessels of Ext1
MCko embryos. Counterstaining of 
arteries in the brain with SMA (green, m-p) confirmed close attachment of vascular 
smooth muscle cells (vSMC) and formation of BM surrounding vSMCs. Staining with 
HS (green) revealed the presence of HS in control (q) and Ext1
MCko embryos (r). 
However, while control vessels express luminal and abluminal HS co-localized with 
isolectin (insert), Ext1
MCko vessels display luminal HS lacking HS at the interface of 
endothelial-pericyte interaction (insert).  
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8.2.3.6 Loss of pericytic HS affects renal development 
Nevertheless,  the  hemorrhagic  phenotype  and  the  abnormal  skin  vessel  morphology 
partially  resembles  the  phenotype  observed  in  Pdgfb  or  Pdgfrb  deficient  animals 
(Lindahl,  Johansson  et  al.  1997).  Lindahl  and  colleagues  showed  that  PDGF-B/ 
PDGFR-β  signalling  controls  mesangial  cell  development  in  the  kidney  glomeruli 
(Lindahl, Hellstrom et al. 1998). Furthermore, PDGF-B retention knockout mice exhibit 
defects in renal glomeruli formation as well as the excessive accumulation of ECM 
similar  to  Pdgfb  null  mice,  indicating  a  function  of  HS  binding  in  this  process. 
Therefore, we analysed embryonic kidneys in mice lacking pericytic HS-production. 
PDGFR-β localizes to undifferentiated metanephric mesenchyme in the rat kidney and 
is later expressed in the cleft of the comma-shaped and S-shaped bodies and in more 
mature glomeruli in a mesangial distribution (Arar, Xu et al. 2000). 
To  test  the  hypothesis  that  pericytic  HS  is  required  for  activation  of  PDGFR-β  in 
mesanglial cells, specialized PC contributing to PDGF-B dependent capillary formation 
of  glomeruli,  we  would  analysed  capillary  formation  in  mice  deficient  for  the 
production of pericytic HS. 
Macroscopical examinations of kidneys of E19.5 mutant embryos revealed a reduction 
in size. More over, the surface of the kidney is nearly fully covered with tiny red dots 
(arrows,  Figure  8.15  a),  possibly  indicating  defects  in  proper  glomerular  capillary 
formation.  
However, paraffin sections indicated that developing glomeruli appear normal (b-e) and 
high magnification revealed no defects in glomeruli and capillary loop formation (c, e) 
but  vacuolated  proximal  tubules  with  cytoplasmic  disruptions.  HS  labeling  also 
illustrated  a  significant  loss  of  HS  in  Ext1
MCko,  suggesting  that  mesangial  HS 
significantly  contributes  to  glomeruli  basement membrane  formation  (f,  g). TUNEL 
staining  (h-l)  confirmed  an  increased  number  of  apoptotic  cells  at  the  metanephric 
cortex  of  Ext1
MCko  kidneys  and  enhanced  apoptotic  bodies  in  proximal  and  distal 
collecting tubules, indicating a function for HS in renal cell survival.   
  214 
 
 
 
 
 
 
Figure 8.15 Lack of HS production affects metanephric cell differentiation and 
survival in Ext1
MCko kidneys 
Macroscopical analysis of E18.5 kidneys of Ext1
MCko embryos revealed red dots 
(arrows, a) indicating hemorrhages. Sectioning and counterstaining of embryonic 
kidneys with H&E showed normal glomeruli formation in Ext1
MCko embryos but 
increased vacuolated proximal tubules (b-e). Co-labeling of paraffin section with HS 
revealed HS expression in control kidneys (f) that is absent in Ext1
MCko (g) indicating 
efficient Cre mediated deletion of HS in Pdgfrb positive cells in embryonic kidneys. 
TUNEL staining (h-l) revealed increased apoptotic cell bodies at the metanephric cortex 
and enhanced apoptotic bodies in proximal and distal collecting tubules in Ext1
MCko 
kidneys.  
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In  situ  hybridization  analysis  in  the  murine  embryonic  kidney  revealed  preferential 
expression  of  Pdgfc  mRNA  in  the  metanephric  mesenchyme  during  epihthelial 
conversion (Li, Ponten et al. 2000). Loss of PDGF receptors alpha shows selective loss 
of mesenchymal cells adjacent to sites of PDGF-C expression. Arar et al. suggest that 
PDGF B-chain acts in a paracrine fashion to stimulate the migration and proliferation of 
mesangial  cell  precursors  from  undifferentiated  metanephric  mesenchyme  to  the 
mesangial  area  (Arar,  Xu  et  al.  2000).  A  recent  study  confirmed  the  mitogenic 
signalling via PDGFR-β in metanephric mesenchymal cells and the PDGF-B induced 
PI3K  activity  in  this  process  (Wagner,  Ricono et  al.  2007). In  line  with  these  data 
reported,  HS  production  of  metanephric  mesenchymal  cells  appear  to  function  in 
differentiation and cell survival however, deficiency of pericytic HS results in apoptotic 
cell bodies. 
 
Embryonic  lethality  is  probably  connected  to  the  various  vascular  defects  observed 
resulting  in  microvascular  dysfunction  in  Ext1
MCko  embryos.  Despite  a  widespread 
function of PDGF-B signalling in PC recruitment, PDGFB/ PDGFR-β signalling has 
been demonstrated to specifically regulate cellular processes in various organs such as 
the  placental  vasculature.  Placenta  trophoblasts  express  PDGF-B  and  PDGFR-β 
(Goustin, Betsholtz et al. 1985) as well as HS (Chen, Liu et al. 2008). Pdgfb or Pdgfrb 
null  mice  show  a  reduction  in  trophoblast  numbers  (Ohlsson,  Falck  et  al.  1999), 
suggesting that the proliferation of these cells is under autocrine control. To further 
investigate  whether  Ext1
MCko  develop  placental  defects  we  analysed  the  placental 
vasculature  of  E17.5  embryos.  Macroscopically  blood  vessels  of  Ext1
MCko  appear 
normal (Figure 8.16 a-d) and visualization of microvessels by IF staining with PECAM-
1 did not show signs of vascular defects and dilation of vessels (e, f) as seen in Pdgfb 
null mice. Therefore, we concluded that MC HS production does not contribute to the 
formation of the placental vasculature.  
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Figure 8.16 Pericytic HS is not required for vessel formation in placental labyrinth 
Macroscopical examination of Ext1
MCko and control placenta at embryonic stage E17.5 
revealed no defects in vessel formation, density and morphology (a-d). Sectioning of the 
placenta and visualization of vessels in the placental labyrinth with PECAM-1 (e, f) 
showed normal vessel development in Ext1
MCko embryos.  
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8.2.4  Loss of MC HS results in reduced MC coverage in the skin  
Increased vessel permeability and regression can directly result from pericyte loss, both 
during development and in disease processes such as diabetic retinopathy (Hellström, 
Gerhardt  et  al.  2001);  (Enge,  Bjarnegard  et  al.  2002);  (Hammes,  Lin  et  al.  2002; 
Hammes, Lin et al. 2004). In order to address whether the regression of vessels and 
vascular dysmorphogenesis is caused by MC detachment/loss, we visualized MCs in 
skin samples using NG2. 
In control embryos MC are closely attached to the endothelium, covering almost the 
entire  vascular  network  (Figure  8.17  a-b).  In  Ext1
MCko  skin  samples  from  identical 
regions, however, MC coverage is clearly reduced, with many vessels lacking properly 
attached MCs (Figure 8.17 c-f). In addition to MCs in contact with the endothelium 
(arrows, Figure 8.17 d, f), NG2 antibodies labelled isolated cells situated in between 
vessels (arrowheads). In control samples, such cells are few and far between, and most 
of these appear spindle-shaped. In contrast, isolated NG2 positive cells in mutant tissues 
are much more abundant and conspicuously round. Such isolated NG2 positive cells 
could represent MCs progenitor cells not yet recruited to the vessels, or MCs that have 
detached. Detached MCs in the CNS of PDGF-B retention mutants or Ndst1-/- mice 
usually appear spindle-shaped or extend multiple processes, but do not appear round. 
TUNEL analysis and Caspase 3 detection does not label these cells, indicating that the 
rounded appearance is not associated with cell death. Whether these cells represent MC 
progenitor cells that fail to be recruited remains to be determined. 
We  further  noted  that  MCs  surrounding  the  cardinal  vein  at  E16.5  also  appear 
disorganized  and  more  rounded  in  Ext1
MCko  embryos,  loosing  the  neat  stratification 
observed in littermate controls (black arrows, Figure 8.17 g, h). Thus it is possible that 
MC that are not in direct cell-cell contact with endothelial cells require cell autonomous 
HS production for proper polarization, recruitment and organization.   
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Figure 8.17 Recruitment and attachment of HS deficient MCs in embryonic skin 
Mural cells of the skin vasculature were visualized with NG2 (green, a-f) in E13.5 
control (a, b) and Ext1
MCko embryos (c-f). Blood vessels in the mutant display a reduced 
number of MC in the vascular plexus (c) compared to the control (a). White arrows 
indicate MCs that attach to the vessel and are in close contact to the endothelium (red; 
d, f) as seen similarly in the control (b). However, Ext1
MCko vessels are dominated by 
rounded NG2 positive cells in close proximity to the vessel (arrowhead; d, e) indicating 
progenitors cells that fail to differentiate. Embryonic transverse section (g, h) confirm 
presence of MC, however MC organization is chaotic (h, black arrows) compared to the 
tight alignment of MC in control cardinal vein (g).  
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To gain further insights in PC attachment and vessel morphology we analysed  skin 
sections of Ext1
MCko using transmission electron microscopy. Applying this technique 
allows us to  study EC morphology and EC-EC as well as EC-PC junction in great 
detail.  
Blood vessels in the control skin of E13.5 embryos formed a monolayer of endothelial 
cells with close cell-cell contacts (black arrows, Figure 8.18 a-b). Pericytes and their 
protrusion align in close proximity to the endothelium and BM is formed. Analyses of 
the mutant vasculature revealed diverse vessel morphology. Sections of blood vessels 
could be seen that resemble those found in the vasculature of control littermates (c). 
However, some blood vessels formed a lumen enclosed by ECs and with PCs attached 
that appear apoptotic (Figure 8.18 d, PC). On the other hand, vessels can be observed 
that  have  a  highly  abnormal  EC  shape  with  long  thin  protrusion  (Figure  8.18  e, 
arrowheads). These abnormalities may explain the defect in lumen and vessel diameter 
control that is associated with fluctuations in the thickness of the ECs. Also, defects in 
endothelial cell alignment may lead to leakiness of the vessels and hemorrhages occur 
as indicated by the erythrocytes in the tissue (asterisk, f). 
 
To study cell-autonomous function of mural cells lacking HS production we 
aimed to isolate primary MCs. However, the early embryonic lethality does not allow 
me  to  extract  MCs  from  whole  Ext1
MCko  embryos.  Therefore,  we  isolated  vascular 
smooth  muscle  cells  (vSMC)  from  adult  aorta  of  Ext1  flox/  flox  mice  and  applied 
retroviral transfection of a Cre plasmid to mediate loxP site excision. Figure 8.19 shows 
primary  vSMC  from  the  aorta,  identified  by  IF  staining  with  MC  markers  smooth 
muscle  actin  (SMA)  and  PDGFR-β  (Figure  8.19  a-c).  Although  the  Cre-plasmid 
contained a fluorescent marker GFP that should be visible upon successful transfection, 
I failed to detect GFP positive MC cells. In addition, primary vSMCs did not proliferate 
and cell number was limited to successfully infect cells.  
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Figure 8.18 Electron microscopic analyses of vessel morphology in the skin 
Vessel morphology and pericyte attachment was analysed in E13.5 Ext1
MCko and control 
embryos by electron microscopy. Vessels of the control skin vasculature form a 
monolayer of endothelial cells (EC) with tight cell -cell contacts (b, black arrows). 
Pericytes (P) align closely to the endothelium (a, b).  
Images c-f represent vessel profiles observed in Ext1
MCko skin vasculature. Vessels 
resembling the morphology of control vessels were detected (c). However, we also 
noticed blood vessels with pericytes attached, which seem apoptotic (d, indicated by 
PC). Furthermore, we observed vessels with strikingly abnormal EC shape (e, f). 
Arrowheads point out long thin protrusion formed between the ECs. The asterisk 
illustrates an erythrocyte outside the blood vessel, indicating leaky vessels that might 
result in hemorrhages (f).  
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Figure  8.19  Characterization  and  morphological  analysis  of  primary  smooth 
muscle cells isolated from dorsal aorta 
Vascular smooth muscle cells (vSMC) were isolated from the aorta of Ext1 floxed mice. 
After culturing cells for 13 days, cells were analysed by immunostaining for SMC 
markers smooth muscle actin (SMA, red, a-c) and PDGFR-b (green, a). Counterstaining 
with DAPI revealed presence of non-SMC (c) deficient in SMA.  
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8.2.5  PDGF-B and TGF-β signalling defects in mice lacking MC HS 
To gain a better understanding of potential signalling pathways affected by MC HS 
depletion, we analysed RNA and protein expression and activation of growth factor 
receptors as well as downstream signalling molecules of signalling pathways that have 
been  described  in  previous  studies  to  be  dependent  on  HS-mediated  binding  and 
interaction.  
After RNA isolation of embryonic skin samples of Ext1
MCko and control embryos we 
performed  quantitative  real  time  PCR  in  order  to  access  whether  loss  of  MC  HS 
production disturbs expression of relevant HS dependent growth factors and receptors. 
However, analysis of Pdgfb, Vegfa and their receptors Pdgfrb, Vegfr2 did not reveal any 
differential gene expression and data obtained were extremely various between control 
and  Ext1
MCko  mice.  Possibly,  the  fluctuations  reflect  the  variation  in  degree  of  the 
phenotype but also the fact that MC numbers are comparably small in embryonic skin 
samples. Ideally, laser capturing of MC followed by single cell qRT-PCR would shed 
light in differential gene expression of Ext1
MCko and control samples. 
 
To  determine  protein  expression  levels  and  phosphorylation  events,  we  dissected 
samples of embryonic back skin for protein analysis. 
Phosphorylation of PDGFR-β is profoundly reduced in various Ext1
MCko skin, consistent 
with the observed reduction in MC coverage. Phospho-ERK1/2 and phospho-SHP-2, 
which  relay  signalling  downstream  of  PDGFR−β  are  consistently  reduced,  while  p-
AKT signalling is unaffected (Figure 8.20 a). The graph summarizes the reduction of p-
PDGFR-β in  the  skin  but  reveal  no  significant  defects  in  p-PDGFR-β  and  its 
downstream  targets  in  protein  samples  of  the  CNS.  Thus,  the  biochemical  data  are 
consistent with the observed phenotype in the skin and with the lack of a MC phenotype 
in the CNS. 
Jakobsson and colleagues previously showed ex vivo that MC HS is sufficient to induce 
vessel formation and to support VEGF signalling during sprouting angiogenesis in 3D-
cultures  of  embryoid  bodies  (Jakobsson,  Kreuger  et  al.  2006).  We  therefore 
hypothesized that VEGF signalling might be affected upon deletion of pericytic HS in 
vivo, possibly leading to the observed alteration in sprouting and regression. However, 
immunoprecipitation of VEGFR2 using total embryonic tissue followed by detection 
with  a  phospho-VEGFR2  antibody  reveal  no  significant  differences  in  VEGFR2  
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phosphorylation  levels  in  Ext1
MCko  compared  to  control  littermates  (Figure  8.20  c). 
Overall  VEGFR2  levels  are  also  comparable  in  several  embryos  (Figure  8.20  b), 
together illustrating that MC HS might not be required for VEGF signalling during 
vessel development in vivo. Matsumoto and colleagues showed differential patterns of 
VEGFR2 phosphorylation within developing blood vessels in mouse embryoid bodies 
(Matsumoto,  Bohman  et  al.  2005).  Interestingly,  more  developed  patent  vessels 
associated with mural cells displayed different patterns of VEGFR2 phosphorylation 
than endothelial cells lining immature blood vessels. 
Therefore, we used a phospho-specific antibody that detects Y951 phosphorylation that 
has been shown to be phosphorylated upon contact with mural cells. However, we could 
not detect any differences in Y951 phosphorylation in Ext1
MCko embryos (Figure 8.20 
d). Although VEGFR2 Y951 phosphorylation levels are similar in Ext1
MCko and control 
embryos, visual analysis of the blot (d) might suggest a decrease in total  VEGFR2 
protein expression levels in Ext1
MCko embryos. Decrease in overall VEGFR2- but equal 
Y951  phosphorylation  levels  therefore,  might  reflect  an  increase  in  activated  Y951 
VEGFR2 upon loss of MC HS.  
Thus, one could imagine that pericytic HS functions as a co-receptor in trans, activating 
VEGFR2 signaling in endothelial cells that are in contact with MCs.  
These speculations are based on preliminary data and further experiments are required 
to  elucidate  a  role  of  MC  HS  in  VEGFR2  phosphorylation.  In  addition,  combined 
analyses of VEGFR2 expression levels (b), and phospho VEGFR2 expression levels in 
Ext1
MCko  and  control  embryos  would  argue  that  pericytic  HS  does  not  function  in 
VEGFR2 activation as expression is not consistently altered in samples analyzed.  
 
Other HS-dependent signalling pathways involved in vascular development and MC 
recruitment  include  the  TGF-β  pathway,  involving  TGF-β,  TGFIIR,  Alk1/Alk5,  the 
auxiliary receptor endoglin and the downstream effectors SMAD1, 2, 3 and SMAD5 
(Belenkaya, Han et al. 2004); (Chen, Sivakumar et al. 2007); (Eickelberg, Centrella et 
al. 2002); (Rider 2006).  
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Figure 8.20 Molecular mechanism and signalling defects in mice lacking pericytic 
HS 
Phospho-PDGFR-β protein expression levels as well as downstream signalling 
molecules p-ERK1/ 2 and p-SHP-2 were analysed by Western Blotting (a). Ext1
MCko 
littermates (a) display reduced levels of pPDGFR-β and pERK in skin samples, while p-
AKT signalling is unaffected (a). Comparison of pPDGFR-β levels in skin and CNS of 
Ext1
MCKO confirmed that PDGFR-β signalling is unchanged in the CNS of Ext1
MCKO 
mice (a). 
VEGFR2 expression levels (b) in the skin of MCs deficient in HS are similar in 
comparison to control littermates (Ext1
MCko and control). Immunoprecipitation of 
VEGFR2 in embryonic skin samples and subsequent detection of phosphorylated 
VEGFR2 (c) revealed no differences in pVEGFR2, indicating no defects in VEGFR2 
signalling and activation. 
Using an antibody directed against VEGFR2 phosphorylation, Y951 (d) we analysed a 
specific phosphorylation site that has been described to be activated upon MC 
attachment. No differences in expression levels were found in Ext1
MCko and control 
embryos.  
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TGF-β is involved in local induction of MC from progenitor cells of the mesenchymal 
cell  lineage  as  well  in  differentiation  and  proliferation  of  ECs  and  MCs  (Hirschi, 
Rohovsky et al. 1998; Hirschi, Burt et al. 2003) . Protein analysis of the embryonic skin 
vasculature reveals reduced SMAD2/3 (data not shown) expression as well as reduced 
phosphorylation of SMAD2, SMAD3 (Figure 8.21 a) and SMAD1 (data not shown). 
Similar  to the  tissue  specific  deficiency  in  phosphorylation  of PDGFR-β,  pSMAD3 
levels are reduced in the skin, but not in the brain of Ext1
MCko embryos (Figure 8.21 b). 
Control littermates show comparable pSMAD3 levels in skin and brain.  
To confirm these findings at the cellular level, we visualized phosphorylated SMAD3 in 
the dermal vasculature of embryos. Immunohistochemistry staining reveals that most 
endothelial as well as perivascular cells express pSMAD3 in control embryos (Figure 
8.21 c, d). In contrast, endothelial cells lining the blood vessels (indicated by asterisk) 
of Ext1
MCko embryos frequently lacked pSMAD3 expression (arrows, Fig.3.21 e, f). Co-
labelling with endomucin to visualize ECs confirmed the specificity of ECs lacking 
pSMAD3 expression indicating that MC HS plays a role in TGF-β signalling between 
MCs and the endothelium (Figure 8.21 g-j).  
Loss  of  endothelial  SMAD4  results  in  defective  vascular  integrity  and  impaired 
vascular smooth muscle cell development. The  failure of patent vessel formation is 
accompanied by a decreased expression of gap junction molecule, connexin 43 (Lan, 
Liu et al. 2007). To analyse whether loss of pericytic HS results in decreased SMAD4 
and  connexin  expression  that  could  account  for  the  reduced  mural  cell  coverage  in 
Ext1
MCko embryos we analysed SMAD4/ connexin 43 by Western Blot. Surprisingly, we 
did not observe differences in protein expression levels of either when comparing to 
control  littermates  (Figure  8.21  i).  Thus,  we  conclude  that  SMAD2/3  signalling  is 
specifically disturbed upon loss of HS production in mural cells. 
Although TGF-β signalling appears specifically reduced in skin samples of Ext1
MCko it 
is not fully clear whether TGF-β signalling is decreased as a consequence of MC loss or 
whether diminished TGF-β signalling causes the failure of MC recruitment in the skin 
vasculature of Ext1
MCko To further characterize we compared TGF-β signalling to skin 
and brain samples from Pdgfrb -/- embryos lacking MC investment (Figure 8.21 a, b). 
As described previously pSMAD2/ pSMAD3 signalling is reduced in skin but not brain 
samples  of  Ext1
MCko  correlating  with  MC  loss.  In  contrast,  Pdgrfb  embryos  show 
diminished signalling in brain but no significant decrease in pSMAD2 and pSMAD3 
expression in the skin (a, b). Since PC investment in the CNS is dependent on PDGF-B  
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mediated  PC  migration  we  concluded  that  the  loss  of  MC  causes  reduced  TGF-β 
signalling rather than TGF-β signalling causes MC dissociation from the CNS. 
 
 
 
Figure 8.21 Loss of pericytic HS production results in reduced TGF-β signalling 
Expression studies of pSMAD2 and pSMAD3 molecules by Western Blotting, 
downstream effectors of the TGF-β pathway revealed a significant down regulation in 
Ext1
MCko embryos (a). The reduction in pSMADs is restricted to Ext1
MCko skin samples  
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while pSMAD levels in the CNS of mice lacking HS in MCs are unchanged when 
compared to control littermates (a). To access whether reduced TGF-b signalling is a 
result of MC loss in the skin of Ext1
MCko embryos, we analysed TGF-b signalling in 
Pdgfrb null mice lacking MC investment (a). Graphs in (b) summarize densiometric 
analyses illustrating the expression levels of pSMAD2 and pSMAD3 normalized to β-
tubulin, internal loading control. *, p < 0.05. Ext1
MCko and control embryos n = 4, 
Pdgfrβ +/- and Pdgfrβ -/- n=2. Values represent mean ± S.E.M.  
Loss of TGF-b signalling could be confirmed by IHC staining with a pSMAD3 
antibody on embryonic skin sections (c-j). While most endothelial cells of blood vessels 
in control mice are stained positively for pSMAD3 (arrows; c, d, g, h) endothelial cells 
in Ext1
MCko lost pSMAD3 expression (arrows; e, f, i, j). Counterstaining with 
endothelial marker endomucin (red) confirmed endothelial specific loss of pSMAD3 
(green) in EXT1
MCko embryos (arrows; i, j). n>3 
Investigation of SMAD4 and connexin43 expression levels, implicated in vessel 
integrity and SMC association are not significantly regulated in Ext1
MCko skin samples 
(k)  
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8.3  Discussion 
The present study underscores the fundamental  importance of HS in tissue biology. 
Selective deletion of all HS in MC is incompatible with embryonic survival due to an 
important role of MC HS during the late stages of vascular morphogenesis and stability. 
 ECs  and  pericytes  share  a  basement  membrane,  and  both  cell  types  potentially 
contribute  to  the  establishment  thereof  by  production  of  various  ECM  proteins 
including  HSPGs.  The  vascular  basement  membrane  at  the  interface  between 
endothelial cells and mural cells is rich in N-sulfated HS. Reduced N-sulfation impairs 
PDGF-B binding and PDGFR-β signalling, leading to delayed pericyte recruitment and 
increased detachment (Abramsson, Kurup et al. 2007); (Kurup, Abramsson et al. 2006). 
Complete loss of N-sulfated HS in vascular structures growing from embryoid bodies ex 
vivo  illustrated  that  VEGFR  signalling  requires  HS  as  co-receptor  during  vascular 
morphogenesis.  In  the  absence  of  endothelial  HS,  MC  derived  N-sulfated  HS  is 
sufficient to support VEGFR signalling, illustrating that HS and VEGFR can interact in 
trans during this process (Jakobsson, Kreuger et al. 2006). 
Our genetic approach to generate Ext1
MCko embryos effectively depleted HS from MCs 
during vascular development. Major vascular defects associated with MC deficiencies 
occur  in  Ext1
MCko  embryos  selectively  outside  of  the  CNS,  most  notably  along  the 
embryonic  back  skin  at  stages  after  E12.5.  Edema  and  swelling,  as  well  as 
haemorrhaging indicate profound vascular dysfunctions as a result of HS deficiency. 
Histological sections confirm edema formation in spite of abundant lymphatic vessel 
development. Central lymphatic development including segregation of jugular lymph 
sacs from the vein appear unaffected, suggesting that the edema is a result of increased 
vascular permeability and not of defective lymphangiogenesis. 
Wholemount analysis of Ext1
MCko skin samples at E13.5 and later illustrates increased 
vascular diameter irregularities and frequent regression profiles, as well as excessive 
sprouting. These abnormalities are similar to those caused by MC deficiencies in Pdgfb 
or Pdgfrb knockouts. MC attachment reduces vessel regression; vessels associated with 
MC undergo less regression upon hypoxia in retinas or VEGF withdraw in tumours. We 
observed increased regression profiles in the skin vasculature coinciding with reduced 
MC coverage. 
 Pericyte/MC detection by NG2 staining confirms a profound reduction in MC coverage 
in the affected vascular plexus areas. At the same time, conspicuously rounded NG2  
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positive cells are found in close proximity to many skin vessels. We speculate that the 
concomitant appearance of these cells and the apparent loss of pericytes may signify a 
defect in recruitment of local progenitor cells. LeJan and Kreuger observed a strikingly 
similar  rounded  pericyte  phenotype  in  embryoid  bodies  deficient  in  Ext1  (personal 
communication; manuscript submitted) suggesting the HS may be cell-autonomously 
required for local induction and/or polarization and spreading of MC progenitor cells. In 
line with this idea, we observed defective alignment of HS deficient MCs around the 
cardinal vein in Ext1
MCko embryos. 
Several studies have highlighted the roles for Syndecan-1, a transmembrane HSPG in 
cell spreading, actin bundling and cell migration (Chakravarti, Sapountzi et al. 2005). 
Also, epithelial cell polarization in organotypic cultures is mediated by Laminin and 
HSPG interaction. Isolated NG2 positive cells were also found in the skin of Pdgfrb
-/- 
embryos  (data  not  shown),  again  correlating  with  a  severe  loss  of  MC  on  vascular 
profiles.  Protein  lysates  from  Ext1
MCko  and  control  skin  samples  revealed  a  strong 
reduction  in  PDGFR-β  activation,  including  loss  of  SHP2  and  ERK1/2  activation. 
Similar to the results obtained in Ndst1-/- MEFs, AKT activation was not affected. Thus 
unlike brain pericytes, pericytes in the periphery require HS production for effective 
PDGFR-β signalling and recruitment to the vessel wall. The differential requirement of 
HS  could  be  related  to  different  modes  of  recruitment.  Longitudinal  recruitment  of 
pericytes during angiogenic sprouting in the CNS relies on migration and proliferation 
of pericytes along the ablumenal endothelial surface (reviewed in (Armulik, Abramsson 
et al. 2005)). This process depends on HS mediated PDGF-B retention close to the 
endothelial surface (Abramsson, Kurup et al. 2007); (Kurup, Abramsson et al. 2006). 
Arguably, endothelial HS production and deposition in the endothelial BM would be 
ideally suited to control PDGF-B retention and function as co-receptor for pericytic 
PDGFR-β activation in trans. In contrast, MC progenitor cells that reside at a distance 
from the vessel may cell autonomously require HS on the cell surface for activation in 
cis. Recruitment of MC to vessels in the skin involves induction of new progenitor cells 
from mesenchymal lineages (reviewed in (von Tell, Armulik et al. 2006)). Thus, the 
spatial relationship between signal sending cell (the endothelium) and signal receiving 
cell (the MC), are very different during longitudinal recruitment in the CNS and local 
progenitor induction in the periphery (see Error! Reference source not found.). In the 
former case, migration will occur along a HS-rich basement membrane even when MCs 
themselves  do  not  produce  HS.  In  the  latter,  however,  recruitment  will  require 
polarization towards the signal, and migration over variable distances and the attractive  
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signal may require transport or diffusion across several neighbouring cells. It is possible 
that  this  particular  spatial  constellation  requires  cell-autonomous  HS  production  by 
MCs or their progenitors. An alterative explanation could be that CNS MCs require 
fundamentally different signals than peripheral MCs, possibly because they derive from 
distinct lineages. Indeed, lineage-tracing studies indicated that MCs in the brain derive 
from neural crest, whereas MC in the periphery are of mesodermal origin (Etchevers, 
Vincent et al. 2001). However it seems unlikely that PDGFR-β signalling differentially 
relies on HS in neural crest versus mesenchymal cell populations. Rather, the proximity 
to normal endothelial basement membrane, and the juxtacrine versus paracrine spatial 
configuration represent a more plausible explanation for the observed differences.  
Ex vivo studies using endothelial and 10T1/2 cell co-cultures illustrated that, in addition 
to PDGF-B/PDGFR-β signalling, TGFβ signalling is involved in pericyte recruitment 
and differentiation (Sato, Tsuboi et al. 1990); (Hirschi, Rohovsky et al. 1998; Hirschi, 
Burt  et  al.  2003).  Defective  vascular  development  associated  with  reduced  MC 
recruitment  and  impaired  vessel  stability  is  observed  in  mouse  mutants  of TGFRII, 
Alk1, Alk5, endoglin and SMAD1/5 (reviewed in (Goumans and Mummery 2000)). 
Similar  defects  are  observed  in  patients  suffering  from  hereditary  telangiectasia,  a 
genetic  disease  associated  with  loss-of  function  mutations  in  TGF-β  pathway 
components (reviewed in (Fernandez, Sanz-Rodriguez et al. 2006)). TGF-β is expressed 
by  both  ECs  and  MCs  and  reciprocal  signalling  regulates  MC  induction  from 
mesenchymal progenitors and various endothelial cell functions including expression of 
stabilizing  matrix  components,  cell  proliferation  and  differentiation.  The  observed 
profound  reduction  in  SMAD1,  2  and  3  phosphorylation  in  western  blots  of  skin 
samples,  and  in  endothelial  cells  identified  on  skin  sections,  indicates  that  indeed 
endothelial TGF-β signalling is defective in the absence of MC HS. In contrast, brain 
samples from the same embryos show no defects in SMAD phosphorylation. Thus, the 
loss of HS impairs both TGF-β and PDGFR-β signalling selectively in the skin, but not 
in the brain. 
In addition to the direct binding of TGF-β dimers to HS, recent work illustrated that HS 
can  play  an  important  role  in  linking  the  latent  TGF-β  binding  protein  LTBP1  to 
fibronectin, providing a mechanism for TGF-β storage in the ECM (Chen, Sivakumar et 
al. 2007). In drosophila wing patterning, a process regulated by gradients of the TGF-β 
family  protein  Dpp,  HS  proved  essential  for  gradient  formation  by  facilitating 
extracellular transport of Dpp across the epithelial cells (Han, Belenkaya et al. 2004).  
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Thus,  HS  could  be  important  for  the  availability,  potential  gradient  formation  and 
activity  of  TGF-β  during  the  induction  and  recruitment  of  MC  from  mesenchymal 
progenitors. In line with these observations, Forsten-Williams and colleagues further 
elaborate  the  control  of  growth  factor  networks  by  HSPG  using  experimental  and 
computer simulation models (Forsten-Williams, Chu et al. 2008). Further TGF-β and 
HSPG  modulate  vSMC  growth  and  migration.  Tran  and  colleagues  suggested  that 
HSPG perlecan contributes to SMC growth control both in vitro and during intimal 
hyperplasia, possibly by sequestering heparin-binding mitogens such as FGF-2 (Tran, 
Tran-Lundmark et al. 2004). 
 Finally, the recent observation that TGF-β induces actin reorganization mediated by 
SMAD2  and  -3  by  activating  Rho-GTPases  (Vardouli,  Vasilaki  et  al.  2008)  could 
potentially  explain  the  rounded  appearance  of  NG2  positive  cells  residing  in  the 
mesenchyme, as well as changes in endothelial cell responses. Studies from the blood 
brain barrier (BBB) revealed that the expression of HSPG agrin correlates with cell 
polarization  of  astrocytes  and  is  important  for  BBB  integrity  (reviewed  in  (Abbott, 
Ronnback et al. 2006)). One could speculate that HS also controls polarization and 
directed migration of MC progenitors towards the blood vessel. 
8.3.1  Future perspective 
The  data  presented  in  this  chapter  demonstrate  a  vital  role  for  pericytic  HS  during 
embryonic  development.  The  phenotyical  analyses  of  mice  lacking  pericytic  HS 
production are still incomplete. So far, no Ext1
MCko mice are born though the cause of 
death remains unclear. Recent findings indicate a function for PDGF-B/PDGFR-β in 
epicardial  development.  Loss  of  PDGF-B  ligand  or  its  receptor  results  in  muscular 
ventricular septal defects, maldevelopment of the atrioventricular cushions and valves, 
impaired coronary arteriogenesis, and hypoplasia of the myocardium and cardiac nerves 
(Van den Akker, Winkel et al. 2008). Although initial analyses of coronary vessels and 
macroscopical  observation  of  the  heart  in  mice  lacking  pericytic  HS  revealed  no 
apparent defects, a detailed study of the ventrical and septa might be of interest. 
 
Mice lacking pericytic HS accumulate rounded NG2 positive cells in the peripheral 
vasculature. Crossing ROSA26 eYFP mice with Ext1
MCko mice would allows us to detect 
GFP  positive  pericytes  that  lack  HS.  Using  embryonic  cultures  and  live-imaging 
techniques, it would be interesting to monitor GFP expressing HS negative pericytes  
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and study their migration, directed movement and polarization in vivo. Applying this 
method, we would be able to follow the dynamics and study pericyte induction in vivo. 
 
Isolating mural cells from the CNS and the peripheral skin would complete our studies. 
One could test differential signalling pathways that are involved in the skin but not in 
the  CNS  (e.g.  TGF-β)  and  vice  versa.  Further,  that  would  allow  us  to  study  cell-
autonomous  function  in  vitro,  e.g.  whether  pericytic  HS  is  required  for  TGF-  β 
dependent  proliferation  or  directed  migration  using  gradient  chambers.  One  could 
further  analyse  gene  expression  of  MCs  lacking  HS.  It  would  be  of  interest  to 
investigate the function of pericytic HS in the induction of pericytes from progenitor 
cell and the induction of MC specific genes such as SM22α, SMA and desmin (Xie, 
Fang et al. 2008); (Han, Dong et al. 2009); (Ding, Darland et al. 2004). 
 
After  addressing  the  function  of  pericytic  HS  in  MC  recruitment  during  embryonic 
development, it would be interesting to understand the role of endothelial HS in this 
process. Since mice lacking PDGF-B retention motif and mice deficient in N-sulfation 
display defects in pericyte migration and association to the vessel, one would speculate 
that endothelial HS is required for MC recruitment in the CNS. 
8.3.2  Summary 
In conclusion, the present work provides evidence for a differential involvement of cell 
autonomous  HS  production  in  activating  PDGFR-β  and  TGF-β  signalling  during 
pericyte recruitment in the CNS and in the periphery (Figure 8.22). Our results also 
suggest that the involvement of HS in receptor activation acting in cis or in trans may 
be  context  dependent  and  will  arguably  be  affected  by  the  distance  between  signal 
sending and receiving cell. For pericyte/mural cell biology, the current findings advance 
our  understanding  of  selective  cellular  interactions  during  recruitment  and  of  the 
importance of mural cell-derived heparan sulfate proteoglycans for functional vascular 
patterning.  
  233 
 
 
Figure 8.22 Proposed model of MC recruitment and induction in skin and brain 
Production of pericytic HS is dispensable during MC recruitment in the CNS but is 
required for the local induction and possibly polarization and migration of MC 
progenitors in the peripheral vasculature.  
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9  Conclusion 
The  work  presented  in  this  thesis  addressed  the  function  of  ECM  molecules  during 
developmental angiogenesis. I studied the expression and localization of several matrix 
components in the mouse retina. Further, I demonstrated how distinct matrix molecules 
shape and influence endothelial cell behaviour. 
 
During the last decade, the scientific community studying the process of angiogenesis- the 
formation  of  new  blood  vessels-  almost  exclusively  focused  on  finding  pro-and  anti-
angiogenic  inhibitors.  The  field  experienced  major  insight  in  the  function  of  vascular 
endothelial growth factor (VEGF) and its receptors during developmental and pathological 
angiogenesis.  At  the  present  time,  multiple  drugs  with  anti-angiogenic  activity  are  in 
clinical trials. In 2004, the Food and Drug administration (FDA) approved Bevacizumab 
(Avastin), a monoclonal antibody against VEGF-A for the treatment of cancer and several 
anti-angiogenic drugs e.g. targeting VEGFR2 are approved and will follow (reviewed in 
(Folkman 2007)). However, most drugs did not display the anticipated and desired outcome 
in mice transplanted with tumours, possibly due to compensatory effects by other growth 
factors and resistance to the drug. 
Further  in  this  field,  many  laboratories  including  ours  focused  their  research  on 
understanding the role of Dll4/Notch signalling in regulating angiogenic sprouting. The 
signalling pathway is upregulated in many tumours and disruption of Dll4/ Notch signalling 
results in excessive sprouting and vessel formation. Endothelial cells that are exposed to an 
angiogenic  stimulus,  induce  Dll4  expression  and  signal  to  the  adjacent  cells  to  restrict 
sprouting. 
Virtually all these studies exclusively concentrated on cellular and molecular mechanisms 
between endothelial cells in the formation of new vascular sprouts but lack information on 
the extracellular microenvironment. 
 
Already in the early 1980, Mina Bissell, a pioneer in the extracellular matrix field proposed 
that  extracellular  matrix  molecules  direct  gene  expression.  Her  radical  idea  that  the 
surrounding of a cancer cell is just as important in shaping its behaviour as the genes inside 
it, has long been ignored.  
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The extracellular matrix often considered as a passive scaffold for cells, is now widely 
recognized as an important source of signals that regulate the changes in gene expression, 
cell division, survival, shape and movement that control tumour progression. Mina Bissell 
and her lab demonstrated over the last decades that normal cell behaviour can be induced 
when cancerous cells are placed in 3D microenvironment. Her studies indicate that the 
extracellular matrix and its receptors dictate the phenotype of mammary epithelial cells, 
and thus in this model system the tissue phenotype is dominant over the cellular genotype 
(Weaver, Petersen et al. 1997). 
In accordance with the finings that ECM molecules direct cell behaviour, Maniotis and 
colleagues  described  matrix-embedded  channels  devoid  of  endothelial  cells  in  human 
tumours, referred to as vasculogenic mimicry (Maniotis, Folberg et al. 1999). Tumour cells 
may therefore, generate vascular channels that facilitate tumour perfusion independent of 
tumour  angiogenesis.  Because  the  microcirculation  of  many  tumours  may  be 
heterogeneous,  including  incorporated  or  co-opted  vessels,  angiogenic  vessels,  mosaic 
vessels, and vasculogenic mimicry of the tubular and patterned matrix types, therapeutic 
regimens that target angiogenesis alone may be ineffective against highly invasive tumours 
that contain patterned matrices (Folberg and Maniotis 2004).  
Tumour  blood  vessel  morphology  is  dramatically  altered  compared  to  the  normal 
vasculature. Pre-existing vessels come in contact with tumour cells, releasing a series of 
factors altering the basement membranes and the intrinsic properties of endothelial cell 
lining. Defective and architectural abnormal tumour vessels feature reduced blood flow and 
hyperpermeability, leading to plasma protein leakage and the basis for perivascular tumour 
matrix alteration (Del Rosso, Fibbi et al. 2002); (Chiarug, Ruggiero et al. 2002). In turn, 
these matrix alterations likely influence tumour cells as well as endothelial and smooth 
muscle  cells  of  the  tumour  vasculature  by  modulating  cell  morphology  and  invasive, 
migratory behaviour. 
Cells  can  sense  physical  forces  such  as  stretch  through  adhesions  to  the  extracellular 
matrix. Several investigators have demonstrated that cell–ECM adhesions are critical in the 
transduction  of  mechanical  stretch  into  biochemical  signals,  e.g.  stretch  induces 
proliferation in cells attached to different ECM proteins by activating integrins (Wilson, 
Sudhir et al. 1995); (Katsumi, Naoe et al. 2005). In addition, matrix stiffness, i.e. the degree 
to which the surrounding adhesive scaffold resists deformation plays a role in endothelial 
cell behaviour and biological outcome. Chen and colleagues propose that matrix stiffness  
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influences growth factor mediated endothelial cell responses. Endothelial cells require cell– 
cell  contact  and  vascular  endothelial  cadherin  engagement  to  transduce  stretch  into 
proliferative signals. Both, endothelial and smooth muscle cells exhibited an increase in 
proliferation in response to stretch but using distinct mechanisms (Liu, Nelson et al. 2007), 
suggesting that elasticity of matrix modulates cellular behaviour and needs to be taken into 
account when targeting EC proliferation by anti-angiogenic drugs such as Bevacizumab 
(Avastin) inhibiting EC proliferation. 
 
Taken  together,  the  extracellular  matrix  provides  essential  cues  for  physiological  and 
pathological  angiogenesis.  My  own  studies  highlight  that  distinct  matrix  molecules 
modulate  endothelial  behaviour  in  very  different  ways  by  regulating  essential  cellular 
mechanism. 
Fibronectin influences endothelial cell migration by modulating the availability of growth 
factor, VEGF. Laminin a4 modulates Dll4/ Notch signalling and thereby, restricts excessive 
vascular  sprouting.  And  heparan  sulfate  expressed  by  mural  cells,  cell-autonomously 
controls the local induction of mural cells to peripheral blood vessels. 
 
- Life emerged, I suggest, not simple, but complex and whole, and has remained complex 
and whole ever since—not because of a mysterious élan vital, but thanks to the simple, 
profound transformation of dead molecules into an organization by which each molecule's 
formation is catalyzed by some other molecule in the organization. The secret of life, the 
wellspring of reproduction, is not to be found in the beauty of Watson-Crick pairing, but in 
the achievement of collective catalytic closure. So, in another sense, life—complex, whole, 
emergent—is simple after all, a natural outgrowth of the world in which we live. - 
Stuart Kaufman 
(At Home in the Universe, Oxford University Press, 1995, pp 47-48)  
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